‫תשע"ב‬/'‫ג‬

12/2011

‫ג' בטבת התשע"ב‬

December 29 ,2011

‫יומן הפטנטים והמדגמים‬

PATENTS AND DESIGNS JOURNAL
Page/‫עמוד‬
Patents
Applications filed
Applications accepted
Patents granted
Patents renewed
Patents not in force
Patents renewed for 20 years
Country codes
Indices of applications accepted
Designs
Designs registered
Designs canceled

1

4
149
416
416
416
419
465
455
437
453

‫פטנטים‬
‫בקשות שהוגשו‬
‫בקשות שקובלו‬
‫פטנטים שניתנו‬
‫פטנטים שחודשו‬
‫פטנטים שתוקפם פקע‬
‫פטנטים שחודשו לעשרים שנה‬
‫קודים למדינות‬
‫מפתחות לבקשות שהתקבלו‬
‫מדגמים‬
‫מדגמים שנרשמו‬
‫מדגמים שבוטלו‬

December 29, 2011-‫ג' בטבת התשע"ב‬

‫ידיעות כלליות‬
:‫ וכו' בענייני פטנטים ומדגמים יש לשלוח אל‬,‫ מסמכים‬,‫מכתבים‬
.‫ ירושלים‬,‫ מלחה‬5 ‫ בנין‬,‫ גנים טכנולוגיים ירושלים‬,‫רשם הפטנטים והמדגמים‬
'‫אגרות ללשכת הפטנטים מתקבלות אך ורק על ידי תשלום לחשבון הרשות בבנק הדואר מס‬
‫ יש להציג קבלת בנק הדואר ללשכה יחד עם הבקשה לפעולה שעבורה האגרה‬. 0-24145-2
.‫שולמה‬

GENERAL INFORMATION
Letters, documents, etc. concerning Patents and Designs should be addressed to:
The Patent Authority, Jerusalem Technology Park, Building5, Malcha., Jerusalem.
Fees to the Patent Office can be accepted only by payment to the Postal Bank Account of the
Authority, No. 0-24145-2. The receipt of the Postal Bank must be presented to the office
together with the application for the action for which the fee has been paid.

Copyright by the State of Israel. No
Extracts may be published except with the
permission of the Patent Office.

2

‫זכות היוצרים בתקצירים אלה שמורה למדינת‬
‫ אין להעתיק מתקצירים אלה אלא‬,‫ישראל‬
.‫ברשות לשכת הפטנטים‬

December 29, 2011-‫ג' בטבת התשע"ב‬

PATENTS
NOTICE UNDER SECTION 16 OF THE
PATENTS LAW, 5727-1967
In the following there are listed new
applications complying with the provisions
of rule 32(a) of the Patent Regulations, 57281968:
Particulars of the applications are given in
the following order:
Number and date of application and the first
four symbols of the International
Classification.
Title of invention (as proposed by applicant)
Applicant
Priority right:
Convention countryNumber and date of
Foreign application
International Application Number
International Publication Number

3

‫פטנטים‬
-‫ תשכ"ז‬,‫ לחוק הפטנטים‬16 ‫הודעה לפי סעיף‬
1967
‫להלן רשימת בקשות חדשות הממלאות אחר‬
‫(א) לתקנות‬32 ‫הדרישות שנקבעו בתקנה‬
:1968-‫ תשכ"ח‬,‫הפטנטים‬
:‫פרטי הבקשות מובאים לפי סדר זה‬
‫מספר הבקשה – ותאריך הגשתה וארבעה‬
‫הסמנים הראשונים של הסיווג הבינלאומי‬
)‫שם האמצאה (כפי שהוצע ע"י המבקש‬
‫המבקש‬
– ‫מדינת האיגוד‬
:‫דין קדימה‬
‫תאריך ומספר‬
‫בקשת החוץ‬
‫מספר בקשה בינלאומית‬
‫מספר פרסום בינלאומי‬

December 29, 2011-‫ג' בטבת התשע"ב‬

01//4/0/22

‫יחידה אנרגטית המבוססת על גשר מוליך‬
‫למחצה‬

ENERGETIC UNIT BASED ON
SEMICONDUCTOR BRIDGE
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD.

1///4/0/22

F41H )2011.01(

768<;;

‫רפאל מערכות לחימה מתקדמות בע"מ‬

768=;:

ANTIBALLISTIC ARTICLE AND
METHOD OF PRODUCING SAME
ISRAEL MILITARY INDUSTRIES LTD.

20//1/0/2/

27//1/0/2/

‫מוצר אנטי–בליסטי ושיטה לייצורו‬
‫התעשייה הצבאית לישראל בע"מ‬

76:5>;

STIMULATED EMISSION
LUMINESCENT LIGHT-GUIDE SOLAR
CONCENTRATORS
MORGAN SOLAR INC.
CA
2,658193
12/03/2009
42/07624/
04//2/0/2/
US
PCT/CA/2010/000363
WO/2010/102408

H01L )2011.01(

‫מתקנים לריכוז והולכת אנרגיה סולארית‬
‫ע"י סטימולציה של פליטה לומינסנטית‬
‫מורגן סולאר בע"מ‬

76:5>=

ALCOHOL AS SANDALWOOD ODORANT
FIRMENICH SA
IB
PCT/IB2009/051223 24/03/2009
PCT/IB/2010/051199
4

F41H )2011.01(

C07C )2011.01(
‫אלכוהול בניחוח אלגום‬

December 29, 2011-‫ג' בטבת התשע"ב‬

WO/2010/109391

26//1/0/2/

76:5>>

MEMS STRUCTURE WITH A
FLEXIBLE MEMBRANE AND
IMPROVED ELECTRIC ACTUATION
MEANS
DELFMEMS
EP
09370007.8 20/03/2009
PCT/EP/2010/001701
WO/2010/105827

26//1/0/2/

‫) בעל‬MEMS( ‫מבנה מיקרו אלקטרו מכני‬
‫הממברנה גמישה ואמצעי הפעלה‬
‫אלקטרוניים משופרים‬

76:655

IMPROVED CHEMICAL SYNTHESIS
OF DIAZAINDOLES BY CHICHIBABIN
CYCLIZATION
SANOFI
US
61/161440
19/03/2009
/736753
23/20/0//7
FR
PCT/US/2010/027755
WO/2010/107969

20//1/0/2/

76:656

COMBINED CRYOTHERAPY AND
BRACHYTHERAPY DEVICE AND
METHOD
ICECURE MEDICAL LTD
US
61/159497
12/03/2009
PCT/US/2010/027142
WO/2010/105158

23//1/0/2/

5

H01H )2011.01(

76:658

C07D )2011.01(
‫שיפור סינטזה כימית של דיאזאינדולים‬
‫על ידי ציקליזציה של חיחיבאבין‬

A61B )2011.01(
‫מכשיר ושיטה לשילוב קריותרפיה עם‬
‫ברכיתרפיה‬
‫אייסקיור מדיקל בע"מ‬

C07D )2011.01(

December 29, 2011-‫ג' בטבת התשע"ב‬

N-[(6-AZA-bicyclo[3.2.1]OCT-5-YL]ARYL-METHYL]HETEROBENZAMIDE DERIVATIVES,
PREPARATION THEREOF, AND
THERAPEUTIC USE OF SAME
SANOFI
FR
09/01220
16/03/2009
PCT/FR/2010/050448
WO/2010/106270

23//1/0/2/

76:659

DERIVATIVES OF N-[(2-AZABICYCLO[2.1.1]HEX-1-YL)-ARYLMETHYL]-HETEROBENZAMIDE,
PREPARATION THEREOF AND
APPLICATION OF SAME IN
THERAPEUTICS
SANOFI
FR
09/01219
16/03/2009
/7//262/
22//2/0//7
FR
PCT/FR/2010/050447
WO/2010/106269

/2//3/0/2/

–‫]אוקט‬1.2.3[‫–אזא–ביציקלו‬N–[(6 ‫נגזרות‬
,‫–איל)–אריל–מתיל]–הטרובנזאמיד‬1
‫ ושימוש רפואי שלהן‬,‫הכנתן‬

–1–‫] הקס‬1.1.2[‫–אזאביצקלו‬N–[(2 ‫נגזרות‬
,‫ הכנתן‬,‫אין)–אריל–מתיל]–הטרובנזאמיד‬
‫ויישום שלהן ברפואה‬

76:65:

76:65<

BENZODIAZEPINE DERIVATIVE FOR
THE TREATMENTOF
HEMATOPOIETIC NEOPLASM AND
LUEKEMIA
ELI LILLY AND COMPANY
6

C07D )2011.01(
‫סולפונאמידים קוטלי תולעים‬

NEMATOCIDAL SULFONAMIDES
E.I. DU PONT DE NEMOURS AND
COMPANY
US
61/175206
04/05/2009
PCT/US/2010/033471
WO/2010/129500

/6//2/0/2/

C07D )2011.01(

A61K )2011.01(

‫תולדות בנזודיאזפין לטיפול בנאופלסמה‬
‫המטופואטית ולויקמיה‬
December 29, 2011-‫ג' בטבת התשע"ב‬

US
61/169094
PCT/US/2010/030315
WO/2010/120614

/6//2/0/2/

14/04/2009

76:65=

AMATOXIN-ARMED TARGETBINDING MOIETIES FOR THE
TREATMENT OF CANCER
FAULSTICH, HEINZ
US
61/167690
08/04/2009
PCT/EP/2010/002206
WO/2010/115630

06//2/0/2/

‫חלקים קושרי–מטרה מצוידי–אמאטוקסין‬
‫לטיפול בסרטן‬

76:65>

ISOXAZOLE-PYRIDAZINE
DERIVATIVES
F. HOFFMANN-LA ROCHE AG
EP
09159412.7 05/05/2009
PCT/EP/2010/055669
WO/2010/127968

01//2/0/2/

76:668

A21D )2011.01(
‫תהליך נגד אי–טריות של מאפה בצק‬
‫שטוח‬

76:669

METHOD AND DEVICE FOR GASSING
LINDE AG
DE
102009013133.7 13/03/2009
7

C07D )2011.01(
‫תולדות איזוקסאזול–פירידאזין‬

ANTISTALING PROCESS FOR FLAT
BREAD
NOVOZYMES NORTH AMERICA, INC.
US
61/172515
24/04/2009
PCT/US/2010/032233
WO/2010/124206

00//2/0/2/

A61K )2011.01(

F17C )2011.01(
‫שיטה ומכשיר לאספקת גז‬

December 29, 2011-‫ג' בטבת התשע"ב‬

PCT/EP/2010/000397
WO/2010/102693

24//1/0/2/

C12N )2011.01(

76:66;

‫מערכת לייצור חלבון כריסוספוריום‬
‫לוקנוונס‬

CHRYSOSPORIUM LUCKNOWENSE
PROTEIN PRODUCTION SYSTEM
DYADIC NEDERLAND B.V.
EP
09003750
16/03/2009
PCT/NL/2010/000045
WO/2010/107303

20//1/0/2/

76:66>

SUBSTITTED FUSED PYRIMIDINE
COMPOUNDS
ADVINUS THERAPEUTICS PRIVATE
LIMITED
IN
0571/CHE/2009 13/03/2009
PCT/IN/2010/000145
WO/2010/103547

/3//2/0/2/

76:675

HYDROXYTHIENOQUINOLONES
AND RELATED COMPOUNDS AS
ANTI-INFECTIVE AGENTS
ACHILLION PHARMACEUTICALS,
INC
US
61/166371
03/04/2009
PCT/US/2010/029938
WO/2010/115184

25//1/0/2/

8

76:676

A61K )2011.01(

‫תרכובות פירימידין דחוסות ומותמרות‬

C07D )2011.01(
‫הידרוקסיתיאנוקווינולונים ותרכובות‬
‫קשורות כגורמים אנטי–זיהומיים‬

H04W )2011.01(

December 29, 2011-‫ג' בטבת התשע"ב‬

METHOD AND APPARATUS FOR
POWER CONTROL OF SOUNDING
REFERENCE SIGNAL (SRS)
TRANSMISSION
INTERDIGITAL PATENT HOLDINGS,
INC.
US
61/160979
17/03/2009
PCT/US/2010/027617
WO/2010/107880

07//1/0/2/
FAST-ACTING INSULIN
FORMULATION
ADOCIA
US
61/202692
/7//2256
FR
PCT/IB/2010/000711
WO/2010/122385

04//1/0/2/

76:677

9

A61K )2011.01(
‫הרכב אינסולין הפועל במהירות‬

27/03/2009
05//1/0//7

76:678

POLYMER-AGENT CONJUGATES,
PARTICLES, COMPOSITIONS, AND
RELATED METHODS OF USE
CERULEAN PHARMA INC.
US
61/164734
30/03/2009
42/242500
1///1/0//7
US
42/24250/
1///1/0//7
US
42/242503
1///1/0//7
US
42/242506
1///1/0//7
US
42/242512
1///1/0//7
US
42/040771
0//22/0//7
US
42/040772
0//22/0//7
US
PCT/US/2010/028770
WO/2010/117668

21//1/0//7

‫שיטה ומערכת לבקרת כח שידור אות‬
)SRS( ‫התייחסות צלילי‬

A61K )2011.01(

‫ תכשירים‬,‫ חלקיקים‬,‫תצמידי פולימר–גורם‬
‫ושיטות קשורות לשימוש‬

76:679

C10G )2011.01(
December 29, 2011-‫ג' בטבת התשע"ב‬

EXTRACTION OF HYDROCARBONS
FROM HYDROCARBONCONTAINING MATERIALS AND/OR
PROCESSING OF HYDROCARBONCONTAINING MATERIALS
GREEN SOURCE ENERGY LLC

‫מיצוי של פחמימנים מחומרים המכילים‬
‫או עיבוד של חומרים‬/‫פחמימנים ו‬
‫המכילים פחמימנים‬

PCT/US/2009/037112
WO/2010/104516

02//1/0/2/

76:67;

‫משחה תרופתית נגד חיידקים ותהליך‬
‫לייצורה‬

A MEDICINAL ANTIBACTERIAL
CREAM AND A PROCESS TO MAKE IT
VANANGAMUDI, SULUR,
SUBRAMANIAM
IN
701/MUM/2009 25/03/2009
PCT/IB/2010/051280
WO/2010/109417

07//1/0/2/

76:67=

METHOD FOR PRODUCING
ALCOHOL COMPOUND
SUMITOMO CHEMICAL COMPANY,
LIMITED
2009JP
31/03/2009
084832
PCT/JP/2010/056109
WO/2010/114137

00//1/0/2/

10

C07C )2011.01(
‫שיטה לייצור תרכובת אלכוהולית‬

76:686

METHODS OF TREATMENT USING
COMBINATION THERAPY
AMBIT BIOSCIENCES CORPORATION
US
61/202647
23/03/2009
42/2516/1
07//2/0//7
US
42/044767
/2/20/0//7
US
PCT/US/2010/028129

A61K )2011.01(

A61K )2011.01(

‫שיטות לטיפול תוך שימוש בריפוי משולב‬

December 29, 2011-‫ג' בטבת התשע"ב‬

WO/2010/111172

25//1/0/2/

76:688

APPARATUS AND METHODS FOR
SYNDICATION OF ON-DEMAND
VIDEO
ACTIVEVIDEO NETWORKS INC
US
61/160880
17/03/2009
PCT/US/2010/027724
WO/2010/107954

20//0/0/2/

‫התקן ושיטות להפצת וידאו לפי ביקוש‬

76:689

CARRIER MODULATING
ACCELEROMETER
RAYTHEON COMPANY
US
12/435098
04/05/2009
PCT/US/2010/024183
WO/2010/129079

/6//1/0/2/

76:68:

11

F16K )2011.01(
‫התקן שסתום מווסת‬

76:68;

VHF/UHF BROADBAND DUAL
CHANNEL ANTENNA
THALES
FR
0901187
13/03/2009
PCT/EP/2010/052302

G01C )2011.01(
‫מד–תאוצה מאפנן נשא‬

REGULATING VALVE DEVICE
FUJIKIN INCORPORATED
2009JP
17/03/2009
064546
PCT/JP/2010/053749
WO/2010/106935

01//0/0/2/

H04N )2011.01(

H01Q )2011.01(

‫ בעלת פס‬VHF/UHF ‫משושה דו–ערוצית‬
‫רחב‬

December 29, 2011-‫ג' בטבת התשע"ב‬

WO/2010/102901

26//1/0/2/

76:68=

A DOSE OF AVE5026 FOR THE
TREATMENT OF VENOUS
THROMBOEMBOLISM IN PATIENTS
WITH SEVERE RENAL IMPAIRMENT
SANOFI
FR
09290202.2 19/03/2009
PCT/IB/2010/051186
WO/2010/106519

26//1/0/2/

27//1/0/2/

‫ לטיפול בפקקת ורידית‬AVE5026 ‫מנה של‬
‫בחולים עם אי ספיקת כליות חמורה‬

76:68>

HSP90 INHIBITING INDAZOLE
DERIVATIVES, COMPOSITIONS
CONTAINING SAME AND USE
THEREOF
SANOFI
FR
0901274
19/03/2009
2/3/122
27//2/0/2/
FR
PCT/FR/2010/050483
WO/2010/106290

12

C07D )2011.01(

‫ תכשירים‬,HSP90 ‫נגזרות אינדזול מעכבות‬
‫המכילים אותן ושימוש שלהן‬

76:695

REFLECTIVE SURFACE FOR SOLAR
ENERGY COLLECTOR
SKYLINE SOLAR INC.
US
61/162125
20/03/2009
PCT/US/2010/028047
WO/2010/108141

27//1/0//7

A61K )2011.01(

76:696

F24J )2011.01(
‫משטח המחזיר קרני אור עבור קולט‬
‫אנרגיה סולרית‬

C12N )2011.01(
December 29, 2011-‫ג' בטבת התשע"ב‬

THRAUSTOCHYTRIDS, FATTY ACID
COMPOSITIONS, AND METHODS OF
MAKING AND USES THEREOF
MARTEK BIOSCIENCES
CORPORATION

‫ תכשירים של חומצות‬,‫טראוסטוציטרידים‬
‫שומן ושיטות להכנה ושימושים בהם‬

PCT/US/2009/001720
WO/2010/107415

24//1/0/2/

76:697

HIGH PERFORMANCE DRILLING
FLUIDS WITH SUBMICRON-SIZE
PARTICLES AS THE WEIGHTING
AGENT
HALLIBURTON ENERGY SERVICES
INC
US
12/409240
23/03/2009
PCT/GB/2010/000469
WO/2010/109163

03//1/0/2/

76:698

PROCESS FOR THE PREPARATION
OF ALOGLIPTIN
MAPI PHARMA LTD
US
61/163481
26/03/2009
PCT/IL/2010/000260
WO/2010/109468

22//7/0/22
METHOD OF RECOVERING
PLATINUM GROUP METAL
BORIS GOLDIN

13

76:699

C09K )2011.01(
‫נוזלי קידוח בעלי ביצועים גבוהים עם‬
‫חלקיקים בגודל תת–מיקרון כגורם‬
‫הכבידה‬

A01N )2011.01(
‫תהליך להכנת אלוגליפטין‬
‫מאפי פארמה בע"מ‬

C01G )2011.01(
‫שיטה למיצוי מתכות קבוצה פלטינה‬

December 29, 2011-‫ג' בטבת התשע"ב‬

12/20/0//7

76:69;

ABRASIVE TOOL USE AS A
CHEMICAL MECHANICAL
PLANARIZATION PAD
CONDITIONER
Saint-Gobain ABRASIFS
US
61/162893
24/03/2009
42/01376/
02//6/0//7
US
PCT/US/2009/069961
WO/2010/110834

27//1/0/2/

76:69<

COMPOUNDS
MEDICAL RESEARCH COUNCIL
TECHNOLOGY
GB
0904746.5
19/03/2009
42/240/02
0///1/0//7
US
/72001691
22//5/0//7
GB
2//222692
06//2/0/2/
GB
PCT/GB/2010/000498
WO/2010/106333

07//4/0//7

76:69=

CONTENT PROTECTION MESSAGE
EXTRACTION
NDS LIMITED

B24B )2011.01(
–‫כלי ממרט לשימוש כפד החלקה כימי‬
‫מכני מייצב‬

C07D )2011.01(
‫תרכובות‬

G06T )2011.01(
‫חילוץ מודעות מתכנים מוגנים‬

PCT/IB/2009/052784
WO/2011/001204

26//1/0/2/

14

76:69>

A61M )2011.01(

December 29, 2011-‫ג' בטבת התשע"ב‬

INHALER ADAPTOR FOR A LASER
DIFFRACTION APPARATUS AND
METHOD FOR MEASURING
PARTICLE SIZE DISTRIBUTION
MANNKIND CORPORATION
US
61/161379
18/03/2009
PCT/US/2010/027880
WO/2010/108046

26//1/0//7

‫מתאם למשאף עבור מערכת דיפרקצית‬
‫לייזר ושיטה למדידת התפלגות של גדלי‬
‫חלקיקים‬

76:6:5

BOARD OR SLAB FORMED BY
STONE AGGLOMERATE
CONTAINING AN ORGANIC BINDER
OF VEGETABLE ORIGIN
COSENTINO, S.A.

C04B )2011.01(
‫לוח או טבלה המוצרים מצבור אבן‬
‫והמכילים דבק אורגני ממוצא צמחי‬

PCT/ES/2009/000153
WO/2010/106196

01//2/0/2/

76:6:6

METHOD FOR CONTROLLING A
TORPEDO, TORPEDO THEREFOR AND
ANTENNA SECTION OF SUCH A
TORPEDO
ATLAS ELEKTRONIK GMBH
DE
102009019790.7 02/05/2009
PCT/EP/2010/055475
WO/2010/127953

23//1/0/2/

76:6:8

AMIDE DERIVATIVE COMPOUNDS,
COMPOSITIONS COMPRISING THE
SAME AND USES THERE OF
DAIICHI SANKYO COMPANY,
LIMITED
2009JP
17/03/2009
065029
15

F42B )2011.01(
‫ טורפדו עבורה‬,‫שיטה לבקרת טורפדו‬
‫וקטע אנטנה של טורפדו כזה‬

C07D )2011.01(
‫ תכשירים‬,‫תרכובות נגזרות אמיד‬
‫המכילים אותן ושימושים בהן‬

December 29, 2011-‫ג' בטבת התשע"ב‬

PCT/JP/2010/054291
WO/2010/106988

02/2//0//7

76:6:9

PHOTODYNAMIC DISINFECTION
COMPOSITIONS AND USES THEREOF
ONDINE INTERNATIONAL LTD.
US
61/160435
16/03/2009
PCT/US/2009/061442
WO/2010/107454

24//1/0/2/

‫ ושימושים בהם‬,‫תכשירי חיטוי פוטודינמי‬

76:6::

NUTRITIONAL COMPOSITION
COMPRISING CURCUMINOIDS AND
METHODS OF MANUFACTURE
ABBOTT LABORATORIES
US
61/163688
26/03/2009
42/241461
04//1/0//7
US
PCT/US/2010/027477
WO/2010/111070

27//1/0/2/

76:6:;

SUBSTITUTED NUCLEOSIDE AND
NUCLEOTIDE ANALOGS
ALIOS BIOPHARMA INC.
US
61/162198
20/03/2009
42/002623
2///5/0//7
US
42/012247
22//6/0//7
US
PCT/US/2010/028046
WO/2010/108140

12//1/0/2/

16

A61K )2011.01(

76:6:<

A23L )2011.01(
‫תכשיר תזונתי המכיל כורכומינואידים‬
‫ושיטות ייצור‬

A01N )2011.01(
‫נוקליאוזיד מותמר ואנלוגים של‬
‫נוקליאוטיד‬

C25D )2011.01(
December 29, 2011-‫ג' בטבת התשע"ב‬

COMPOSITION FOR METAL PLATING
COMPRISING SUPPRESSING AGENT
FOR VOID FREE SUBMICRON
FEATURE FILLING
BASF SE
EP
09157540.7 07/04/2009
42/034106
1//2//0//7
US
PCT/EP/2010/054281
WO/2010/115796

/2//2/0/2/

‫הרכב לציפוי מתכתי המכיל גורם הסתרה‬
‫עבור מילוי של חלל חופשי תת–מיקרוני‬

76:6:=

IMIDAZO [2,1-B] [1,3,4]
THIADIAZOLE DERIVATIVES
CENTRO NACIONAL DE
INVESTIGACIONES ONCOLOGICAS
(CNIO)
EP
09380069.6 02/04/2009
PCT/GB/2010/000674
WO/2010/112874

26//1/0/2/

76:6:>

THIN FILM COATING AND METHOD
OF MAKING THE SAME
AGC GLASS EUROPE
US
61/161186
18/03/2009
42/0120/7
/2//6/0//7
US
PCT/US/2010/027806
WO/2010/107998

01//1/0/2/

76:6;5

SLIP CHIP DEVICE AND METHODS
THE UNIVERSITY OF CHICAGO
US
61/162922
24/03/2009
42/040153
26/22/0//7
US
42/12/650
00//1/0/2/
US
PCT/US/2010/028316
17

C07D )2011.01(
]B][4,3,1–1,2[ ‫תולדות אימידאזו‬
‫תיאדיאזול‬

B32B )2011.01(
‫שכבת ציפוי דקה ושיטה לייצורה‬

H01L )2011.01(
‫התקן להחלקת שבב ושיטות‬

December 29, 2011-‫ג' בטבת התשע"ב‬

WO/2010/111265

02//2/0/2/

C07D )2011.01(

76:6;6

‫–אלקיניל–פירידינים‬5

5-ALKYNYL-PYRIDINES
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
EP
09158327.8 21/04/2009
PCT/EP/2010/055293
WO/2010/122069

27//1/0/2/

EFFICIENT METHODS FOR
OPERATION WITH HIGH PRESSURE
LIQUIDS
ENERGY RECOVERY, INC.
US
61/161977
20/03/2009
PCT/US/2010/027918
WO/2010/108070

02//1/0/2/

‫שיטות יעילות לפעולה עם נוזלים בלחץ‬
‫גבוה‬

76:6;8

76:6;9

ABSCRIPTION BASED MOLECULAR
DETECTION
RIBOMED BIOTECHNOLOGIES, INC.
US
61/160335
15/03/2009
18

B05D )2011.01(

‫רצועה מצופה ע"י שיחול עבור אריזות‬
‫קשיחות‬

EXTRUSION-COATED STRIP FOR RIGID
PACKAGINGS
HYDRO ALUMINIUM DEUTSCHLAND
GMBH
DE
102009003683.0 26/03/2009
PCT/EP/2010/053833
WO/2010/108953

23//1/0/2/

B01J )2011.01(

76:6;7

C12Q )2011.01(

‫תהליך להגברת אותות המבוסס על זיהוי‬
‫מוליקולרי‬

December 29, 2011-‫ג' בטבת התשע"ב‬

PCT/US/2010/027367
WO/2010/107716

26//1/0/2/

76:6;:

METHOD FOR PREPARING A SITESPECIFIC PHYSIOLOGICALLY
ACTIVE POLYPEPTIDE CONJUGATE
HANMI HOLDINGS CO., LTD.
10-2009KR
20/03/2009
0023953
PCT/KR/2010/001674
WO/2010/107256

02//1/0/2/

01//2/0/2/

‫שיטה להכנת פוליפפטיד קוניוגאנט פעיל‬
‫פיזיולוגית באתר ספציפי‬

76:6;;

TREATMENT REGIMEN UTILIZING
NERATINIB FOR BREAST CANCER
WYETH LLC
US
61/166796
06/04/2009
PCT/US/2010/028448
WO/2010/117633

19

A61K )2011.01(

‫משטר טיפול לסרטן השד העושה שימוש‬
‫בנראטיניב‬

76:6;=

COMPSITIONS COMPOSITIONS AND
METHODS FOR INCREASING
MUSCLE GROWTH
NOVARTIS AG
US
61/173004
27/04/2009
42/1/4215
27//0/0/2/
US
PCT/EP/2010/055458
WO/2010/125003

06//2/0/2/

C07K )2011.01(

76:6;>

C07K )2011.01(
‫תכשירים ושיטות להגברת גדילת שריר‬

C07D )2011.01(
December 29, 2011-‫ג' בטבת התשע"ב‬

ISOXAZOLE -PYRIDINE
DERIVATIVES AS GABA
MODULATORS
F. HOFFMANN-LA ROCHE AG
EP
09159631.2 07/05/2009
PCT/EP/2010/055701
WO/2010/127978

01//2/0/2/

76:6<5

ALCOHOL ALKOXYLATES AS
ADJUVANTS FOR AGROCHEMICAL
FORMULATIONS
SYNGENTA LIMITED
GB
0907003.8
23/04/2009
PCT/GB/2010/000821
WO/2010/122313

24//1/0/2/

76:6<6

A PYROLYTIC REACTOR
T.D.E. RECOVERY TECHNOLOGIES
LTD
US
61/160842
17/03/2009
PCT/IL/2010/000217
WO/2010/106538

24//1/0/2/

76:6<7

FEEDING APPARATUS AND METHOD
FOR A PYROLYTIC REACTOR
T.D.E. RECOVERY TECHNOLOGIES
LTD
US
61/160842
17/03/2009
PCT/IL/2010/000218
WO/2010/106539

20

‫תולדות איזוקסאזול–פירידין כמאפנני‬
GABA

A01N )2011.01(
‫אלכוהול אלקוקסילאטים כחומר מסייע‬
‫לתכשירים אגרוכמיקליים‬

F27B )2011.01(
‫כור פירוליטי‬
‫ טכנולוגיות מיחזור בע"מ‬.‫אי‬.‫די‬.‫טי‬

F23K )2011.01(
‫מכשיר הזנה ושיטה לכור פירוליטי‬
‫ טכנולוגיות מיחזור בע"מ‬.‫אי‬.‫די‬.‫טי‬

December 29, 2011-‫ג' בטבת התשע"ב‬

24//1/0/2/

C08J )2011.01(

76:6<8

ENVIRONMENTALLY CLEAN
PROCESS FOR UTILIZING
PYROLYSIS PRODUCTS
T.D.E. RECOVERY TECHNOLOGIES
LTD
US
61/160842
17/03/2009
PCT/IL/2010/000219
WO/2010/106540

00//1/0/2/

‫תהליך נקי סביבתית לשימוש במוצרי‬
‫פירוליזה‬
‫ טכנולוגיות מיחזור בע"מ‬.‫אי‬.‫די‬.‫טי‬

‫קטון אפוקסי טריפפטיד קריסטלי מעכבי‬
‫פרוטאז‬

CRYSTALLINE TRIPEPTIDE EPOXY
KETONE PROTEASE INHIBITORS
ONYX THERAPEUTICS, INC.
US
61/162196
20/03/2009
42/26/342
00//3/0//7
US
PCT/US/2010/028126
WO/2010/108172

01//1/0/2/

76:6<:

THIENOPYRIMIDINEDIONE
DERIVATIVES AS TRPA1
MODULATORS
GLENMARK PHARMACEUTICALS S.A.
IN
665/MUM/2009 23/03/2009
42/252133
02//2/0//7
US
IN
MUM/2009/0021 01//7/0//7
42/032772
23/2//0//7
US
IN
MUM/2009/07/4 24/20/0//7
42/07225/
20//2/0/2/
US
PCT/IB/2010/000930
WO/2010/109334

/7//1/0/2/
CART
21

C07D )2011.01(

76:6<9

76:6<;

C07D )2011.01(
‫נגזרות של תיאנופירימידינדיאון‬
TRPA1 ‫כמאפנני‬

B62B )2011.01(
‫עגלה‬
December 29, 2011-‫ג' בטבת התשע"ב‬

FINE, AMOS
US
12/382410
PCT/IB/2010/051009
WO/2010/106464

00//1/0/2/

16/03/2009

76:6<<

FUROPYRIMIDINEDIONE DERIVATIVES
AS TRPA1 MODULATORS
GLENMARK PHARMACEUTICALS S.A.
IN
665/MUM/2009 23/03/2009
42/252133
02//2/0//7
US
IN
MUM/2009/0021 01//7/0//7
42/032772
23/2//0//7
US
IN
MUM/2009/07/4 24/20/0//7
42/07225/
20//2/0/2/
US
PCT/IB/2010/000840
WO/2010/109329

25//1/0/2/

76:6<=

FUSED PYRIMIDINEDIONE
DERIVATIVES AS TRPA1 MODULATORS
GLENMARK PHARMACEUTICALS S.A.
IN
665/MUM/2009 23/03/2009
42/252133
02//2/0//7
US
IN
MUM/2009/0022 01//7/0//7
IN
MUM/2009/0020 01//7/0//7
42/032722
23/2//0//7
US
42/031041
0//2//0//7
US
IN
MUM/2009/0672 23/20/0//7
IN
MUM/2009/0670 23/20/0//7
42/072241
20//2/0/2/
US
42/1//022
/2//0/0/2/
US
PCT/IB/2010/000553
WO/2010/109287

00//1/0/2/
22

76:6<>

C07D )2011.01(
‫נגזרות של פורופירימידינדיאון‬
TRPA1 ‫כמאפנני‬

C07D )2011.01(
‫נגזרות מאוחות של פירימידינדיאון‬
TRPA1 ‫כמאפנני‬

C07D )2011.01(
December 29, 2011-‫ג' בטבת התשע"ב‬

ISOTHIAZOLO-PYRIMIDINEDIONE
DERIVATIVES AS TRPA1
MODULATORS
GLENMARK PHARMACEUTICALS S.A.
IN
665/MUM/2009 23/03/2009
42/252133
02//2/0//7
US
PCT/IB/2010/000834
WO/2010/109328

00//2/0/2/

76:6=5

BIOCOMPATIBLE COMPOSITE AND
ITS USE
VIVOXID OY
EP
09158597.6 23/04/2009
PCT/EP/2010/055335
WO/2010/122098

0///2/0/2/

23

C03C )2011.01(

‫תכשירי סיבי זכוכית הניתנים לספיגה‬
‫חוזרת ומתאימים לשימוש בגוף ושימושים‬
‫שלהם‬

76:6=7

IMPROVED DETECTION OF GENE
EXPRESSION
MDxHEALTH S.A.
US
61/160935
17/03/2009
PCT/EP/2010/001674
WO/2010/105815

A61L )2011.01(

‫מרוכב מתאים לשימוש בגוף ושימוש שלו‬

76:6=6

RESORBABLE AND BIOCOMPATIBLE
FIBRE GLASS COMPOSITIONS AND
THEIR USES
VIVOXID OY
EP
09158608.1 23/04/2009
PCT/EP/2010/055192
WO/2010/122019

25//1/0/2/

‫נגזרות של איזותיאזולו–פירימידינדיאון‬
TRPA1 ‫כמאפנני‬

C12Q )2011.01(
‫גילוי משופר של ביטוי גנים‬

December 29, 2011-‫ג' בטבת התשע"ב‬

26//1/0/2/

C07C )2011.01(

76:6=8

PROCESS FOR PREPARING (R)-7VBENZYL-2(BENZYLOXYCARBONYLAMINO)-SMETHOXYPROPIONAMIDE
PLIVA HRVATSKA D.O.O.
US
61/161181
18/03/2009
42/2507/1
05//2/0//7
US
PCT/US/2010/027800
WO/2010/107993

06//1/0/2/

–2–‫–בנזיל‬R)–V7( ‫תהליך להכנת‬
–S–)‫(בנזילאוקסיקרבונילאמינו‬
‫מתוקסיפרופיונאמיד‬

EXHAUST GEOMETRY FOR
PARTICLE GROUPING
RUZAL MICHAL
US
61/164477
30/03/2009
PCT/IL/2010/000269
WO/2010/113156

1///1/0/2/

‫פליטה גיאומטרית של קבוצת חלקיקים‬
‫ערן שר‬

‫שיטה לייצור תרכובת אלכוהולית וזרז‬
‫עבורה‬

76:6>5

A NATURAL TASTE ENHANCING
SAVOURY BASE AND A PROCESS FOR ITS
PREPARATION
NESTEC S.A.
EP
PCT/EP2009/053530 25/03/2009
24

C07C )2011.01(

76:6=>

METHOD FOR PRODUCING
ALCOHOL COMPOUND AND
CATALYST THEREFOR
SUMITOMO CHEMICAL COMPANY,
LIMITED
2009JP
31/03/2009
084833
PCT/JP/2010/056130
WO/2010/114151

01//1/0/2/

F01N )2011.01(

76:6=9

A23L )2011.01(
‫טעם טבעי המגביר את התיבול‬
‫הבסיסי והליך להכנתו‬

December 29, 2011-‫ג' בטבת התשע"ב‬

PCT/EP/2010/053735
WO/2010/108901

04//1/0/2/

76:6>6

‫מיכלים משופרים‬

IMPROVED CONTAINERS
GARMOND PTY. LIMITED
AU
2009901455 03/04/2009
PCT/AU/2010/000340
WO/2010/111729

02//1/0/2/

76:6>7

PROCESS FOR SINTERING
NANOPARTICLES AT LOW
TEMPERATURES
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM LTD.
US
61/162744
24/03/2009
PCT/IL/2010/000249
WO/2010/109465

/4//2/0/2/

NOVEL ANTI-INFLAMMATORY
AGENTS
25

C23C )2011.01(

‫תהליך לסינטור ננו חלקיקים בטמפרטורה‬
‫נמוכה‬

76:6>8

MECHANICAL DEVICE FOR THE
TRANSMISSION OF A FORCE WITH A
THRESHOLD
MESSIER-BUGATTI-DOWTY
FR
09/01683
06/04/2009
PCT/EP/2010/054538
WO/2010/115895

24//1/0/2/

B65D )2011.01(

76:6>9

‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים בע"מ‬

F16D )2011.01(
‫מכשיר מכאני לשידור כח עם סף‬

A61K )2011.01(
‫גורמים חדשים אנטי–דלקתיים‬
December 29, 2011-‫ג' בטבת התשע"ב‬

RESVERLOGIX CORP
US
61/161089
PCT/IB/2010/000826
WO/2010/106436

24//1/0/2/

18/03/2009

76:6>:

METHOD OF TREATING
NONALCOHOLIC STEATOHEPATITIS
WITH ELEVATED DOSES OF
URSODEOXYCHOLIC ACID
AXCAN PHARMA INC
US
61/160955
17/03/2009
PCT/IB/2010/000551
WO/2010/106420

03//1/0/2/

‫ עם מינונים עולים‬NASH–‫שיטה לטיפול ב‬
‫של חומצה אורסודיאוקסיכולית‬

76:6>;

76:6>>

THIA-TRIAZACYCLOPENTAZULENES AS PI3KINASES INHIBITORS FOR THE
TREATMENT OF CANCER
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
EP
09158493.8 22/04/2009
PCT/EP/2010/055295
WO/2010/122071

26

A61K )2011.01(
‫זיהוי מהיר טרום מוות של גורמים‬
‫זיהומיים‬

RAPID ANTEMORTEM DETECTION
OF INFECTIOUS AGENTS
THE RESEARCH FOUNDATION OF
STATE UNIVERSITY OF NEW YORK
US
61/211264
25/03/2009
42/022043
03//1/0//7
US
PCT/US/2010/028698
WO/2010/111514

02//2/0/2/

A61K )2011.01(

C07D )2011.01(

‫תיה–טריאזא–ציקלופנטאזולנים כמעכבי‬
‫–קינאזות לטיפול בסרטן‬PI3

December 29, 2011-‫ג' בטבת התשע"ב‬

02//1/0/2/

76:755

‫מיזוגי ותצמידי תרופות‬

DRUG FUSIONS AND CONJUGATES
GLAXO GROUP LIMITED
US
61/163917
27/03/2009
PCT/EP/2010/053806
WO/2010/108937

27//1/0/2/

76:756

76:757

FUSED RING INHIBITORS OF
HEPATITIS C
PRESIDIO PHARMACEUTICALS, INC.
US
61/164342
27/03/2009
42/022661
06//2/0//7
US
PCT/US/2010/028730
WO/2010/111534

27//0/0/2/
METHOD AND APPARATUS FOR
DELIVERING A SHAPE MEMORY
ARTICLE TO A SURGICAL SITE
CORE ESSENCE ORTHOPAEDICS,
LLC
27

E01F )2011.01(
‫מחסום כביש משופר‬

IMPROVED ROAD BARRIER
INDUSTRIAL GALVANIZERS
CORPORATION PTY LTD
AU
2009901186 19/03/2009
0//77/2436
25//2/0//7
AU
0//77/0475
22//4/0//7
AU
0//77/3343
21/22/0//7
AU
PCT/AU/2010/000321
WO/2010/105307

03//1/0/2/

A61K )2011.01(

A01N )2011.01(

C–‫מעכבים טבעתיים מאוחים של צהבת‬

76:758

A61B )2011.01(
‫שיטה להתקן להעברת פריט זוכר צורה‬
‫לאתר ניתוח‬

December 29, 2011-‫ג' בטבת התשע"ב‬

US
61/161604
PCT/US/2010/024728
WO/2010/107549

1///1/0/2/

19/03/2009

76:759

–‫תפעול אוטומטי של מכשיר בדיקה רב‬
‫נקודתי‬

AUTOMATED MULTI-POINT PROBE
MANIPULATION
CAPRES A/S
EP
09388007.8 31/03/2009
PCT/EP/2010/054180
WO/2010/115771

03//1/0/2/

76:75:

INTRAOCULAR SUSTAINED
RELEASE DRUG DELIVERY
SYSTEMS AND METHODS FOR
TREATING OCULAR CONDITIONS
ALLERGAN, INC.
US
12/411250
25/03/2009
PCT/US/2010/028584
WO/2010/111449

27//2/0/2/

28

A61K )2011.01(

‫מערכות תוך–עיניות למתן תרופות‬
‫בשחרור ממושך ושיטות לטיפול במחלות‬
‫עיניים‬

76:75;

SOLID FORMS OF AN AZOCYCLIC
AMIDE
E.I. DU PONT DE NEMOURS AND
COMPANY
US
61/171573
22/04/2009
42/122320
/6//1/0/2/
US
PCT/US/2010/031546
WO/2010/123791

03//2/0/2/

G01R )2011.01(

76:75<

C07D )2011.01(
‫צורות מוצקות של אמיד אזוציקלי‬

H04W )2011.01(
December 29, 2011-‫ג' בטבת התשע"ב‬

METHOD AND USER EQUIPMENT
FOR HANDLING A SCHEDULING
REQUEST TRIGGER
TELEFONAKTIEBOLAGET L M
ERICSSON (PUBL)
US
61/175668
05/05/2009
PCT/SE/2010/050063
WO/2010/128927

25//1/0/2/

76:75=

ANTIBODIES BINDING
ATHEROSCLEROTIC CORONARY
PLAQUE, PROCESSES FOR THE
PREPARATION OF THE SAME AND
USES THEREOF
BRACCO IMAGING S.P.A.
EP
09155614.2 19/03/2009
PCT/EP/2010/053430
WO/2010/106088

20//1/0/2/

29

C07C )2011.01(

–‫שיטה לייצור תולדות קארבוקסילי–טרו‬
‫יוד ארומטייות‬

76:765

DRUG DELIVERY DEVICE WITH AN
IMPROVED PISTON ROD
SANOFI-AVENTIS DEUTSCHLAND
GMBH
EP
09004570.9 30/03/2009
PCT/EP/2010/053968
WO/2010/112409

C07K )2011.01(

‫נוגדנים הנקשרים לפלאק טרשת עורקים‬
‫ שיטות להכנתם ושימושם בהם‬,‫כלילית‬

76:75>

PROCESS FOR THE PREPARATION
OF TRIIODINATED CARBOXYLIC
AROMATIC DERIVATIVES
BRACCO IMAGING S.P.A.
EP
09155695.1 20/03/2009
PCT/EP/2010/053186
WO/2010/105983

04//1/0/2/

‫שיטה וציוד לטיפול בתיחול בקשת תזמון‬

A61M )2011.01(
‫התקן לשחרור תרופה עם מקל בוכנה‬
‫משופר‬

December 29, 2011-‫ג' בטבת התשע"ב‬

12//1/0/2/

76:766

DOSE BUTTON FOR A DRUG
DELIVERY DEVICE AND METHOD
FOR MANUFACTURING A DOSE
BUTTON
SANOFI-AVENTIS DEUTSCHLAND
GMBH
EP
09004674.9 31/03/2009
42/24766/
24//2/0//7
US
PCT/EP/2010/054352
WO/2010/112565

12//1/0/2/

‫מתן מינון להתקן לשחרור תרופה ושיטות‬
‫לייצור מתג המינון‬

76:767

FIXING MEANS
SANOFI-AVENTIS DEUTSCHLAND
GMBH
EP
09004673.1 31/03/2009
42/247655
24//2/0//7
US
PCT/EP/2010/054351
WO/2010/115822

12//1/0/2/

76:768

MEDICAL DEVICE HAVING A
MECHANISM AND USE OF A LOWFRICTION SYNTHETIC MATERIAL
WITHIN A MEDICAL DEVICE
SANOFI-AVENTIS DEUTSCHLAND
GMBH
EP
09004672.3 31/03/2009
42/247650
24//2/0//7
US
PCT/EP/2010/054349
WO/2010/112563

30

A61M )2011.01(

A61M )2011.01(
‫אמצעי קיבוע‬

A61M )2011.01(
‫התקן רפואי בעל מנגנון ושימוש בחומר‬
‫בעל חיכוך נמוך בתוך ההתקן הרפואי‬

December 29, 2011-‫ג' בטבת התשע"ב‬

12//1/0/2/

76:769

METHOD FOR MANUFACTURING A
COMPOSITE WORK PIECE FOR A
DRUG DELIVERY DEVICE AND
COMPOSITE WORK PIECE FOR A
DRUG DELIVERY DEVICE
SANOFI-AVENTIS DEUTSCHLAND
GMBH
EP
09004671.5 31/03/2009
42/247652
24//2/0//7
US
PCT/EP/2010/054348
WO/2010/112562

12//1/0/2/

‫שיטות לייצור חלק העשוי מחומר מרוכב‬
‫להתקן לשחרור תרופה ושימוש בחלק זה‬
‫להתקן לשחרור תרופה‬

76:76:

PEN CAP
SANOFI-AVENTIS DEUTSCHLAND
GMBH
EP
09004670.7 31/03/2009
42/247647
24//2/0//7
US
PCT/EP/2010/054347
WO/2010/115821

12//1/0/2/

76:76;

METHOD FOR MANUFACTURING A
DRUG DELIVERY DEVICE BODY
USING AN ADHESIVE AND DRUG
DELIVERY DEVICE BODY
SANOFI-AVENTIS DEUTSCHLAND
GMBH
EP
09004669.9 31/03/2009
42/247645
24//2/0//7
US
PCT/EP/2010/054346
WO/2010/115820

12//1/0/2/

31

B29C )2011.01(

76:76<

A61M )2011.01(
‫מכסה עט‬

G09F )2011.01(
‫שיטות ליצירת גוף של התקן לשחרור‬
‫תרופה בשימוש בחומר דביק והתקן‬
‫לשחרור תרופה‬

A61M )2011.01(
December 29, 2011-‫ג' בטבת התשע"ב‬

MEDICAL DEVICE HAVING A
MECHANISM WITH A SPRING AND
USE OF A WAVE SPRING OR WAVE
WASHER WITHIN A MEDICAL
DEVICE
SANOFI-AVENTIS DEUTSCHLAND
GMBH
EP
09004668.1 31/03/2009
42/247643
24//2/0//7
US
PCT/EP/2010/054345
WO/2010/112561

12//1/0/2/

‫התקן רפואי בעל מנגנון עם קפיץ ושימוש‬
‫בקפיץ גלי או בטבעת אוטמת גלית בהתקן‬
‫הרפואי‬

76:76=

MOUNTING ARRANGEMENT AND
COUPLING ASSEMBLY FOR A DRUG
DELIVERY DEVICE
SANOFI-AVENTIS DEUTSCHLAND
GMBH
EP
09004667.3 31/03/2009
42/247642
24//2/0//7
US
PCT/EP/2010/054344
WO/2010/115819

12//1/0/2/

76:76>

DRUG DELIVERY DEVICE
SANOFI-AVENTIS DEUTSCHLAND
GMBH
EP
09004666.5 31/03/2009
42/247636
24//2/0//7
US
PCT/EP/2010/054343
WO/2010/115818

12//1/0/2/

76:775

DRUG DELIVERY DEVICE
SANOFI-AVENTIS DEUTSCHLAND
GMBH
EP
09004665.7 31/03/2009
32

A61M )2011.01(
‫סידור הרכבה ומיכלול צימוד להתקן‬
‫לשחרור תרופה‬

A61M )2011.01(
‫התקן לשחרור תרופה‬

A61M )2011.01(
‫התקן לשחרור תרופה‬

December 29, 2011-‫ג' בטבת התשע"ב‬

42/247630
US
PCT/EP/2010/054342
WO/2010/115817

12//1/0/2/

24//2/0//7

76:776

SPRING ELEMENT FOR A DRUG
DELIVERY DEVICE, USE THEREOF
AND DRUG DELIVERY DEVICE
SANOFI-AVENTIS DEUTSCHLAND
GMBH
EP
09004663.2 31/03/2009
42/24676/
22//2/0//7
US
PCT/EP/2010/054339
WO/2010/112559

12//1/0/2/

,‫מרכיב קפיצי להתקן לשחרור תרופה‬
‫שימוש בו והתקן לשחרור תרופה‬

76:777

76:77;

AMIDE DERIVATIVES AS
NEUROPEPTIDE Y5 RECEPTOR
LIGANDS
H. LUNDBECK A/S
US
61/161802
20/03/2009
PCT/US/2010/027892
WO/2010/108052

33

A61M )2011.01(
‫התקן לשחרור תרופה‬

DRUG DELIVERY DEVICE
SANOFI-AVENTIS DEUTSCHLAND
GMBH
EP
09004661.6 31/03/2009
42/246756
22//2/0//7
US
PCT/EP/2010/054336
WO/2010/112557

27//1/0/2/

F16F )2011.01(

C07D )2011.01(

‫נגזרות אמיד כליגנדים לקולטן ניורופפטיד‬
Y5

December 29, 2011-‫ג' בטבת התשע"ב‬

04//1/0/2/

76:77<

PYRIMIDINYL AND 1,3,5-TRIAZINYL
BENZIMIDAZOLE SULFONAMIDES
AND THEIR USE IN CANCER
THERAPY
PATHWAY THERAPEUTICS, INC.
US
61/164359
27/03/2009
42/001465
/5//5/0//7
US
42/025232
1///7/0//7
US
PCT/NZ/2010/000060
WO/2010/110685

04//1/0/2/

‫–טריאזיניל בנזאימידזול‬1,3,5–‫פירימידין ו‬
‫סולפונאמידים ושימושים שלהם בטיפול‬
‫בסרטן‬

76:77=

TUMOR SUPPRESSION USING
HUMAN PLACENTA-DERIVED
INTERMEDIATE NATURAL KILLER
CELLS AND IMMUNOMODULATORY
COMPOUNDS
ANTHROGENESIS CORPORATION
US
61/163449
25/03/2009
PCT/US/2010/028885
WO/2010/111631

06/2//0/2/

76:77>

CARBINOL COMPOUND HAVING
HETEROCYCLIC LINKER
KOWA COMPANY, LTD.
US
61/173690
29/04/2009
PCT/JP/2010/003039
WO/2010/125811

/5//2/0/2/
ONCE-DAILY ORAL IR/CR
PRAMIPEXOLE FORMULATION
PURDUE PHARMA
34

C07D )2011.01(

76:785

C12N )2011.01(
‫דיכוי גידול בעזרת שימוש בתאי הרג‬
‫ביניים טבעיים שמקורם בשליה אנושית‬
‫ותרכובות אימונומודולטוריות‬

C07D )2011.01(
‫תרכובת קרבינול עם מקשר הטרוציקלי‬

A61K )2011.01(
‫פורמולצית פראציפקסול למתן פומי‬
‫ פעם ביום‬CR/IR
December 29, 2011-‫ג' בטבת התשע"ב‬

US
61/167980
PCT/CA/2010/000482
WO/2010/115267

09/04/2009

27//1/0/2/

76:786

DEVIE FOR FIXING WORKPIECES ON A
WORKPIECE CARRIER AND METHOD
FOR MACHINING WORKPIECES
MTU AERO ENGINES GMBH
DE
102009013726.2 20/03/2009
PCT/DE/2010/000308
WO/2010/105612

/2//2/0/2/

76:789

METHOD FOR PURIFYING
RECOMBINANT FSH
BIOGENERIX AG
EP
09157133.1 01/04/2009
PCT/EP/2010/002111
WO/2010/115586

03//1/0/2/

‫התקן לקביעה של חפץ מעובד על‬
‫מנשא ושיטה לעיבוד חפצים המיועדים‬
‫לעיבוד‬

C07K )2011.01(
‫ רקומביננטי‬FSH ‫שיטה לטיהור‬

C07D )2011.01(

PYRAZOLE COMPOUND
TAKEDA PHARMACEUTICAL
COMPANY LIMITED
2009JP
26/03/2009
077078
PCT/JP/2010/055257
WO/2010/110378

‫תרכובת פיראזול‬

00//2/0/2/

H01R )2011.01(

ELECTRICALLY CONDUCTIVE
BEARING RETAINERS
35

76:78:

B25B )2011.01(

76:78;

‫מחזיקי מיסבים מוליכים חשמלית‬
December 29, 2011-‫ג' בטבת התשע"ב‬

RAYTHEON COMPANY
US
12/411168
PCT/US/2010/021745
WO/2010/110933

01//1/0/2/

25/03/2009

76:78<

ANALYSIS OF REAL TIME
BACKSCATTER DATA FOR FAULT
SIGNAL GENERATION IN A
MEDICAL HIFU DEVICE
MEDICIS TECHNOLOGIES
CORPORATION
US
61/162641
23/03/2009
PCT/US/2010/028254
WO/2010/111233

03//1/0/2/

‫אנליזה של נתוני פיזור לאחור בזמן אמת‬
‫ רפואי‬HIFU ‫ליצירת אות ליקוי בהתקן‬

76:78=

INVERSE DISPLACEMENT
ASYMMETRIC ROTARY (IDAR)
ENGINE
LUMENIUM LLC
US
61/211192
25/03/2009
PCT/US/2010/028754
WO/2010/111557

03//1/0/2/

36

F01C )2011.01(
,‫מנוע בעל העברת מיקום הפכית‬
)IDAR( ‫וסיבוביות אסימטרית‬

76:78>

SALMONELLA ENTERICA
PRESENTING C.JEJUNI N-GLYCAN
OR DERIVATIVES THEREOF
EIDGENOSSISCHE TECHNISCHE
HOCHSCHULE ZURICH
EP
09004445.4 27/03/2009
PCT/EP/2010/001884
WO/2010/108682

A61N )2011.01(

C12N )2011.01(

–‫ אן‬JEJUNI.C ‫סלמונלת המעיים המציגה‬
‫גליקן או נגזרות מתאימות‬

December 29, 2011-‫ג' בטבת התשע"ב‬

07//1/0/2/

76:795

‫הקצאת כלי נשק לסכנות‬

ASSIGNING WEAPONS TO THREATS
BAE SYSTEMS PLC
GB
0905563.3
31/03/2009
/703/7639/
12//1/0//7
EP
PCT/GB/2010/050530
WO/2010/112907

/7//1/0/2/

76:796

CURED IN PLACE PIPE LINER WITH
STYRENE BARRIER
LUBRIZOL ADVANCED MATERIALS,
INC.
US
61/162725
24/03/2009
PCT/US/2010/026580
WO/2010/111025

26//1/0/2/

76:798

37

A61F )2011.01(
‫מכשיר ושיטה ליצירת חתך מעגלי‬
‫ הקסיס בע"מ‬.‫אר‬.‫וי‬

76:799

APPARATUS AND METHOD FOR
INTERACTIVE DIGITAL MEDIA
CONTENT REQUESTS
AKOO INTERNATIONAL, INC.
US
12/415096
31/03/2009
PCT/US/2010/029306
WO/2010/117828

F16L )2011.01(

‫ לחיבור צינור לצינור עם‬CIPP ‫טכנולוגית‬
‫מחסום מסטירן‬

APPARATUS AND METHOD FOR
MAKING A CIRCULAR INCISION
V.R, HEXIS LTD
US
12/408841
23/03/2009
PCT/IL/2010/000225
WO/2010/109447

12//1/0/2/

F41G )2011.01(

G11B )2011.01(

‫מכשיר ושיטה אינטראקטיביות לבקשות‬
‫תוכן במדיה דיגיטלית‬

December 29, 2011-‫ג' בטבת התשע"ב‬

26//1/0/2/

USE OF NKP46 FOR PREVENTING
DIABETES
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM LTD
US
61/202629
19/03/2009
42/03712/
/7/22/0//7
US
PCT/IL/2010/000228
WO/2010/106542

04//0/0/2/

‫ למניעת סוכרת‬NKP46–‫שימוש ב‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים בע"מ‬

76:79=

PROCESS FOR SEPARATING
ENANTIOMERS OF 3,6-DIHYDRO-1,3,5TRIAZINE DERIVATIVES
MERCK PATENT GMBH
DE
102009014898.1 25/03/2009
PCT/EP/2010/001219
WO/2010/108583

1///2/0/2/

38

76:7:5

C07D )2011.01(

‫תהליך להפרדת אננטיומרים של‬
‫–טריאזין‬5,3,1–‫–דיהידרו‬6,3 ‫נגזרות של‬

76:79>

CYCLIC INHIBITORS OF 11BETAHYDROXYSTEROID DEHYDROGENASE 1
VITAE PHARMACEUTICALS, INC.
US
PCT/US09/002653 30/04/2009
US
PCT/US09/004261 01//5/0//7
PCT/US/2010/033157
WO/2010/127237

20//1/0/2/

A61K )2011.01(

76:79:

C07D )2011.01(
–‫ בתא‬11 ‫מעכבים ציקליים של‬
1 ‫הידרוקסיסטירואיד דהידרוגנאז‬

F28D )2011.01(

December 29, 2011-‫ג' בטבת התשע"ב‬

HEAT TRANSFER SHEET FOR
ROTARY REGENERATIVE HEAT
EXCHANGER
ALSTOM TECHNOLOGY LTD.
US
12/437914
08/05/2009
PCT/US/2010/027076
WO/2010/129092

02//1/0/2/

‫יריעה מעבירה חום עבור ממיר חם משובי‬
‫סיבובי‬

ATROPISOMERS OF2-PURINYL-3TOLYL-QUINAZOLINONE
DERIVATIVES AND METHODS OF
USE
GILEAD CALISTOGA LLC
US
61/162980
24/03/2009
42/01233/
/3//6/0//7
US
PCT/US/2010/028554
WO/2010/111432

26//3/0/2/

–3–‫–פוריניל‬2 ‫אטרופאיזומרים של תולדות‬
‫טוליל–קווינאזולינון ושיטות לשימוש בהן‬

76:7:7

CATHODE FOR ELECTROLYTIC
PROCESSES
INDUSTRIE DE NORA S.P.A
IT
MI2009A000880 19/05/2009
PCT/EP/2010/056797
WO/2010/133583

/5//2/0/2/

76:7:8

METHODS OF PREDICTING CANCER
RISK USING GENE EXPRESSION IN
PREMALIGNANT TISSUE
GENOMIC HEALTH, INC.
US
61/167503
07/04/2009
42/0215/6
26//7/0//7
US
PCT/US/2010/030285
WO/2010/118166
39

C07D )2011.01(

76:7:6

C25B )2011.01(

‫קטודה עבור תהליכים אלקטרוליטיים‬

C12Q )2011.01(
‫שיטות לחיזוי סיכון לסרטן ע"י שימוש‬
‫בביטוי גני ברקמה טרום–ממאירה‬

December 29, 2011-‫ג' בטבת התשע"ב‬

/1//0/0/22

76:7:9

AUDIO DECODER AND DECODING
METHOD USING EFFICIENT
DOWNMIXING
DOLBY LABORATORIES LICENSING
CORPORATION
US
61/305871
18/02/2010
42/137541
07//4/0/2/
US
PCT/US/2011/023533
WO/2011/102967

00//2/0/2/

03//1/0/2/

‫מפענח אודיו ושיטה פענוח המשתמשת‬
‫בערבוב יעיל‬

76:7::

REAL-TIME OPTICAL
COMPENSATION OF ORBITINDUCED DISTORTION EFFECTS IN
LONG INTEGRATION TIME IMAGERS
RAYTHEON COMPANY
US
12/412118
26/03/2009
PCT/US/2010/021748
WO/2010/110934

HETEROCYCLIC COMPOUNDS AS
AUTOTAXIN INHIBITORS
40

G02B )2011.01(

‫קיזוז אופטי בזמן אמת של השפעות עיוות‬
‫נגרמות–מסלול במדמים בעלי זמן‬
‫אינטגרציה ארוך‬

76:7:;

SURGICAL SUTURING DEVICE,
METHOD AND TOOLS USED
THEREWITH
ALPHA SCIENTIFIC CORPORATION
US
12/384326
02/04/2009
PCT/US/2010/000891
WO/2010/114591

/1//1/0/2/

G10L )2011.01(

76:7:=

A61B )2011.01(
‫ שיטה וכלים‬,‫התקן תפירה כירורגי‬
‫שמשתמשים בהם אתו‬

C07D )2011.01(
‫תרכובות הטרוציקליות כמעכבי‬
‫אוטוטקסין‬
December 29, 2011-‫ג' בטבת התשע"ב‬

MERCK PATENT GMBH
EP
09004858.8
PCT/EP/2010/001324
WO/2010/112116

/7//1/0/2/

02/04/2009

76:7:>

‫מעכבי אוטוטקסין‬

AUTOTAXIN INHIBITORS
MERCK PATENT GMBH
EP
09004866.1 02/04/2009
PCT/EP/2010/001457
WO/2010/112124

/1//1/0/2/

76:7;5

PIPERIDINE AND PIPERAZINE
DERIVATIVES AS AUTOTAXIN
INHIBITORS
MERCK PATENT GMBH
EP
09004856.2 02/04/2009
PCT/EP/2010/001323
WO/2010/115491

27//1/0/2/

41

C07D )2011.01(
‫נגזרות של פיפרידין ופיפראזין כמעכבי‬
‫אוטוטקסין‬

76:7;6

MODULATORS OF CYSTIC FIBROSIS
TRANSMEMBRANE CONDUCTANCE
REGULATOR, COMPOSITIONS
CONTAINING THE SAME AND USES
THEREOF
VERTEX PHARMACEUTICALS
INCORPORATED
US
61/162130
20/03/2009
PCT/US/2010/028062
WO/2010/108155

C07D )2011.01(

C07D )2011.01(

‫מאפנני הרגולטור למוליכות‬
,‫הטרנסממברני של סיסטיק פיברוזה‬
‫תכשירים המכילים אותם ושימושים בהם‬

December 29, 2011-‫ג' בטבת התשע"ב‬

27//1/0/2/

76:7;7

PROCESS FOR PRODUCING A
CYSTIC FIBROSIS
TRANSMEMBRANE CONDUCTANCE
MODULATOR, PRODUCTS THEREOF
AND USES OF THE SAME
VERTEX PHARMACEUTICALS
INCORPORATED
US
61/162148
20/03/2009
42/0241/1
06//7/0//7
US
42/026343
/3/2//0//7
US
PCT/US/2010/028069
WO/2010/108162

06//1/0/2/

‫שיטה לייצור מאפנני הרגולטור למוליכות‬
,‫הטרנסממברני של סיסטוק פיברוזה‬
‫מוצרים שלהם ושימושים בהם‬

76:7;9

00//1/0/2/

C07K )2011.01(

‫ חדשים ושימושים בהם‬a5?1 ‫נוגדנים אנטי‬

76:7>7

COMPOUNDS AND METHODS FOR
MODULATING AN IMMUNE
RESPONSE
THE WALTER AND ELIZA HALL
INSTITUTE OF MEDICAL RESEARCH
42

‫ידע חברה למחקר ופיתוח בע"מ‬

76:7>6

NOVEL ANTI-a5?1 ANTIBODIES AND
USES THEREOF
GENENTECH, INC.
US
61/163241
25/03/2009
PCT/US/2010/028291
WO/2012/111254

C07D )2011.01(
HIV–1 ‫ליפופפטידים מעכבי‬

LIPOPEPTIDE INHIBITORS OF HIV-1
YEDA RESEARCH AND
DEVELOPMENT CO. LTD.
US
61/165536
01/04/2009
PCT/IL/2010/000271
WO/2010/113157

01//1/0/2/

C07D )2011.01(

A61K )2011.01(

‫תרכובות ושיטות לאפנון תגובה חיסונית‬

December 29, 2011-‫ג' בטבת התשע"ב‬

US
61/162616
PCT/AU/2010/000325
WO/2010/108215

/2//2/0/2/

23/03/2009

76:7>8

PROVIDING ACCESS TO A DATA
ITEM USING ACCESS GRAPHS
MICROSOFT CORPORATION
US
12/416164
01/04/2009
PCT/US/2010/029712
WO/2010/115059

04//2/0/2/

‫מתן גישה לפריט נתונים באמצעות גרפי‬
‫גישה‬

76:7>9

SYSTEMS AND METHODS FOR
APPLYING MODEL TRACKING TO
MOTION CAPTURE
MICROSOFT CORPORATION
US
61/174950
01/05/2009
20/26351/
24//4/0//7
US
PCT/US/2010/032366
WO/2010/126816

24//0/0/2/

24//2/0/2/
43

A63F )2011.01(
‫מערכות ושיטות ליישום מודל מעקב‬
‫ללכידת תנועה‬

76:7>;

PCR METHODS FOR
CHARACTERIZING THE 5'
UNTRANSLATED REGION OF THE
FMR1 AND FMR2 GENES
ASURAGEN, INC.
US
61/162977
24/03/2009
PCT/US/2010/000426
WO/2010/110835

G06F )2011.01(

C12Q )2011.01(

‫ לאפיון האיזור הלא מתורגם‬PCR ‫שיטות‬
FMR2–‫ ו‬FMR1 ‫ של הגנים‬5'

76:7><

C07D )2011.01(
December 29, 2011-‫ג' בטבת התשע"ב‬

‫אימידאזופיראזינים לשימוש כמעכבי‬
‫קינאז‬

IMIDAZOPYRAZINES FOR USE AS
KINASE INHIBITORS
CENTRO NACIONAL DE
INVESTIGACIONES ONCOLOGICAS
(CNIO)
EP
09380079.5 16/04/2009
PCT/GB/2010/000773
WO/2010/119264

02//1/0/2/

76:7>=

USEFUL PHARMACEUTICAL SALTS
OF 7[(3R,4R)-3-HYDROXY-4HYDROXYMETHYL-PYRROLIDIN-1YLMETHYL]-3,5-DIHYDROPYRROLO[3,2-D]PYRIMIDIN-4-ONE
BIOCRYST PHARMACEUTICALS ,
INC.
US
61/162805
24/03/2009
PCT/US/2010/028490
WO/2010/111381

01//1/0/2/

25//1/0/2/
SYSTEM AND METHOD FOR
COMPRESSING VIDEO BASED ON
LATENCY MEASUREMENTS AND
OTHER FEEDBACK
44

R3,R4)–([–7 ‫מלחי רוקחות שימושיים של‬
–‫–הידרוקסימתיל–פירולידין‬4–‫–הידרוקסי‬3
–2,3[‫–דיהידרו–פירולו‬5,3–]‫–אילמתיל‬1
‫–און‬4–‫]פירימידין‬D

76:7>>

SUBSTITUTED 1,4-DIOXA-8AZASPIRO[4,5]DECANES USEFUL AS
FUNGICIDES AND A PROCESS FOR
THE PREPARATION THEREOF
COUNCIL OF SCIENTIFIC AND
INDUSTRIAL RESEARCH
IN
612/DEL/2009 27/03/2009
PCT/IB/2010/000648
WO/2010/109299

C07D )2011.01(

A01N )2011.01(

‫]דקאנים‬5,4[–‫–אזאספירו‬8–‫–דיאוקסא‬4,1
‫המותמרים משמשים כקוטלי פטריות‬
‫ותהליך להכנתם‬

76:855

H04N )2011.01(

‫מערכת ושיטה לדחיסת וידאו המבוססות‬
‫על מדידות זמן המתנה או היזון חוזר אחר‬
December 29, 2011-‫ג' בטבת התשע"ב‬

ONLIVE, INC.
US
61/210,888
20/3165/62
US
PCT/US/2010/027692
WO/2010/111092

25//1/0/2/

23/03/2009
/5//6/0//7

76:856

SYSTEM AND METHOD FOR
ACCELERATED MACHINE
SWITCHING
ONLIVE, INC.
US
61/210,888
23/03/2009
20/3165/55
/5//6/0//7
US
PCT/US/2010/027730
WO/2010/111102

25//1/0/2/

25//1/0/2/

H04N )2011.01(

‫מערכת ושיטה לדחיסת וידאו ע"י שימוש‬
‫בהיזון חוזר הכולל נתונים הקשורים‬
‫לקבלה מוצלחת של תוכן וידאו‬

76:858

SYSTEM AND METHOD FOR
ENCODING VIDEO USING A
SELECTED TILE AND TILE
ROTATION PATTERN
ONLIVE, INC.
US
61/210,888
23/03/2009
20/3165/54
/5//6/0//7
US
PCT/US/2010/027718
45

‫מערכת ושיטה עבור מיתוג מכונה מואץ‬

76:857

SYSTEM AND METHOD FOR VIDEO
COMPRESSION USING FEEDBACK
INCLUDING DATA RELATED TO THE
SUCCESSFUL RECEIPT OF VIDEO
CONTENT
ONLIVE, INC.
US
61/210,888
23/03/2009
20/3165/74
/5//6/0//7
US
PCT/US/2010/027712
WO/2010/111095

A63F )2011.01(

H04B )2011.01(

‫מערכת ושיטה להצפנת וידאו ע"י שימוש‬
‫בקטע נבחר ותבנית רוטצית קטע‬

December 29, 2011-‫ג' בטבת התשע"ב‬

WO/2010/111097

25//1/0/2/

76:859

SYSTEM AND METHOD FOR
UTILIZING FORWARD ERROR
CORRECTION WITH VIDEO
COMPRESSION
ONLIVE, INC.
US
61/210,888
23/03/2009
20/3165/40
/5//6/0//7
US
PCT/US/2010/027727
WO/2010/111101

25//1/0/2/

76:85:

SYSTEM AND METHOD FOR MULTISTREAM VIDEO COMPRESSION
ONLIVE, INC.
US
61/210,888
23/03/2009
20/3165/22
/5//6/0//7
US
PCT/US/2010/027725
WO/2010/111100

25//1/0/2/

76:85;

SYSTEM AND METHOD FOR MULTISTREAM VIDEO COMPRESSION
USING MULTIPLE ENCODING
FORMATS
ONLIVE, INC.
US
61/210888
23/03/2009
20/316/70
/5//6/0//7
US
PCT/US/2010/027723
WO/2010/111099

46

H04N )2011.01(
‫מערכת ושיטה לשימוש בתיקון שגיאה‬
‫מתמשך בדחיסת וידאו‬

G06K )2011.01(
‫מערכת ושיטה לדחיסת וידאו מרובה‬
‫זרמים‬

G06K )2011.01(
‫מערכת ושיטה לדחיסת וידאו מרובה‬
‫זרמים ע"י שימוש בפורמטי הצפנה‬
‫מרובים‬

December 29, 2011-‫ג' בטבת התשע"ב‬

25//1/0/2/

76:85<

TEMPORARY DECODER APPARATUS
AND METHOD
ONLIVE, INC.
US
61/210,888
23/03/2009
20/3165/64
/5//6/0//7
US
PCT/US/2010/027720
WO/2010/111098

25//1/0/2/

‫מערכת ושיטה לפענוח זמני‬

76:85=

SYSTEM AND METHOD FOR
SELECTING A VIDEO ENCODING
FORMAT BASED ON FEEDBACK
DATA
ONLIVE, INC.
US
61/210,888
23/03/2009
20/3165/7/
/5//6/0//7
US
PCT/US/2010/027699
WO/2010/111093

25//1/0/2/

/7//2/0/2/

47

H04N )2011.01(

‫מערכת ושיטה לדחיסת פרימים בוידאו או‬
‫חלקים מהם המבוססות על היזון חוזר של‬
‫מידע ממכשיר לקוח‬

76:865

ORGANIC COMPOUNDS AND THEIR
USES
NOVARTIS AG

H04N )2011.01(
‫מערכת ושיטה לבחירת פורמט הצפנה‬
‫לוידאו המבוססות על היזון חוזר של‬
‫נתונים‬

76:85>

SYSTEM AND METHOD FOR
COMPRESSING VIDEO FRAMES OR
PORTIONS THEREOF BASED ON
FEEDBACK INFORMATION FROM A
CLIENT DEVICE
ONLIVE, INC.
US
61/210,888
23/03/2009
20/3165/32
/5//6/0//7
US
PCT/US/2010/027716
WO/2010/111096

G06K )2011.01(

C07D )2011.01(
‫תרכובות אורגניות ושימושן‬
December 29, 2011-‫ג' בטבת התשע"ב‬

US
61/168,408
42/2625/16
US
PCT/IB/2010/000784
WO/2010/116248

10/04/2009
04//3/0//7

00//1/0/2/

76:869

HUMANIZED ANTIBODIES AGAINST
LIGHT AND USES THEREOF
TEVA BIOPHARMACEUTICALS USA,
INC.
US
61/202,661
24/03/2009
PCT/US/2010/028144
WO/2010/111180

04//1/0/2/

‫נוגדנים אנושיים כנגד לייט ושימושהם‬

76:86:

SOLID STATE FORMS OF
SITAGLIPTIN SALTS
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
61/164,563
30/03/2009
42/25/5475
0///2/0//7
US
42/2525/51
1///2/0//7
US
42/2605550
/2//4/0//7
US
42/2645/12
22//4/0//7
US
42/1/05404
/7//0/0/2/
US
42/1/25423
23//0/0/2/
US
42/1/75/02
/2//1/0/2/
US
42/1205154
2///1/0/2/
US
42/1235227
26//1/0/2/
US
PCT/US/2010/029098
WO/2010/117738

01//1/0/2/
TREATMENT OF CANCER WITH
IMMUNOSTIMULATORY HIV TAT
DERIVATIVE POLYPEPTIDES
NANIRX INC.
48

C07K )2011.01(

C07D )2011.01(
‫מבנים גבישיים של מלחי סיטאגליפטין‬
‫טבע תעשיות פרמצבטיות בע"מ‬

76:86;

A61K )2011.01(

‫ פעילים‬TAT HIV‫פוליפפטידים נגזרים מ‬
‫ לטיפול בסרטן‬,‫אימונית‬
December 29, 2011-‫ג' בטבת התשע"ב‬

US
61/162605
42/1/4056
US
42/12/002
US
PCT/US/2010/028347
WO/2010/111292

2///2/0/2/

23/03/2009
27//0/0/2/
/1//1/0/2/

76:86<

STRUT, SYSTEM AND METHOD FOR
A SOLAR MIRROR FRAME
WERNER EXTRUSION SOLUTIONS
LLC
US
61/212854
16/04/2009
PCT/US/2010/001062
WO/2010/120349

07//2/0/2/

76:86=

TRANSISTOR JUNCTION DIODE
CIRCUITRY SYSTEMS AND
METHODS
ENTROPIC COMMUNICATIONS, INC.
US
61/174813
01/05/2009
20/27/125
02//4/0//7
US
PCT/US/2010/032917
WO/2010/127078

04//1/0/2/

76:86>

AN ARRANGEMENT FOR MANAGING
WIRELESS COMMUNICATION
BETWEEN DEVICES
XPED HOLDINGS PTY LTD
AU
2009901298 26/03/2009
PCT/AU/2010/000358
WO/2010/108235

49

F24J )2011.01(
‫ מערכת ושיטה עבור‬,‫התקן תמיכה‬
‫מסגרת של מראה סולארית‬

H02M )2011.01(
‫מערכות ושיטות של חיבורי דיודה‬
‫במעגלים חשמליים בטרנזיסטורים‬

H04B )2011.01(
‫הסדר לניהול תקשורת אלחוטית בין‬
‫מכשירים‬

December 29, 2011-‫ג' בטבת התשע"ב‬

01//1/0/2/

76:875

DEVICE AND METHOD FOR
AUTOMATED VERIFICATION OF
POLARIZATION-VARIANT IMAGES
LATENT IMAGE TECHNOLOGY LTD.
US
12/419360
07/04/2009
PCT/IB/2010/051250
WO/2010/116279

12//1/0/2/

‫מכשיר ושיטה לאימות אוטומטי של‬
‫תמונות בגרסת פולריזאציה‬
.LATENT IMAGE TECHNOLOGY LTD

76:876

METHOD FOR DETECTING
SUBSTANCE IN BIOLOGICAL
SAMPLE
VIRUS IKAGAKU KENKYUSHO INC
2009JP
31/03/2009
087839
PCT/JP/2010/055887
WO/2010/114031

12//1/0/2/

76:877

50

G01N )2011.01(
‫ בדגימה‬SITH–1 ‫שיטה לגילוי נוגדן נגד‬
‫ביולוגית‬

76:879

LOW VOLTAGE DRIVER SCHEME
FOR INTERFEROMETRIC
MODULATORS
QUALCOMM MEMS TECHNOLOGIES,
INC.
US
12/413336
27/03/2009

G01N )2011.01(
‫שיטה לגילוי חומר בדגימה ביולוגית‬

METHOD FOR DETECTING
ANTIBODY AGAINST SITH-1 IN
BIOLOGICAL SAMPLE
VIRUS IKAGAKU KENKYUSHO INC
2009JP
31/03/2009
087816
PCT/JP/2010/055884
WO/2010/114029

02//1/0/2/

B42D )2011.01(

G09G )2011.01(

‫סכימת מניע בעל וולטאג' נמוך למאפננים‬
‫אינטרפרומטריים‬

December 29, 2011-‫ג' בטבת התשע"ב‬

20/47/172
US
PCT/US/2010/028552
WO/2010/111431

/2//2/0/2/

0///2/0/2/

76:87:

LYOPHILIZATION CAKES OF
PROTEASOME INHIBITORS
CEPHALON. INC.
US
61/166529
03/04/2009
/71/307296
/5//2/0//7
EP
42/066733
00/20/0//7
US
PCT/US/2010/029597
WO/2010/114982

04//1/0/2/

‫נתחי ליופיליזציה של מעכבי פרוטיאזום‬

76:87;

AGROCHEMICAL COMPOSITION FOR
PEST CONTROL AND PEST CONTROL
METHOD
ISHIHARA SANGYO KAISHA LTD.
2009JP
31/03/2009
084618
PCT/JP/2010/055314
WO/2010/113775

03//1/0/2/

51

A01N )2011.01(
‫תכשיר כימי המשפר את היבול לבקרת‬
‫מזיקים ושיטה לבקרת מזיקים‬

76:87<

DEVICE AND METHOD TO CONDUCT
AN ELECTROCHEMICAL REACTION
ON A SURFACE OF A SEMICONDUCTOR SUBSTRATE
ALCHIMER
FR
0901518
27/03/2009
PCT/EP/2010/053955
WO/2010/108996

A61K )2011.01(

C25D )2011.01(

–‫התקן ושיטה לניהול ריאקציה אלקטרו‬
‫כימית על פני–שטח של מצע מוליך‬
‫למחצה‬

December 29, 2011-‫ג' בטבת התשע"ב‬

07//1/0/2/

76:87=

METHOD FOR INDUCING CELL
DEATH IN PLURIPOTENT STEM
CELLS AND DIFFERENTIATED
CELLS OTHER THAN CARDIAC
MYOCYTES
KEIO UNIVERSITY
2009JP
30/03/2009
083553
PCT/JP/2010/056108
WO/2010/114136

01//1/0/2/

‫שיטה להשריית מוות תאי בתאי גזע‬
‫פלוריפוטנטיים ובתאים שעברו התמיינות‬
‫מלבד קרדיומיוציטים‬

76:87>

SEED COATING COMPOSITIONS AND
METHODS FOR APPLYING SOIL
SURFACTANTS TO WATERREPELLENT SOIL
BRIGHAM YOUNG UNIVERSITY
US
61/210868
23/03/2009
PCT/US/2010/028371
WO/2010/111309

01//1/0/2/

01//1/0/2/
DIELECTRIC METAL OXIDE FILMS
AND PROCESSES FOR PRODUCING
THE SAME
52

A01B )2011.01(
‫תכשירים לציפוי זרעים ושיטות להנחת‬
‫חומרים פעילי שטח לאדמה על קרקע‬
‫דוחת מים‬

76:885

POLYPEPTIDES AND IMMUNIZING
COMPOSITIONS CONTAINING GRAM
POSITIVE POLYPEPTIDES AND
METHODS OF USE
EPITOPIX, LLC
US
61/210772
23/03/2009
PCT/US/2010/028326
WO/2010/111273

C12N )2011.01(

A61K )2011.01(

‫פוליפפטידים ותכשירים מחסנים המכילים‬
‫פוליפפטידים גראם חיוביים ושיטות‬
‫לשימוש‬

76:886

H01B )2011.01(

‫סרטי תחמוצת מתכת דיאלקטרי ושיטות‬
‫להכנתם‬
December 29, 2011-‫ג' בטבת התשע"ב‬

SBA MATERIALS, INC.
US
61/162549
PCT/US/2010/028374
WO/2010/111311

00//1/0/2/

23/03/2009

76:88:

CARTILAGE REPAIR
GENZYME CORPORATION
US
61/162447
23/03/2009
PCT/US/2010/028086
WO/2010/111161

/4//2/0/2/

76:88;

ISOXAZOL-3(2H)-ONE ANALOGS AS
THERAPEUTIC AGENTS
ASTRAZENECA AB
US
61/167224
07/04/2009
42/252734
01//2/0//7
US
PCT/SE/2010/050375
WO/2010/117323

04//1/0/2/

76:88<

CITRULLINATED PEPTIDES FOR
DIAGNOSING AND PROGNOSING
RHEUMATOID ARTHRITIS
PROMETHEUS LABORATORIES INC.
US
61/164840
30/03/2009
42/021274
25//7/0//7
US
42/033/36
04/2//0//7
US
PCT/US/2010/028946
WO/2010/117694

02//1/0/2/
53

76:88=

A61L )2011.01(
‫תיקון סחוס‬

C07D )2011.01(
‫)–און‬H2( 3–‫אנאלוגים של איזוקסאזול‬
‫כחומרים טיפוליים‬

C07K )2011.01(
‫פפטידים שעברו ציטרוליניזציה לאבחון‬
‫וצפי של דלקת מפרקים שיגרונית‬

C07K )2011.01(
December 29, 2011-‫ג' בטבת התשע"ב‬

ADENYLYL CYCLASE-ASSOCIATED
PROTEIN (CAP1) AND USES
THEREOF AS A TARGET FOR
IMMUNO-MODULATION
PROTAB LTD
US
61/164489
30/03/2009
PCT/IL/2010/000231
WO/2010/113148

/1//7/0/2/

CAP) PROTEIN 1( ‫החלבון‬
ASSOCIATED–CYCLASE ADENYLYL
‫ושימושיו כמטרה לאימונומודולציה‬
‫פרוטאב בע"מ‬

76:88>

PARABOLIC CONCENTRATOR WITH
PARABOLICALLY CURVED ROTATING
SECTORS
FARINA, GIUSEPPE
IT
RM2009A000457 09/09/2009
PCT/IT/2010/000384
WO/2011/030364

/7//1/0/2/

12//1/0/2/

C12M )2011.01(

‫כור פוטוסינטטי לתרבות מיקרואורגניזמים‬
‫ושיטה לתרבות מיקרואורגניזמים‬

76:897

NOVEL AMIDE DERIVATIVES OF
STEROIDAL[3,2-C]PYRAZOLE
COMPOUNDS WITH
GLUCOCOTRICOID ACTIVITY
ASTRAZENECA AB
US
61/166324
03/04/2009
PCT/SE/2010/050354
WO/2010/114471
54

‫מרכזת פרבולית עם חלקי סיבוב‬
‫עקמומים פרבולית‬

76:896

A PHOTOSYNTHETIC REACTOR FOR
CULTURE OF MICROORGANISMS
AND METHOD FOR CULTURE OF
MICROORGANISMS
MICROPHYT
FR
09/51917
25/03/2009
PCT/FR/2010/050395
WO/2010/109108

F24J )2011.01(

C07J )2011.01(
‫תולדות אמיד חדשות של תרכובות‬
‫]פיראזול עם פעילות‬C–2,3[ ‫סטרואידל‬
‫גלוקוקורטיקואיד‬

December 29, 2011-‫ג' בטבת התשע"ב‬

01//1/0/2/

76:898

‫שכבה לייצור חפצים מחומרים‬
‫ שיטת ייצור של אותה‬,‫מורכבים‬
‫שכבה ושיטת ייצור של החפצים‬
‫מהחומרים המורכבים תוך שימוש‬
‫באותה שכבה‬

FILM FOR PRODUCTION OF COMPOSITE
MATERIAL ARTEFACTS, PRODUCTION
METHOD OF SAID FILM AND
PRODUCTION METHOD OF COMPOSITE
MATERIAL ARTEFACTS USING SAID
FILM
A. PERUZZA S.R.L.
IT
TV2009A000056 23/03/2009
PCT/EP/2010/053768
WO/2010/108916

/7//1/0/2/

76:899

VEHICLE HAVING ROLLING
COMPENSATION
BOMBARDIER TRANSPORTATION
GMBH
DE
102009014866.3 30/03/2009
PCT/EP/2010/052978
WO/2010/112306

/2//2/0/2/

76:89:

SYSTEMS AND METHODS FOR
DETECTING ANOMALIES FROM
DATA
I-CETANA PTY LTD
AU
2009901406 01/04/2009
0//77/3715
/2/20/0//7
AU
PCT/AU/2010/000379
WO/2010/111748

20//3/0/2/
55

76:89;

B29C )2011.01(

B61F )2011.01(
‫רכב בעל מנטרל טלטול‬

G06T )2011.01(
‫מערכות ושיטות לזיהוי חריגות במידע‬

A61P )2011.01(
December 29, 2011-‫ג' בטבת התשע"ב‬

COMPOSITIONS AND METHODS FOR
INHIBITING EXPRESSION OF
GLUCOCORTICOID RECEPTOR (GCR)
GENES
F. HOFFMANN-LA ROCHE AG
EP
09160411.6 15/05/2009
PCT/EP/2010/056527
WO/2010/130771

/2//0/0/2/

‫תכשירים ושיטות לעיכוב ביטוי של גנים‬
‫של קולטן גלוקוקורטיקואיד‬

76:89<

‫עיבוד זרם גז‬

GAS STREAM PROCESSING
ALSTOM TECHNOLOGY LTD.
US
61/164185
27/03/2009
20/4/7/54
1//2//0//7
US
PCT/US/2010/022710
WO/2010/110939

/2//2/0/2/

76:89=

NOVEL DICARBOXYLIC ACID
LINKED AMINO ACID AND PEPTIDE
PRODRUGS OF OPIOIDS AND USES
THEREOF
SHIRE LLC
US
61/211831
02/04/2009
42/005524
00//5/0//7
US
PCT/GB/2010/050584
WO/2010/112942

02//1/0/2/

56

A61K )2011.01(

‫חומצה דיקרבוקסילית חדשה הקשורה‬
‫לחומצת אמינו ומטרימי תרופות פפטידים‬
‫של אופיאוידים ושימושים בהם‬

76:89>

FERTILIZATION MODULATION
COMPOUNDS AND PROCESS FOR
IMPLEMENTING THEM
UNIVERSITE JOSEPH FOURIER
EP
09305261.1 24/03/2009
PCT/EP/2010/053815
WO/2010/108942

B01D )2011.01(

A61K )2011.01(
‫תרכובות מאפננות הפריה ותהליך‬
‫ליישומם‬

December 29, 2011-‫ג' בטבת התשע"ב‬

03//1/0/2/

76:8:5

‫מערכת קירור סופרסונית‬

SUPERSONIC COOLING SYSTEM
CAITIN, INC.
US
61/163438
25/03/2009
42/006335
03//5/0//7
US
PCT/US/2010/028761
WO/2010/111560

04//1/0/2/

76:8:6

METHOD FOR IMAGING ON THIN
SOLID-STATE INTERFACE BETWEEN
TWO FLUIDS
TRUSTEES OF BOSTON UNIVERSITY
US
61/211260
26/03/2009
PCT/US/2010/028845
WO/2010/111602

24//2/0/2/

76:8:7

76:8:9

FORMULATION FOR STABILIZING
PROTEINS, WHICH IS FREE OF
MAMMALIAN EXCIPIENTS
MERZ PHARMA GMBH & CO. KGaA
57

G01N )2011.01(

‫שיטת הדמיה על ממשק דק במצב מוצק‬
‫בין שני זורמים‬

SYNTHESIS OF 1-AMINO-1,3,3,5,5PENTAMETHYLCYCLOHEXANE
MESYLATE
MERZ PHARMA GMBH & CO. KGaA
EP
09005471.9 17/04/2009
42/022/23
25//2/0//7
US
PCT/EP/2010/002361
WO/2010/118889

24//2/0/2/

F25B )2011.01(

C07C )2011.01(
MESYLATE ‫סינתזה של‬
PENTAMETHYLCYCLOHEXANE–
1,3,3,5,5–AMINO–1

A61K )2011.01(
‫ נקייה מחומרים‬,‫נוסחה לייצוב חלבונים‬
‫לא פעילים שמקורם ביונקים‬
December 29, 2011-‫ג' בטבת התשע"ב‬

EP
09005470.1
42/020730
US
PCT/EP/2010/002360
WO/2010/118888

17/04/2009
25//2/0//7

04//1/0/2/

76:8::

IMPROVEMENTS TO APPARATUS,
ARTICLE AND METHOD FOR REDUCING
PAIN DURING SKIN PUNCTURING
PROCESURES
BING INNOVATIONS, LLC
US
61/163945
27/03/2009
US
PCT/US2009/066033 07/22/0//7
PCT/US/2010/028858
WO/2010/111611

22//2/0/2/

03//1/0/2/

F41A )2011.01(

‫מערכת שיגור טילים ניידת ושיטה לכך‬

76:8:<

A METHOD FOR PRODUCING
BICYCLIC Y-MINO ACID
DERIVATIVES
DAIICHI SANKYO COMPANY,
LIMITED
2009JP
26/03/2009
075792
58

‫ חפץ ושיטה‬,‫שיפורים להתקן‬
‫להקטנה כאב במהלך תהליכי‬
‫דיקור עור‬

76:8:;

A MOBILE MISSILE LAUNCH SYSTEM
AND METHOD THEREOF
DIRECTOR GENERAL, DEFENCE
RESEARCH & DEVELOPMENT
ORGANISATION
IN
00648/DEL/2009 30/03/2009
IN
DEL/2009///462 12//1/0//7
IN
DEL/2009///463 12//1/0//7
IN
DEL/2009///5/1 /4//2/0//7
PCT/IN/2010/000018
WO/2010/113171

A61M )2011.01(

C07C )2011.01(

–Y–‫שיטה לייצור נגזרת חומצת ביציקלו‬
‫אמינו‬

December 29, 2011-‫ג' בטבת התשע"ב‬

PCT/JP/2010/055202
WO/2010/110361

03//1/0/2/

76:8:=

CARBOXYLIC ACID COMPOUNDS
AND PROCESSES FOR PRODUCING
THE SAME
JAPAN TOBACCO INC.
2009JP
26/03/2009
077601
42/022520
/0//2/0//7
US
PCT/JP/2010/055160
WO/2010/110352

03//1/0/2/

‫תרכובות חומצות קארבוקסיליות ושיטות‬
‫לייצורן‬

76:8:>

COMPOUND CONTAINED IN A BLUE
ROSE
SUNTORY HOLDINGS LIMITED
2009JP
27/03/2009
080524
0//7-223500 20//3/0//7
JP
0//7-251/74 02//5/0//7
JP
PCT/JP/2010/055262
WO/2010/110382

04//1/0/2/

76:8;6

PROCESS FOR PRODUCING PLASTIC
BOTTLES
ADEKA CORPORATION
2009JP
27/03/2009
078851
PCT/JP/2010/055366
WO/2010/110422

59

C07C )2011.01(

C07D )2011.01(
‫תרכובת הנמצאת בוורד כחול‬

C08L )2011.01(
‫שיטה לייצור בקבוקים מפלסטיק‬

December 29, 2011-‫ג' בטבת התשע"ב‬

76:8;7

A61K )2011.01(

LIQUID FORMULATIONS OF SALTS OF 1-[2-(2,4DIMETHYLPHENYLSULFANYL)PHENYL]PIPERAZINE

‫פורמולציות נוזליות של מלחים‬
–4,2(–2[–1 ‫של‬
‫דימתילפנילסולפניל)פניל]פיפרזין‬

24//2/0/2/

H. LUNDBECK A/S
DK
PA200900531
PCT/DK/2010/050084
WO/2010/121621

/4//2/0/2/

24/04/2009

COMBINATION THERAPY USING AN
ANTI-EGFR AGENT(S) AND IGF-1R
SPECIFIC INHIBITORS
MERCK SHARP & DOHME CORP
US
61/169768
16/04/2009
PCT/US/2010/030022
WO/2010/120592

03//1/0/2/

EGFR–‫טיפול משולב על–ידי חומרי אנטי‬
R–IGF1–‫ומעכבים ספציפיים ל‬

76:8;9

APPARATUS FOR COMPACTING A
FIBROUS WEB
TRUTZSCHLER NONWOVENS GMBH
DE
102009016996.2 08/04/2009
2/0//7/2550797
22//2/0//7
DE
PCT/DE/2010/000337
WO/2010/115400

26//1/0/2/

76:8;:

ADAPTIVE METHOD AND SYSTEM
FOR EXTRACTING A BRIGHT IMAGE
FROM A THERMAL IMAGE
ITT MANUFACTURING
ENTERPRISES, INC.
US
12/410714
25/03/2009
PCT/US/2010/027791
60

A61K )2011.01(

76:8;8

D04H )2011.01(
‫התקן לדחיסת רשת סיבית‬

H04N )2011.01(
‫שיטה ומערכת מסתגלות לחילוץ דמות‬
‫בהירה מדמות תרמית‬

December 29, 2011-‫ג' בטבת התשע"ב‬

WO/2010/111110

/2//2/0/2/

76:8;;

FALL BACK USING MOBILE DEVICE
ASSISTED TERMINATING ACCESS
DOMAIN SELECTION
QUALCOMM INCORPORATED
US
61/165717
01/04/2009
20/5106/4
04//1/0/2/
US
PCT/US/2010/029692
WO/2010/115045

25//1/0/2/

03//1/0/2/

‫נסיגה המשתמשת בבחירת תחום גישה‬
‫מסיים בסיוע התקן נייד‬

76:8;<

SOLAR REFLECTING MIRROR
HAVING A PROTECTIVE COATING
AND METHOD OF MAKING SAME
PPG INDUSTRIES OHIO, INC.
US
61/164047
27/03/2009
20/5/7/23
27//0/0/2/
US
20/5/7/72
27//0/0/2/
US
PCT/US/2010/027556
WO/2010/111075

61

G02B )2011.01(

‫מראה המשקפת אור השמש בעלת ציפוי‬
‫מגן ושיטה להכנתה‬

76:8;=

THERAPEUTIC USES OF
QUINAZOLINEDIONE DERIVATIVES
SANOFI
FR
0901460
27/03/2009
PCT/FR/2010/050549
WO/2010/109148

12//1/0/2/

H04L )2011.01(

76:8;>

A61K )2011.01(
‫שימושים רפואיים של נגזרות קונאזולין‬

A61K )2011.01(

December 29, 2011-‫ג' בטבת התשע"ב‬

INHIBITION OF BIOFILM
ORGANISMS
NOVABIOTICS LTD
US
61/165396
01/03/2009
/7/323292
/2//1/0//7
GB
PCT/GB/2010/000631
WO/2010/112848

27//1/0/2/

‫דיכוי יצורי ביופילם‬

VEHICLE HAVING ARTICULATED
VEHICLE STEERING, IN PARTICULAR
ARMORED VEHICLE
SKOFF, GERHARD
DE
102009014401.3 26/03/2009
PCT/EP/2010/001735
WO/2010/108629

03//1/0/2/

‫ במיוחד רכב‬,‫רכב בעל היגוי מפרקי‬
‫משוריין‬

76:8<6

METHOD AND DEVICE FOR
PRODUCING POLYPHOSPHORIC ACID
PRAYON TECHNOLOGIES
BE
BE2009/0186 26/03/2009
PCT/EP/2010/053947
WO/2010/108991

24//2/0/2/

C01B )2011.01(

‫שיטה ומתקן לייצור חומצה רב–זרחתית‬

76:8<7

METHODS AND TOOLS FOR PREDICTING
THE EFFICIENCY OF ANTHRACYCLINES
IN CANCER
UNIVERSITE LIBRE DE BRUXELLES
EP
PCT/EP2009/054606 17/04/2009
PCT/EP/2010/055067
WO/2010/119133

62

B62D )2011.01(

76:8<5

C12Q )2011.01(
‫שיטות וכלים לניבוי היעילות של‬
‫אנתראציקלינים בסרטן‬

December 29, 2011-‫ג' בטבת התשע"ב‬

02//1/0/2/

76:8<;

METHODS AND MICROORGANISMS
FOR PRODUCTION OF C4DICARBOXYLIC ACIDS
DSM IP ASSETS B.V.
US
61/163019
24/03/2009
PCT/US/2010/028429
WO/2010/111344

03//1/0/2/

‫שיטות ומיקרואורגניזימים לייצור של‬
‫ דיקארבוקסיליות‬C4 ‫חומצות‬

76:8<<

76:8=5

PROCESS FOR BROMINATING
UNSATURATED ORGANIC
COMPOUNDS WITH REMOVAL OF
QUATERNARY AMMONIUM OR
QUATERNARY PHOSPHONIUM
MONOCHLORIDES
DOW GLOBAL TECHNOLOGIES LLC
US
61/165402
31/03/2009
PCT/US/2010/022802
WO/2010/114637

04//7/0/22
A WATER DISPENSER WITH A
TILTED CONTAINER
NEVIOT NATURE GALILEE LTD

63

C12Q )2011.01(
‫שיטה לגנוטיפיזציה‬

METHOD OF GENOTYPING
MERCK SERONO S.A.
EP
09156487.2 27/03/2009
42/243222
12//1/0//7
US
PCT/EP/2010/053871
WO/2010/127906

/0//0/0/2/

C12N )2011.01(

C08C )2011.01(

‫תהליך לברומינציה של תרכובות‬
–‫אורגניות בלתי רוויות עם הפחתה של חד‬
‫כלורידים בעלי אמוניום או פוספוניום‬
‫רביעוני‬

76:8=6

B65D )2011.01(
‫מתקן מים עם מיכל מים הניתן להסתה‬

December 29, 2011-‫ג' בטבת התשע"ב‬

1///1/0/2/

76:8=7

HYDROGEN GENERATION SYSTEMS
AND METHODS UTILIZING SODIUM
SILICIDE AND SODIUM SILICA GEL
MATERIALS
SIGNA CHEMISTRY, INC.
US
61/164888
30/03/2009
42/263357
/7//4/0//7
US
PCT/US/2010/029257
WO/2010/114849

12//1/0//7

B01J )2011.01(

‫שיטות ומערכות ליצור מימן בשימוש‬
‫לסיליצידי נטרן ג'ל וחומרי מסיליקט נתרן‬

76:8=8

ANNULAR LIGHT GUIDE
ILLUMINATOR AND OPTICAL
SCANNER
SICPA HOLDING SA

G06K )2011.01(
‫מאיר מנחה או טבעתי וסורק אופטי‬

PCT/IB/2009/005137
WO/2010/112950

20//2/0/2/

76:8=9

METHODS AND APPARATUS FOR
OVERLAYING CONTENT ONTO A
COMMON VIDEO STREAM
ECHOSTAR TECHNOLOGIES L.L.C.
US
12/422398
13/04/2009
PCT/US/2010/030752
WO/2010/120693

00//1/0/2/
APPLICATION SHARING
64

76:8=<

H04N )2011.01(
‫שיטות והתקנים להנחת תוכן על זרם‬
‫וידאו משותף‬

G06F )2011.01(
‫יישום שיתוף‬
December 29, 2011-‫ג' בטבת התשע"ב‬

SOCIAL COMMUNICATIONS
COMPANY
US
12/418270
03/04/2009
PCT/US/2010/028088
WO/2010/114724

00//2/0/2/

PROCESS FOR THE PREPARATION
OF 4-(3-CHLORO-2-FLUOROANILINO)-7-METHOXY-6-[1-(NMETHYLCARBAMOYLMETHYL)PIPERIDIN-4-YL]QUINAZOLINE
ASTRAZENECA AB
US
61/171994
23/04/2009
PCT/GB/2010/050653
WO/2010/122340

25//1/0/2/

C07D )2011.01(

76:8==

–‫–פלואורו‬2–‫–כלורו‬3(–4 ‫תהליך להכנת‬
–N(–1[–6–‫–מתוקסי‬7–)‫אנילינו‬
–4–‫מתילקרבמוילמתיל)–פיפרידינ‬
‫יל]קווינזולין‬

A61K )2011.01(

76:8=>

PNEUMOCOCCAL VACCINE AND
USES THEREOF
COLEY PHARMACEUTICAL GROUP,
INC.
US
61/174068
30/04/2009
42/016121
12//6/0//7
US
PCT/IB/2010/051150
WO/2010/125480

07//1/0/2/

76:8>5

A MANUALLY OPERATED
CONTINUOUS FLOW TYPE DRINKING
WATER DISINFECTOR USING
CONCENTRATED SOLAR RADIATION
COUNCIL OF SCIENTIFIC AND
INDUSTRIAL RESEARCH
IN
615/DEL/2009 27/03/2009
PCT/IN/2010/000323
WO/2010/119457
65

‫חיסון פנאומקוקאלי ושימושיו‬

C02F )2011.01(

‫מטהר מי שתייה מסוג זרימה מתמשכת‬
‫מופעל ידנית המשתמש בקרינה‬
‫סולארית מרוכזת‬

December 29, 2011-‫ג' בטבת התשע"ב‬

07//1/0/2/

76:8>6

PROCESS FOR SIMULTANEOUS
PRODUCTION OF POTASSIUM
SULPHATE, AMMONIUM SULFATE,
MAGNESIUM HYDROXIDE AND/OR
MAGNESIUM OXIDE FROM KAINITE
MIXED SALT AND AMMONIA
COUNCIL OF SCIENTIFIC AND
INDUSTRIAL RESEARCH
IN
618/DEL/2009 27/03/2009
PCT/IN/2010/000194
WO/2010/109492

06//1/0/2/

76:8>7

METHODS OF PREDICTING
CLINICAL COURSE AND TREATING
MULTIPLE SCLEROSIS
TEL HASHOMER MEDICAL
RESEARCH INFRASTRUCTURE AND
SERVICES LTD.
US
61/202703
30/03/2009
PCT/IB/2010/051344
WO/2010/113096

07//1/0/2/

76:8>8

THERAPY FOR PROMOTING CELL
GROWTH
MOLEAC PTE. LTD
US
61/164352
27/03/2009
PCT/SG/2010/000122
WO/2010/110755

12//1/0/2/
66

76:8>9

C01C )2011.01(

–‫תהליך להכנה בו זמנית של אשלגן‬
–‫ מגנזיום‬,‫ אמוניום–סולפט‬,‫סולפט‬
‫או מגנזיום אוקסיד ממלח‬/‫הידרוקסיד ו‬
‫קיינייט מעורב ואמוניה‬

C12Q )2011.01(
‫שיטות לקביעת מהלך קליני וטיפול‬
‫בטרשת נפוצה‬
‫תשתית ושירותים‬, ‫מחקרים‬-‫תל השומר‬
‫רפואיים בע"מ‬

A61K )2011.01(
‫טיפול להגברת גדילת תאים‬

G03H )2011.01(
December 29, 2011-‫ג' בטבת התשע"ב‬

METHOD AND SYSTEM FOR
IMAGING AND OBJECT USING
INCOHERENT LIGHT
BEN-GURION UNIVERSITY OF THE
NEGEV RESEARCH AND
DEVELOPMENT AUTHORITY
US
61/202763
01/04/2009
PCT/IB/2010/051401
WO/2010/113123

/2//2/0/2/

–‫שיטה ומערכת להדמיית עצם באור לא‬
‫קוהרנטי‬
‫אוניברסיטת בן גוריון בנגב הרשות למחקר‬
‫ופיתוח‬

76:8>>

METHODS AND INTERMEDIATES
FOR PREPARING PHARMACEUTICAL
AGENTS
GILEAD SCIENCES, INC.
US
61/166498
03/04/2009
PCT/US/2010/029633
WO/2010/115000

12//1/0/2/

/1//2/0//7

C07K )2011.01(

‫ ותצמידים חיסוניים‬FCRH5–‫נוגדנים אנטי‬
‫ושיטות לשימוש‬

76:958

METHOD FOR PROCESSING A
DIGITAL FILE NOTABLY OF THE
IMAGE, VIDEO AND/OR AUDIO TYPE
I-CES (INNOVATIVE COMPRESSION
ENGINEERING SOLUTIONS)
67

‫שיטות וחומרי ביניים להכנת גורמים‬
‫רוקחיים‬

76:957

ANTI-FCRH5 ANTIBODIES AND
IMMUNOCONJUGATES AND
METHODS OF USE
GENENTECH, INC.
US
61/211695
01/04/2009
42/244025
/0//2/0//7
US
42/044750
/2/20/0//7
US
PCT/US/2010/029516
WO/2010/120561

C07C )2011.01(

H04N )2011.01(
‫ בעיקר‬,‫שיטה לעיבוד קובץ דיגיטלי‬
‫או מסוג אודיו‬/‫ וידיאו ו‬,‫הדמות‬

December 29, 2011-‫ג' בטבת התשע"ב‬

PCT/IB/2009/005550
WO/2010/112957

12//1/0/2/

76:959

ANTI-FCRH5 ANTIBODIES AND
IMMUNOCONJUGATES AND
METHODS OF USE
GENENTECH, INC.
US
61/211754
01/04/2009
42/244022
/0//2/0//7
US
PCT/US/2010/029521
WO/2010/114940

02//4/0/2/

‫ ותצמידים חיסוניים‬FCRH5–‫נוגדנים אנטי‬
‫ושיטות לשימוש‬

76:95:

O-RING INSERYION TOOL AND
METHOD
ZEST IP HOLDINGS LLC
US
61/220086
24/06/2009
PCT/US/2010/039830
WO/2010/151676

12//1/0/2/

76:95<

PROCESS FOR CO2 CAPTURE WITH
IMPROVED STRIPPER
PERFORMANCE
ALSTOM TECHNOLOGY LTD.
US
61/164944
31/03/2009
20/510742
04//1/0/2/
US
PCT/US/2010/029420
WO/2010/120527

/4//2/0/2/

68

C07K )2011.01(

76:95=

A61C )2011.01(
‫מכשיר החדרה טבעתי ושיטה‬

B01D )2011.01(
‫תהליך ללכידת פחמן דו–חמצני עם‬
‫ביצועים משופרים‬

F16D )2011.01(

December 29, 2011-‫ג' בטבת התשע"ב‬

A SELECTIVE FORCE
TRANSMISSION DEVICE AND AN
UNDERCARRIAGE CONSISTING OF
AN APPLICATION THEREOF
MESSIER-BUGATTI-DOWTY
FR
0901684
06/04/2009
PCT/EP/2010/054536
WO/2010/115893

01//2/0/2/

76:969

DATA VISUALIZATION PLATFORM
PERFORMANCE OPTIMIZATION
MICROSOFT CORPORATION
US
12/433288
30/04/2009
PCT/US/2010/032307
WO/2010/126802

01//2/0/2/

‫מכשיר כח הילוכים בררני ותושבת‬
‫הכוללת יישום שלו‬

‫אופטימיזצית ביצוע של תוכנית להדמיית‬
‫נתונים‬

76:96:

FAST MERGE SUPPORT FOR LEGACY
DOCUMENTS
MICROSOFT CORPORATION
US
12/432817
30/04/2009
PCT/US/2010/032309
WO/2010/126804

1///2/0/2/

76:96;

SHARED JOB SCHEDULING IN
ELECTRONIC NOTEBOOK
MICROSOFT CORPORATION
US
12/433907
01/05/2009
PCT/US/2010/033235
WO/2010/127286

69

G06F )2011.01(

G06F )2011.01(
‫תמיכה למיזוג מהיר עבור מסמכים‬
‫במערכות מסורתיות‬

G06F )2011.01(
‫תזמון עבודה משותפת במחברת‬
‫אלקטרונית‬

December 29, 2011-‫ג' בטבת התשע"ב‬

1///2/0/2/

76:96<

CROSS-CHANNEL COAUTHORING
CONSISTENCY
MICROSOFT CORPORATION
US
12/433929
01/05/2009
PCT/US/2010/033241
WO/2010/127291

2///3/0/2/

‫עקביות בכתיבה משותפת בין ערוצים‬

76:96=

HIERARCHICALLY-ORGANIZED
CONTROL GALLERIES
MICROSOFT CORPORATION
US
12/464584
12/05/2009
PCT/US/2010/034277
WO/2010/132376

07//1/0/2/

76:96>

70

A63B )2011.01(
‫ניטור אירועי אימון פיזיים‬

76:975

AIR VEHICLE METHOD FOR
OPERATING AN AIR VEHICLE
ISRAEL AEROSPACE INDUSTRIES
LTD.
IL
198124
16/04/2009
PCT/IL/2010/000298
WO/2010/119442

G06F )2011.01(
‫גלריות בקרה מאורגנות באופן היררכי‬

MONITORING OF PHYSICAL
TRAINING EVENTS
INFOMOTION SPORTS
TECHNOLOGIES, INC.
US
61/164277
27/03/2009
42/027304
/5/2//0//7
US
PCT/US/2010/029068
WO/2010/111705

21//2/0/2/

G06F )2011.01(

B64C )2011.01(

‫כלי רכב אווירי ושיטה להפעלת כלי רכב‬
‫אווירי‬
‫התעשייה האוירית לישראל בע"מ‬

December 29, 2011-‫ג' בטבת התשע"ב‬

12//1/0/2/

76:976

NON-DEWETTING POROUS
MEMBRANES
SOLVAY SOLEXIS S.P.A
US
61/166879
06/04/2009
PCT/US/2010/029344
WO/2010/117845

/0//1/0/2/

76:977

ACTIVE DISPLAY IMAGING SYSTEM
PROVIDED WITH AN EYECUP
THALES
FR
0901502
27/03/2009
PCT/EP/2010/052627
WO/2010/108764

04//1/0/2/

76:985

METHODS AND COMPOSITIONS FOR
ACADEMIA SINICA
US
61/164385
27/03/2009
42/242165
06//1/0//7
US
42/242166
06//1/0//7
US
42/242167
06//1/0//7
US
42/121454
20//1/0/2/
US
PCT/US/2010/028968
WO/2010/111687

/0//2/0/2/

76:988

ACRYLAMIDE COMPOUNDS AND
THE USE THEREOF
SHIONOGI & CO. LTD.
US
61/166206
02/04/2009
71

C08J )2011.01(
‫ממברנות נקבוביות שאינן נרטבות‬

G02B )2011.01(
‫מערכת הדמיה עם תצוגה פעילה‬
‫המסופקת עם עינית‬

A61K )2011.01(
‫שיטות ותכשירים לחיסון נגד וירוס‬

C07D )2011.01(
‫תרכובות אקרילמיד והשימוש בהן‬

December 29, 2011-‫ג' בטבת התשע"ב‬

PCT/JP/2010/056404
WO/2010/114181

23//1/0/2/

GUARDRAIL ASSEMBLY,
BREAKAWAY SUPPORT POST FOR A
GUARDRAIL AND METHODS FOR
THE ASSEMBLY AND USE THEREOF
ENERGY ABSORTION SYSTEMS, INC.
US
61/211522
31/03/2009
42/014065
02//6/0//7
US
20/407162
/0/20/0//7
US
PCT/US/2010/027331
WO/2010/114693

/4//2/0/2/

‫ עמוד תמיכה עם מכלול‬,‫מעקה בטיחות‬
‫ניתוק ושיטות לחיבורים ולשימוש בהם‬

76:98:

METHOD FOR RENDERING THE
MEMBRANES OF BIOLOGICAL
CELLS PERVIOUS BY USING A
PULSED ELECTRIC FIELD
COMMISSARIAT A L'ENERGIE
ATOMIQUE ET AUX ENERGIES
ALTERNATIVES
FR
0952262
07/04/2009
PCT/EP/2010/054511
WO/2010/115875

/4//2/0/2/

A23L )2011.01(

‫שיטה להענקת חדירות לממברנות של‬
‫תאים ביולוגיים על ידי שדה חשמלי פועם‬

76:98;

IDENTIFICATION AND AUTHENTICATION
USING POLYMERIC LIQUID CRYSTAL
MATERIAL MARKINGS
SICPA HOLDING SA
EP
PCT/EP2009/002434 02/04/2009
20/16212/
/0//2/0//7
US
PCT/EP/2010/054515
WO/2010/115879
72

E01F )2011.01(

76:989

G06K )2011.01(
‫זיהוי ווידאו על ידי שימוש בסימני‬
‫חומר גבישי נוזלי פולימרי‬

December 29, 2011-‫ג' בטבת התשע"ב‬

12//1/0/2/

76:98=

METHODS AND APPARATUS FOR
GENERATION AND USE OF
REFERENCE SIGNALS IN A
COMMUNICATIONS SYSTEM
QUALCOMM INCORPORATED
US
61/165456
31/03/2009
20/53/334
1///1/0/2/
US
PCT/US/2010/029437
WO/2010/120530

/2//2/0/2/

04//1/0/2/

C12N )2011.01(

‫נוגדן מונוקלונול שיכול לקשור לאפיטופ‬
AD1 ‫בלתי–רציף מסוים שנמצא באיזור‬
‫ וקטע‬,‫ גלקוחלבון‬GB ‫של ציטומגלווירוס‬
‫מקשר–אנטיגן‬

76:995

SYSTEMS AND METHODS FOR
WOUND PROTECTION AND
EXUDATE MANAGEMENT
AALNEX, INC.
US
12/416826
01/04/2009
PCT/US/2010/028785
WO/2010/120470

73

‫שיטות והתקן לייצור ושימוש באיתותים‬
‫יחוסיים במערכת תקשורת‬

76:98>

MONOCLONAL ANTIBODY
CAPABLE OF BINDING TO SPECIFIC
DISCONTINUOUS EPITOPE
OCCURRING IN AD1 REGION OF
HUMAN CYTOMEGALOVIRUS GB
GLYCOPROEIN, AND ANTIGENBINDING FRAGMENT THEREOF
EVEC INCORPORATED
2009JP
01/04/2009
089442
PCT/JP/2010/056037
WO/2010/114106

H04L )2011.01(

A61F )2011.01(
‫מערכות ושיטות להגנה על פצע וטיפול‬
‫בהפרשות‬

December 29, 2011-‫ג' בטבת התשע"ב‬

01//2/0/2/

76:996

MEANS AND METHODS FOR THE
DETERMINATION OF THE AMOUNT
OF NEUROTOXIN POLYPEPTIDE AND
OF ITS CATALYTIC AND
PROTEOLYTIC ACTIVITIES
MERZ PHARMA GMBH & CO. KGaA
EP
09158788.1 27/04/2009
42/02243/
05//2/0//7
US
PCT/EP/2010/055432
WO/2010/124998

26//0/0/2/

76:997

INSTALLATION DESIGNED TO
CONVERT ENVIRONMENTAL
THERMAL ENERGY INTO USEFUL
ENERGY
COHEN, YOAV
EP
09157592.8 08/04/2009
PCT/EP/2010/052027
WO/2010/115654

01//1/0/2/
INFRARED DETECTOR
UD HOLDINGS, LLC
US
61/168601
PCT/US/2010/028293
WO/2010/120447

22//1/0/2/

76:998

‫אמצעים ושיטות להגדרת כמות‬
‫הפוליפפטיד נוירוטוקסין ואת פעילות‬
‫ שבו‬PROTEOYTIC–‫החומר המזרז וה‬

F01K )2011.01(
‫התקן המיועד להמרת אנרגיה תרמית‬
‫סביבתית לאנרגיה מועילה‬

H01L )2011.01(
‫גלאי אינפרא–אדום‬

12/04/2009

76:999

NOVEL P2X7R ANTAGONISTS AND
THEIR USE
AFFECTIS PHARMACEUTICALS AG
EP
09005324.0 14/04/2009
PCT/EP/2010/053097
74

G01N )2011.01(

C07D )2011.01(
‫ והשימוש‬R7X2P‫אנטגוניסטים חדשים ל‬
‫בהם‬

December 29, 2011-‫ג' בטבת התשע"ב‬

WO/2010/118921

12//1/0/2/

76:99:

A COMMUNICATIONS PROCESS,
DEVICE AND SYSTEM
FREESTYLE TECHNOLOGY PTY LTD
AU
2009901397 31/03/2009
PCT/AU/2010/000367
WO/2010/111738

27//4/0//7

/2//2/0/2/

‫ התקן ומערכת לתקשורת‬,‫תהליך‬

76:99=

ISOLATION OF HUMAN UMBILICAL
CORD BLOOD-DERIVED
MESENCHYMAL STEM CELLS
THE BOARD OF REGENTS OF THE
UNIVERSITY OF TEXAS SYSTEM
US
61/165193
31/03/2009
PCT/US/2009/047981
WO/2010/114572

76:99>

76:9:6

PHARMACEUTICAL COMPOSITION
K.U. LEUVEN RESEARCH &
DEVELOPMENT
75

C12N )2011.01(

‫בידוד של תאי גזע מזנכימאליים שמקורם‬
‫בדם תבורי אנושי‬

L-ORNITHINE PHENYL ACETATE
AND METHODS OF MAKING
THEREOF
OCERA THERAPEUTICS, INC.
US
61/166676
03/04/2009
PCT/US/2010/029708
WO/2010/115055

/2//2/0/2/

G01R )2011.01(

A61K )2011.01(
‫–אורניטין פניל אצטט ושיטות להכנתו‬L

A61K )2011.01(
‫תכשיר רוקחות‬

December 29, 2011-‫ג' בטבת התשע"ב‬

EP
09157303.0
PCT/EP/2010/054418
WO/2010/115843

04//1/0/2/

03/04/2009

76:9:7

COMPONENT HAVING AN
OVERLAPPING LASER TRACK;
METHOD FOR PRODUCING SUCH A
COMPONENT
CERAMTEC GMBH,
DE
102009015087.0 31/03/2009
PCT/EP/2010/053972
WO/2010/112412

01//2/0/2/

76:9:8

SUBLINGUAL SPRAY FORMULATION
COMPRISING DIHYDROARTEMESININ
LONDONPHARMA LTD
GB
0906971.7
23/04/2009
GB
PCT/GB09/050415 01//2/0//7
PCT/GB/2010/050672
WO/2010/122356

01//2/0/2/

76:9:9

SUBLINGUAL PHARMACEUTICAL
COMPOSITION COMPRISING A NEUTRAL
OIL
LONDONPHARMA LTD
GB
0906977.4
23/04/2009
GB
PCT/GB09/050416 01//2/0//7
PCT/GB/2010/050671
WO/2010/122355

76

B23K )2011.01(
‫ שיטה‬,‫רכיב בעל נתיב לייזר חופף‬
‫ליצור רכיב כזה‬

A61K )2011.01(
‫הרכב לתרסיס תת לשוני המכיל‬
‫דיהידרוארטמסינין‬

A61K )2011.01(
‫תכשיר רוקחות תת לשוני המכיל‬
‫שמן ניטראלי‬

December 29, 2011-‫ג' בטבת התשע"ב‬

/3//2/0/2/

76:9::

METHODS AND MATERIALS FOR
DELIVERING MOLECULES
MAYO FOUNDATION FOR MEDICAL
EDUCATION AND RESEARCH
US
61/166929
06/04/2009
PCT/US/2010/029985
WO/2010/117957

03//1/0/2/

76:9:;

PROCESS FOR THE MANUFACTURE
OF A SOLUTION OF SALTS OF
DIACIDS/ DIAMINE (S)
RHODIA OPERATIONS
FR
0952333
09/04/2009
PCT/EP/2010/053946
WO/2010/115727

21//3/0/2/

76:9:<

INTEGRATED RAIL SYSTEM AND
METHOD FOR MAKING AND USING
SAME
THE OTIS PATENT TRUST
US
12/466857
15/05/2009
PCT/US/2010/034673
WO/2010/132643

21//3/0/2/

76:9:=

INTERGATED RAIL SYSTEM AND
METHOD FOR MAKING AND USING
SAME
THE OTIS PATENT TRUST
US
12/466905
15/05/2009
PCT/US/2010/034681
WO/2010/132649
77

A61K )2011.01(
‫שיטות וחומרים למתן מולקולות‬

C08G )2011.01(
‫תהליך לייצור תמיסה של מלחי‬
‫דיאמין‬/‫דיחומצה‬

F41A )2011.01(
‫מערכת מסילה משולבת ושיטה ליצורה‬
‫ושימוש בה‬

F41A )2011.01(
‫מערכת מסילה משולבת ושיטה ליצורה‬
‫ושימוש בה‬

December 29, 2011-‫ג' בטבת התשע"ב‬

27//2/0/2/

76:9:>

ANCHORING HARPOON INTENDED
IN PARTICULAR FOR AN AIRCRAFT
AND ANCHORING SYSTEM
INCLUDING ONE SUCH HARPOON
DCNS
FR
0952177
03/04/2009
PCT/FR/2010/050076
WO/2010/112717

/4//2/0/2/

12//1/0/2/

‫צלצל עיגון המיועד במיוחד עבור מטוס‬
‫ומערכת עיגון הכוללת צלצל אחד כזה‬

76:9;5

COMPOSITIONS AND METHODS FOR
TREATMENT OF AORTIC FIBROSIS
VECTUS BIOSYSTEMS PTY LIMITED
AU
2009901425 02/04/2009
PCT/AU/2010/000391
WO/2010/111753

MULTI-PRIMER AMPLIFICATION
METHOD FOR BARCODING OF
TARGET NUCLEIC ACIDS
FLUIDIGM CORPORATION
78

A61K )2011.01(

‫תכשירים ושיטות לטיפול בלייפת ותינית‬

76:9;6

THINNERS FOR AQUEOUS
SUSPENSIONS OF MINERAL
PARTICLES AND HYDRAULIC
BINDER PASTES
CHRYSO
FR
0952132
02/04/2009
PCT/FR/2010/050614
WO/2010/112775

/0//2/0/2/

B64F )2011.01(

C08G )2011.01(
‫מדללים עבור תרחיפים מימיים של‬
‫חלקיקי מינרלים ומשחות כורכן‬
‫הידראוליות‬

76:9;7

C12Q )2011.01(

‫שיטה להגברת ריבוי תחלים עבור ברקוד‬
‫של חומצות מיועדות‬

December 29, 2011-‫ג' בטבת התשע"ב‬

US
61/166105
42/244262
US
42/264105
US
42/1/37/5
US
PCT/US/2010/029854
WO/2010/115154

12//1/0/2/

02/04/2009
/0//2/0//7
22//4/0//7
26//0/0/2/

76:9;8

DECELLULARIZATION AND
RECELLULARIZATION OF ORGANS
AND TISSUES
REGENTS OF THE UNIVERSITY OF
MINNESOTA,
US
61/211613
31/03/2009
PCT/US/2010/029463
WO/2010/120539

/2//2/0/2/

02//1/0/2/

B64F )2011.01(

‫ ומערכת‬,‫ לדוגמא עבור מטוס‬,‫צלצל עיגון‬
‫עיגון הכוללת צלצל אחד כזה‬

76:9;:

AN APPARTUS, SYSTEM AND
METHOD FOR PREVENTING
BIOLOGICAL CONTAMINATION TO
MATERIALS DURING STORAGE
USING PULSED ELECTRICAL
ENERGY
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM LTD.
79

‫דה–סלולריזציה ורה–סלולריזציה של‬
‫איברים ורקמות‬

76:9;9

ANCHORING HARPOON, FOR
EXAMPLE FOR AN AIRCRAFT, AND
ANCHORING SYSTEM INCLUDING
ONE SUCH HARPOON
DCNS
FR
0952175
03/04/2009
PCT/FR/2010/050625
WO/2010/112780

A61K )2011.01(

A61L )2011.01(
‫ מערכת ושיטה למניעת זיהום‬,‫מכשיר‬
‫ביולוגי לחומרים במהלך אחסון ע"י‬
‫שימוש באנרגיה חשמלית פועמת‬

‫רמות ליד אוניברסיטת תל אביב בע"מ‬
December 29, 2011-‫ג' בטבת התשע"ב‬

US
61/164502
PCT/IL/2010/000251
WO/2010/113150

/4//2/0/2/

30/03/2009

76:9;;

METHOD FOR ASSAYING INOSITOL
HEXAPHOSPHATE (IHP)
ERYTECH PHARMA
FR
0952208
03/04/2009
PCT/EP/2010/054516
WO/2010/115880

/4//2/0/2/

22//2/0/2/

C07K )2011.01(

‫גורמים טיפוליים לטיפול במחלות‬
‫הקשורות עם התרבות מהירה בלתי רצויה‬
‫של תאים‬

76:9;=

ANCHORING HARPOON INTENDED
IN PARTICULAR FOR AN AIRCRAFT
AND ANCHORING SYSTEM
INCLUDING ONE SUCH HARPOON
DCNS
FR
0952183
03/04/2009
PCT/FR/2010/050030
WO/2010/112716

80

‫שיטה לבדיקת אינוסיטול הקסאפוספט‬

76:9;<

THERAPEUTIC AGENTS FOR THE
TREATMENT OF DISEASES
ASSOCIATED WITH UNDESIRED
CELL PROLIFERATION
FUNDACIO PRIVADA INSTITUT
D'INVESTIGACIO ONCOLOGICA DE
VALL HEBRON
ES
P200900928 03/04/2009
PCT/EP/2010/054499
WO/2010/115868

G01N )2011.01(

B64F )2011.01(
‫צלצל עיגון המיועד במיוחד עבור מטוס‬
‫ומערכת עיגון הכוללת צלצל אחד כזה‬

December 29, 2011-‫ג' בטבת התשע"ב‬

00//1/0/2/

76:9;>

‫שכבות טיהור באמצעות חמצן‬

OXYGEN SCAVENGING FILMS
MULTISORB TECHNOLOGIES, INC.
US
12/416685
01/04/2009
PCT/US/2010/028102
WO/2010/120435

12//1/0/2/

76:9<5

PLASTICIZERS FOR AQUEOUS
SUSPENSIONS OF MINERAL
PARTICLES AND HYDRAULIC
BINDER PASTES
CHRYSO
FR
0952132
02/04/2009
PCT/FR/2010/050614
WO/2010/112775

/4//2/0/2/

76:9<6

81

F24F )2011.01(
‫מערכת מיזוג אויר המונעת על ידי חום‬
‫שיורי‬
‫לינום סיסטמס בע"מ‬

76:9<7

SALT OF ABT-263 AND SOLID-STATE
FORMS THEREOF
ABBOTT LABORATORIES
US
61/174274
30/04/2009
PCT/US/2010/033072
WO/2010/127190

C08G )2011.01(

‫חומרים שמקנים פלסטיות עבור תרחיפים‬
‫מימיים של חלקיקי מינרלים ומשחות‬
‫כורכן הידראוליות‬

WASTE HEAT AIR CONDITIONING
SYSTEM
LINUM SYSTEMS LTD
US
61/165533
01/04/2009
PCT/IL/2010/000272
WO/2010/113158

1///2/0/2/

C08J )2011.01(

C07D )2011.01(

‫ וצורותיו במצב מוצק‬ABT–263 ‫מלח של‬

December 29, 2011-‫ג' בטבת התשע"ב‬

1///2/0/2/

76:9<8

LIPID FORMULATION OF APOPTOSIS
PROMOTER

A61K )2011.01(

‫פורמולציה ליפידית של מקדם לאפופטוזה‬

ABBOTT LABORATORIES
US
61/174245
30/04/2009
PCT/US/2010/033074
WO/2010/127192

1///2/0/2/

76:9<9

STABILIZED LIPID FORMULATION
OF APOPTOSIS PROMOTER
ABBOTT LABORATORIES
US
61/174299
30/04/2009
42/067032
00/20/0//7
US
PCT/US/2010/033075
WO/2010/127193

/2//2/0/2/

76:9<:

APPARATUS AND METHOD FOR FAT
REMOVAL
THE GENERAL HOSPITAL
CORPORATION
US
61/165844
01/04/2009
PCT/US/2010/029607
WO/2010/114987

/2//2/0//7

76:9<;

CONTENT SUB-ITEM SUBSTITUTION
NDS LIMITED

A61K )2011.01(
‫פורמולציה ליפידית מיוצבת של מקדם‬
‫אפופטוזה‬

A61B )2011.01(
‫מנגנון ושיטה להסרת שומן‬

H04N )2011.01(
‫החלפת תת–פריט של תוכן‬

PCT/IB/2009/051370
WO/2010/112978

82

December 29, 2011-‫ג' בטבת התשע"ב‬

1///1/0/2/

76:9<<

USE OF THE HEART RATE
VARIABILITY CHANGE TO CORRELATE
MAGNETIC FIELD CHANGES WITH
PHYSIOLOGICAL SENSITIVITY AND
METHOD THEREFOR
PLANK, ELISABETH
DE
102009002134.5 02/04/2009
PCT/EP/2010/054191
WO/2010/112503

1///1/0//7

‫שימוש בשינויים בקצב הלב להתאמת‬
‫שינויים בשדה מגנטי לרגישות‬
‫פיזיולוגית ושיטה תואמת‬

76:9<>

METHOD FOR THE RECOVERY OF
DEGRADED AREAS USING
GENETICALLY MODIFIED PLANT
SPECIES
JUAN PEDRO NAVARRO AVINO

A61B )2011.01(

B09C )2011.01(

‫שיטה להתאוששות של שטחים מפוררים‬
‫על ידי שימוש בזני צמחים מותאמים‬
‫גנטית‬

PCT/ES/2009/070080
WO/2010/112622

23//2/0/2/

76:9=5

CONTROL OF PROTEIN
GLYCOSYLATION AND
COMPOSITIONS AND METHODS
RELATING THERETO
PFIZER INC.
US
61/170897
20/04/2009
PCT/IB/2010/051650
WO/2010/122460

/5//2/0/2/

83

76:9=6

C07K )2011.01(
‫שליטה בגליקוזילציה של חלבון‬
‫ותרכובות ושיטות הקשורות לכך‬

A61K )2011.01(

December 29, 2011-‫ג' בטבת התשע"ב‬

IMPROVED GLUCOCORTICOID
THERAPY
DUOCORT PHARMA AB
DK
PA200900470 07/04/2009
PCT/EP/2010/002178
WO/2010/115615

1///1/0/2/

‫טיפול גלוקוקורטקואיד משופר‬

76:9=7

PREPARATION OF ISOLATED AGONIST
ANTI-EDAR MONOCLONAL ANTIBODIES
UNIVERSITE DE LAUSANNE
IB
PCT/IB2009/005118 30/03/2009
PCT/IB/2010/051385
WO/2010/113117

/0//2/0/2/

76:9=8

COMPOSITION OF 2,4,6-TRIFLUORON-[6-(1-METHYL-PIPERIDIN-4CARBONYL)-PYRIDIN-2-YL]BENZAMIDE
COLUCID PHARMACEUTICALS, INC.
US
61/166097
02/04/2009
PCT/US/2010/029810
WO/2010/115125

12//1/0//7
METHOD AND SYSTEM FOR
DETERMINING SECOND-ORDER
NONLINEAR OPTICAL
COEFFICIENTS
SELEX SISTEMI INTEGRATI S.P.A

C07K )2011.01(
‫הכנה של נוגדנים מונוקלוניים‬
‫אגוניסט אנטי–אדאר מבודדדים‬

A61K )2011.01(

–N–[6–(1–‫–טריפלואורו‬6,4,2 ‫תכשיר של‬
–2–‫–קרבוניל)–פירימידין‬4–‫מתיל–פיפרידין‬
‫יל]–בנזאמיד‬

76:9=9

G02F )2011.01(

‫שיטה ומערכת הכרעת מקדמים אופטיים‬
‫בלתי–לינאריים מסדר–שני‬

PCT/IT/2009/000131
WO/2010/113190

84

December 29, 2011-‫ג' בטבת התשע"ב‬

12//1/0/2/

76:9=:

‫העברת מומנט הפיתול בין מודולי אבוס‬
‫מאסף‬

TORQUE TRANSFER BETWEEN
TROUGH COLLECTOR MODULES
ABENGOA SOLAR INC.
US
12/416536
01/04/2009
PCT/US/2010/029481
WO/2010/120545

/0//2/0/2/

76:9=;

COMPOSITIONS OF
CHOLINESTERASE INHIBITORS
COLUCID PHARMACEUTICALS, INC.
US
61/166143
02/04/2009
PCT/US/2010/029809
WO/2010/115124

/0//2/0/2/

76:9=>

85

A61K )2011.01(
‫מערכות ושיטות לייצור מימן‬

76:9>5

AMINO PYRIMIDINE ANTICANCER
COMPOUNDS
OSI PHARMACEUTICALS, LLC
US
61/182898
01/06/2009
42/076127
04//2/0/2/
US
PCT/US/2010/036808
WO/2010/141406

A61K )2011.01(
‫תכשירים של מעכבי קולינאסטרייס‬

SYSTEMS AND METHODS FOR
GENERATING NITROGEN
ST. RENATUS, LLC
US
61/166680
03/04/2009
PCT/US/2010/001002
WO/2010/114622

/2//4/0/2/

F24J )2011.01(

C07D )2011.01(

‫תרכובות אמינו פירימידין אנטי סרטניות‬

December 29, 2011-‫ג' בטבת התשע"ב‬

/7//4/0//7

76:9>6

AUTOLOGOUS AND ALLOGENIC
ADIPOSE-DERIVED STROMAL STEM
CELL COMPOSITION FOR TREATING
FISTULAS
ANTEROGEN CO, LTD
10-2009KR
28/04/2009
0036942
PCT/KR/2009/003078
WO/2010/126194

/2//2/0/2/

‫הרכב תאי גזע משתית עצמיים וחיצונים‬
‫ממקור שומני לטיפול בפסיטולות‬

76:9>8

SERVICES FUND OF THE TEL AVIV
MEDICAL CENTER THE MEDICAL
RESEARCH, INFRASTRUCTURE AND
HEALTH
US
61/165946
02/04/2009
PCT/IB/2010/051438
WO/2010/113138

76:9>9

A METHOD OF REGULATING
PROLIFERTATION AND
DIFFERENTIATION OF
KERATINOCYES
THE MEDICAL RESEARCH AND
INFRASTRUCTURE FUND OF THE
TEL-AVIV SOURASKY MEDICAL
CENTER
US
61/202760
01/04/2009
PCT/IL/2010/000167
WO/2010/113146

86

A61F )2011.01(
GRAFT ‫פתיחת פתחים בתומכן מסוג‬
STENT

STENT GRAFT FENESTRATION

06//0/0/2/

A61K )2011.01(

‫קרן מחקרים רפואיים פיתוח תשתית‬
‫ושירותי בריאות ע"י המרכז הרפואי תל‬
‫אביב‬

A61K )2011.01(
‫שיטה לבקרת ריבוי והתמיינות של‬
‫קראטינוציטים‬
‫קרן מחקרים רפואיים פתוח תשתית‬
‫ושרותי בריאות ליד המרכז הרפואי תל‬
‫אביב‬

December 29, 2011-‫ג' בטבת התשע"ב‬

02//1/0/2/

76:9>:

COMPOSITIONS AND METHODS FOR
INCREASING OIL CONTENT IN
ALGAE
ROSETTA GREEN LTD
US
61/165912
02/04/2009
PCT/IL/2010/000247
WO/2010/113149

07//1/0/2/

‫תירכובות ושיטות להגברת תכולת שומן‬
‫באצות‬

76:9><

OXADIAZILE DERIVATIVES AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THEM
MERCK SERONO S.A.
EP
09157301.4 03/04/2009
42/247551
24//2/0//7
US
PCT/EP/2010/054100
WO/2010/115751

07//1/0/2/

76:9>=

OXADIAZOLE DERIVATIVES AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THEM
MERCK SERONO SA,
EP
09157301.4 03/04/2009
42/247551
24//2/0//7
US
PCT/EP/2010/054103
WO/2010/112461

20//3/0/2/
CONNECTOR ASSEMBLIES FOR
CONNECTING PANELS
87

C12N )2011.01(

76:9>>

‫רוסטה גרין בע"מ‬

C07D )2011.01(
‫תולדות אוקסאדיאזול ותכשירי רוקחות‬
‫המכילים אותן‬

C07D )2011.01(
‫תולדות אוקסאדיאזול ותכשירי רוקחות‬
‫המכילים אותן‬

E04D )2011.01(
‫מערכת חיבור עבור לוחות מחוברים‬

December 29, 2011-‫ג' בטבת התשע"ב‬

SABIC INNOVATIVE PLASTICS IP
B.V.
US
61/177693
13/05/2009
PCT/US/2010/034485
WO/2010/132529

0///2/0//7

76::57

PNEUMATIC DOOR ASSIST SYSTEM
WITH LOCK
INTERNATIONAL TRUCK
INTELLECTUAL PROPERTY
COMPANY, LLC.

E05F )2011.01(

‫מערכת עזר עם מנעול לדלת פניאומטית‬

PCT/US/2009/041073
WO/2010/123486

24//2/0/2/

76::58

PEPTIDES USED IN THE TREATMENT
AND/OR CARE OF THE SKIN AND/OR
HAIR AND THEIR USE IN COSMETIC
OR PHARMACEUTICAL
COMPOSITIONS
LIPOTEC S.A.
US
61/170891
20/04/2009
0//7/2/20
25//2/0/22
ES
PCT/EP/2010/002348
WO/2010/118880

2///1/0/2/

88

‫או‬/‫פפטידים לשימוש בטיפול בעור ו‬
‫בשיער והשימוש בהם בתכשירים‬
‫קוסמטיים או של רוקחות‬

76::59

HEMODIALYSIS AND PERITONEAL
DIALYSIS SOLUTIONS COMPRISING
ONE OR MORE CREATINE
COMPOUNDS
CREARENE LTD
EP
09005038.6 06/04/2009
PCT/CH/2010/000065
WO/2010/115291

C07K )2011.01(

A61K )2011.01(

‫המודיאליזה ופתרונות להפרדה של הצפק‬
‫המכיל אחת או יותר של קריאטין‬

December 29, 2011-‫ג' בטבת התשע"ב‬

/5//2/0/2/

76::5:

‫פסטה אינסטנט מדגנים מלאים‬

WHOLEGRAIN INSTANT PASTA
NESTEC S.A.
EP
09158132.2 17/04/2009
PCT/EP/2010/054562
WO/2010/118974

26//3/0/2/
PROTEASE INHIBITORS
ORION CORPORATION
IN
758/KOL/2009
PCT/FI/2010/000031
WO/2010/133748

22/20/0//7

76::5;

A61P )2011.01(
‫מעכבי פרוטאז‬

18/05/2009

76::5=

FUNCTIONAL UNDERPANTS FOR
MEN
BAEK, GYEONG-SU,
10-2009KR
13/04/2009
0031932
PCT/KR/2009/007459
WO/2010/120030

/3//2/0/2/

A23L )2011.01(

76::5>

INDIRECT COOLING OF A CUTTING
TOOL

A41B )2011.01(
‫תחתונים פונקציונליים לגברים‬

B23B )2011.01(
‫קירור בלתי–ישיר עבור כלי חתיכה‬

CREARE INCORPORATED
US
12/418688
06/04/2009
PCT/US/2010/029950
WO/2011/005340
89

December 29, 2011-‫ג' בטבת התשע"ב‬

/5//2/0/2/

76::65

‫אלמנט ביטחון פיאזוכרומי‬

PIEZOCHROMIC SECURITY ELEMENT
SICPA HOLDING SA
IB
PCT/IB2009/005198 07/04/2009
PCT/EP/2010/054597
WO/2010/115928

20//0/0/2/

76::66

NANO-ANTENNA FOR WIDEBAND
COHERENT CONFORMAL IR
DETECTOR ARRAYS
RAYTHEON COMPANY
US
12/433576
30/04/2009
PCT/US/2010/024169
WO/2010/126641

/4//2/0/2/

76::67

90

C07D )2011.01(
‫)–און‬H1(4–‫–אלקילסינון‬1 ‫נגזרות‬
‫ הכנתן ויישום רפואי שלהן‬,‫מותמרות‬

76::68

METHOD AND APPARATUS FOR
OPRATION OF POOL CLEANER WITH
INTEGRAL CHLORINE GENERATOR
AQUATRON, INC.
US
12/384806
08/04/2009

G01J )2011.01(

‫ קונפורמי‬IR ‫ננו– משושות למערכי גלאי‬
‫קוהקנטי בעל פס רחב‬

SUBSTITUTED 1-ALKYLCINNOLIN4(1H)-ONE DERIVATIVES,
PREPARATION THEREOF AND
THERAPEUTIC APPLICATION OF
SAME
SANOFI
FR
0901696
07/04/2009
PCT/FR/2010/050657
WO/2010/116084

/5//2/0/2/

C09D )2011.01(

E04H )2011.01(

‫שיטה והתקן להפעלת מנקה בריכות עם‬
‫מחולל כלור משולב‬

December 29, 2011-‫ג' בטבת התשע"ב‬

PCT/US/2010/001071
WO/2010/117469

/4//2/0/2/

VIDEO MOTION COMPENSATION
AND STABILIZATION GIMBALED
IMAGING SYSTEM
NEXTVISION STABILIZED SYSTEMS
LTD
US
61/167226
07/04/2009
PCT/IL/2010/000280
WO/2010/116366

23//2/0/2/

G06K )2011.01(

76::6:

‫מערכת הדמייה הכוללת ייצוב ופיצוי‬
‫לתנועת המצלמה במרחב‬
‫נקסט ויז'ן מערכות מיוצבות בע"מ‬

C07C )2011.01(

76::6;

‫תחליבים המורכבים מפר–פלואורו‬
‫פחמנים‬

EMULSIONS OF
PERFLUOROCARBONS
OXYGEN BIOTHERAPEUTICS, INC.
US
61/212689
15/04/2009
42/022770
07//2/0//7
US
42/057137
27/2//0//7
US
42/062272
21/22/0//7
US
PCT/US/2010/031320
WO/2010/121082

/5//2/0/2/

76::6<

6-(3-AZA-BICYCLO[3.1.0]HEX-3-YL)-2PHENYL-PYRIMIDINES
ACTELION PHARMACEUTICALS LTD.
IB
PCT/IB09/051486 08/04/2009
PCT/IB/2010/051499
WO/2010/116328

/3//2/0/2/
91

76::6=

C07D )2011.01(

–)‫–יל‬3–‫]הקס‬3.1.0[‫–אזא–ביציקלו‬3(–6
‫–פניל–פירימידינים‬2

G06F )2011.01(
December 29, 2011-‫ג' בטבת התשע"ב‬

REMOTE ANALYSIS AND
CORRECTION OF CROP CONDITION
SMARTFIELD, INC.
US
61/166819
06/04/2009
42/244606
/4//2/0//7
US
PCT/US/2010/029947
WO/2010/117944

07//2/0/2/

‫אנליזה ותיקון מרחוק של תנאי יבול‬

76::6>

PROCESS FOR PREPARING
SUBSTITUTED ISOXAZOLINE
COMPOUNDS AND THEIR
PRECURSORS
BASF SE
EP
09159246.9 30/04/2009
PCT/EP/2010/055773
WO/2010/125130

23//2/0/2/

‫תהליך להכנת תרכובות איזוקסאזולין‬
‫מותמרות וחומרים מקדימים שלהן‬

76::75

SYSTEM FOR TRANSFERRING
FLUIDS BETWEEN TWO VESSELS
PLACED SIDE BY SIDE
TECHNIP FRANCE,
FR
0952368
09/04/2009
PCT/FR/2010/050731
WO/2010/116113

04//3/0/2/

92

B63B )2011.01(
‫מערכת להעברת נוזלים בין שני כלים‬
‫המוצבים זה לצד זה‬

76::76

DERIVATIVES OF 6,7-DIHYDRO-5HIMIDAZO[1,2-a]IMIDAZOLE-3CARBOXYLIC ACID AMIDES
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
US
61/183098
02/06/2009
PCT/US/2010/036094
WO/2010/141273

C07D )2011.01(

C07D )2011.01(

–H5–‫–דיהידרו‬7,6 ‫תולדות של אמידים של‬
‫–חומצה‬3–‫]אימידאזול‬a–2,1[‫אימידאזו‬
‫קרבוקסילית‬

December 29, 2011-‫ג' בטבת התשע"ב‬

/2//2/0/2/

76::77

COPPER BROMIDE HUMIDITY
INDICATING CARD
MULTISORB TECHNOLOGIES, INC.
US
12/419116
06/04/2009
PCT/US/2010/029567
WO/2010/117865

/5//2/0/2/

‫כרטיס זיהוי ללחות המכיל נחושת ברומית‬

76::78

SYSTEM AND METHOD FOR HYBRID
COURSE INSTRUCTION
LEARNIG TREE INTERNATIONAL
US
61/167364
07/04/2009
PCT/US/2010/030257
WO/2010/118145

21//2/0/2/

76::79

93

A61K )2011.01(
‫שיטה למתן אמצעי מניעה לפי דרישה‬

76::7:

IMPROVED AMINO ACID
SEQUENCES DIRECTED AGAINST IL6R AND POLYPEPTIDES
COMPRISING THE SAME FOR THE
TREATMENT OF IL-6R RELATED
DISEASES AND DISORDERS
ABLYNX NV

G06Q )2011.01(
‫מערכת ושיטה לנתיב הנחיה מוכלא‬

METHOD FOR ON-DEMAND
CONTRACEPTION
LABORATOIRE HRA-PHARMA
US
61/169149
14/04/2009
PCT/EP/2010/054812
WO/2010/119029

20//2/0/2/

C07D )2011.01(

C07K )2011.01(

‫רצפי חומצות אמיניות משופרים המכוונים‬
‫ ופוליפפטידים המכילים אותם‬R6–IL ‫נגד‬
–‫לטיפול במחלות והפרעות הקשורות ל‬
R6–IL

December 29, 2011-‫ג' בטבת התשע"ב‬

US
61/168410
PCT/EP/2010/054764
WO/2010/115998

/4//2/0/2/

10/04/2009

76::7;

SOLAR MIRROR PANLES AND THEIR
MANUFACTURE
WIZARD POWER PTY LTD
AU
2009901467 06/04/2009
PCT/AU/2010/000390
WO/2010/115237

07//1/0/2/

/6//2/0/2/

C07D )2011.01(

‫תרכובות ציקליות מותמרות בקבוצת‬
‫ תכשירים המכילים אותן ושימושים‬,‫פניל‬
‫בהן‬

76::87

SURFACE MODIFICATION OF
REVERSE OSMOSIS MEMBRANES BY
HYDROPHILIC DENDRITIC
POLYMERS
MICHIGAN MOLECULAR INSTITUTE
US
61/212206
08/04/2009
PCT/US/2010/001058
WO/2010/117460

94

‫לוחות מראות סולרים וייצורם‬

76::86

CYCLIC COMPOUNDS HAVING A
SUBSTITUTED PHENYL GROUP,
COMPOSITIONS COMPRISING THE
SAME AND USES THEREOF
DAIICHI SANKYO COMPANY,
LIMITED
2009JP
06/04/2009
091671
PCT/JP/2010/055547
WO/2010/116915

F24J )2011.01(

B32B )2011.01(
‫התאמת פני השטח ממברנות אוסמוזה‬
‫הפוכה באמצעות פולימרים דנדריטיים‬
‫הידרופיליים‬

December 29, 2011-‫ג' בטבת התשע"ב‬

/7//2/0/2/

76::88

CLEAR MAGNETIC INTAGLIO PRINTING
INK
SICPA HOLDING SA
IB
PCT/IB2009/005227 09/04/2009
PCT/EP/2010/054716
WO/2010/115986

/5//2/0/2/

76::8:

WIRELESS POWER TRANSMISSION
SYSTEM AND METHOD
RAYTHEON COMPANY
US
12/421789
10/04/2009
PCT/US/2010/030153
WO/2010/118075

0///2/0/2/

76::8<

95

H02J )2011.01(

C07K )2011.01(
‫–אנטיטרפזין רקומביננטי אנושי‬1‫אלפא‬

76::8=

ANTIBODY FUSION PROTEINS WITH
MODIFIED FCRN BINDING SITES
MERCK PATENT GMBH
US
61/171650
22/04/2009
PCT/EP/2010/002377
WO/2010/121766

‫דיו הדפסת חריטה מגנטית שקופה‬

‫מערכת העברת כוח אלחוטי ושיטה‬

RECOMBINANT HUMAN ALPHA1ANTITRYPSIN
CRUCELL HOLLAND B.V.
US
61/214492
23/04/2009
/723642/92
01//2/0//7
EP
PCT/EP/2010/055177
WO/2010/127939

27//2/0/2/

C09D )2011.01(

C07K )2011.01(

–‫חלבוני איחוי נוגדנים עם אתרי קישור ל‬
‫ שעברו שינוי‬FCRN

December 29, 2011-‫ג' בטבת התשע"ב‬

22//2/0/2/

76::8>

POWDER IN-MOLD COATING BY
COMPRESSING ITEMS
ORLITE INDUSTRIES (MILLENIUM
2000) LTD.
US
61/170280
17/04/2009
PCT/IB/2010/051631
WO/2010/119414

/5//2/0/2/

‫צביעת איבוק בתוך תבנית‬
‫) בע"מ‬2000 ‫אורלייט תעשיות (מילניום‬

76::95

ENERGY RELEASE BUOYANT
ACTUATOR
CETO IP PTY LTD
AU
2009901502 07/04/2009
PCT/AU/2010/000398
WO/2010/115241

/4//2/0/2/

00//2/0//7

B64C )2011.01(

‫ יחדיה מעופפת ושיטה להעלאת‬,‫מערכת‬
‫מטענים‬

76::98

AUDIENCE MEASUREMENT SYSTEM

F03B )2011.01(
‫מפעיל צף משחרר אנרגיה‬

76::96

SYSTEM, FLOATING UNIT AND
EMTHOD FOR ELEVATING
PAYLOADS
SHY COHEN
US
61/166820
06/04/2009
PCT/IL/2010/000273
WO/2010/116362

B29C )2011.01(

‫שי כהן‬

H04H )2011.01(
‫מערכת למדידת קהל צופים‬

NDS LIMITED
PCT/IB/2009/051657
WO/2010/122373

96

December 29, 2011-‫ג' בטבת התשע"ב‬

12//1/0/2/

76::9;

PROCESS FOR REMOVING PESTICIDES
FROM GINKGO BILOBA EXTRACTS,
AND EXTRACTS OBTAINABLE BY SAID
PROCESS
INDENA S.P.A.
IT
MI2009A000548 06/04/2009
PCT/EP/2010/002046
WO/2010/115566

/5//2/0/2/

2///3/0/2/

‫תהליך להסרת קוטלי מזיקים מתמציות‬
‫גינקגו דו–אונתי ותמציות המתקבלות‬
‫באמצעות תהליך זה‬

76::9<

IMPROVED SILICON THIN FILM
DEPOSITION FOR PHOTOVOLTAIC
DEVICE APPLICATIONS
ASAHI GLASS COMPANY LIMITED
US
61/167349
07/04/2009
PCT/US/2010/030199
WO/2010/118105

PSEUDOMONAS AERUGINOSA
ANTIBODY SPECIFIC FOR
LIPOPOLYSACCARIDES (LPS) OF
SEROTYPE IATS 01 OF
PSEUDOMONAS AERUGINOSA
97

H01L )2011.01(

‫שיקוע משופר של שכבה דקה של סיליקון‬
‫עבור יישומי מכשיר פוטווולטאי‬

76::9=

MULTIMODAL CONVERSATION
PARK AND RETRIEVAL
MICROSOFT CORPORATION
US
12/465421
13/05/2009
PCT/US/2010/034280
WO/2010/132379

/4//2/0/2/

A23L )2011.01(

H04W )2011.01(
‫מערך מגוון להשהיית הודעות ושליפתן‬

76::9>

C07K )2011.01(

‫נוגדן חד–שבטי ממקור אנושי בררני עבור‬
01 ‫) של סרוטייפ‬LPS( ‫ליפופוליסאכרידים‬
AERUGINOSA ‫ של‬IATS
PSEUDOMONAS
December 29, 2011-‫ג' בטבת התשע"ב‬

KENTA BIOTECH AG
EP
09005245.7
PCT/EP/2010/002158
WO/2010/115606

22//2/0/2/

09/04/2009

76:::5

PROCESS FOR THE PREPARATION
OF A BIPHENYL-2-YLCARBAMIC
ACID ESTER
GLAXO GROUP LIMITED
US
61/169046
14/04/2009
PCT/EP/2010/054893
WO/2010/119064

22//2/0/2/

‫–יל‬2–‫תהליך להכנת אסטר של ביפניל‬
‫חומצה קרבמית‬

76:::6

76:::7

SUBSTITUTED 4-AMINO-5-BENZOYL2-(PHENYLAMINO)THIOPHENE-3CARBONITRILES AND SUBSTITUTED
4-AMINO-5-BENZOYL-2(PHENYLAMINO)THIOPHENE-3CARBOXAMIDES AS TUBULIN
POLYMERIZATION INHIBITORS
TELIK, INC.
US
61/169785
16/04/2009
PCT/US/2010/023561
WO/2010/120400

98

C07D )2011.01(
7 ‫מאפנני נגזרת אינדולית של אלפא‬
NACHR

INDOLE DERIVATIVE MODULATORS
OF THE ALPHA 7 NACHR
PROXIMAGEN LIMITED
US
61/169742
16/04/2009
PCT/EP/2010/054910
WO/2010/119078

/7//0/0/2/

C07D )2011.01(

C07D )2011.01(

‫–(פניל‬2–‫–בנזואיל‬5–‫–אמינו‬4
‫–קרבוניטרילים מותמרים‬3–‫אמינו)תיאופן‬
‫–(פניל‬2–‫–בנזואיל‬5–‫–אמינו‬4–‫ו‬
‫–קרבוקסאמידים מותמרים‬3–‫אמינו)תיאופן‬
‫כמכעבי פילמור טובולין‬

December 29, 2011-‫ג' בטבת התשע"ב‬

00//2/0/2/

C07D )2011.01(

76:::8

PROCESSES FOR THE PREPARATION
OF MORPHINANE AND
MORPHINONE COMPOUNDS
BROCK UNIVERSITY
US
61/172521
24/04/2009
PCT/CA/2010/000587
WO/2010/121369

24//2/0/2/

‫תהליכים להכנת תרכובות מורפינאן‬
‫ומורפינון‬

DIAMIDE COMPOUNDS HAVING
MUSCARINIC RECEPTOR
ANTAGONIST AND ?2 ADRENERGIC
RECEPTOR AGONIST ACTIVITY
THERAVANCE, INC.
US
61/172039
23/04/2009
PCT/US/2010/031356
WO/2010/123766

/6//4/0/2/
VALVE
MOKVELD VALVES B.V.
DE
102009026838.3
PCT/EP/2010/058005
WO/2010/142677

23//2/0/2/

‫תרכובות דיאמיד בעלות פעילות‬
‫אנטגוניסטית לקולטן מוסקריני ופעילות‬
‫?–אדרנרגי‬2 ‫אגוניסטית לקולטן‬

76::::

F16K )2011.01(
‫שסתום‬

09/06/2009

76:::;

METHOD AND COMPOSITION FOR
TREATING MACULAR
DEGENERATION
SUCAMPO AG
US
61/169512
15/04/2009
20/53633/
20//2/0/2/
US
99

C07D )2011.01(

76:::9

A61K )2011.01(
‫שיטה ותכשיר לטיפול ניוון כתמי‬

December 29, 2011-‫ג' בטבת התשע"ב‬

PCT/JP/2010/057108
WO/2010/119986

21//2/0/2/

76:::<

CONDENSED PYRROLOPYRIDINE
DERIVATIVE
ASTELLAS PHARMA INC.
2009JP
14/04/2009
097974
PCT/JP/2010/056619
WO/2010/119875

24//1/0/2/

76:::=

METHOD OF MANUFACTURING A
METAL VESSEL
THE COCA COLA COMPANY
US
12/418758
06/04/2009
PCT/US/2010/027410
WO/2010/117564

/3//2/0/2/

76:::>

INDOLE DERIVATIVES AND
METHODS FOR ANTIVIRAL
TREATMENT
PTC THERAPEUTICS, INC
US
61/166893
06/04/2009
PCT/US/2010/029923
WO/2010/117932

/0//2/0/2/
HYPERLINK TO COMPUTER
GENERATED CONTENT
BCInnovation
100

76::;5

C07D )2011.01(
‫תולדת פירולופירידין דחוסה‬

B21D )2011.01(
‫שיטה לייצור כלי מתכתי‬

C07D )2011.01(
–‫תולדות אינדול ושיטות לטיפול אנטי‬
‫ויראלי‬

G06F )2011.01(
‫קישור היפרטקסט לתוכן תוצרת מחשב‬

December 29, 2011-‫ג' בטבת התשע"ב‬

US
61/166757
PCT/IB/2010/051450
WO/2010/116311

/5//2/0/2/

05/04/2009

C07K )2011.01(

76::;7

PROCESS FOR ISOLATING
THERAPEUTIC PEPTIDE
CORDEN PHARMA COLORADO, INC.
US
61/168259
10/04/2009
PCT/EP/2010/054577
WO/2010/115916

/2//2/0/2/

‫תהליך להפרדת פפטיד ריפויי‬

UNIFIED INPUT AND DISPLAY
SYSTEM AND METHOD
RADION ENGINEERING CO. LTD
US
61/166747
05/04/2009
PCT/IB/2010/051439
WO/2010/116308

/5//2/0/2/

101

‫מערכת ושיטה לתצוגה מאוחדת קלט‬
‫רדיון חברה להנדסה בע"מ‬

F04C )2011.01(

76::;9

COMPRESSOR HAVING CAPACITY
MODULATION ASSEMBLY
EMERSON CLIMATE
TECHNOLOGIES, INC.
US
61/167309
07/04/2009
20/53270/
/4//2/0/2/
US
PCT/US/2010/030248
WO/2010/118140

04//6/0/2/

G06F )2011.01(

76::;8

‫מדחס הכולל מכלול ויסות קיבולת‬

76::;=

B01J )2011.01(

December 29, 2011-‫ג' בטבת התשע"ב‬

METHOD FOR PREVENTING PLUGGING OF
A CONTINUOUS-REACTION CHANNELSYSTEM AND MICRO-REACTOR FOR
CARRYING OUT THE METHOD
LONZA AG
EP
PCT/EP2009/061143 28/08/2009
/7/2250496
22//7/0//7
EP
2/23506395
01//1/0/2/
EP
PCT/EP/2010/062476
WO/2011/023761

23//2/0/2/

20//3/0/2/

‫וידאו עם משתמש‬/‫שיתוף תוכן אודיו‬
‫נבחר‬

76::<5

CONTINUOUS REACTION MICROREACTOR
LONZA AG
EP
PCT/EP2009/055739 12/05/2009
PCT/EP/2010/056594
WO/2010/130808

76::<6

PLANT SNFI-RELATED PROTEIN
KINASE GENE
DOW AGROSCIENCES LLC
US
61/168532
10/04/2009
PCT/US/2010/030563
WO/2010/118338

102

H04L )2011.01(

76::;>

SHARING OF AUDIO/VISUAL
CONTENT WITH A SELECTED USER
SLING MEDIA, INC.
US
12/424249
15/04/2009
PCT/US/2010/031150
WO/2010/120972

/7//2/0/2/

‫שיטה למניעת סתימת מערכת‬
‫תעלות לתגובה רציפה ומיקרו–כור‬
‫לביצוע השיטה‬

B01J )2011.01(
‫מיקרו–כור לתגובה רציפה‬

A01H )2011.01(
SNFI–‫גן קינאז חלבון צמח קשור ל‬

December 29, 2011-‫ג' בטבת התשע"ב‬

20//3/0/2/

76::<7

METHOD OF MANUFACTURING A
REACTOR AND SET OF REACTORS
LONZA AG
EP
PCT/EP2009/055740 12/05/2009
PCT/EP/2010/056597
WO/2010/130811

/4/2//0/22

76::<8

SCOURING SPONGE WITH SYMBOL
OF "MEET", "MILK" AND "PARVE"
MAYA ARAD

/4/2//0/22

SYSTEM FOR MULTI-LAYER
ORGANIZATIONAL, FUNCTIONAL,
ACTIVITIES AND NETWORK
MAPPING, ANALYZING AND
DECISION MAKING
T.E. COMMERCIALIZE
INNOVATIONS LTD
103

‫שיטה לייצור כור ומערכך כורים‬

A47J )2011.01(

,"‫ספוג לרחיצת כלים הנושא סימון "חלבי‬
"‫"בשרי" או "פרווה‬
‫מאיה ארד‬

76::<9

A TWO-WHEELED VEHICLE
STABILIZER
ELIYAHU MASHIAH

/4/2//0/22

B01J )2011.01(

B62H )2011.01(
‫מייצב לכלי רכב דו גלגלי‬
‫אליהו משיח‬

76::<:

G06F )2011.01(

‫ ניתוח וקבלת‬,‫מערכת רב שכבתית למיפוי‬
‫ פונקציות פעילויות‬,‫החלטות של ארגונים‬
‫ורשתות‬
‫ ייזום וישום חידושים בע"מ‬.‫ע‬.‫ת‬
December 29, 2011-‫ג' בטבת התשע"ב‬

/4/2//0/22

76::<;

A METHOD AND A SYSTEM FOR
AUTHENTICATION AND
PREVENTING DATA BREACHES IN
CLOUP COMPUTING
CONCEALIUM I.T. SECURITY LTD
US
61/390877
07/10/2010

/1//4/0//7

‫שיטה ומערכת לאימות ווידוא למנוע‬
‫דליפת מידע במחשוב ענן‬
‫קונסליום אבטחת טכנולוגיות מידע בע"מ‬

76::<<

METHOD AND SYSTEM FOR
CONTROLLING THE USE OF AN
ELECTRONIC DEVICE
VAZQUEZ DEL MERCADO HABIF,
DAVID
EP
09157658
08/04/2009
PCT/MX/2009/000051
WO/2010/117252

/6//2/0/2/

76::<=

BEVERAGE PREPARATION DEVICE
HAVING A CLOSING MECHANISM
WITH FORCE DEMULTIPLYING
MEANS
NESTEC S.A.
EP
09157751.0 09/04/2009
PCT/EP/2010/054621
WO/2010/115946

104

G06F )2011.01(

H04N )2011.01(
‫שיטה ומערכת לבקרת שימוש במכשיר‬
‫אלקטרוני‬

A47J )2011.01(
‫מתקן להכנת משקה בעל סגירה מיכנית‬
‫עם אמצעי כוח שאינו מרובה‬

December 29, 2011-‫ג' בטבת התשע"ב‬

04//3/0/2/

76::=5

BICYCLIC PYRIMIDINE PI3K
INHIBITOR COMPOUNDS SELECTIVE
FOR P110 DELTA, AND METHODS OF
USE
GENENTECH, INC.
US
61/181452
27/05/2009
42/0654/5
25/20/0//7
US
PCT/US/2010/036199
WO/2010/138589

21//2/0/2/

‫תרכובות פירימידין ביציקליות המעכבות‬
‫ ושיטות‬,‫ דלתא‬P110 ‫ בררניות עבור‬K3PI
‫לשימוש‬

76::=6

ENGINEERED MESENCHYMAL STEM
CELLS AND METHOD OF USING
SAME TO TREAT TUMORS
APCETH GMBH & CO. KG
US
61/168787
13/04/2009
PCT/EP/2010/054844
WO/2010/119039

/7//2/0/2/

76::=8

METHODS FOR PREVENTING
AND/OR TREATING LYSOSOMAL
STORAGE DISORDERS
AMICUS THERAPEUTICS, INC.
US
61/168109
09/04/2009
PCT/US/2010/030472
WO/2010/118283

/7//2/0/2/

76::=9

METHODS FOR PREVENTING
AND/OR TREATING DEGENERATIVE
DISORDERS OF THE CENTRAL
NERVOUS SYSTEM
AMICUS THERAPEUTICS, INC.
US
61/168101
09/04/2009
105

C07D )2011.01(

A61K )2011.01(
‫תאי גזע מסנכימלים מהונדסים ושיטה‬
‫לשימוש בהם לטיפול בגידולים‬

A01N )2011.01(
‫או טיפול בהפרעות‬/‫שיטות למניעת ו‬
‫באחסון ליזוזומלי‬

A01N )2011.01(
‫או טיפול בהפרעות‬/‫שיטות למניעת ו‬
‫ניווניות של מערכת העצבים המרכזית‬

December 29, 2011-‫ג' בטבת התשע"ב‬

PCT/US/2010/030470
WO/2010/118282

/0//5/0//7

76::=:

APPARATUS FOR THERMOLYSIS
WASTE PLASTICS AND METHOD
FOR THERMOLYSIS WASTE
CLARITER POLAND SPOLKA Z
ORGANICZONA
ODPOWIEDZIALNOSCIA
PL
P-387742
08/04/2009
PCT/IB/2009/052879
WO/2010/116211

/4//2/0/2/

05/2//0//7

H04W )2011.01(

‫שיטות ומכשירים עבור השקטת ערוץ פס‬
‫טלוויזיה דרך טכנולוגיות גישת רדיו‬

76::=<

A MASS-STORAGE SYSTEM
UTILIZING AUXILIARY SOLIDSTATE STORAGE SUBSYSTEM
KAMINARIO TECHNOLOGIES LTD.
US
61/168346
10/04/2009
PCT/IL/2009/001004
WO/2010/116349

106

‫התקן ושיטה לפירוק בחום של פסולת‬
‫פלסטיק‬

76::=;

METHODS AND APPARATUS FOR
TELEVISION BAND (TVBD)
CHANNEL QUIETING ACROSS
DIVERSE RADIO ACCESS
TECHNOLOGIESS
INTERDIGITAL PATENT HOLDINGS,
INC.
US
61/167050
06/04/2009
42/074137
27//2/0/2/
US
PCT/US/2010/030063
WO/2010/117998

C10G )2011.01(

G06F )2011.01(

–‫מערכת לאחסון מסה המשתמשת בתת‬
‫מערכת אחסון מסייעת במצב מוצק‬

December 29, 2011-‫ג' בטבת התשע"ב‬

/5//2/0//7

76::>5

SPACER FOR SPACING GLASS PANES
IN A MULTIPLE GLASS PANE, A
MULTIPLE GLASS PANE, AND A
METHOD FOR PRODUCING A
MULTIPLE GLASS PANE
PROWERB ST. GALLEN AG

E06B )2011.01(
‫חוצץ לרווח חלונות זכוכית בחלונות‬
‫ חלון מרובה זכוכיות‬,‫מרובי זכוכיות‬
‫ושיטה לייצור חלון מרובה זכוכיות‬

PCT/EP/2009/054153
WO/2010/115456

01//2/0/2/

76::>6

A TUBERCULOSIS TB VACCINE TO
PREVENT REACTIVATION
STATENS SERUM INSTITUT
DK
PA200900539 24/04/2009
PCT/DK/2010/000054
WO/2010/121618

21//2/0/2/

76::>7

COMPOSITIONS AND METHODS FOR
THE TREATMENT OF
INFLAMMATION
C.T. RESOLVE SARL
US
61/168739
13/04/2009
42/2526/4
/2//3/0//7
US
PCT/US/2010/030813
WO/2010/120719

22//2/0/2/
COMPOSITIONS FOR IMMUNISING
AGAINST STAPHYLOCOCCUS
AUREUS
107

76::>8

A61K )2011.01(
‫חיסון נגד שחפת למניעת התעוררות‬
‫חוזרת‬

C07C )2011.01(
‫תכשירים ושיטות לטיפול בדלקת‬

A61K )2011.01(
‫תכשירים לחיסון נגד סטפילוקוקוס‬
AUREUS
December 29, 2011-‫ג' בטבת התשע"ב‬

NOVARTIS AG
US
61/212705
42/012/57
US
PCT/IB/2010/000998
WO/2010/119343

21//2/0/2/

14/04/2009
22//6/0//7

76::>9

HIGH FIBER NUTRITIONAL
EMULSIONS
ABBOTT LABORATORIES
US
61/169022
14/04/2009
PCT/US/2010/030834
WO/2010/120734

21//2/0/2/

76::>:

HIGH FIBER NUTRITIONAL
EMULSIONS FOR BLOOD GLUCOSE
CONTROL
ABBOTT LABORATORIES
US
61/169030
14/04/2009
PCT/US/2010/030837
WO/2010/120736

21//2/0/2/

76::>;

HIGH FIBER NUTRITIONAL
EMULSION WITH GLYCERIN
ABBOTT LABORATORIES
US
61/169027
14/04/2009
PCT/US/2010/030884
WO/2010/120772

12//1/0/2/
108

76::>=

A23L )2011.01(
‫אמולסיות תזונתיות בעלות כמות סיבים‬
‫גבוהה‬

A23L )2011.01(
‫אמולסיות תזונתיות בעלות כמות סיבים‬
‫גבוהה לבקרת רמת גלוקוז בדם‬

A23L )2011.01(
‫אמולסיות תזונתיות בעלות כמות סיבים‬
‫גבוה עם גליצרין‬

H04M )2011.01(
December 29, 2011-‫ג' בטבת התשע"ב‬

METHOD AND SYSTEM FOR
OBTAINING RADIO ACCESS
NETWORK (RAN) INFORMATION OF
CELLULAR TELECOMMUNICATIONS
NETWORKS
INTUCELL LTD
IL
198100
07/04/2009
PCT/IB/2010/051400
WO/2010/116292

05//2/0/2/

‫שיטה ומערכת להשגת מידע על רשת‬
‫) של רשת תקשורת‬RAN( ‫גישה רדיו‬
‫סלולרית‬
‫אינטיוסל בע"מ‬

76:;55

METHOD AND APPARATUS FOR
AUTOMATIC VERIFICATION OF
ENDOTRACHEAL INTUBATION
TUBEEYE MEDICAL LTD
US
61/173324
28/04/2009
PCT/IB/2010/051833
WO/2010/125520

/6//2/0/2/

/7//2/0/2/

C07C )2011.01(

,‫נגזרות של רזורצינול שעברו סולפוריזציה‬
‫הכנתן ושימושים קוסמטיים בהן‬

76:;57

METHOD FOR THE CULTIVATION OF
CELL POPULATION IN A SERUM
FREE MEDIUM
CELLCA GMBH
EP
09005211.9 09/04/2009
PCT/EP/2010/002217
109

‫שיטה והתקן לווידןא אוטומטי של‬
‫אינטובציה תוך קנה הנשימתית‬

76:;56

SULPHURATED DERIVATIVES OF
RESORCINOL, PREPARATION OF
SAME AND COSMETIC USES
THEREOF
PIERRE FABRE DERMOCOSMETIQUE
FR
0952289
08/04/2009
PCT/EP/2010/054619
WO/2010/115945

A61M )2011.01(

C12N )2011.01(
‫שיטה לתרבות אוכלוסית תאים במדיום‬
‫בלי נסיוב‬

December 29, 2011-‫ג' בטבת התשע"ב‬

WO/2010/115634

/5//2/0/2/

76:;58

HUMAN PROTEIN SCAFFOLD WITH
CONTROLLED SERUM
PHARMACOKINETICS,
COMPOSITIONS COMPRISING THE
SAME AND USES THEREOF
THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA
US
61/167844
08/04/2009
PCT/US/2010/030291
WO/2010/118169

/7//2/0/2/

/6//2/0/2/

A01N )2011.01(

‫תכשירים המכילים אמינואלקיל‬
‫גלוקוסאמיניד פוספאט לשימוש בטיפול‬
‫בבצקת הקשורה לאיסכמי–ה–רפרפוזי–ה‬

76:;5;

SYSTEM AND METHOD FOR IMAGE
COMPRESSION
WATCHITOO, INC.
US
61/167536
08/04/2009
PCT/US/2010/030425
WO/2010/118254

110

‫שלדי חלבון אנושי עם פרמקוקינטיקה‬
‫ תכשירים המכילים אותם‬,‫בנסיוב מבוקר‬
‫ושימושים בהם‬

76:;59

COMPOSITIONS COMPRISING
AMINOALKYL GLUCOSAMINIDE
PHOSPHATE FOR USE IN TREATING
EDEMA RELATED TO ISCHEMIAREPEFUSION
THE UNIVERSITY OF NORTH
CAROLINA AT CHAPEL HILL
US
61/168089
09/04/2009
PCT/US/2010/030556
WO/2010/118334

A61K )2011.01(

H04N )2011.01(
‫מערכת ושיטה לעיבוד תמונה‬

December 29, 2011-‫ג' בטבת התשע"ב‬

/6//2/0//7

76:;5<

MACHINABLE COPPER-BASED
ALLOY AND METHOD FOR
PRODUCING THE SAME
SWISSMETAL-UMS
SCHWEIZERISCHE METALL WERKE
AG

C22C )2011.01(

‫סגסוגת מבוססת נחושת שניתנת לעיבוד‬
‫ושיטה לייצורה‬

PCT/EP/2009/054250
WO/2010/115462

/6//2/0/2/

76:;5=

‫תכשיר לשחרור תרופה‬

DRUG DELIVERY COMPOSITION
ALKERMES PHARMA IRELAND
LIMITED
US
61/168040
09/04/2009
PCT/US/2010/030387
WO/2010/118228

/5//2/0/2/

76:;5>

QUINAZOLINEDIONE DERIVATIVES,
PREPARATION THEREOF AND
VARIOUS THERAPEUTIC USES
THEREOF
SANOFI
FR
0901760
09/04/2009
PCT/FR/2010/050664
WO/2010/116088

/5//2/0/2/

111

C07D )2011.01(

‫ הכנתן ושימושים‬,‫נגזרות קינאזולינדיאון‬
‫רפואיים מגוונים שלהן‬

76:;65

THERAPEUTIC APPLICATIONS IN
THE CARDIOVASCULAR FIELD OF
QUINAZOLINEDIONE DERIVATIVES
SANOFI
FR
09/01755
09/04/2009
PCT/FR/2010/050672

A61K )2011.01(

A61K )2011.01(
‫יישומים רפואיים של נגזרות‬
‫קינאזולינדיאון בתחום הלב וכלי הדם‬

December 29, 2011-‫ג' בטבת התשע"ב‬

WO/2010/116090

21//2/0/2/

ENZYME DELIVERY SYSTEMS AND
METHODS OF PREPARATIONS AND
USE
CUREMARK LLC
US
12/386051
13/04/2009
PCT/US/2010/030895
WO/2010/120781

21//2/0/2/

‫מערכות למתן אנזימים ושיטות להכנה‬
‫ושימוש‬

COMPRESSED SHEET
DSM IP ASSETS B.V.
EP
09158621.4
PCT/EP/2010/055337
WO/2010/122099

/3//3/0/2/

H01S )2011.01(

76:;68

–‫התקני ספיגה הניתנים לרוויה מבוססי‬
‫גרפן ושיטות‬

GRAPHENE-BASED SATURABLE
ABSORBER DEVICES AND METHODS
NATIONAL UNIVERSITY OF
SINGAPORE
US
61/168661
13/04/2009
PCT/SG/2010/000148
WO/2010/120246

00//2/0/2/

A01N )2011.01(

76:;67

76:;69

‫יריעה דחוסה‬
23/04/2009

76:;6:

SUBSTITUTED 1CYANOETHYLHETEROCYCLYLCARBOXAMIDE
COMPOUNDS 750
ASTRAZENECA AB
112

B29C )2011.01(

C07D )2011.01(
–1 750 ‫תרכובות‬
‫ציאנואתילהטרוציקלילקרבוקסאמיד‬
‫מותמרות‬

December 29, 2011-‫ג' בטבת התשע"ב‬

US
61/176279
42/263407
US
PCT/GB/2010/050736
WO/2010/128324

07/05/2009
2///4/0//7

01//2/0/2/

76:;6;

3-AZABICYCLO [4.1.0] HEPTANES
USED AS OREXIN ANTAGONISTS
GLAXO GROUP LIMITED
GB
0907112.7
24/04/2009
/72/26195
25//4/0//7
GB
/70025094
00/20/0//7
GB
PCT/EP/2010/055449
WO/2010/122151

22//2/0/2/

‫] הפטנים המשמשים‬0.1.4]‫–אזאביציקלו‬3
‫כאנטגוניסטים לאורקסין‬

76:;6=

PREDICTIVE MODELS AND METHOD
FOR ASSESSING AGE
CARDIODX, INC
US
61/169241
14/04/2009
PCT/US/2010/031076
WO/2010/120914

22/2//0/22

76:;=<

LARYNGOSCOPE HANDLE
113

C12Q )2011.01(
‫מודלים מנבאים ושיטה להערכת גיל‬

G11C )2011.01(
‫מערכת הקלטה בזמן אמת‬

REAL-TIME RECORDING SYSTEM
ISRAEL AEROSPACE INDUSTRIES
LTD.

22/2//0/22

C07D )2011.01(

‫התעשייה האוירית לישראל בע"מ‬

76:;>=

A61B )2011.01(
‫ידית לרינגוסקוף‬
December 29, 2011-‫ג' בטבת התשע"ב‬

‫תרופאטק אינטרנשיונל בע"מ‬

TRUPHATEK INTERNATIONAL LTD.

22/2//0/22

76:;>>

LIQUID DRUG RECONSTITUTION
ASSEMBLAGE FOR USE WITH IV
BAG AND DRUG VIAL
MEDIMOP MEDICAL PROJECTS LTD.

22/2//0/22

‫התקן לשחזור תרופה נוזלית לשימוש עם‬
‫ ובקבוקון תרופה‬IV ‫שקית‬

76:<55

76:<6:

DEHUMIDIFIER AND METHOD OF
USE THEREOF
AGAM ENERGY SYSTEMS LTD.
114

F28F )2011.01(

G02B )2011.01(
‫אמצעי ביתי להפקת מדבקות‬
‫לנטיקולריות אישיות‬
‫יצחק בר יונה‬

MEANS FOR PRODUCING HOME
MADE IENTICULAR STICKERS
ITZHAK BAR YONA

22/2//0/22

‫מדימופ פרוייקטים רפואיים בע"מ‬

‫מערכת ושיטה לקירור‬
‫אלתא מערכות בע"מ‬

COOLING SYSTEM AND METHOD
ELTA SYSTEMS LTD.

22/2//0/22

A61M )2011.01(

76:<75

C25B )2011.01(
‫מייבש אוויר ושיטת שימושו‬
‫אג"מ מערכות אנרגיה בע"מ‬
December 29, 2011-‫ג' בטבת התשע"ב‬

22/2//0/22

76:<89

RAISABLE BED
AMINACH BEDDING & FURNITURE
MANUFACTURING LTD

22/2//0/22

76:<8:

IN-LINE PRINTING PROCESS ON WET
NON-WOVEN FABRIC AND
PRODUCTS THEREOF
N.R. SPUNTECH INDUSTRIES LTD.
US
61/394407
19/10/2010

22/2//0/22

76:<8;

A SYSTEM FOR PROVIDING WAKEUP ALERTS TO PASSENGERS OF
PUBLIC TRANSPORTATION
GRATZYA CHECHIK

01/2//0/22

115

76:<98

G08B )2011.01(
‫מיטה מתרוממת‬
‫עמינח תעשיות רהיטים ומזרונות‬

D21H )2011.01(
‫תהליך הדפסה על בדים רטובים לא‬
‫ארוגים ומוצרים כתוצאה מכך‬
‫ ספאנטק תעשיות בע"מ‬.‫ר‬.‫נ‬

G06F )2011.01(
‫מערכת למתן אתראות התעוררות‬
‫לנוסעים בתחבורה ציבורית‬
‫גרציה צ'צ'יק‬

G06Q )2011.01(

December 29, 2011-‫ג' בטבת התשע"ב‬

AUTOMATIC SYSTEM MONITORING
EXISTENCE OF MAIL IN A MAIL BOX
AND SENDING ALERT INCLUDING A
PICTURE OF THE BOX'S CONTENT
AVI PARASH

01/2//0/22

‫מערכת אוטומטית לבדיקת הימצאות‬
‫דואר בתיבת הדואר ושליחת התראה‬
‫הכוללת צלום תוכן התיבה‬
‫אבי פרש‬

76:<99

ZERO-DRIFT DETECTION AND
CORRECTION IN CONTACT FORCE
MEASUREMENTS
BIOSENSE WEBSTER (ISRAEL) LTD
US
12/938458
03/11/2010

01/2//0/22

01/2//0/22

A61B )2011.01(

‫הצגת מגע בין צנתר לרקמה ע"י עיוות של‬
‫מפה‬

76:<=7

METHOD FOR TREATING A
PERIODONTAL DISEASE
DEXCEL PHARMA TECHNOLOGIES
LTD.
US
61/406288
25/10/2010

116

‫גילוי ותיקון של סחיפת נקודת האפס‬
‫במדידות של כוח מגע‬

76:<9;

VISUALIZATION OF CATHETERTISSUE CONTACT BY MAP
DISTORTION
BIOSENSE WEBSTER (ISRAEL) LTD
US
12/939259
04/11/2010

G01L )2011.01(

A61K )2011.01(
‫שיטה לטיפול במחלת חניכיים‬
‫דקסל פארמה טכנולוגיות בע"מ‬

December 29, 2011-‫ג' בטבת התשע"ב‬

06//2/0//4

76:<==

PROCESS FOR THE PREPARATION
OF POLYCYCLIC
CARBAMOYLPYRIDONE
DERIVATIVE HAVING HIV
INTEGRASE INHIBITORY ACTIVITY
SHIONOGI & CO., LTD.
2005JP
28/04/2005
131161
0//3-120/54 05/2//0//3
JP
PCT/US/2006/016604
WO/2006/116764

01/2//0/22

‫תהליך להכנת נגזרת פוליציקלית של‬
‫קרבאמוילפירידון בעלת פעילות מעכבת‬
‫של נגיף האיידס‬

76:=7:

SELABLE STORAGE CONTAINER
THE STANLEY WORKS ISRAEL LTD
US
12/969352
15/12/2010

/6//1/0//4

76:=89

LIQUID HUMAN MILLC FORTIFIER
(HMF) COMPOSITION FOR ADDING
TO HUMAN MILK OR INFANT
NUTRITIONAL FORMULA
ABBOTT LABORATORIES
US
60/660087
09/03/2005
PCT/US/2006/008354
WO/2006/099013

2///1/0//4

117

C07D )2011.01(

76:=:7

B65D )2011.01(
‫מיכל איחסון הניתן לאיטום‬
‫דה סטנלי וורקס ישראל בע"מ‬

A23L )2011.01(
)HMF( ‫תוסף חיזוק נוזלי לחלב אנושי‬
‫ולתרכובות הזנה לתינוקות‬

C07K )2011.01(

December 29, 2011-‫ג' בטבת התשע"ב‬

ACUTE LEUKEMIA AND
LYMPHOBLASTIC LYMPHOMASPECIFIC CD43 EPITOPE AND USE
THEREOF
DINONA INC.
US
60/679910
11/05/2005
2/-0//302//6/0//3
KR
//557/4
22/120204
0//20/0//3
US
PCT/KR/2006/000870
WO/2006/121240

20//2/0//4

‫ ספציפי ללאוקמיה‬CD 43 ‫אפיטופ‬
‫אקוטית וללימפומה לימפובלסטית‬
‫ושימוש בו‬

76:=;8

CATHETER FOR THE TRANSVASCULAR
IMPLANTATION OF PROSTHETIC
HEART VALVES
JENAVALVE TECHNOLOGY, INC.
DE
102005003632.5 20/01/2005
PCT/DE/2006/000056
WO/2006/076890

01/2//0/22

76:=<8

A METHOD FOR ESTIMATING THE
TOTAL COST OF OWNERSHIP (TCO)
FOR A REQUIREMENT
MY SINGLE POINT LTD

02/2//0/22

76:=<<

ROUTING OF PACING SIGNALS
BIOSENSE WEBSTER (ISRAEL) LTD
US
12/914199
28/10/2010

118

A61F )2011.01(

‫רכיב להפעלת צנתר השתלה דרך כלי‬
‫דם של שסתומי לב תותבים‬

G07B )2011.01(
‫שיטה להערכת עלות הבעלות הכוללת‬
‫לדרישה‬
‫מיי סינגל פוינט בע"מ‬

A61B )2011.01(
‫ניתוב של אותות קיצוב‬

December 29, 2011-‫ג' בטבת התשע"ב‬

02/2//0/22

SIMULTANEOUS ABLATION BY
MULTIPLE ELECTRODES
BIOSENSE WEBSTER (ISRAEL) LTD
US
12/941165
08/11/2010

02/2//0/22

‫אבלציה ע"י אלקטרודות רבות בו–זמנית‬

A23L )2011.01(

‫אריזת מזון קפוא להכנת מוצר מזון מוגמר‬
‫והכנתו‬
‫סנפרוסט בע"מ‬

76:==:

A ROTABLE ELECTRIC CONNECTOR
ALON ALMOULI
UA
GB1017782.2 21/10/2010

119

‫אבלציה רב–ערוצית עם הפרדת תדרים‬

76:==7

A FROZEN FOOD PACKAGE FOR
PREPARING A FINISHED FOOD
PRODUCT AND ITS PREPARATION
SUNFROST LTD

02/2//0/22

H04J )2011.01(

76:==6

MULTICHANNEL ABLATION WITH
FREQUENCY DIFFERENTIATION
BIOSENSE WEBSTER (ISRAEL) LTD
US
12/941165
08/11/2010
20/7320//
00/22/0/2/
US

02/2//0/22

H04J )2011.01(

76:==5

H01R )2011.01(
‫מחבר אלקטרוני בעל יכולת סיבובית‬
‫אלון אלמולי‬

December 29, 2011-‫ג' בטבת התשע"ב‬

02/2//0/22

76:==;

A CROWD-SOURCE BASED SYSTEM
AND METHOD OF SUPERVISING
AND DISPATCHING ON-LINE
CONTENT PRODUCTING FOR
ADVOCACY AND SEARCH ENGINE
OPTIMIZATION
YECHEZKEL ZVI GREEN
US
61406339
25/10/2010

12//6/0//2

76:=>5

PEPTIDOMIMETIC PROTEASE
INHIBITORS
VERTEX PHARMACEUTICALS
INCORPORATED
US
60/229398
31/08/2000
4//055422
02//1/0//2
US
PCT/US/2001/026008
WO/2002/018369

12//6/0//2

76:=>6

PEPTIDOMIMETIC PROTEASE
INHIBITORS
VERTEX PHARMACEUTICALS
INCORPORATED
US
60/229398
31/08/2000
4//055422
02//1/0//2
US
PCT/US/2001/026008
WO/2002/018369

12//6/0//2
120

76:=>7

G06F )2011.01(

‫פלטפורמה אוטומטית לניהול כותבי‬
‫תכנים לצרכי שיווק אינטרנטי והסברה‬
‫יחזקאל צבי גרין‬

C07D )2011.01(
‫מעכבים של פרוטאז פפטידומימטיים‬

C07D )2011.01(
‫מעכבים של פרוטאז פפטידומימטיים‬

C07D )2011.01(
December 29, 2011-‫ג' בטבת התשע"ב‬

PEPTIDOMIMETIC PROTEASE
INHIBITORS
VERTEX PHARMACEUTICALS
INCORPORATED
US
60/229398
31/08/2000
4//055422
02//1/0//2
US
PCT/US/2001/026008
WO/2002/018369

23//5/0//3

76:=>;

COMPOUNDS AND METHODS FOR
TREATMENT OF CANCER
THE TEXAS A&M UNIVERSITY
SYSTEM
US
60/588596
16/07/2004
PCT/US/2005/025192
WO/2006/020048

26//1/0//3

76:=><

PHARMACEUTICAL COMPOSITION
AT THE EQUILIBRIUM STATE
COMPRISING 4-HYDROXY
TAMOXIFEN AND METHOD FOR
MAKING IT
LABORATOIRES BESINS
INTERNATIONAL
EP
04290762.6 22/03/2004
2//6/331/
00//1/0//2
US
PCT/EP/2005/003455
WO/2005/092310

03//0/0//2

76:>6<

P38 INHIBITORS AND METHODS OF
USE THEREOF
ARRAY BIOPHARMA, INC
US
10/378164
03/03/2003
2//466627
23/2//0//1
US
121

‫מעכבים פרוטאז פפטידומימטיים‬

A61K )2011.01(
‫תרכובות ושיטות לטיפול בסרטן‬

A61K )2011.01(
–4 ‫תכשיר רוקחי שיווי משקל המכיל‬
‫הידרוקסי טאמוקסיפן ושיטה להכנתו‬

C07D )2011.01(
‫ ושיטות לשימוש בהם‬P38 ‫מדכאי‬

December 29, 2011-‫ג' בטבת התשע"ב‬

PCT/US/2004/005693
WO/2004/078116

1///2/0/2/

76:>6=

PURIFYING DEVICE AND METHOD FOR
ELIMINATION OF XENOBIOTICS IN
WATER
LOIRA
FR
PCT/FR2009/050800 30/04/2009
PCT/IB/2010/000982
WO/2010/125450

07//2/0/2/

76:>6>

ANTI CXCR4 ANTIBODIES FOR THE
TREATMENT OF HIV
PIERRE FABRE MEDICAMENT
EP
09159076.0 29/04/2009
42/25146/
07//2/0//7
US
PCT/EP/2010/055863
WO/2010/125162

03/2//0/22
APPARATUS AND METHOD FOR
SMART LIGHT EMISSION AND
SMART LIGHT EMITTER
CONSTRUCTION
ISRAEL AEROSPACE INDUSTRIES
LTD.

01//4/0//7
122

C02F )2011.01(
‫התקן לטיהור ושיטה לסילוק‬
‫קסנוביוטיים ממים‬

C07K )2011.01(

‫ לטיפול בנגיף האיידס‬CXCR4 ‫נוגדנים נגד‬

76:>75

G02C )2011.01(

‫התקן ושיטות לפליטת אור חכמה ולבניית‬
‫פולט אור חכם‬
‫התעשייה האוירית לישראל בע"מ‬

76:>77

A61K )2011.01(
December 29, 2011-‫ג' בטבת התשע"ב‬

INTRAVENOUS FORMULATION
WITH WATER-SOLUBLE
COCRYSTALS OF
ACETYLSALICYLIC ACID AND
THEANINE
SOLUPRIN PHARMACEUTICALS,
INC.
US
12/437735
08/05/2009
PCT/US/2009/048275
WO/2010/128977

04//6/0//2

‫תכשיר תוך ורידי עם גבישים–משותפים‬
‫מסיסים במים של חומצה אצטילסליצילית‬
‫ותיאנין‬

76:>78

OPTICAL ELEMENT AND EXPOSURE
APPARATUS
NIKON CORPORATION
2003JP
26/08/2003
302122
0//1-1/1210 05//6/0//1
JP
0//1-1/0327 05//6/0//1
JP
0//1-114240 04//7/0//1
JP
0//2-/22626 26//0/0//2
JP
0//2-/20235 26//0/0//2
JP
0//2-/20530 27//0/0//2
JP
0//2-/22007 0///0/0//2
JP
PCT/JP/2004/012296
WO/2005/020298

05//2/0/2/

123

‫רכיב אופטי והתקן חשיפה‬

76:>79

ANTI-LPS ENRICHED
IMMUNOGLOBULIN PREPARATIONS
FOR THE TREATMENT AND/OR
PROPHYLAXIS OF A PATHOLOGIC
DISORDER
IMMURON LIMITED
US
61/172922
27/04/2009
PCT/IL/2010/000339
WO/2010/125565

H01L )2011.01(

C07K )2011.01(

LPS–‫תכשיר אימונוגלובולין מועשר נגד‬
‫או מניעה של הפרעה פתולוגית‬/‫לטיפול ו‬

December 29, 2011-‫ג' בטבת התשע"ב‬

05//2/0/2/

76:>7:

ELECTROKINETICALLY-ALTERED
FLUID COMPOSITIONS AND USE
THEREOF FOR TREATING INSULIN
RESISTANCE AND DIABETES
MELLITUS
REVALESIO CORPORATION
US
61/173134
27/04/2009
PCT/US/2010/032620
WO/2010/126908

02//3/0/2/

‫תכשירי נוזל שעבר שינוי אלקטרוקינטי‬
‫ושימוש בו לטיפול בהתנגדות לאינסולין‬
‫בסכרת‬

76:>7;

HARD DRIVE DESTRUCTION
SYSTEM
SCOTT ANTHONY WOZNY
US
61/180841
23/05/2009
PCT/US/2010/035881
WO/2010/138427

22//0/0//3

1///2/0/2/

124

A01H )2011.01(

‫צמחי וזרעי עגבניות המכילות אלל עמיד‬
‫לנגיף ושיטות להכנתם‬

76:>7=

DUAL VARIABLE DOMAIN
IMMUNIGLOBULINS AND USES
THEREOF
ABBOTT LABORATORIES
US
61/174711
01/05/2009
PCT/US/2010/033231

B02C )2011.01(
‫מערכת השמדת כונן קשיח‬

76:>7<

TOMATO PLANTS AND SEEDS
COMPRISING A VIRUS RESISTANT
ALLELE AND METHODS OF
PRODUCING THE SAME
SEMINIS VEGETABLE SEEDS, INC.
US
10/777984
12/02/2004
PCT/US/2005/004547
WO/2005/079342

A61K )2011.01(

A61K )2011.01(

‫נוגדנן בעל איזור משתנה כפול ושימושיו‬

December 29, 2011-‫ג' בטבת התשע"ב‬

WO/2010/127284

/2/2//0//4

76:>7>

NOVEL PYRAZOLOPYRIMIDINES AS
CYCLIN DEPENDENT KINASE
INHIBITORS
SCHERING CORPORATION
US
11/245401
06/10/2005
PCT/US/2006/038939
WO/2007/044449

1///2/0/2/

76:>85

NOVEL CRYSTAL FORM OF
TRICYCLIC BENZOPYRAN
COMPOUND AND PRODUCTION
METHOD THEREOF
NISSAN CHEMICAL INDUSTRIES
LTD.
2009JP
30/04/2009
111281
PCT/JP/2010/057698
WO/2010/126138

03/2//0/22

76:>86

LABYRINTH WITH MEMBRANE
AMIRIM PRODUCTS DEVELOPMENT
& PATENTS LTD
GB
1017985.1
25/10/2010

23//2/0/2/

125

76:>87

C07D )2011.01(
‫פירזולופירימידינים חדשים כמעכבים‬
‫לקינאזים תלויי ציקלין‬

C07D )2011.01(
‫צורה גבישית של תרכובת בנזופיראן‬
‫טריציקלית ושיטה לייצורה‬

A01G )2011.01(
‫מבוך עם ממברנה‬
‫אמירים פיתוח מוצרים ופטנטים בע"מ‬

A61K )2011.01(

December 29, 2011-‫ג' בטבת התשע"ב‬

COMPOSITIONS AND METHODS FOR
TREATING BURNS
MINDCAKE, LLC
US
12/429169
23/04/2009
PCT/US/2010/031315
WO/2010/123759

21/2//0//2

‫תרכובות ושיטות לטיפול בכוויות‬

76:>88

MACROCYCLIC CARBOXYLIC ACIDS
AND ACYLSULFONAMIDES AS
INHIBITORS OF HCV REPLICATION
INTERMUNE, INC.
US
60/511541
14/10/2003
4//42024/
00//7/0//2
US
PCT/US/2004/033970
WO/2005/037214

21/2//0//2

06//2/0/2/
COMBINED PLANT
YOSUKE IIDA,
JP
200910149706.3
PCT/JP/2010/057918
WO/2010/128682

126

‫חומצות קרבוקסיליות ואצילסופונאמידים‬
HCV ‫מקרוציקליים כמעכבי שכפול‬

76:>89

MACROCYCLIC CARBOXYLIC ACIDS
AND ACYLSULFONAMIDES AS
INHIBITORS OF HCV REPLICATION
INTERMUNE, INC.
US
60/511541
14/10/2003
4//42024/
00//7/0//2
US
PCT/US/2004/033970
WO/2005/037214

C07D )2011.01(

C07D )2011.01(

‫חומצות קרבוקסיליות ואצילסופונאמידים‬
HCV ‫מקרוציקליים כמעכבי שכפול‬

76:>8:

C01C )2011.01(
‫מפעל משולב‬

05/05/2009

December 29, 2011-‫ג' בטבת התשע"ב‬

/5//3/0/2/

76:>8;

COMPOSITIONS AND METHODS FOR
MAKING ALPHA-(1,2)-BRANCHED
ALPHA-(1,6) OLIGODEXTRANS
TATE & LYLE INGREDIENTS
FRANCE SAS
US
61/176242
07/05/2009
PCT/US/2010/033984
WO/2010/129839

/2//3/0/2/

76:>8<

FGF21 MUTANTS AND USES
THEREOF
AMGEN INC.
US
61/175736
05/05/2009
42/063226
/7/20/0//7
US
PCT/US/2010/033478
WO/2010/129503

/6/22/0//4

76:>8=

METHOD FOR MANUFACTURING OF
CELLULAR BOARD, CELLULAR
BOARD, METHOD FOR PRODUCING
CELLULAR BOARD ELEMENT OF
STEEL PLATE STRIP, AND
PRODUCTION LINE
OY SHIPPAX LTD
FI
20051131
08/11/2005
0//32105
05/20/0//3
FI
0//4/225
/5//0/0//4
FI
0//4/221
/6//3/0//4
FI
0//4/437
/4//5/0//4
FI
0//4/616
0///7/0//4
FI
PCT/FI/2006/000359
WO/2007/054608

127

C08B )2011.01(
–)2,1(–‫תכשירים ושיטות להכנת אלפא‬
‫)–אוליגודקסטראנים‬6,1(–‫מסועף אלפא‬

A61K )2011.01(
‫ ושימושים שלהם‬FGF21 ‫מוטנטים של‬

B21D )2011.01(

‫שיטה להפקת אלמנטים של לוח סלולר‬
‫מסרטי משטח מתכת ושורת הפקה‬

December 29, 2011-‫ג' בטבת התשע"ב‬

22//1/0//1

76:>99

USE OF A TESTOSTERONE
COMPRISING PHARMACEUTICAL
COMPOSITION IN THE
PREPARATION OF MEDICAMENT
FOR TREATING OR PREVENTING
THE RISK OF DEVELOPING A
DEPRESSIVE DISORDER
UNIMED PHARMACEUTICALS, LLC
US
10/098232
15/03/2002
2//231246
02//3/0//0
US
PCT/US/2003/007910
WO/2004/091631

04/2//0/22

‫שימוש בתכשיר רוקחי המכיל טסטוסטרון‬
‫להכנת תרופה לטיפול או מניעה בסיכון‬
‫של התפתחות מחלה דיכאונית‬

76:>;5

76:>;>

CMP POROUS PAD WITH
COMPONENT-FILLED PORES
CABOT MICROELECTRONICS
CORPORATION
US
10/807064
23/03/2004
PCT/US/2005/008527
WO/2005/100497

04/2//0/22
ADJUSTABLE SINK
GAD TAVORI

128

G07B )2011.01(
‫מתקן עזר להחלקת מזומן‬
‫חיים שלומי‬

CASH SLIDING SLIDING ASSISTANT
HALM SHELEMEY

22//1/0//3

A61K )2011.01(

C09G )2011.01(

‫כרית נקבובית למריקה כימית–מכנית עם‬
‫נקבוביות מלאות ברכיב‬

76:><5

E03C )2011.01(
‫כיור מתכון‬
‫גד תבורי‬

December 29, 2011-‫ג' בטבת התשע"ב‬

05/2//0/22

76:><6

‫התקן יציבות לאופנוע‬
‫ארן יעקביאן‬

MOTORCYCLE STABILITY
OREN YAKOBIAN

05/2//0/22

76:><7

DIGITAL PRINTING METHOD AND
APPARATUS
MICHAL IVRI

/2/2//0//5

129

B41L )2011.01(
‫שיטה והתקן להדפסה דיגיטאלית‬
‫מיכל עברי‬

76:><=

HIGH-PURITY LARGE SCALE
PREPARATION OF STANNSOPORFIN
INFACARE PHARMACEUTICAL
CORPORATION
US
60/849641
04/10/2006
4//7/24/2
06//0/0//5
US
PCT/US/2007/021485
WO/2008/045377

2///4/0//2

B62J )2011.01(

A61K )2011.01(

‫הכנת סטנסופורפין עם דרגת טיהור גבוהה‬
‫בקנה מידה גדול‬

76:>><

C07D )2011.01(

December 29, 2011-‫ג' בטבת התשע"ב‬

FUSED COMPOUNDS CONTAINING
AN UREIDO GROUP THAT INHIBIT
VANILLOID RECEPTOR SUBTYPE 1
(VR1) RECEPTOR ,FOR TREATING
DISORDERS CAUSED BY VANILLOID
RECEPTOR ACTIVITY AND PROCESS
FOR THEIR PREPARATION
ABBOTT LABORATORIES
US
10/459925
12/06/2003
2//642/46
/7//4/0//2
US
PCT/US/2004/018590
WO/2004/111009

05/2//0/22

‫תרכובות מאוחות המכילות קבוצת‬
–‫אוראידו המעכבות קולטן וינלואיד תת‬
‫ לטיפול‬,‫) של הקולטן‬VR1( 1 ‫סוג‬
‫בהפרעות הנגרמות על–ידי פעילות של‬
‫קולטן וינלואיד ותהליך להכנתן‬

76;575

IMPROVED DATA ENTRY SYSTEMS
BENJAMIN FIROOZ GHASSABIAN

03//0/0/2/

76;598

ISOLATED POPULATIONS OF RENAL
STEM CELLS AND METHODS OF
ISOLATING AND USING GAME
TEL HASHOMER MEDICAL
RESEARCH INFRASTRUCTURE AND
SERVICES LTD.
US
61/202425
26/02/2009
42/0/0204
04//0/0//7
US
PCT/IL/2010/000158
WO/2010/097793

1//2//0/22
IMPROVED DATA SYSTEMS
BENJAMIN FIROOZ GHASSABIAN

130

76;59:

G06F )2011.01(
‫שיטות משופרות להכנסת נתונים‬
‫בנימין פירוז גסביאן‬

C12N )2011.01(
‫אוכלוסיות מבודדות של תאי נבט‬
‫כיליתיים ושיטות לבידוד ושימוש בהם‬
‫ תשתית ושירותים‬,‫תל השומר מחקרים‬
‫רפואיים בע"מ‬

G06F )2011.01(
‫שיטות משופרות להכנסת נתונים‬
‫בנימין פירוז גסביאן‬
December 29, 2011-‫ג' בטבת התשע"ב‬

2///4/0//2

76;59;

FUSED COMPOUNDS CONTAINING
AN UREIDO GROUP THAT INHIBIT
VANILLOID RECEPTOR SUBTYPE 1
(VR1) RECEPTOR ,FOR TREATING
DISORDERS CAUSED BY VANILLOID
RECEPTOR ACTIVITY AND PROCESS
FOR THEIR PREPARATION
ABBOTT LABORATORIES
US
10/459925
12/06/2003
2//642/46
/7//4/0//2
US
PCT/US/2004/018590
WO/2004/111009

12/2//0/22

‫תרכובות מאוחות המכילות קבוצת‬
–‫אוראידו המעכבות קולטן וינלואיד תת‬
‫ לטיפול‬,‫) של הקולטן‬VR1( 1 ‫סוג‬
‫בהפרעות הנגרמות על–ידי פעילות של‬
‫קולטן וינלואיד ותהליך להכנתן‬

76;5::

76;5:;

COMBINED DATABASE SYSTEM
AND METHOD
VERINT SYSTEMS LTD.

12/2//0/22
131

B65D )2011.01(
‫סל חזק הניתן להגדלה‬
‫הרטל גיא‬

STRONG AND ENLARGEABLE BAG
HARTAL GUY

12/2//0/22

C07D )2011.01(

G06F )2011.01(
‫מערכת ושיטה לשילוב בסיסי נתונים‬
‫ורינט מערכות בע"מ‬

76;5:=

G06T )2011.01(
December 29, 2011-‫ג' בטבת התשע"ב‬

SYSTEM AND METHOD FOR LINK
ANALYSIS BASED ON IMAGE
PROCESSING
VERINT SYSTEMS LTD.

12/2//0/22

‫מערכת ושיטה לניתוח קשרים על ידי‬
‫עיבוד תמונה‬
‫ורינט מערכות בע"מ‬

76;5:>

SYSTEM AND METHOD FOR TARGET
PROFILING USING SOCIAL
NETWORK ANALYSIS
VERINT SYSTEMS LTD.

/7//4/0//1

‫מערכת ושיטה לאפיון מטרות על ידי‬
‫ניתוח רשתות חברתיות‬
‫ורינט מערכות בע"מ‬

76;5;=

AUDIO CODING SYSTEM USING
CHARACTERISTICS OF A DECODED
SIGNAL TO ADAPT SYNTHESIZED
SPECTRAL COMPONENTS
DOLBY LABORATORIES LICENSING
CORPORATION

G06F )2011.01(

G10L )2011.01(

‫מערכת לקידור אודיו המשתמש‬
‫כמאפיינים של סיגנל מפוענח כדי לתאם‬
‫מרכיבים ספקטראליים מסונתזים‬

PCT/US/2003/018065
WO/2003/107329

/7//4/0//1

76;5;>

AUDIO CODING SYSTEM USING
CHARACTERISTICS OF A DECODED
SIGNAL TO ADAPT SYNTHESIZED
SPECTRAL COMPONENTS
DOLBY LABORATORIES LICENSING
CORPORATION
US
10/174493
17/07/2002
2//016/25
/4//7/0//0
US
132

G10L )2011.01(

‫מערכת לקידור אודיו המתשמש‬
‫כמאפיינים של סיגנל מפוענח כדי לתאם‬
‫מרכיבים ספקטרואליים‬

December 29, 2011-‫ג' בטבת התשע"ב‬

PCT/US/2003/018065
WO/2003/107329

03//4/0//2
DISPENSING DEVICE
PFIZER LIMITED
GB
0315509.0
PCT/GB/2004/002748
WO/2005/002654

/2/22/0/22

76;5<5

‫מתקן מינון‬
02/07/2003

76;5<>

ELECTRICAL POWER FOR VEHICLES
JOSEF JEFFRIES

03//4/0//2

76;5=>

PRODRUGS OF 9-AMINOMETHYL
TETRACYCLINE COMPOUNDS
PARATEK PHARMACEUTICALS, INC.
US
60/486017
09/07/2003
4//303065
03/22/0//1
US
4//31/201
24/20/0//1
US
4//34423/
05//2/0//2
US
PCT/US/2004/020305
WO/2005/009944

/2/22/0/22

76;5>5

LOGICAL BRIDGING SYSTEM AND
METHOD
MARVELL ISRAEL (M.I.S.L) LTD.
US
60/889809
14/02/2007
133

A61M )2011.01(

B60L )2011.01(
‫מנוע כח חשמלי עבור כלי רכב‬
‫יוסף ארווין ג'פריס‬

C07D )2011.01(
‫–אמינומתיל‬9 ‫קדם–תרופות מתרכובות‬
‫טטראציקליניות‬

H04L )2011.01(
‫מערכת גישור לוגית ושיטה‬
‫אל) בע"מ‬.‫אס‬.‫איי‬.‫מארוול ישראל (אמ‬
December 29, 2011-‫ג' בטבת התשע"ב‬

US

4//724/43

/2//3/0//5

/2/22/0/22

76;5>8

VEHICULAR DISPOSABLE
PROTECTIVE COVER
SHLOMO VANUNU

21//7/0//3

‫כיסוי הגנתי חד–פעמי לרכב‬
‫שלמה ואנונו‬

76;5>:

FUSION PROTEINS AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME
GENZYME CORPORATION
US
60/608887
13/09/2004
4//4360/7
/2//1/0//3
US
PCT/US/2005/032320
WO/2006/031689

/0/22/0/22

CATHETER WITH OPTICAL
CONTACT SENSING
BIOSENSE WEBSTER (ISRAEL) LTD
134

A61K )2011.01(

‫חלבוני איחוי ותכשירי רוקחות המכילים‬
‫אותם‬

76;5>;

G02C )2011.01(
‫משקפיים רב תכליתיים‬
‫רושדי עאסי‬

MULTI FUNCTIONAL GLASSES
ROSHDI ASSI

/0/22/0/22

B60S )2011.01(

76;658

A61B )2011.01(
‫צנתר עם חישת מגע אופטית‬

December 29, 2011-‫ג' בטבת התשע"ב‬

US

12/946910

16/11/2010

07/22/0//3

76;659

COATED DRUG DELIVERY
FORMULATIONS
WESTERN UNIVERSITY OF HEALTH
SCIENCES
US
10/999831
30/11/2004
PCT/US/2005/042958
WO/2006/060325

/3/22/0//2

‫שחרור פורמולציות מתרופה מצופה‬

76;66;

76;66<

METHOD AND APPARATUS FOR
ENHANCED UPLINK MULTIPLEXING
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/588960
19/07/2004
22/221541
03//2/0//3
US
PCT/US/2005/023891
WO/2006/019562

/1/22/0/22
FLOATING OIL RIG PROTECTION
135

A61M )2011.01(
‫משאף לאבקה‬

POWDER INHALER
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
DE
10352277.8 08/11/2003
PCT/EP/2004/012535
WO/2005/044353

/3//5/0//3

A61K )2011.01(

H04W )2011.01(

‫שיטה והתקן לריבוב מוגבר בהעברת אות‬
‫ללויין‬

76;67<

E02B )2011.01(
‫הגנה להתקנות ימיות ותשתיות‬
December 29, 2011-‫ג' בטבת התשע"ב‬

‫אגרו ספנות בע"מ‬

AGRO SHIPPING LTD

/1/22/0/22

76;67>

A METHOD AND SYSTEM FOR
AUTHORIZING VEHICLES
OPERATION
ERM ELECTRONIC SYSTEMS LTD

/1/22/0/22
POLYGRAPH
ZEEV DANIELI
US
000000

23//3/0//7

‫שיטה ומערכת לאישור הפעלת רכב‬
‫אי אר אם מערכות אלקטרוניות בע"מ‬

76;689

136

A61B )2011.01(
‫פוליגרף‬
‫שאול בר לב‬

31/10/2011

76;68>

SPATIAL INTERFERENCE
MITIGATION FOR WIRELESS
COMMUNICATION
QUALCOMM INCORPORATED
US
61/053564
15/05/2008
42/225630
03/22/0//6
US
20/241501
22//3/0//7
US
PCT/US/2009/044204
WO/2009/140633

/4/22/0/22

G08B )2011.01(

H04L )2011.01(

‫שיכוך הפרעה מרחבי לתקשורת אלחוטית‬

76;6:=

A61M )2011.01(
December 29, 2011-‫ג' בטבת התשע"ב‬

ELECTRONIC AUTOINJECTOR
APPARATUS AND CASSETTES FOR
USE THEREWITH
MEDIMOP MEDICAL PROJECTS LTD.

/4/22/0/22

‫התקן מזרק אוטומטי אלקטרוני ומחסניות‬
‫לשימוש איתו‬

76;6;6

AUTOMATED INSURER INSURED
INTERACTIONS
DAVIDSHIELD L.I.A. (2000) LTD
US
12/949367
18/11/2010

/4/22/0/22

76;6;9

76;6;:

AN ADHESIVE SPRAY SYSTEM THAT
HINDERS INTRUDERS
OFER HAI

/5/22/0/22
137

G06Q )2011.01(
‫אינטראקציות מבוטחות על ידי מבטח‬
‫אוטומטי‬
‫) בע"מ‬2000( .‫איי‬.‫אי‬.‫דודשילד אל‬

A61B )2011.01(
‫קונדום אוראלי‬
‫אלון ז'בוקריצקי‬

AN ORAL CONDOM
ALON ZHABOKRITSKY

/4/22/0/22

‫מדימופ פרוייקטים רפואיים בע"מ‬

76;6<5

G08B )2011.01(
‫מערכת להתזת חומר דביק לעיכוב‬
‫פורצים‬
‫עופר חי‬

G06F )2011.01(
December 29, 2011-‫ג' בטבת התשע"ב‬

IMPROVED DATA ENTRY SYSTEMS
BENJAMIN FIROOZ GHASSABIAN

/5/22/0/22

76;6=6

76;6>:

SYNERGISTIC MIXTURES OF
ANTHRANILAMIDE INVERTEBRATE
PEST CONTROL AGENTS
E.I. DU PONT DE NEMOURS AND
COMPANY
US
60/584601
01/07/2004
4//444/51
07//1/0//3
US
PCT/US/2005/023813
WO/2006/007595

1///4/0//3

76;6>;

SYNERGISTIC MIXTURES OF
ANTHRANILAMIDE INVERTEBRATE
PEST CONTROL AGENTS
E.I. DU PONT DE NEMOURS AND
COMPANY
US
60/584601
01/07/2004
4//444/51
07//1/0//3
US
PCT/US/2005/023813
WO/2006/007595

138

B41J )2011.01(
‫מדפסת ניידת‬
‫יחזקאל אהרון בורנשטין‬

MOBILE PRINTER
YEHEZKEL AHARON BORNSTEIN

1///4/0//3

‫שיטות משופרות להכנסת נתונים‬
‫בנימין פירוז גסביאן‬

A01N )2011.01(
‫תערובות סינרגיסטיות של חומרים‬
‫אנתרנילאמידיים מדבירי מזיקים חסרי‬
‫חוליות‬

A01N )2011.01(
‫תערובות סינרגיסטיות של חומרים‬
‫אנתרנילאמידיים מדבירי מזיקים חסרי‬
‫חוליות‬

December 29, 2011-‫ג' בטבת התשע"ב‬

1///4/0//3

‫תערובות סינרגיסטיות של חומרים‬
‫אנתרנילאמידיים מדבירי מזיקים חסרי‬
‫חוליות‬

SYNERGISTIC MIXTURES OF
ANTHRANILAMIDE INVERTEBRATE
PEST CONTROL AGENTS
E.I. DU PONT DE NEMOURS AND
COMPANY
US
60/584601
01/07/2004
4//444/51
07//1/0//3
US
PCT/US/2005/023813
WO/2006/007595

1///4/0//3

‫תערובות סינרגיסטיות של חומרים‬
‫אנתרנילאמידיים מדבירי מזיקים חסרי‬
‫חוליות‬

139

H04M )2011.01(

76;776

SYSTEM AND METHOD FOR
CORRELATION OF VEHICLES AND
DRIVERS
MIZRACHI GIL
US
12/941360
08/11/2010

27/22/0//0

A01N )2011.01(

76;6>=

SYNERGISTIC MIXTURES OF
ANTHRANILAMIDE INVERTEBRATE
PEST CONTROL AGENTS
E.I. DU PONT DE NEMOURS AND
COMPANY
US
60/584601
01/07/2004
4//444/51
07//1/0//3
US
PCT/US/2005/023813
WO/2006/007595

/6/22/0/22

A01N )2011.01(

76;6><

‫מערכת ושיטה לקורלציה של כלי רכב‬
‫ונהגים‬
‫גיל מזרחי‬

76;785

C07C )2011.01(
December 29, 2011-‫ג' בטבת התשע"ב‬

2-ARYL-PROPIONIC ACIDS AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THEM
DOMPE S.P.A.
IT
MI2001A002434 20/11/2001
PCT/EP/2002/012939
WO/2003/043625

/7/22/0/22

76;788

A SYSTEM FOR INTERLOCKING A
PLURALITY OF STACKABLE
CYLINDRICAL SECTIONS
YUVAL COHEN

25//5/0//4

‫יובל כהן‬

76;79<

C07D )2011.01(

‫טטראהידרובנזאזפינים מותמרי–אריל‬
‫והטרואריל והשימוש בהם כדי למנוע‬
‫ דופאמין‬,‫קליטה מחודשת של נוראפינפרין‬
‫וסרוטונין‬

76;79>

A DIMALEATE SALT OF AN AMINO
CROTONYL COMPOUND, A PROCESS
FOR PREPARING THE SALT AND
USES THEREOF
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
DE
10349113.9 17/10/2003
140

B25H )2011.01(

‫מערכת המשלבת יחדיו אחד על פני השני‬
‫חלקים גליליים מרובים‬

ARYL-AND HETEROARYLSUBSTITUTED
TETRAHYDROBENZAZEPINES AND
USE THEREOF TO BLOCK REUPTAKE
OF NOREPINEPHRINE, DOPAMINE
AND SEROTONIN
BRISTOL-MYERS SQUIBB COMPANY
US
60/700057
15/07/2005
PCT/US/2006/027574
WO/2007/011820

20/2//0//2

‫–אריל–פרופיוניות ותכשירי‬2 ‫חומצות‬
‫רוקחות המכילים אותן‬

A61P )2011.01(

‫מלח די–מאליאט של תרכובת אמינו‬
‫ תהליך להכנתו והשימוש בו‬,‫קרוטונילית‬

December 29, 2011-‫ג' בטבת התשע"ב‬

PCT/EP/2004/011378
WO/2005/037824

2//22/0/22

76;7<<

‫מתקן להסתרה ושיטות שימוש‬

OBSTRUCTING DEVICE AND
METHODS OF USE
YIFAT HAFNER

22//5/0//3

‫יפעת הפנר‬

76;87;

EFFICIENT SIGNALING OVER
ACCESS CHANNEL
QUALCOMM INCORPORATED
US
60/590113
21/07/2004
22//0/235
00/20/0//2
US
PCT/US/2005/024614
WO/2006/019710

21//1/0//5

76;89;

SUBSURFACE SOIL INJECTION
APPARATUS WITH IMPROVED
DELIVERY DEVICE
ARYSTA LIFESCIENCE NORTH
AMERICA, LLC.
US
11/389054
27/03/2006
PCT/US/2007/063839
WO/2007/117833

/3//4/0//0

141

E01F )2011.01(

76;8<7

H04W )2011.01(
‫איתות יעיל מעבר ערוץ גישה‬

A01C )2011.01(
‫מערכת להזרקה תת–קרקעית עם התקן‬
‫נתינה משופר‬

A01H )2011.01(

December 29, 2011-‫ג' בטבת התשע"ב‬

COTTON EVENT MON15985 AND
METHODS FOR DETECTION
THEREOF
MONSANTO TECHNOLOGY LLC
US
60/297406
11/06/2001
PCT/US/2002/017853
WO/2002/100163

23/2//0//2

‫ ושיטות‬MON15985 ‫אירוע גנטי בכותנה‬
‫לאבחונו בהם‬

76;8<=

HIGH SPEED MEDIA ACCESS
CONTROL AND DIRECT LINK
PROTOCOL
QUALCOMM INCORPORATED
US
60/511904
15/10/2003
4//32253/
23/2//0//1
US
4//321017
02/2//0//1
US
4//304134
/2/20/0//1
US
4//304125
/2/20/0//1
US
4//310572
01/20/0//1
US
4//323741
26//0/0//2
US
4//354323
/0//4/0//2
US
4//364622
/6//5/0//2
US
4//4//74/
22//6/0//2
US
2//742122
21/2//0//2
US
PCT/US/2004/034259
WO/2005/039105

02//6/0//5

142

‫פרוטוקול מהיר לשליטה לגישה למדיה‬
‫וקשר ישיר‬

76;8=6

ANTAGONISTIC HUMAN LIGHTSPECIFIC HUMAN MONOCLONAL
ANTIBODIES
LA JOLLA INSTITUTE FOR ALLERGY
AND IMMUNOLOGY
US
60/840774
28/08/2006
4//675653
03//2/0//5
US
PCT/US/2007/018832
WO/2008/027338

H04L )2011.01(

C07K )2011.01(

‫נוגדנים אנושיים מונוקלונליים‬
‫ לפוליפפטיד‬LIGHT–‫אנטגוניסטים מוכווני‬
‫אנושי‬

December 29, 2011-‫ג' בטבת התשע"ב‬

27//5/0//4

76;956

SUSTAINED RELEASE OF
ANTIINFECTIVES
TRANSAVE, INC.
US
11/185448
19/07/2005
PCT/US/2006/027859
WO/2007/011940

/6//2/0//2

‫שחרור מושהה של נוגדי זיהומים‬

76;958

METHODS FOR TREATMENT OF
PARKINSON'S DISEASE
NEWRON PHARMACEUTICALS S.P.A.
US
60/462205
11/04/2003
PCT/IB/2004/001408
WO/2004/089353

23//5/0//2

76;99>

143

C07F )2011.01(
‫תהליך להכנת נגזרות של טטרזול‬

76;9:9

HETEROCYCLIC INHIBITORS OF
MEK AND METHODS OF USE
THEREOF
ARRAY BIOPHARMA INC.
US
60/523270
19/11/2003
PCT/US/2004/039060
WO/2005/051301

C07C )2011.01(
‫שיטות לטיפול במחלת פרקינסון‬

PROCESS FOR THE PREPARATION
OF TETRAZOLE DERIVATIVES
NOVARTIS AG
GB
0316546.1
15/07/2003
PCT/EP/2004/007980
WO/2005/014602

26/22/0//2

A61K )2011.01(

C07D )2011.01(

‫ ושיטות‬MEK ‫מעכבים הטרוציקליים של‬
‫שימוש בהם‬

December 29, 2011-‫ג' בטבת התשע"ב‬

26/22/0//2

76;9::

HETEROCYCLIC INHIBITORS OF
MEK AND METHODS OF USE
THEREOF
ARRAY BIOPHARMA INC.
US
60/523270
19/11/2003
PCT/US/2004/039060
WO/2005/051301

0///0/0//5

23//1/0//4

‫ ושיטות‬MEK ‫מעכבים הטרוציקליים של‬
‫שימוש בהם‬

76;9:>

LEAD-FREE PRIMARY EXPLOSIVE
COMPOSITION AND METHOD OF
PREPARATION
PACIFIC SCIENTIFIC ENERGETIC
MATERIALS COMPANY
US
60/800816
16/05/2006
PCT/US/2007/004846
WO/2008/048351

A SELF-FASTENING CAGE
SURROUNDING A MAGNETIC
RESONANCE DEVICE AND
METHODS THEREOF
144

C07F )2011.01(

‫תרכובת ושיטת הכנת חומר נפץ ראשוני‬
‫נטול עופרת‬

76;9;:

METHOD OF PREPARING PRIMARY
REFRACTORY METAL
H.C. STARCK INC.
US
11/085876
22/03/2005
PCT/US/2006/009174
WO/2006/101850

/2//3/0//6

C07D )2011.01(

76;:5:

C22B )2011.01(
‫שיטה להכנת מתכת ראשונית עמידה‬
‫בפני חם‬

G06K )2011.01(
‫כלוב בעל יכולת להידוק עצמי ומקיף‬
‫מכשיר רזוננס מגנטי ושיטה לכך‬

December 29, 2011-‫ג' בטבת התשע"ב‬

ASPECT MAGNET TECHNOLOGIES
LTD.
US
60/732654
03/11/2005
22/1544/6
23//1/0//4
US

00//0/0//6

76;:68

THERAPEUTIC APPLICATIONS OF
ACTIVATION OF HUMAN ANTIGENPRESENTING CELLS THROUGH
DECTIN-1
BAYLOR RESEARCH INSTITUTE
US
60/891425
23/02/2007
PCT/US/2008/054798
WO/2008/118587

/2//6/0//4

‫אספקט טכנולוגיות מגנטים בע"מ‬

‫יישומים רפואיים של הפעלה של תאים‬
1–‫מציגי–אנטיגן הומניים באמצעות דקטין‬

76;:6;

NITROOXY DERIVATIVES OF
GLUCOCORTICOIDS, PROCESS FOR
THEIR PREPARATION AND USE
THEREOF IN THE MANUFACTURE
OF MEDICAMENTS
NICOX S.A.
EP
05019155.0 02/09/2005
PCT/EP/2006/007746
WO/2007/025632

06//2/0//4

76;:8:

PHARMA-INFORMATICS SYSTEM
PROTEUS BIOMEDICAL, INC
US
60/676145
28/04/2005
4//472/56
02//4/0//3
US
4//52146/
/2//7/0//3
US
4//57/113
/5//2/0//4
US
PCT/US/2006/016370
WO/2006/116718
145

C12N )2011.01(

C07J )2011.01(
‫תולדות ניטרואוקסי של‬
‫ תהליך להכנתן‬,‫גלוקוקורטיקואידים‬
‫והשימוש בהן להכנת תרופות‬

A61J )2011.01(
‫מערכת פארמה–אינפורמטיקה‬

December 29, 2011-‫ג' בטבת התשע"ב‬

04/2//0//4

76;::6

MEASURING DEVICE FOR
MEASURING THE DEGREE OF
PURITY OF A MEDIUM
SIEMENS AKTIENGESELLSCHAFT
EP
05027687.2 16/12/2005
PCT/EP/2006/067791
WO/2007/071478

146

B08B )2011.01(
‫התקן מדידה למדידת דרגת הניקיון של‬
‫מדיום‬

December 29, 2011-‫ג' בטבת התשע"ב‬

NOTICE UNDER SECTION 26 OF THE
PATENTS LAW, 5727-1967
The applications, particulars of which are set
out below, have been accepted pursuant to
Section 17 of the Patents Law. Any person
wishing to oppose the grant of a patent on any
of the applications published here, may,
within three months from the date of this
journal, give to the Commissioner of Patents
notice under Section 30 of the Patents Law, in
the manner prescribed in regulations 57 et seq
of the Patents Regulations, 5728-1968

- ‫ לחוק הפטנטים תשכ"ז‬26 ‫הודעה לפי סעיף‬
1976
‫הבקשות שפרטיהן מתפרסמים להלן קובלו‬
‫ כל המעונין‬.‫ לחוק הפטנטים‬17 ‫לפי סעיף‬
‫להתנגד למתן פטנט על פי בקשה מהבקשות‬
‫ תוך שלושה חדשים‬,‫המתפרסמות רשאי‬
‫ להגיש לרשם הפטנטים‬,‫מתאריך יומן זה‬
‫ לחוק הפטנטים‬30 ‫הודעת התנגדות לפי סעיף‬
‫ ואילך לתקנות‬57 ‫בדרך הקבועה בתקנה‬
.1968 – ‫ תשכ"ח‬,‫הפטנטים‬

Particulars of the applications, where
applicable, are given in the following order:
[11] [21] Number of application
[54] Title of invention
[22] Application date
[31] [32] [33] Number and date of foreign
application – convention country.
*[51] Int.Cl.
[61] Application for patent of addition
[62] Divisional application
[71] Applicant
[72] Inventor
[87] International Publication Number
[74] Address for service
[57] Abridgement of invention (in the
language in which the specification is drawn
up)

‫פרטי הבקשות במידה ויישימים מובאים לפי‬
:‫סדר זה‬
‫מספר הבקשה‬
‫שם האמצאה‬
‫תאריך הבקשה‬
‫מספר ותאריך של בקשות החוץ – מדינת‬
‫האגוד‬
‫*סיווג בינלאומי‬
‫בקשה לפטנט מוסף‬
‫בקשת חלוקה‬
‫המבקש‬
‫הממציא‬
‫מס' פרסום של בקשה הבינלאומית‬
‫מען למסירת מסמכים‬
)‫תקציר האמצאה (בשפה בה ערוך הפירוט‬

*Note:, patent applications published in this
journal were classified according to the
International Classification version that was
in force when this journal was prepared.

‫ בקשות הפטנטים שפורסמו ביומן‬:‫**הערה‬
‫זה סווגו בהתאם לגרסת הסיווג הבינלאומי‬
.‫שהייתה בתוקף בעת הכנת הבקשות לפרסום‬

147

December 29, 2011-‫ג' בטבת התשע"ב‬

]11[]21[

493931
‫תכשיר יציב של בנזימידאזול ושיטה להכנתו‬

]54[

STABLE BENZIMIDAZOLE
COMPOSITION AND A METHOD
FOR PRODUCING IT

]22[
]51[
]71[
]74[

23.11.2000
Int. Cl.(2010.01) A61K 09//10, 31//4164, A61P 01//00, C07D 40/1/12
DEXCEL LTD.
‫ חדרה‬,‫דקסל בע"מ‬
DR. D. GREIZER LTD.,
,‫ גרייזר בע"מ‬.‫ד"ר ד‬
13 HASADNA ST., P.O.B. 2496,
13 ‫הסדנא‬
RAANANA 43650
‫רעננה‬2496 .‫ד‬.‫ ת‬,
A stable composition of a benzimidazole derivative, the composition comprising:

]57[

)a) a neutral core;
)b) an alkaline coating layered on said core;
)c) an active coating, comprising the benzimidazole derivative, layered over said
alkaline coating; and

)d) a single layer comprising neutralized enteric coating material having a pH
value of at least 6.5 layered directly over said active coating, said neutralized
enteric coating material being neutralized with alkaline compound prior to
applying said single layer to said active coating, with the proviso that said
enteric coating material does not include HPMCP (hydroxypropyl
methylcellulose phthalate).

__________________
]11[]21[
]54[

148

USE OF PMBC IN THE
PREPARATION OF AN AGENT
FOR THE SELECTIVE BINDING
OF CELLS, A METHOD FOR THE
DETECTION OF APOPTOSIS AND
A PHARMACEUTICAL

145210
‫ להכנת חומר לקישור‬PMBC–‫שימוש ב‬
‫ שיטה לגילוי אפופטוזיס‬,‫סלקטיבי לתאים‬
‫ותכשיר רוקחי לטיפול במחלה המאופיינית ע''י‬
‫ רקמות או מבנים‬,‫נוכחות אפופטוזים בתאים‬
‫תאיים‬
December 29, 2011-‫ג' בטבת התשע"ב‬

COMPOSITION FOR THE
TREATMENT OF A DISEASE
CHARACTERIZED BY THE
PRESENCE OF APOPTOSIS IN
CELLS, TISSUES OR CELLULAR
STRUCTURES
]22[
]31[
]51[
]71[
]74[

]57[

30.08.2001
140114
]32[ 06.12.2000
]33[ IL
141571
21.02.2001
IL
Int. Cl.(2010.01) A61K 31//18, 31//195, A61P 09//00, 35//00, 37//00, C07C 31/1/37,
C12Q 01//00
APOSENSE LTD.
‫ פתח תקוה‬,‫אפוסנס בע"מ‬
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
Use of a perturbed membrane binding compound (PMBC), in the preparation of an
agent for selective binding of cells undergoing perturbation of their normal
organization of membrane, said PMBC having the formula (XI) as depicted in the
specification including pharmaceutically acceptable salts and hydrates thereof.

__________________
]11[]21[

146479
‫אדנווירוס רקומביננטי המכיל חומצה גרעינית‬
E1 ‫אדנוויראלית המכילה החסרה באזור‬

]54[

RECOMBINANT ADENOVIRUS
COMPRISING AN ADENOVIRAL
NUCLEIC ACID COMPRISING A
DELETION IN THE E1 REGION

]22[
]31[
]51[
]71[

16.05.2000
99201545.3
]32[ 17.05.1999
]33[ EP
Int. Cl.(2010.01) A61K 48//00, C12N 05//10, 15//34, 15//861
CRUCELL HOLLAND B.V., THE
NETHERLANDS
ABRAHAM BOUT, MENZO JANS
EMCO HAVENGA, RONALD
VOGELS
WO/2000/070071
EITAN MEHULAL LAW GROUP,
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
10 ABBA EBEN BLVD.,
,‫פטנטים‬
P.O.B. 2081,
10 ‫שדרות אבא אבן‬
HERZLIYA 46120
December 29, 2011-‫ג' בטבת התשע"ב‬

]72[
]87[
]74[

149

]57[

‫הרצליה‬2081 .‫ד‬.‫ ת‬,
A recombinant adenovirus comprising an adenoviral nucleic acid comprising a
deletion in the E1 region, said deletion rendering the recombinant adenovirus
replication defective.

The applications for division
from this application have
not yet been published

5022221

‫בקשות חלוקה מבקשה זו‬
9‫שטרם פורסמו‬

__________________
]11[]21[

147349
‫שיטה לאיפיון של מצב דלקתי בשימוש פרופילי‬
‫ביטוי גן מדודים‬

]54[

METHOD FOR EVALUATING AN
INFLAMMATORY CONDITION
USING CALIBRATED GENE
EXPRESSION PROFILES

]22[
]31[

28.06.2000
60/141542
]32[ 28.06.1999
]33[ US
60/195522
07.04.2000
US
Int. Cl.(2010.01) C12Q 01//68, G01N 33//50, G06F 19//00
SOURCE PRECISION MEDICINE,
INC., U.S.A.
WO/2001/025473
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
124 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11490 .‫ד‬.‫ ת‬,
TEL AVIV 62038
The invention provides a method, for evaluating a biological condition of a subject,
comprising: a. obtaining from the subject a sample having at least one of RNAs and
proteins; b. deriving from the sample a first profile data set, the first profile data set
including a plurality of members, each member being a quantitative measure of the
amount of a distinct RNA or protein constituent in a panel of constituents selected so
that measurement of the constituents enables measurement of the biological condition;
and c. producing a calibrated profile data set for the panel, wherein each member of
the calibrated profile data set is a function of a corresponding member of the first
profile data set and a corresponding member of a baseline profile data set for the panel,
the calibrated profile data set providing a measure of the biological condition of the
subject.

]51[
]71[
]87[
]74[

]57[

150

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[
]54[

SYSTEM AND METHOD FOR
TIME-TO-INTERCEPT
DETERMINATION

]22[
]51[
]71[
]87[
]74[

12.02.2001
Int. Cl.(2010.01) F41G 07//22
RAYTHEON COMPANY, U.S.A.
WO/2002/065048
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122

]57[

151

152185
‫מערכת ושיטה לקביעת זמן עד ירוט‬

,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A method and system of time-to-intercept determination for a radiation source using
passively-sensed irradiance data. The invention provides a plurality of noise reduction
features to reduce the noise present in the data and improve the accuracy of the timeto-intercept computation. The method includes reducing data noise by defining an
acceptable noise level and eliminating any excessively noisy data from the time-tointercept computation. The method further includes constantly updating the time-tointercept computation by using irradiance values that are advanced in time. Other
features of the present invention includes averaging of irradiance values over a time
interval, filtering of the irradiance data received by the method, and triggering at a
predetermined time-to-intercept. The invention also includes a time-to-intercept
system and processor implementing the above method.

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

152589
‫מקליט מידע‬

]54[

DATA RECORDER

]22[
]31[
]51[
]71[
]87[
]74[

20.11.2001
2001-65074
]32[ 08.03.2001
]33[ JP
Int. Cl.(2010.01) G11B 20//10, H04N 07//24
SONY CORPORATION, JAPAN
WO/2002/075739
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A data recorder for adequately managing the contents of data and reproduced info even
if a part of AV data is deleted. When a part of a clip is deleted and an ATC-sequence
becomes discontinuous, the value of an offset_STC_id of the first STC sequence on
the ATC sequence is so determined that the value of the stc_id (value for identifying
an STC-sequence) of each STC-sequence contained in the part of the ATC-sequence,
after the ATC discontinuous point. The invention can be applied to a technique of
recording an AV stream on an optical disc.

]57[

152

December 29, 2011-‫ג' בטבת התשע"ב‬

The applications for division
from this application have
not yet been published

5272614

‫בקשות חלוקה מבקשה זו‬
9‫שטרם פורסמו‬

__________________
]11[]21[

153456
‫שיטה לטיפול במים המכילים ברומיד של‬
‫מתכות אלקליות או ברומיד של מתכות אלקליות‬
‫עפרוריות‬

]54[

METHOD OF TREATING WATER
CONTAINING AN ALKALINE
EARTH METAL BROMIDE OR
ALKALI METAL BROMIDE

]22[
]31[
]51[
]71[

15.12.2002
2001/10311
]32[ 14.12.2001
]33[ ZA
Int. Cl.(2010.01) A01N 25//22, C01B 11//20, C02F 01//50
THE GERD BORCHERS FAMILY
TRUST, SOUTH AFRICA
JAN BASTIAAN CILLIERS, SOUTH
AFRICA
MARTHA SOPHIA CILLIERS,
SOUTH AFRICA
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45087 .‫ד‬.‫ ת‬,
JERUSALEM 91450
A method of treating water containing an alkaline earth metal bromide or alkali metal
bromide, the method including the steps of: determining the bromine demand of the
water; adding sufficient hypobromous acid solution to the water to satisfy or almost
satisfy the bromine demand; and adding sufficient alkali or alkaline earth metal
hypochlorite solution to activate the alkali or alkaline earth metal bromide in the water

]74[

]57[

153

December 29, 2011-‫ג' בטבת התשע"ב‬

and to provide residual bromine in water .

__________________
]11[]21[

154008
‫תכשירי רוקחות המכילים אורליסטאט כמעכב‬
‫ ערכות המכילות‬,‫ תהליכים לייצורם‬,‫ליפאז‬
‫אותם ושימושם בהכנת תרופות לטיפול ומניעת‬
‫השמנת יתר‬

]54[

PHARMACEUTICAL
COMPOSITIONS COMPRISING
ORLISTAT AS A LIPASE
INHIBITOR, PROCESSES FOR
THEIR PREPARATION, KITS
COMPRISING THEM AND USE
THEREOF IN THE PREPARATION
OF MEDICAMENTS FOR
TREATMENT AND PREVENTION
OF OBESITY

]22[
]31[
]51[
]71[

19.07.2001
00116393.0
]32[ 28.07.2000
]33[ EP
Int. Cl.(2010.01) A61K 45//00, 45//06
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND
WO/2002/009815
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The present invention relates to pharmaceutical combinations, compositions and
methods for treating obesity. More particularly, the invention relates to a combination
or composition comprising a lipase inhibitor, preferably orlistat and a bile acid
sequestrant.

]87[
]74[

]57[

154

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

155213
‫קטונים ושימוש בהם להכנת תכשירים רוקחיים‬

]54[

KETONE COMPOUNDS AND USE
THEREOF IN PREPARATION OF
PHARMACEUTICAL
COMPOSITIONS

]22[
]31[
]51[
]71[

11.10.2001
60/239232
]32[ 11.10.2000
]33[ US
Int. Cl.(2010.01) A61K 31//336, 31//665, C07D 47/1/02
ESPERION THERAPEUTICS, INC.,
U.S.A.
WO/2002/030860
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]87[
]74[

]57[

155

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

The present invention relates to novel ketone compounds, compositions comprising
ketone compounds, and methods useful for treating and preventing cardiovascular
diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
comprising administering a composition comprising a ketone compound. The
compounds, compositions, and methods of the invention are also useful for treating
and preventing Alzheimer's Disease, Syndrome X, peroxisome proliferator activated
December 29, 2011-‫ג' בטבת התשע"ב‬

receptor-related disorders, septicemia, thrombotic disorders, obesity, pancreatitis,
hypertension, renal disease, cancer, inflammation, and impotence. In certain
embodiments, the compounds, compositions, and methods of the invention are useful
in combination therapy with other therapeutics, such as hypocholesterolemic and
hypoglycemic agents.

__________________
]11[]21[

155249
‫אוכלוסיה של תאים מועשרים בתאי אב‬
‫ביפוטנטים מבודדים של הכבד ושיטות לקבלתה‬

]54[

POPULATION OF CELLS
ENRICHED IN ISOLATED
BIPOTENT HEPATIC
PROGENITORS AND METHODS
FOR OBTAINING THE SAME

]22[
]51[
]71[

03.10.2000
Int. Cl.(2010.01) A61K 35//407, A61P 01//16, C12N 05//0735
UNIVERSITY OF NORTH
CAROLINA AT CHAPEL HILL,
U.S.A.
WO/2002/028997
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
'‫א‬26 ‫רחוב הברזל‬
26A HABARZEL ST.,
‫רמת החייל‬
RAMAT HACHAYAL 69710

]87[
]74[

]57[

156

A method of obtaining a mixture of cells enriched in hepatic progenitors is developed
which comprises methods yielding suspensions of a mixture of cell types, and
selecting those cells that are classical MHC class I antigen(s) negative and ICAM-1
antigen positive. The weak or dull expression of nonclassical MHC class I antigen(s)
can be used for further enrichment of hepatic progenitors. Furthermore, the
progenitors can be selected to have a level of side scatter a measure of granularity or
cytoplasmic droplets, that is higher than that in non-parenchymal cells, such as
hemopoietic cells, and lower than that in mature parenchymal cells, such as
hepatocytes. Furthermore, the progeny of the isolated progenitors can express alphafetoprotein and/or albumin and/or CK19. The hepatic progenitors, so isolated, can
grow clonally, that is an entire population of progeny can be derived from one cell.
The clones of progenitors have a growth pattern in culture of piled-up aggregates or
clusters. These methods of isolating the hepatic progenitors are applicable to any
vertebrates including human. The hepatic progenitor cell population is expected to be
useful for cell therapies, for bioartificial livers, for gene therapies, for vaccine
December 29, 2011-‫ג' בטבת התשע"ב‬

development, and for myriad toxicological, pharmacological, and pharmaceutical
programs and investigations.

__________________
]11[]21[

155791

]54[

USE OF CD81 PROTEIN FOR THE
PREPARATION OF A
PHARMACEUTICAL
COMPOSITION AND METHOD OF
DIAGNOSING USING A CD81
EXPRESSION

]22[
]31[
]51[
]71[

07.11.2001
60/246868
]32[ 08.11.2000
]33[ US
Int. Cl.(2010.01) A61K 38//17, 48//00, A61P 35//00, G01N 33//574
ALBERT EINSTEIN COLLEGE OF
MEDICINE OF YESHIVA
UNIVERSITY, U.S.A.
WO/2002/058709
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬

]87[
]74[

]57[

‫ להכנת תכשיר רפואי‬CD81 ‫שימוש בחלבון‬
CD81 ‫ושיטה לאבחון בעזרת ביטוי של‬

The present invention provides methods for inhibiting proliferation of astrocytes and
astrocytic tumor cells. The present invention further provides methods for treating a
condition associated with a defect in astrocyte proliferation in a subject, and methods
for treating a condition associated with astrocytic tumor cell proliferation in a subject.
Additionally, the present invention is directed to pharmaceutical compositions
comprising CD81 protein or nucleic acid and a pharmaceutically-acceptable carrier.
Finally, the present invention provides a method for determining whether a subject has
an astrocytoma, and a method for assessing the efficacy of astrocytoma therapy in a
subject.

__________________
]11[]21[
157

156090
December 29, 2011-‫ג' בטבת התשע"ב‬

]54[

SUSTAINED DELIVERY OF AN
ACTIVE AGENT USING AN
IMPLANTABLE SYSTEM

]22[
]31[
]51[
]62[
]71[

15.01.1997
08/595761
]32[ 02.02.1996
Int. Cl.(2010.01) A61M 31//00
DIVISION FROM 125596
INTARCIA THERAPEUTICS, INC.,
U.S.A.
WO/1997/027840
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]87[
]74[

]57[

‫שחרור מושהה של חומר פעיל ע"י שימוש‬
‫במערכת הניתנת להשתלה‬

]33[

US

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

An implantable device for delivering an active agent to a fluid environment of use,
said device comprising an impermeable reservoir and a back-diffusion regulating
outlet in mating relationship, wherein a flow path for the active agent comprises a
pathway formed between the mating surfaces of the reservoir and the back diffusion
regulating outlet.

__________________
]11[]21[

156377
‫התקן לאיכון רקמה בתוך גוף של נבדק‬

]54[

APPARATUS FOR LOCATING A
TISSUE WITHIN A BODY OF A
SUBJECT

]22[
]31[
]51[
]71[
]74[

10.06.2003
10/173197
]32[ 17.06.2002
]33[ US
Int. Cl.(2010.01) A61B 05//00
BIOSENSE WEBSTER INC., U.S.A.
D. KLIGLER I.P. SERVICES LTD.,
,‫ קליגלר שירותי קניין רוחני בע"מ‬.‫ד‬
P.O.B. 33111
‫תל אביב‬33111 .‫ד‬.‫ ת‬,
TEL AVIV 61330
Apparatus for locating a tissue within a body of a subject includes an acoustic tag
configured to be fixed to the tissue and adapted, responsive to acoustic waves incident
thereon, to return acoustic echoes. Acoustic tranducers are placed at respective
positions so as to direct the acoustic waves into the body toward the tissue and to
receive the acoustic echoes returned from the tag responsive to the acoustic waves,
generating first signals responsive to the received echoes. Transducer position sensors
are coupled respectively to the acoustic transducers so as to generate second signals

]57[

158

December 29, 2011-‫ג' בטבת התשע"ב‬

indicative of the repective positions of the acoustic transducers in an external frame of
reference. A processing unit processes the first signals and the second signals so as to
determine coordinates of the acoustic tag in the external frame of reference.

__________________
]11[]21[

157326
‫תכשירי רוקחות בצורה המתאימה לשאיפה‬
PDE IV ‫המכילים מלח טיאוטרופים ומעכב‬
‫ גז נדיף‬,‫באופן ברירתי בצורת אבקה לשאיפה‬
‫המכיל אירוסול לשאיפה ותכשיר או תרחיף של‬
‫תכשירי רוקחות אלו‬

]54[

PHARMACEUTICAL
COMPOSITIONS CONTAINING
TIOTROPIUM SALTS AND PDE-IV
INHIBITOR, OPTIONALLY IN
THE FORM OF INHALABLE
POWDERS, PROPELLANTCONTAINING INHALABLE
AEROSOLS AND INHALABLE
SOLUTIONS OR SUSPENSIONS
COMPRISING SAID
COMPOSITIONS

]22[
]31[
]51[

26.02.2002
10110772.2
]32[ 07.03.2001
]33[ DE
Int. Cl.(2010.01) A61K 09//12, 09//72, 31//00, 31//4745, 31//505, A61P 11//00,
11//08, C07D 45/1/00, 48/7/00
BOEHRINGER INGELHEIM
PHARMA GMBH & CO. KG,
GERMANY
WO/2002/069945
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬

]71[
]87[
]74[

]57[

The invention relates to novel medicament compositions on the basis of
anticholinergics and PDE IV inhibitors, and to the use thereof in the therapy of
respiratory tract diseases.

__________________
]11[]21[
159

157360
December 29, 2011-‫ג' בטבת התשע"ב‬

‫פורמולצית פיברינוגן נוזלית עמידה לאחסון‬
‫ושימושים שלה‬

]54[

STORAGE-STABLE, LIQUID
FIBRINOGEN FORMULATION
AND USES THEREOF

]22[
]31[

12.08.2003
10237643.3
]32[ 13.08.2002
]33[ DE
10261126.2
20.12.2002
DE
Int. Cl.(2010.01) A61K 38//36, 38//39
CSL BEHRING GMBH, GERMANY
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
Storage-stable, liquid or viscous liquid fibrinogen formulation, characterized in that,
besides fibrinogen, divalent metal ions in a concentration of up to 100mM and a
complexing agent are present and the fibrinogen formulation is stable at storage
temperatures between 0 and 30 C for at least 1 month.

]51[
]71[
]74[

]57[

__________________
]11[]21[

157378
‫תהליך להכנת פוליפפטידים‬

]54[

PROCESS FOR PRODUCTION OF
POLYPEPTIDES

]22[
]31[
]51[
]71[
]87[
]74[

22.02.2002
60/274384
]32[ 09.03.2001
]33[ US
Int. Cl.(2010.01) C07K 14//245, C12N 15//09, 15//12, 15//70, 15//71, C12P 21//02
GENENTECH, INC., U.S.A.
WO/2002/072847
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬

]57[

Vectors for producing polypeptides heterologous to prokaryotes are described
comprising, along with the polypeptide-encoding nucleic acid, anti-termination nucleic
acid that inhibits intragenic transcription termination with a non-lambda promoter
therefor and/or nucleic acid encoding a GreA or GreB protein and a promoter therefor.
Also described are processes for producing a heterologous polypeptide in prokaryotic
host cells utilizing such elements to improve the quality and/or quantity of
heterologous polypeptide produced.

160

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

157443
‫תכשירים המכילים גורם כימורפואי ואנלוג של‬
‫אפותילין ושימושים בהם‬

]54[

COMPOSITIONS COMPRISING A
CHEMOTHERAPEUTIC AGENT
AND EPOTHILONE ANALOG AND
USES THEREOF

]22[
]31[

05.03.2002
60/275801
]32[ 14.03.2001
]33[ US
60/316395
31.08.2001
US
Int. Cl.(2010.01) A61K 31//00, 31//335, C07D 41/3/10
BRISTOL-MYERS SQUIBB
COMPANY, U.S.A.
WO/2002/072085
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
Compositions and methods are disclosed which are useful of the treatment and
prevention of proliferative disorders.

]51[
]71[
]87[
]74[
]57[

__________________
]11[]21[
]54[

CHAOS-THEORETICAL HUMAN
FACTOR EVALUATION
APPARATUS

]22[
]31[
]51[
]71[

10.04.2002
2001-116408 ]32[ 16.04.2001
Int. Cl.(2010.01) A61B 10//00
ELECTRONIC NAVIGATION
RESEARCH INSTITUTE, JAPAN
KAKUICHI SHIOMI, JAPAN
MITSUBISHI SPACE SOFTWARE
CO., LTD., JAPAN
WO/2002/085215

]87[
161

158325
‫התקן להערכה תיאורטית כאוטית של מצב‬
‫אנושי‬

]33[

JP

December 29, 2011-‫ג' בטבת התשע"ב‬

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

]74[

REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]57[

A chaos−theoretical human factor evaluation apparatus includes a Liapunov exponent
calculator (23) for chaos−theoretically analyzing a speech signal generated by
digitizing a speech uttered by a human and calculating a Liapunov exponent and a
Liapunov exponent change detector (24) for detecting a change of the Liapunov
exponent of the speech calculated by the Liapunov index calculator (23). By
calculating the load level in a cerebrum through a change of the Liapunov exponent
detected by the Liapunov exponent change detector (24), it is possible to predict and
determine a mental&sol;physical activity.

__________________
]11[]21[

159426
3 –‫ – ציאנואידול‬5(–'4–1 ‫צורות פולימורפיות של‬
– 5– ‫ –קרבמואילבנזופורן‬2(– 4 – ‫–איל) בוטיל‬
‫איל) פיפראזין הידרוכלוריד‬

]54[

POLYMORPHIC FORMS OF 1-4'(5-CYANOINDOL- 3-YL) BUTYL-4(2-CARBAMOYLBENZOFURAN- 5YL)PIPERAZINE
HYDROCHLORIDE

]22[
]31[
]51[

05.06.2002
01113647.0
]32[ 19.06.2001
]33[ EP
Int. Cl.(2010.01) A61K 31//496, A61P 01//14, 09//12, 25//18, 25//22, 25//24, C07D
40/5/00, 40/5/12
MERCK PATENT GMBH,
GERMANY
WO/2002/102794
EITAN MEHULAL LAW GROUP,
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
10 ABBA EBEN BLVD.,
,‫פטנטים‬
P.O.B. 2081,
December 29, 2011-‫ג' בטבת התשע"ב‬

]71[
]87[
]74[

162

10 ‫שדרות אבא אבן‬
‫הרצליה‬2081 .‫ד‬.‫ ת‬,
The invention relates to new crystalline modifications of the hydrochloride of 1-[4-(5cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine, crystalline
modification of the dihydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)-piperazine and amorphous 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2carbamoyl-benzofuran-5-yl)-piperazine hydrochloride which are suitable in particular
for the preparation of solid medicaments for the treatment or prevention of depressive
disorders, anxiety disorders, bipolar disorders, mania, dementia, substance-related
disorders, sexual dysfunctions, eating disorders, obesity, fibromyalgia, sleeping
disorders, psychiatric disorders, cerebral infarct, tension, for the therapy of side-effects
in the treatment of hypogonadism, secondary amenorrhea, premenstrual syndrome and
undesired puerperal lactation.
HERZLIYA 46120

]57[

__________________
]11[]21[

159506
‫פירולופירימידינים כמעכבי חלבון קינאז‬

]54[

PYRROLOPYRIMIDINES AS
PROTEIN KINASE INHIBITORS

]22[
]31[

21.06.2002
0115393.1
]32[ 23.06.2001
]33[ GB
60/301678
28.06.2001
US
Int. Cl.(2010.01) A61K 31//505, A61P 29//00, 35//00, C07D 48/7/04
AVENTIS PHARMACEUTICALS
INC., U.S.A.
WO/2003/000695
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
This invention is directed to compounds of the formula (I) to N-oxides, prodrugs, acid
bioisosteres, pharmaceutically acceptable salts or solvates of such compounds, or Noxides, prodrugs, or acid bioisosteres of such salts or solvates, to compositions
comprising such compounds, and to methods of treatment comprising administering, to
a patient in need thereof, such compounds and compositions.

]51[
]71[
]87[
]74[

]57[

163

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

160873
‫צינור מוליך לשימוש כעדשת מחזיר אור ושיטת‬
‫שימוש בו‬

]54[

CONDUCTIVE TUBE FOR USE AS
A REFLECTRON LENS AND
METHOD OF USE THEREOF

]22[
]31[
]51[
]71[

15.03.2004
60/455801
]32[ 19.03.2003
]33[ US
Int. Cl.(2010.01) H01J 49//40
BURLE TECHNOLOGIES, INC.,
U.S.A.
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
A reflectron lens and method are provided. The reflectron lens comprises a tube having
a continuous conductive surface along the length of the tube for providing an electric
field interior to the tube that varies in strength along the length of the tube. The tube
may comprise glass, and in particular, a glass comprising metal ions, such as lead,
which may be reduced to form the conductive surface. The method includes a step of
introducing a beam of ions into a first end of a dielectric tube having a continuous
conductive surface along the length of the tube. The method further includes a step of
applying an electric potential across the tube to create an electric field gradient that
varies in strength along the length of the tube so that the electric field deflects the ions
to cause the ions to exit the tube through the first end of the tube.

]74[
]57[

164

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[
]54[

METHOD AND KIT FOR
MONITORING RECRUITMENT
OF PROTEINS TO THE
INTRACELLULAR DOMAIN OF A
RECEPTOR IN INTACT CELLS

]22[
]31[
]51[
]71[

14.10.2002
145918
]32[ 14.10.2001
Int. Cl.(2010.01) G01N 33//53, 33//68
HARTMUT ENGELMANN,
GERMANY
HARTMUT ENGELMANN
WO/2003/034073
INTERPHARM LABORATORIES
LTD.,
18 HAKISHON ST.,
P.O.B. 151,
YAVNE 81101

]72[
]87[
]74[

165

161309
‫שיטה וקיט לגילוי גיוס חלבונים לאזור‬
‫האינטרא– סלולרי של קולטן בתאים שלמים‬

]33[

IL

,‫אינטרפארם מעבדות בע"מ‬
18 ‫רחוב הקישון‬
‫יבנה‬151 .‫ד‬.‫ ת‬,
December 29, 2011-‫ג' בטבת התשע"ב‬

]57[

The present invention relates to an immunological method and kit for monitoring
recruitment of a protein to the intracellular domain of a receptor in intact cells.

__________________
]11[]21[

161513
‫תכשיר רוקחי נרתיקי הכולל לידוקאין ונשא‬
‫ביואדהזי ושימושיו להכנת תרופה לטיפול‬
‫בדיסריטמיה של הרחם‬

]54[

PHARMACEUTICAL VAGINAL
COMPOSITION COMPRISING
LIDOCAINE AND A
BIOADHESIVE CARRIER, AND
ITS USE IN THE MANUFACTURE
OF A MEDICAMENT FOR THE
TREATMENT OF UTERINE
DYSRHYTHMIA

]22[
]31[

28.10.2002
60/330684
]32[ 29.10.2001
]33[ US
10/278912
24.10.2002
US
Int. Cl.(2010.01) A61K 09//22, 47//00, 47//12, 47//32, A61P 15//02
COLUMBIA LABORATORIES
(BERMUDA) LIMITED, BERMUDA
WO/2003/037381
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The invention relates to a pharmaceutical composition for relieving pelvic pain or
infertility associated with uterine dysrhythmia. The composition includes a locallyadministered anti-dysrhythmic treating agent and a bioadhesive extended-release
carrier. The composition may be delivered in an extended release formulation that
includes a bioadhesive, water-swellable , water-insoluble, cross-linked polycarboxylic
acid polymer, such as polycarbophil. The treating agent may be a local anesthetic, such
December 29, 2011-‫ג' בטבת התשע"ב‬

]51[
]71[
]87[
]74[

]57[

166

as lidocaine. The invention also relates to a method of treating or preventing pelvic
pain, or treating or improving infertility, by inserting a mixture of an anti-dysrhythmic
treating agent and a bioadhesive carrier into the vagina of the patient to be treated.

5022066

The applications for division
from this application have
not yet been published

‫בקשות חלוקה מבקשה זו‬
9‫שטרם פורסמו‬

__________________
]11[]21[

161938
‫מערכת הכוללת ספר אליקטרני פלוס תוספת‬
‫שניתן להתחבר אליו‬

]54[

SYSTEM COMPRISING AN
ELECTRONIC BOOK AND A
PROPRIETARY APPENDAGE

]22[
]51[
]71[
]74[

12.05.2004
Int. Cl.(2010.01) G06F 03//033, 03//14, 15//02, 17//30
LIGHT BOOK LTD.
‫ צפת‬,‫לייט בוק בע"מ‬
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45087 .‫ד‬.‫ ת‬,
JERUSALEM 91450
A system comprising an light book (10) and a proprietary appendage couplable to said
light book; said light book comprising a visual display screen (12), a data reader,
navigational tools and a first section of a unique identification code for identifying
said light book. Said proprietary appendage comprising a memory (46) and a second
section of unique identification code; such that data in the memory of said proprietary
appendage has a second section of unique identification code that can only be
accessed when said proprietary appendage is connected to said light book having said
first section of unique identification code.

]57[

167

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[
]54[

HIGH SECURITY HOLSTER
ASSEMBLY AND ENCLOSURE
SYSTEM

]22[
]31[

29.01.2003
60/352909
]32[ 29.01.2002
60/352910
29.01.2002
Int. Cl.(2010.01) F41C 33//02
JOHN N. RASSIAS, U.S.A.
WO/2003/064957
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]51[
]71[
]87[
]74[

]57[

168

163231
‫מכלול נרתיק בעל בטיחות גבוהה ומערכת סגירה‬

]33[

US
US

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

A holster assembly for a firearm includes a shroud (20, 92, 168) with a muzzle
receiving space (31), a firearm holding member (100, 174, 246) and a bias activating
assembly mounted in the shroud (20, 92, 168) for biasing the firearm into a stowed
position against the holding member (100, 174, 246). A hood enclosure (166) is
movable between open and closed positions. The hood enclosure (166) includes a pair
of guide slots (188) within the shroud (20, 92, 168) , a pivot pin (182) and a guide pin
(186). The hood enclosure (166) may include an illumination device (238) mounted to
the firearm, a hip mount platform (256) to mount a hip mount assembly (34), or a
secondary stowage mount (270) to attach a magazine carrier (278), expandable baton
carrier (266), etc.. The shroud (20, 92, 168) includes a detent (178) that receives a
locking safety lever (146) of the firearm. An L-shaped slot (138, 106, 162) receives a
projection from a handle portion (132), a take down button (88), a safety lever (158),
or another side extending projection of the firearm
December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

163312

]54[

USE OF AN AGENT THAT
STIMULATES CPT-1 ACTIVITY FOR
THE MANUFACTURE OF A
MEDICAMENT FOR TREATING
OBESITY

]22[
]31[
]51[
]71[

10.02.2003
60/354480
]32[ 08.02.2002
]33[ US
Int. Cl.(2010.01) A61K 31//195, 31//198, 31//34, 31//381, 45//00
THE JOHNS HOPKINS UNIVERSITY
SCHOOL OF MEDICINE, U.S.A.
WO/2003/066043
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬

]87[
]74[

]57[

169

‫– לייצור‬CPT1 ‫שימוש בגורם המעורר פעילות‬
‫תרופה המטפלת בהשמנת יתר כאמצעי‬
‫להורדת משקל‬

This invention provides methods and compositions for inducing weight loss and
maintaining optimum weight comprising administering an agent that stimulates
carnitine palmitoyl transferase - 1 (CPT-1) activity to the patient in need, including
human patients. These methods do not require inhibition of fatty acid synthesis. In
particular, this invention provides methods for development of therapeutics that
selectively enhance fatty acid oxidation, increase energy production, and reduce
adiposity while preserving lean mass, through the pharmacological stimulation of CPT1 activity. In a preferred mode, the agent is administered in an amount sufficient to
increase fatty acid oxidation. In another preferred mode, the agent is administered in an
amount sufficient to antagonize malonyl CoA inhibition of CPT-1. In yet another
preferred mode, the agent is administered in an amount sufficient to increase malonyl
CoA level.
December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

163563
‫נוגדנים נגד אמילואיד ביתא והשימוש בהם‬
‫ברפואה‬

]54[

ANTI-AMYLOID BETA
ANTIBODIES AND THEIR USE IN
MEDICINE

]22[
]31[
]51[
]71[

20.02.2003
02003844.4
]32[ 20.02.2002
]33[ EP
Int. Cl.(2010.01) A61K 39//395, C07K 14//47, 16//18, G01N 33//68
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND
MORPHOSYS AG, GERMANY
WO/2003/070760
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬

]87[
]74[

]57[

The present invention relates to antibody molecules capable of specifically recognizing
two regions of the R-A4 peptide, wherein the first region comprises the amino acid
sequence AEFRHDSGY as shown in SEQ ID NO: 1 or a fragment thereof and wherein
the second region comprises the amino acid sequence VHHQKLVFFAEDVG as
shown in SEQ ID NO: 2 or a fragment thereof. Furthermore, nucleic acid molecules
encoding the inventive antibody molecules and vectors and hosts comprising said
nucleic acid molecules are disclosed. In addition, the present invention provides for
compositions, preferably pharmaceutical or diagnostic compositions, comprising the
compounds of the invention as well as for specific uses of the antibody molecules,
nucleic acid molecules, vectors or hosts of the invention.

__________________
]11[]21[
]54[
170

METHOD FOR OBTAINING A
SKY VIEW OF A BATTLE SITE

163609
‫שיטה לקבלת תמונת שמיים של שדה קרב‬
December 29, 2011-‫ג' בטבת התשע"ב‬

]22[
]51[
]71[
]72[
]74[

]57[

19.08.2004
Int. Cl.(2010.01) F41G 07//00
ISRAEL AEROSPACE
INDUSTRIES LTD.
ELI SHUKRUN
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

‫ לוד‬,‫התעשייה האוירית לישראל בע"מ‬
‫אלי שוקרון‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

A method for obtaining a sky view of an event site, comprising: (a) launching an
interceptor missile (2) toward at least one detect threat (3); and (b) the interceptor
missile tracking the at least one detected threat, the interceptor missile comprising at
least one detachable vehicle (7) comprising at least one guidable local sensor (8)
configured to sense the event and to communicate the sensed data, and wherein the
tracking uses at least one remote sensor for achieving a kill of the threat at a
designated kill site (4), where the event site is different than the kill site.

__________________
]11[]21[

163626
‫נוגדים מאונשים המזהים פפטיד ביטא‬
‫עמילאויד‬

]54[

HUMANIZED ANTIBODIES THAT
RECOGNIZE BETA AMYLOID
PEPTIDE

]22[
]31[
]51[
]71[

12.03.2003
60/363751
]32[ 12.03.2002
]33[ US
Int. Cl.(2010.01) A61K 39//395, A61P 25//28, C07K 16//18, 16//46
WYETH LLC, U.S.A.
ELAN PHARMA INTERNATIONAL
LTD., IRELAND
WO/2003/077858
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
December 29, 2011-‫ג' בטבת התשע"ב‬

]87[
]74[

171

]57[

The invention provides improved agents and methods for treatment of diseases
associated with amyloid deposits of Abeta in the brain of a patient. Preferred agents
include humanized antibodies.

__________________
]11[]21[

163763
‫שימוש בנגזרת פפטיד להכנת תרופה לטיפול‬
‫במלנומה ובהמובלסטוזיס‬

]54[

USE OF A PEPTIDE DERIVATIVE
IN THE MANUFACTURE OF A
MEDICAMENT FOR TREATING
MELANOMA AND
HEMOBLASTOSIS

]22[
]31[
]51[

28.02.2003
2002105392
]32[ 28.02.2002
]33[ RU
Int. Cl.(2010.01) A61K 31//16, 31//195, 31//4164, 31//417, 31//4178, 38//05, C07K
05//00, 05//037, 05//06
OBSCHESTVO S OGRANICHENNOI
OTVETSTVENNOSTIYU
"PHARMENTERPRISES", RUSSIA
WO/2003/072124
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬

]71[
]87[
]74[

]57[

The invention relates to the induction method for cell differentiation which consists in
injecting peptide derivatives having the following general formula (I): and used as a
differentiation-inducing factor. Said peptide derivatives are used for curing oncological
diseases, in particular for stabilising melanoma growth, increasing the efficiency of
melanoma immunotherapy and reducing haematological toxicity of chemotherapy. The
utilisation of said peptide derivatives is also disclosed.

The applications for division
from this application have
not yet been published
172

50/7431

‫בקשות חלוקה מבקשה זו‬
9‫שטרם פורסמו‬
December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

164003
‫ תכשירים רוקחיים‬,‫תולדות סולפונילאמיניות‬
‫ תהליכים להכנתן ושימושים‬,‫המכילים אותן‬
‫בהן להכנת תרופות לעיכוב היסטון‬
‫דיאצטילאז‬

]54[

SULFONYLAMINO-DERIVATIVES,
COMPOSITIONS THEREOF,
PROCESS OF PREPARATION AND
USES FOR THE MANUFACTURE OF
MEDICAMENTS FOR INHIBITING
HISTONE DEACETYLASE

]22[
]31[

11.03.2003
60/363799
]32[ 13.03.2002
]33[ US
PCT/EP02/14481
18.12.2002
WO
Int. Cl.(2010.01) A61K 31//4545, A61P 35//00, C07D 20/7/09, 20/7/14, 21/1/28,
21/1/58, 22/3/04, 22/3/12, 22/5/02, 40/1/04, 40/3/04, 40/3/14, 40/5/12, 40/9/12,
40/9/14, 41/3/14, 41/7/12, 47/1/04, 48/7/04, 48/7/08, 49/5/04, 51/3/04
JANSSEN PHARMACEUTICA, N.V.,
BELGIUM
WO/2003/076401
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬

]51[
]71[
]87[
]74[

]57[

This invention comprises the novel compounds of formula (I) wherein n, m, t, R 1, R2,
R3, R4, R5, L, Q, X, Y, Z and have defined meanings, having histone deacetylase
inhibiting enzymatic activity; their preparation, compositions containing them and their
use as a medicine.

__________________
]11[]21[
]54[

173

COMMUNICATION IN A
DISTRIBUTED SYSTEM

164577
‫תקשורת במערכת מובזרת‬

December 29, 2011-‫ג' בטבת התשע"ב‬

]22[
]51[
]71[
]74[

]57[

14.10.2004
Int. Cl.(2010.01) H04L 12//66, 29//06, H04M 07//00
TADIRAN TELECOM LTD.
‫ פתח תקוה‬,‫תדיראן טלקום בע"מ‬
ECI TELECOM LTD.,
,‫ טלקום בע"מ‬.‫ איי‬.‫ סי‬.‫אי‬
30 HASIVIM ST.,
30 ‫רחוב הסיבים‬
PETACH TIKVA 49517
‫פתח תקוה‬
A method for conducting a real-time, voice-over IP media type of communication
session between at least two peer users, each associated with a platform comprised in
a distributed communication network, wherein the method comprises: at a platform
comprised in said distributed communication network, creating a data object
associated with a specific user; iynaoroa v ilayvlolr ni ytilorvlonai ni ivor
ltrrvlv na trl ln tvro nloty ni lot nloty ilvlinyci viinrovwith said
distributed communication network so that that each of said plurality of replications
resides at a different platform associated with the distributed communication network;
and providing a notification at all other platforms associated with said distributed
communication network, indicating the creation or modification of said data object.

__________________
]11[]21[
]54[

174

USE OF POLYNUCLEOTIDE
SEQUENCES IN THE
MANUFACTURE OF A
MEDICAMENT FOR
STIMULATING AN IMMUNE
RESPONSE

164664
‫שימוש ברצפים פולינוקלאוטידים לייצור תרופה‬
‫להמרצת תגובות חיסוניות‬

December 29, 2011-‫ג' בטבת התשע"ב‬

]22[
]31[
]51[
]71[
]87[
]74[

]57[

22.04.2003
60/374,540
]32[ 22.04.2002
]33[ US
Int. Cl.(2010.01) A61K 31//70, A61P 35//00, 37//00, C12N 15//117
BIONICHE LIFE SCIENCES INC.,
CANADA
WO/2003/089642
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
7 ‫רחוב שנקר‬
P.O.B. 12688,
‫הרצליה‬12688 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The present invention relates to 3'-OH, 5'-OH polynucleotide sequence compositions
and methods for activating an immune response in an individual, and more preferably,
for activating an antigen presenting cells in the individual. In one embodiment, the
antigen presenting cell is a dendritic cell. The present invention also includes
compositions and methods for activating dendritic cells in vitro. These dendritic cells
may then be administered to an individual. Preferred 3'-OH, 5'-OH polynucleotide
sequences comprise six bases wherein at least 50% of the bases are guanine and the 5'
base is guanine. The compositions may comprise a phosphodiester or phosphorothioate
backbone.

__________________
]11[]21[
]54[

7, 10-BIS-TRICHLOROACETYL10 DEACTYLBACCATIN III

]22[
]51[
]71[
]87[
]74[

23.02.2000
Int. Cl.(2010.01) C07D 30/5/14
INDENA S.P.A., ITALY
WO/2000/052003
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]57[

A compound of the formula

175

165436
– 10–‫ – ביס– טריכלורואצטיל‬10 ,7
III ‫דיאצטילבאקאטין‬

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

165619
‫מחזיר אור רב–שכבתי עבור גלאי טומוגרפיה‬
‫ממוחשבת‬

]54[

MULTI-LAYER REFLECTOR
FOR CT DETECTOR

]22[
]51[
]71[

07.12.2004
Int. Cl.(2010.01) A61B 06//03, G01T 01//24
GE MEDICAL SYSTEMS GLOBAL
TECHNOLOGY COMPANY, LLC,
U.S.A.
SELIGSOHN GABRIELI & CO.,
,'‫זליגסון גבריאלי ושות‬
31 YAVNE ST.,
31 ‫רח' יבנה‬
P.O.B. 1426,
‫תל אביב‬1426 .‫ד‬.‫ ת‬,
TEL AVIV 61013
A CT detector comprising: a scintillator array having a plurality of scintillators; a
reflector interstitially disposed between at least two adjacent scintillators, the reflector
including a light absorption element disposed between a pair of reflective elements;
and a reflective layer coated to a top face of the scintillator array, wherein the light
absorption element extends in length to an upper surface of the reflective layer.

]74[

]57[

__________________
]11[]21[
]54[

2,4-PYRIMIDINEDIAMINE
COMPOUNDS FOR USE IN THE
TREATMENT OF AUTOIMMUNE
DISEASES

]22[
]31[

29.07.2003
60/399673
60/443949

176

]32[

29.07.2002
31.01.2003

166241
‫–פירימידין דיאמין לשימוש בטיפול‬4,2 ‫תרכובות‬
‫של מחלות אוטואימוניות‬

]33[

US
US
December 29, 2011-‫ג' בטבת התשע"ב‬

]51[
]71[
]87[
]74[

]57[

60/452339
06.04.2003
10/631029
29.07.2003
Int. Cl.(2010.01) A61K 31//506, 31//519
RIGEL PHARMACEUTICALS, INC.,
U.S.A.
WO/2004/014382
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

US
US

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

The present invention provides methods of treating or preventing autoimmune diseases
with 2,4-pyrimidinediamine compounds, as well as methods of treating, preventing or
ameliorating symptoms associated with such diseases. Specific examples of
autoimmune diseases that can be treated or prevented with the compounds include
rheumatoid arthritis and/or its associated symptoms, systematic lups erythematosis
and/or its associated symptoms and multiple sclerosis and/or its associated symptoms.

50224/5

The applications for division
from this application have
not yet been published

‫בקשות חלוקה מבקשה זו‬
9‫שטרם פורסמו‬

__________________
]11[]21[

166494
‫הטרואריל מצומד–ציקלואלקנילאמינים שעברו‬
‫ ושימוש שלהם לייצור תכשירי‬,‫אצילציה‬
‫רוקחות‬

]54[

ACYLATED, HETEROARYLCONDENSED
CYCLOALKENYLAMINES AND
THEIR USE FOR THE
MANUFACTURE OF
PHARMACEUTICALS

]22[
]31[
]51[

24.07.2003
02017586.5
]32[ 07.08.2002
]33[ EP
Int. Cl.(2010.01) A61K 31//381, 31//428, 31//435, 31//495, A61P 03//10, 09//00,
09//10, 25//00, C07D 20/9/12, 22/1/18, 23/7/26, 23/9/70, 24/1/36, 27/5/04, 27/7/60,
33/3/50, 33/3/78, 40/1/12, 40/5/12, 40/9/14, 41/3/12, 41/3/14, 41/7/12

177

December 29, 2011-‫ג' בטבת התשע"ב‬

]71[
]87[
]74[

]57[

SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2004/014372
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
7 ‫רחוב שנקר‬
P.O.B. 12688,
‫הרצליה‬12688 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The present invention relates to acylated, heteroaryl-condensed cycloalkenylamines of
the formula I, (I) in which A, R1, R2, R3, R4, R5 and n have the meanings indicated in
the claims. The compounds of formula I are valuable pharmacologically active
compounds which are useful in the treatment of various disease states including
cardiovascular disorders such as atherosclerosis, thrombosis, coronary artery disease,
hypertension and cardiac insufficiency. They upregulate the expression of the enzyme
endothelial nitric oxide (NO) synthase and can be applied in conditions in which an
increased expression of said enzyme or an increased NO level or the normalization of a
decreased NO level is desired. The invention furthermore relates to processes for the
preparation of compounds of the formula I, their use, in particular as active ingredients
in pharmaceuticals, and pharmaceutical preparations comprising them.

__________________
]11[]21[
]54[

DRUG DELIVERY SYSTEM

]22[
]31[
]51[
]71[

18.07.2003
0218126.1
]32[ 05.08.2002
Int. Cl.(2010.01) A61M 05//20
GLIDE PHARMACEUTICAL
TECHNOLOGIES LIMITED, UNITED
KINGDOM
WO/2004/014468
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]87[
]74[

]57[
178

166508
‫מערכת להספקת תרופה‬
]33[

GB

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

A drug delivery system is disclosed which may be a throwaway or reusable device for
delivery at least one drug to a patient. Also described is a method for administering a
December 29, 2011-‫ג' בטבת התשע"ב‬

drug using said device and a packaged drug for use with said device. The drug delivery
device (10) comprises a housing (12), a means (14) for generating a force capable of
pushing a drug (16) from a packaging (18) into a human or animal body, a means (20)
for transmitting said force to push the drug (16) from the packaging (18) into the
human and animal body, and a means (38, 42b) for triggering the device. Where the
device is a single use drug delivery (10) a packaged drug (100) forms an integral part
of the device. The packaged drug (100) comprises packaging (18) containing a drug
(16), having a housing (18a, 18b) wit a channel (106) running there through and in
which is disposed a drive pin or other element (108), a skin piercing means (110, 112),
and the drug (16), said housing (18a, 18b) further comprising a region (102) allowing
the packaged drug (100) to be slidably mounted to the drug delivery device (10) and an
end (104) adapted to engage and tension the skin.

__________________
]11[]21[
]54[

PRODRUGS OF 1-METHYL-2(4AMIDINOPHENYLAMINOMETHYL)BENZIMIDAZOL-5-YL- CARBOXYLIC
ACID -(N-2-PYRIDYL-N-2HYDROXYCARBONYLETHYL)-AMIDE,
PHARMACEUTICAL COMPOSITIONS
CONTAINING THEM , USE THEREOF IN
PREPARATION OF PHARMACEUTICAL
COMPOSITIONS AND PROCESSES TO
PREPARE THEM

]22[

28.07.2003

179

166584
–4(–2–‫–מתיל‬1 ‫מטרימי תרופות של‬
–‫אמידינופנילאמינומתיל)– בנזאימידזול‬
– N–2(–‫–איל–חומצה קרבוקסלית‬5
– N – 2 –‫פירידיל‬
,‫הידרוקסיקרבונילאתיל)– אמיד‬
, ‫תכשירים רפואיים המכילים אותם‬
‫ושימושם בהכנת תרופות ותהליכים‬
‫להכנתם‬

December 29, 2011-‫ג' בטבת התשע"ב‬

]31[
]51[
]71[
]87[
]74[

]57[

10235639.4
]32[
02.08.2002
]33[ DE
Int. Cl.(2010.01) A61K 31//4439, A61P 07//02, C07D 40/1/12
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH, GERMANY
WO/2004/001489
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
The invention relates to novel compounds of general formula (1) wherein R' and R are
defined as in claim 1, the tautomers and the salts thereof, especially the salts thereof
which are physiologically compatible with inorganic or organic acids or bases,
exhibiting valuable properties, especially a thrombin inhibiting effect.

__________________
]11[]21[
]54[

METHOD FOR ALTERING THE
COLOUR OF A SINGLE CRYSTAL
DIAMOND, CRYSTAL DIAMONDS
OBTAINED THEREBY AND USES
THEREOF

]22[
]31[

05.09.2003
0220772.8
]32[ 06.09.2002
0304029.2
21.02.2003
Int. Cl.(2010.01) C30B 29//04, 33//00
ELEMENT SIX LIMITED, UNITED
KINGDOM
WO/2004/022821
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]51[
]71[
]87[
]74[

]57[

180

166905
‫ גבישי יהלום‬,‫שיטה לשינוי צבע של גביש יהלום‬
‫המתקבלים בשיטה האמורה ושימושים בהם‬

]33[

GB
GB

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

A method of producing a single crystal CVD diamond of a desired colour which
includes the steps of providing single crystal CVD diamond which is coloured and heat
treating the diamond under conditions suitable to produce the desired colour. Colours
which may be produced are, for example, in the pink-green range.
December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

166911
‫שיטה להפעלת מכונת מכירה אוטומטית‬
‫ומערכת מכירה‬

]54[

METHOD FOR OPERATING A
VENDING MACHINE AND
VENDING SYSTEM

]22[
]31[
]51[
]71[
]87[
]74[

07.08.2003
10238341.3
]32[ 16.08.2002
]33[ DE
Int. Cl.(2010.01) A47G 29//12, G07F 09//10, 11//62
DEUTSCHE POST AG, GERMANY
WO/2004/019289
EITAN MEHULAL LAW GROUP,
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
10 ABBA EBEN BLVD.,
,‫פטנטים‬
P.O.B. 2081,
10 ‫שדרות אבא אבן‬
HERZLIYA 46120
‫הרצליה‬2081 .‫ד‬.‫ ת‬,
The invention relates to a method for operating a vending machine, whereby goods can
be arranged in storage compartments and can be subsequently removed therefrom. The
inventive method is characterised in that offer-related data is captured in a central data
processing unit, whereby matching offers are associated with identical offer
identification codes such that offer identification codes are transmitted to a plurality of
electronic vending machines, and storage compartments which are provided for the
distribution of goods are stocked with goods, and offer identification codes associated
with the goods are captured. The invention also relates to a vending system comprising
a plurality of vending machines, in addition to individual vending machines for
carrying out said method.

]57[

181

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[
]54[

HAND HELD COLD WEAPON
SUCH AS A KNUCKLEDUSTER

]22[
]51[
]71[

28.02.2005
Int. Cl.(2010.01) F41B 15//08
AMNON SHILONI
AMNON MAOR
BLUM, GADOR & CO.,
53 HASHALOM RD.,
GIVATAYIM 53454

]74[

]57[

167142
‫כלי נשק ידני קר כגון אגרופן‬

‫ שהם‬,‫אמנון שילוני‬
‫ מודיעין‬,‫אמנון מאור‬
,'‫ גדור ושות‬,‫בלום‬
‫ מגדל הורד‬23 ‫ קומה‬,53 ‫דרך השלום‬
‫גבעתיים‬
A weapon (10) comprising: a hand-grip portion (12), an independent extension (14)
from each end of said hand-grip portion having a hand-engaging extension configured
to extend partially around a hand of a user so as to extend around and protect a
pointer, a ring finger an pinky of a user, thus partially surrounding the hand and
retaining the weapon on the hand when the fingers do not grip the weapon; at least one
portion of at least one of said independent extensions being shaped to create painful
pressure when pressed against an adversary when used as a hand-held weapon; and at
least one additional extension (18) extending from said hand-grip portion in a
direction opposite from said independent extensions, said additional extension being
shaped to create painful pressure when pressed against an adversary.

__________________
]11[]21[
]54[

]22[
]31[
182

167400
‫ מכשיר ומערכת לאפיון שינה‬,‫שיטה‬

METHOD, APPARATUS AND
SYSTEM FOR CHARACTERIZING
SLEEP
18.09.2003
60/411829

]32[

19.09.2002

]33[

US
December 29, 2011-‫ג' בטבת התשע"ב‬

]51[
]71[
]72[
]87[
]74[

]57[

60/439029
10.01.2003
US
Int. Cl.(2010.01) A61B 05//04
RAMOT AT TEL AVIV UNIVERSITY
,‫רמות ליד אוניברסיטת תל אביב בע"מ‬
LTD.
‫אביב‬-‫תל‬
SOLANGE AKSELROD, ARMANDA
,‫ ארמנדה ליה בהרב‬,‫סולנז' אקסלרוד‬
LIA BAHARAV, ZVIKA SHINAR
‫צביקה שנער‬
WO/2004/026133
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬1995( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
A method of determining a Rapid-Eye-Movement (REM) sleep and a Non-REM
(NREM) sleep from signals of electrical activity recorded from the chest of a sleeping
subject, the signals being measured over a plurality of epochs, the method comprising:
extracting a series of cardiac R-R intervals from the signals; constructing a Poincare
plot of said series of cardiac R-R intervals; calculating a plurality of moments of
inertia with respect to a predetermined line along said Poincare plot, each of said
plurality of moments of inertia being calculated within a predetermined time-window;
and using said plurality of moments of inertia to determine REM sleep and NREM
sleep of the sleeping subject.

The applications for division
from this application have
not yet been published

50/4311

‫בקשות חלוקה מבקשה זו‬
9‫שטרם פורסמו‬

__________________
]11[]21[

167410
‫בדיקות העברת אנרגיית תהודת פלורצנטיות‬
‫) מבוססות – תא לרעלנים של‬FRET(
‫ ותאים לשימוש בהן‬,‫קלוסטרידיום‬

]54[

CELL-BASED FLUORESCENCE
RESONANCE ENERGY
TRANSFER (FRET) ASSAYS FOR
CLOSTRIDIAL TOXINS AND
CELLS FOR USE THEREIN

]22[
]31[
]51[
]71[
]87[
]74[

04.09.2003
10/261161
]32[ 27.09.2002
]33[ US
Int. Cl.(2010.01) C12Q 01//00, G01N 33//52, 33//553
ALLERGAN, INC., U.S.A.
WO/2004/029576
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122

]57[
183

,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
The present invention provides a method of determining clostridial toxin activity by (a)
contacting with a sample a cell containing a clostridial toxin substrate that includes a
December 29, 2011-‫ג' בטבת התשע"ב‬

donor fluorophore; an acceptor having an absorbance spectrum overlapping the
emission spectrum of the donor fluorophore; and a clostridial toxin recognition
sequence containing a cleavage site that intervenes between the donor fluorophore and
the acceptor, where resonance energy transfer is exhibited between the donor
fluorophore and the acceptor under the appropriate conditions; (b) exciting the donor
fluorophore; and (c) determining resonance energy transfer of the contacted cell
relative to a control cell, where a difference in resonance energy transfer of the
contacted cell as compared to the control cell is indicative of clostridial toxin activity.

__________________
]11[]21[

167629
‫מערכת לאיסוף ואיחסון מידע ונתוני מדעי–חיים‬

]54[

SYSTEM FOR COLLECTING AND
STORING LIFE SCIENCE
INFORMATION AND DATA

]22[
]31[

29.09.2003
60/414637
]32[ 30.09.2002
]33[ US
10/644582
20.08.2003
AM
Int. Cl.(2010.01) G01N 33//48, G05B 19//42, G06F 19//00
GENSTRUCT, INC., U.S.A.
WO/2004/031765
BOROCHOV, KORAKH & CO.,
15TH FLOOR, ATIDIM TOWER,
KIRYAT ATIDIM,
P.O.B. 58100,
TEL AVIV 61580

]51[
]71[
]87[
]74[

]57[

184

,'‫בורוכוב קורח ושות‬
‫מגדל כלל עתידים‬
‫אביב‬-‫תל‬58100 .‫ד‬.‫ ת‬,

A computer system for storing life science information in a database, the computer
system comprising: a processor; an electronic database storage module for storing in
the database a library of machine-readable symbolic representations into which life
science knowledge is adapted to be encoded according to a life sciences ontology, each
machine-readable symbolic representation comprising: at least two unspecified object
identifiers; a relationship connector, wherein the relationship connector relates two of
the at least two object identifiers to each other based on a casual relationship between
the object identifiers; and constraint information that defines which connections among
the object identifiers are permitted so that life sciences knowledge encoded into the
machine-readable symbolic representation is semantically rigorous and based on the
life sciences ontology; and a graphical user interface for managing addition of new life
December 29, 2011-‫ג' בטבת התשע"ב‬

sciences data to a database, the graphical user interface comprising: a display screen
that receives an input selecting one of the machine-readable symbolic representations
as a template to represent the new data based at least in part on the life science
ontology; the graphical user interface restricting input of any data element that does
not conform to the constraint information associated with the selected machinereadable symbolic representation such that the semantically rigorous relationships for
the life sciences ontology are maintained; the graphical user interface receiving input
of at least one data element that conforms to the constraint information to instantiate
the machine-readable symbolic representation.

__________________
]11[]21[
]54[

METHOD FOR REDUCING VIRAL
BUDDING FROM A MAMMALIAN
CELL INFECTED BY AN
ENVELOPED VIRUS, AN
ANTIBODY USING THE METHOD
AND USES THEREOF

]22[
]31[
]51[
]71[

01.10.2003
60/415299
]32[ 01.10.2002
Int. Cl.(2010.01) C07K 16//18, 16//32
FUNCTIONAL GENETICS, INC.,
U.S.A.
WO/2004/031209
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]87[
]74[

]57[

185

167774
‫שיטה להורדה של הנצה ויראלית מתאי יונקים‬
‫ נוגדן המשמש‬,‫שהודבקו ע"י וירוס מעטפת‬
‫בשיטה זו ושימושים בו‬

]33[

US

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

The present invention provides methods of using antibodies that bind a TSG101
protein to inhibit or reduce viral production. The invention also provides methods of
using the TSG101 antibodies for the treatment of viral infections, including HIV
infection. The invention further provides methods of detecting viral infected cells
using TSG101 antibodies.

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

167782
‫אנטנה עבור מערכת הדמיה תוך גופית‬

]54[

ANTENNA FOR IN-VIVO
IMAGING SYSTEM

]22[
]51[
]71[
]74[

31.03.2005
Int. Cl.(2010.01) A61B 01//06, 05//05
GIVEN IMAGING LTD.
‫ יקנעם‬,‫גיוון אימג'ינג בע"מ‬
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
An in-vivo imaging device comprising: an antenna folded to form a three-dimensional
antenna; and a support, said support comprising at least one flexible portion
comprising at least one layer, said at least one flexible portion interconnecting two
rigid portions having at least one layer; wherein said antenna is embedded within said
at least one flexible portion of said support and within said two rigid portions of said
support, and wherein a transmitter is disposed on one of said rigid portions.

]57[

__________________
]11[]21[

168121
‫תרופה לשלפוחית שתן פעילה ביתר המכילה‬
‫תולדת אניליד של חומצה אצטית כמרכיב הפעיל‬

]54[

REMEDY FOR OVERACTIVE
BLADDER COMPRISING ACETIC
ACID ANILIDE DERIVATIVE AS
THE ACTIVE INGREDIENT

]22[
]31[
]51[
]71[
]87[
]74[

04.11.2003
2002-323792 ]32[ 07.11.2002
Int. Cl.(2010.01) C07D 27/7/00
ASTELLAS PHARMA INC., JAPAN
WO/2004/041276
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]57[

(R)-2-(2-aminothiazol-4-yl)-4’-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]acetic acid
anilide or its salt shows a potent bladder relaxation effect in “isolated rat bladder
smooth muscle relaxation test”, dose-dependently lowers the contraction frequency of
rhythmic bladder contractions in “rat rhythmic bladder contraction measurement test”
December 29, 2011-‫ג' בטבת התשע"ב‬

186

]33[

JP

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

and, moreover, prolongs the urination intervals in “urination function measurement
test on cyclophosphamide-induced overactive bladder model rat”. Owing to these
effects, the above compound is useful as a remedy for overactive bladder.

__________________
]11[]21[
]54[

MOBILE TELEPHONE GATEWAY
APPARATUS, COMMUNICATION
SYSTEM AND GATEWAY
OPERATING SYSTEM

]22[
]31[
]51[
]71[
]74[

01.05.2005
PCT/IL03/00906 ]32[ 02.11.2003
Int. Cl.(2010.01) H04W 88//06, 92//06
YOSSY SELA
YOSSY SELA,
39 SHESHET HAYAMIM ST.,
JERUSALEM 97804

]57[

168298
‫ מערכת תקשורת‬,‫מתמר תקשורת לטלפון נייד‬
‫ומערכת הפעלה למתמר תקשורת‬

]33[

WO

‫ ירושלים‬,‫יוסי סלע‬
,‫יוסי סלע‬
39 ‫ששת הימים‬
‫ירושלים‬
A mobile phone gateway apparatus for providing wireless communication capabilities
through at least second communication network in accordance with at least second
communication protocol, to a mobile phone operative on at least first communication
network in accordance with at least first communication protocol, said mobile phone
gateway comprising: means for protocol conversion between at least said first protocol
and said second protocol; means for data/signaling communication between said
mobile phone gateway and said mobile phone through an electrical signaling
transmission medium; means for controlling and wrapping SIM (subscriber
identification module) functionalities, said SIM functionalities provided to said mobile
phone and to said mobile phone gateway by one or more SIM card logics, said SIM
card logics being the same or different.

__________________
]11[]21[
]54[

187

CERAMIC ROOF TILES FROM
MAMSHIT CALCAREOUS CLAY
AND GRANITE AND OTHER
POWDERED FILLERS AND

168332
‫רעפי גג קרמים המיוצרים מחמר עתיר סידן‬
‫ממשית עם מלאן גרניט וכן מלאנים אבקתיים‬
‫אחרים ותהליך ליצורם‬

December 29, 2011-‫ג' בטבת התשע"ב‬

PROCESS FOR THEIR
MANUFACTURE
]22[
]51[
]71[
]72[
]74[

]57[

02.05.2005
Int. Cl.(2010.01) C04B 14//04, 14//10, 14//20, 35//00, 35//14
HASSIN ESH INDUSTRIES LTD.
‫ באר שבע‬,‫חסין אש תעשיות בע"מ‬
YOSEF GAL, RON BUCHMAN
‫ רון בוכמן‬,‫יוסף גל‬
HASSIN ESH INDUSTRIES LTD.,
,‫חסין אש תעשיות בע"מ‬
P.O.B. 36 DERECH HEVRON
36 .‫ד‬.‫דרך חברון ת‬
BEER-SHEVA
‫באר שבע‬
Ceramic roof tiles of red -brown color with shining golden Mica dots on their surface
manufactured by dry mixing of powdered Soft Negev Mamshit clay No.2 with
powdered Granite Eilat stone filler No.1(as described in the specification), sintered at
the temperature range from 760ºC to 950ºC and characterized by the fact that they
contain the crystallographic Gehlenite, Augite, Anorthite, Albite and orthoclase
phases, the said Gehlenite being evidenced by the X-ray reflection peak at d value of
2.859 Ångstrom, Orthoclase is evidenced by reflection peaks at d value of 4.05, 3.28,
2.23 Ångstrom, and a strong broad reflection peak being of
Anorthite+Albite+orthoclase, centered at about d value of 3.21 Ångstrom.

__________________
]11[]21[
]54[

ARTIFICIAL NIPPLE

]22[
]31[

05.11.2003
60/424954
]32[ 08.11.2002
10/696910
29.10.2003
Int. Cl.(2010.01) A61J 11//00
MEDELA HOLDING AG,
SWITZERLAND
WO/2004/043325
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]51[
]71[
]87[
]74[

]57[

188

168355
‫פטמה מלאכותית‬
]33[

US
US

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

An artificial baby-feeding nipple (310) includes a substantially solid nipple portion
(312) with one or more ducts (316) formed there through for conveying fluids through
the nipple. The nipple is radially compressible so as to prevent passage of fluids
through the one or more ducts when so compressed through use of a material having a
low durometer material.
December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

168361
‫התקן עם פתח למתן תרופות המכיל מספר‬
‫ערוצים עם קצבי זרימה משתנים‬

]54[

ORIFICE DEVICE HAVING
MULTIPLE CHANNELS WITH
VARYING FLOW RATES FOR
DRUG DELIVERY

]22[
]31[
]51[
]61[
]71[
]74[

03.05.2005
10/855239
]32[ 27.05.2004
]33[
Int. Cl.(2010.01) A61J 03//07, B65D 83//04
162046
CORDIS CORPORATION, U.S.A.
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]57[

An orifice device for delivering one or more drugs includes an innermember having a
proximal end and a distal end; and a winding helically wound around the inner
member. The winding includes a plurality of distinct wires helically wound in parallel
around the inner member. The winding and the inner member define at least three
separate channels for carrying one or more drugs therethrough. The inlet is at the
proximal end of the winding and an outlet is at the distal end of the winding for the
plurality of distinct wires. In some embodiments at least two of the plurality of distinct
wires have a different dimension. An outer member is used over the winding. Also, at
least two of the at least three separate channels have a different fluid flow rate. In some
embodiments at least two of the at least three separate channels carry a different drug.

189

US

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

168399
‫קצף פרמצבטי וקוסמטי‬

]54[

COSMETIC AND
PHARMACEUTICAL FOAM

]22[
]31[

24.10.2003
152486
]32[ 25.10.2002
]33[ IL
60/429546
29.11.2002
US
Int. Cl.(2010.01) A61K 08//60, 09//00, 09//12, 35//00
FOAMIX LTD.
‫ רחובות‬,‫פואמיקס בע"מ‬
WO/2004/037225
FOAMIX LTD.,
,‫פואמיקס בע"מ‬
2 HOLZMAN STREET
‫פארק וייצמן לתעשיות מדע‬,2 ‫הולצמן‬
P.O.B 4038
‫רחובות‬4038 .‫ד‬.‫ ת‬,
REHOVOT 74140
The invention relates to an alcohol-free cosmetic or pharmaceutical foam carrier
comprising water, a hydrophobic solvent, a foam adjuvant agent, a surface-active agent
and a water gelling agent. The cosmetic or pharmaceutical foam carrier does not
contain aliphatic alcohols, making it non-irritating and non-drying. The alcohol-free
foam carrier is suitable for inclusion of both water-soluble and oil soluble
pharmaceutical and cosmetic agents.

]51[
]71[
]87[
]74[

]57[

This specification was examined in accordance
with regulation 35 of the Patent Regulations,
5728 - 1968

‫ לתקנות‬13 ‫פירוט זה נבחן בהתאם לתקנה‬
2746 – ‫ תשכ"ח‬5‫הפטנטים‬

__________________
190

December 29, 2011-‫ג' בטבת התשע"ב‬

]11[]21[

168429
‫נחושת‬/‫מצע חצי–מוליך בעל חומר מרוכב יהלום‬
‫ושיטה לייצורו‬

]54[

SEMICONDUCTOR SUBSTRATE
HAVING COPPER/DIAMOND
COMPOSITE MATERIAL AND
METHOD OF MAKING SAME

]22[
]31[
]51[
]71[
]87[
]74[

24.10.2003
10/291126
]32[ 07.11.2002
]33[ US
Int. Cl.(2010.01) H01L 21//44
KYOCERA AMERICA, INC., U.S.A.
WO/2004/044950
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
A semiconductor package for power transistors of the LDMOS type has a metallic
substrate with a die mounted directly thereon, lead frame insulators mounted thereon
adjacent the die and a plurality of leads mounted on the insulators and electrically
coupled to the die by bond wires. The substrate includes a body having opposite
surfaces comprising pure copper layers, and with the body interior being at least
partially comprised of a copper/diamond composite so as to act as a heat spreader and
provide improved heat removal and low thermal expansion, as well as an electrical
connection for the die. The body may be entirely comprised of a copper/diamond
composite, or it may be comprised of a copper/tungsten composite having a
copper/diamond composites insert therein. The copper/diamond composite is
comprised of diamond, particles within a copper matrix. In a method of making the
copper/diamond composite, diamond particles are coated with multiple layers of
element or inorganic compounds, mixed with a dry-processing binder and compacted
in a die under pressure to form a compacted body. The body is placed on a quantity of
copper, heated in a vacuum or hydrogen atmosphere to evaporate or decompose the
binder, heated in a vacuum or hydrogen atmosphere to 4ause bonding or partial
sintering of the coated diamond particles, then heated in a hydrogen atmosphere to a
temperature slightly above the melting point of copper to melt and draw the copper
into the bonded or partially sintered diamond particles. Following that, the compacted
body is cooled and cut to the desired shape.

]57[

__________________
]11[]21[
191

168606
December 29, 2011-‫ג' בטבת התשע"ב‬

‫צורת מינון דמויית דף לשחרור ניקוטין בחלל‬
‫הפה או האף‬

]54[

SHEET LIKE DOSAGE FORM FOR
RELEASING NICOTINE IN THE
ORAL OR NASAL CAVITY

]22[
]31[
]51[
]62[
]71[

22.06.2001
10032456.8
]32[ 04.07.2000
]33[ DE
Int. Cl.(2010.01) A61K 09//00
DIVISION FROM 153716
LTS LOHMANN THERAPIESYSTEME AG, GERMANY
WO/2002/002085
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The invention relates to an especially flat administrable form which decomposes or
dissolves rapidly in an aqueous medium, and is used to rapidly release active
ingredients in the oral cavity, in bodily openings or in bodily cavities. Said
administrable form comprises a matrix which contains at least one water-soluble
polymer in the form of a base substance; in addition to at least one active ingredient;
and is characterised in that the polymer matrix is provided with spaces or cavities, the
content thereof differing with regard to the state of aggregation of the matrix.

]87[
]74[

]57[

The parent application from which
this application has been divided has
not yet been published

231524

‫בקשת הורה לבקשה זו שטרם פורסמה‬

__________________
]11[]21[
192

168686
December 29, 2011-‫ג' בטבת התשע"ב‬

]54[

FLOOR CLEANING
FORMULATION COMPRISING
AN AGENT FOR CONTROLLING
INSECTS

]22[
]51[
]71[

19.05.2005
Int. Cl.(2010.01) C11D 07//32
SANO BRUNO'S ENTERPRISES
LTD.
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]74[

]57[

‫תכשיר לניקוי רצפות המכיל גורם לבקרה על‬
‫חרקים‬

‫ תל אביב‬,‫סנו מפעלי ברונוס בע"מ‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

A cleaning formulation comprising a cleaning agent and an insect growth regulator
wherein said cleaning agent comprises: 2-5 wt% non-ionic surfactant; 0.5-2 wt% ETA
70; 0.001-0.1 wt% insect growth regulator; 0.3-2 wt% fragrance; and 0.01-1 wt%
stabilizer; and water up to 100 wt%.

__________________
]11[]21[

168718
‫ תכשירים הכוללים את‬,‫נגזרות ביגואניד‬
–‫ תהליך להכנת תרכובות אנטי‬,‫הנגזרות‬
‫מיקרוביאליות ושימוש בנגזרות בהכנת תרופות‬

]54[

BIGUANIDE DERIVATIVES,
COMPOSITIONS COMPRISING
THE DERIVATIVES, PROCESS
FOR PREPARING AN
ANTIMICROBIAL COMPOUND
AND USE OF THE DERIVATIVES
IN THE PREPARATION OF
MEDICAMENTS

]22[
]31[

20.11.2003
60/428306
]32[ 22.11.2002
]33[ US
10/716283
18.11.2003
US
Int. Cl.(2010.01) A61K 31//155, A61P 31//04, C07C 27/9/26, 31/7/22, 32/3/20, C07D
31/7/64, 31/9/20
JACOBUS PHARMACEUTICAL
COMPANY, INC., U.S.A.
WO/2004/048320
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬2273 .‫ד‬.‫ ת‬,
Biguanide and dihydrotriazine derivatives, preferably substituted asymmetrical
imidodicarbonimidic diamides derived from hydroxylamines, and compositions
December 29, 2011-‫ג' בטבת התשע"ב‬

]51[
]71[
]87[
]74[

]57[
193

containing biguanide and dihydrotriazine derivatives are disclosed. In addition,
methods of using the biguanide and dihydrotriazine derivatives, inter alia, as
antimicrobial agents and methods of using the dihydrotriazine derivatives in biological
assays are disclosed. Methods of making the biguanide and dihydrotriazine derivatives
are also disclosed.

The applications for division
from this application have
not yet been published

50//025

‫בקשות חלוקה מבקשה זו‬
9‫שטרם פורסמו‬

__________________
]11[]21[
]54[

COMPOSITIONS COMPRISING
BOTULINUM TOXIN AND A
HUMAN SERUM ALBUMIN,
METHOD FOR PRODUCING THE
SAME AND USE THEREOF IN
THE PREPARATION OF
MEDICAMENTS

]22[
]31[
]51[
]71[

22.12.2003
60/435901
]32[ 20.12.2002
Int. Cl.(2010.01) A61K 47//42, 47//48
BOTULINUM TOXIN RESEARCH
ASSOCIATES, INC., U.S.A.
WO/2004/060384
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122

]87[
]74[

]57[

194

168745
‫תכשירים הכוללים רעלן הבוטולינום ואלבומין‬
‫ שיטה להכנתם ושימוש בהם‬,‫פלזמה אנושי‬
‫להכנת תרופות‬

]33[

US

,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
Botulinum toxin, a well know systemic poison, produces favorable therapeutic effect
by virtue of regionally attaching to nerves within the myoneural junction and possibly
other tissues in a target region of a particular tissue. The present invention provides
compositions of botulinum toxin and a sequestration agent that increase sequestration
and delivery of the botulinum toxin to neural and associated tissues, as compared with
available formulations of botulinum toxins, and thereby produce a beneficial clinical
effect. The sequestration agents of the present invention include proteins, lipids and
carbohydrates. A preferred composition of the present invention comprises a
botulinum toxin and an albumin. The present invention also provides methods of
treating neuromuscular diseases and pain using the disclosed compositions and
methods of making the disclosed compositions.

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

169307
‫נגזרות של ביפניל ושימושן כקוטלי פטריות‬

]54[

BIPHENYL DERIVATIVES AND
THEIR USE AS FUNGICIDES

]22[
]31[
]51[

15.12.2003
0230155.4
]32[ 24.12.2002
]33[ GB
Int. Cl.(2010.01) A01N 43//36, 43//56, 43//78, C07C 21/1/44, 23/3/02, C07D 20/7/34,
23/1/14, 23/1/16, 27/7/56, C07F 07//08
SYNGENTA PARTICIPATIONS AG,
SWITZERLAND
WO/2004/058723
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A fungicidally active compound of formula (I): where Het is a substituted 5- or 6membered heterocyclic ring; R1 is hydrogen, formyl, CO-C1-4 alkyl, COO-C1-4 alkyl,
C1-4 alkoxy(C1-4)alkylene, CO-C1-4 alkylenoxy(C1-4)alkyl, propargyl or allenyl; R2, R3,
R4 and R5 are each, independently, hydrogen, halogen, methyl or CF 3; each R6 is,
independently, halogen, methyl or CF3; R7 is (Z)mC=C(Y1), (Z)mC(Y1)=C(Y2)(Y3) or
tri(C1-4)alkylsilyl; X is O or S; Y1, Y2 and Y3 are each, independently, hydrogen,
halogen, C1-6 alkyl [optionally substituted by one or more substituents each
independently selected from halogen, hydroxy, C1-4 alkoxy, C1-4 haloalkoxy, C1-4
alkylthio, C1-4 haloalkylthio, C1-4 alkylamino, di(C1-4)alkylamino, C1-4 alkoxycarbonyl,
C1-4 alkylcarbonyloxy and tri(C1-4)alkylsilyl], C2-4 alkenyl [optionally substituted by
one or more substituents each independently selected from halogen], C 2-4 alkynyl
[optionally substituted by one or more substituents each independently selected from
halogen], C3-7 cycloalkyl [optionally substituted by one or more substituents each
independently selected from halogen, C1-4 alkyl and C1-4 haloalkyl] or tri(C14)alkylsilyl; Z is C1-4 alkylene [optionally substituted by one or more substituents each
independently selected from hydroxy, cyano, C1-4 alkoxy, halogen, C1-4 haloalkyl, C1-4
haloalkoxy, C1-4 alkylthio, COOH and COO-C1-4 alkyl]; m is 0 or 1; and n is 0, 1 or 2;
the invention also relates to novel intermediates used in the preparation of these
compounds, to agrochemical compositions which comprise at least one of the novel
compounds as active ingredient and to the use of the active ingredients or
compositions in agriculture or horticulture for controlling or preventing infestation of
plants by phytopathogenic microorganisms, preferably fungi.

]71[
]87[
]74[

]57[

195

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

169527
‫תולדות פירידין ותהליך להכנתן‬

]54[

PYRIDINE DERIVATIVES AND
PROCESS FOR THEIR
PREPARATION

]22[
]31[
]51[
]71[
]87[
]74[

12.02.2004
03356029.3
]32[ 19.02.2003
]33[ EP
Int. Cl.(2010.01) C07D 40/5/00, 40/5/12, 40/9/12
BAYER S.A.S., FRANCE
WO/2004/074280
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
Compound of general formula (I): Process for preparing this compound. Novel
intermediate of general formula (E): for the preparation of compound of general
formula (I). Fungicidal composition comprising a compound of general formula (I).
Method for treating plants by applying a compound of general formula (I) or a
composition comprising it.

]57[

196

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

169881
‫טלאים דביקים עבור נתינת גרניסטרון דרך העור‬

]54[

ADHESIVE PATCHES FOR THE
TRANSDERMAL DELIVERY OF
GRANISETRON

]22[
]31[
]51[
]71[

05.02.2004
0302662.2
]32[ 05.02.2003
]33[ GB
Int. Cl.(2010.01) A61K 09//70
STRAKAN INTERNATIONAL
LIMITED, BERMUDA
WO/2004/069141
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
Adhesive patches for the transdermal administration of granisetron, comprise an
acrylic adhesive containing non-acidic nucleophilic moieties which substantially
increase flux of granisetron across the skin.

]87[
]74[
]57[

__________________
]11[]21[
]54[
197

ANTIBODIES TO ISOLATED
BIOLOGICALLY ACTIVE HUMAN

170076
‫נוגדנים לחלבון מבודד פעיל ביולוגית הקשור‬
VEGF ‫לגורם צמחיה וסקולארי אנדותליאלי‬
December 29, 2011-‫ג' בטבת התשע"ב‬

VASCULAR ENDOTHELIAL
GROWTH FACTOR (VEGF)
RELATED PROTEIN, THEIR USE
AND MEDICAMENTS
COMPRISING THEM

‫ השימוש בהם ותכשירים רפואיים‬,‫אנושי‬
‫המכילים אותם‬

]22[
]31[
]51[
]62[
]71[
]87[
]74[

30.08.1996
60/003491
]32[ 08.09.1995
]33[ US
Int. Cl.(2010.01) A61K 39//395, C07K 14//52, 14//71, 16//24
DIVISION FROM 123332
GENENTECH, INC., U.S.A.
WO/1997/009427
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬

]57[

A monoclonal antibody which binds to an isolated biologically active human VEGFrelated protein (VRP) and neutralizes a biological activity of said isolated biologically
active human VRP, wherein said isolated biologically active human VRP contains at
least 265 amino acids of Figure 1, as depicted in the specification, which binds
receptor tyrosine kinase Flt4.
.

__________________
]11[]21[

170178
‫מגביר מוקדם‬/‫קלטת ביטוי הכוללת אזור מקדם‬
‫ אנושי ווקטור הכולל את‬CMV ‫ של‬1 ‫מיידי‬
‫קלטת הביטוי הנ"ל‬

]54[

EXPRESSION CASSETTE
COMPRISING A HUMAN CMV
IMMEDIATE EARLY 1
PROMOTER/ENHANCER REGION
AND A VECTOR COMPRISING
SAID EXPRESSION CASSETTE

]22[
]31[
]51[
]71[
]87[
]74[

13.02.2004
60/448179
]32[ 14.02.2003
]33[ US
Int. Cl.(2010.01) A61K 48//00, C12N 05//10, 15//79
BIOGEN IDEC MA INC., U.S.A.
WO/2004/074439
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]57[

The disclosure provides an expression cassette and a vector comprising the cassette for
expression of a polynucleotide. The expression cassette includes a promoter/enhancer,
December 29, 2011-‫ג' בטבת התשע"ב‬

198

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

an intervening region, and a polyadenylation signal domain. Expression systems and
methods of using the expression cassette and vector are also provided .

__________________
]11[]21[

170438
‫תהליך לבניית מקטע של מבנה חיצוני על ידי‬
‫הכנה מראש של חלקי מבנה וחלק מבנה‬
‫המוכן מראש המתייחס לתהליך זה‬

]54[

PROCESS FOR THE
CONSTRUCTION OF A SEGMENT
OF AN OPEN-AIR WORK BY
PREFABRICATED STRUCTURAL
MEMBERS AND PREFABRICATED
STRUCTURAL MEMBER RELATED
THERETO

]22[
]31[
]51[
]71[
]87[
]74[

24.03.2004
TO2003A000243 ]32[ 28.03.2003
]33[ IT
Int. Cl.(2010.01) E02D 29//045
CARLO CHIAVES, ITALY
WO/2004/085749
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A process for the construction of a segment of an openair work by prefabricated
structural members of reinforcing concrete, comprises the steps of arranging first and
second prefabricated structural members (18, 19) including an upright portion (22) and
at least a cover portion (26), and the phase of installing the two structural members (18,
19) by resting the free ends (20) of the respective upright portions (22) on respective
foundation portions (12), in such a manner that the two structural members (18, 19) are
arranged symmetrically opposed. Each structural member (18, 19) has a cavity in
correspondence of the respective cover portion (26), the cavities of the two structural
members (18, 19) constituting a continuous channel (34) in order to allow to form a
beam superimposed to the two members (18, 19) and fastened to them, by executing a
casting (36) in said continuous channel (34) during the work.

]57[

199

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[
]54[

SIGNAL ACQUISITION SYSTEM
AND METHOD FOR ULTRAWIDEBAND (UWB) RADAR

]22[
]51[
]71[
]74[

07.09.2005
Int. Cl.(2010.01) G01S 07//288, 13//89
CAMERO-TECH LTD.
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]57[

170726
UWB ‫מערכת ושיטה לרכישת אותות מכ"מ‬

‫ נתניה‬,‫טק בע"מ‬-‫קמרו‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

A signal acquisition system configured to be used with an ultra-wideband radar and
capable of integrating at least one received signal whereby providing a desired
compensation of a signal loss; the system comprising: (a) at least one sampler
configured to sample the received signal and to provide samples of different range
cells; (b) at least one analog integrator coupled to the sampler and configured to
integrate said samples during Na>1 integration cycles whereby providing
compensation of at least part of the signal loss and giving rise to analog integrated
samples; (c) at least one analog/digital converter coupled to the analog integrator and
configured to convert said analog integrated samples into digital samples; (d) at least
one digital integrator coupled to the analog/digital converter and configured to
integrate said digital samples during Nd digital integration cycles whereby
substantially providing the rest of desired signal loss compensation.

__________________
200

December 29, 2011-‫ג' בטבת התשע"ב‬

]11[]21[

‫–ציס חומצה רטינואית‬9 ‫תהליך להכנת‬

]54[

PROCESS FOR THE
PRODUCTION OF 9-CIS
RETINOIC ACID

]22[
]31[
]51[
]71[

02.04.2004
03008020.4
]32[ 11.04.2003
Int. Cl.(2010.01) C07C 40/3/20
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND
WO/2004/089887
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]87[
]74[

]57[

170829

]33[

EP

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

A new industrially applicable process for the production of 9-(Z)-retinoic acid is
described which is characterized by the conversion of an alkali metal salt of 3-methyl4-oxocrotonic acid with a C15-triphenyl-phosphonium salt. 9-(Z)-retinoic acid is a
versatile compound for the treatment of numerous dermatological diseases.

__________________
]11[]21[

171177
‫שיטה להכנת פולימרים פוטוריאקטיביים עם‬
‫מולקולות מקובעות עליהם‬

]54[

METHOD FOR THE
PREPARATION OF
PHOTOREACTIVE POLYMERS
WITH MOLECULES
IMMOBILIZED THEREON

]22[
]51[
]71[

31.03.2003
Int. Cl.(2010.01) C12N 11//06, 11//08, G01N 33//543
COUNCIL OF SCIENTIFIC AND
INDUSTRIAL RESEARCH, INDIA
WO/2004/088316
DR. EYAL BRESSLER,
11 TUVAL ST.,
RAMAT GAN 52522

]87[
]74[

]57[
201

,‫דר' אייל ברסלר עו"פ‬
11 ‫תובל‬
‫ גן‬- ‫רמת‬
This invention relates to a quick method for preparation of photoreactive polymers and
December 29, 2011-‫ג' בטבת התשע"ב‬

immobilization of biomolecules onto these polymers. Particularly, this invention
relates to a microwave-mediated rapid and efficient method for the preparation of
photoreactive polymer having atleast one photoactivable functional group capable of
forming a covalent bond with the biomolecule in a photochemical reaction. Any
matrix either organic or inorganic having a nucleophilic group preferably, amino,
hydroxyl or thiol group can be modified by the invented method. Immobilization of
biomolecules onto the photoreactive polymers was carried out by UV radiation. The
method has applications for immobilization of bio-molecules irrespective of their
functional groups in the fields of molecular biology, proteomics, genomics,
diagnostics, chemical or biochemical industry or other related fields.

__________________
]11[]21[
]54[

RAPID HEAT-MEDIATED
METHOD FOR ENZYMELINKED IMMUNOSORBENT
ASSAY PROCEDURE

]22[
]51[
]71[

31.03.2003
Int. Cl.(2010.01) G01N 33//543
COUNCIL OF SCIENTIFIC AND
INDUSTRIAL RESEARCH, INDIA
WO/2004/088315
DR. EYAL BRESSLER,
11 TUVAL ST.,
RAMAT GAN 52522

]87[
]74[

]57[

202

171178
‫שיטה מהרה מתווכת–חום לביצוע הליך בחינה‬
‫באמצעות סורבנט אימוני קשור–אנזימים‬

,‫דר' אייל ברסלר עו"פ‬
11 ‫תובל‬
‫ גן‬- ‫רמת‬
This invention relates to a rapid and efficient method for carrying out enzyme-linked
immunosorbent assay for detection of minute quantities of biomolecules such as
antigen, antibody etc. This invention particularly relates to heat-mediated
immobilization of antigen or antibody on to the activated surface followed by
performing subsequent steps of ELISA by controlled temperature. The invented
procedure has reduced the total time required for ELISA to around 3 h. The invented
ELISA procedure is rapid, economical, reproducible and simple. The invented
procedure is useful for carrying out ELISA required in clinical diagnostics, molecular
biology, agriculture, food technology, environmental science, etc. The invented
ELISA method is simple, time saving and obviates the time consuming procedure.
This method has the potential for automation.

__________________
December 29, 2011-‫ג' בטבת התשע"ב‬

]11[]21[

171217
‫מעבד מיקום רב מעברים‬

]54[

MULTIPLE PASS LOCATION
PROCESSOR

]22[
]31[
]51[
]71[
]87[
]74[

31.03.2004
10/414982
]32[ 15.04.2003
]33[ US
Int. Cl.(2010.01) G01S 03//02
TRUEPOSITION, INC., U.S.A.
WO/2004/092762
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
A multiple pass location processing method, for use in a wireless location system
(WLS), comprises identifying a received transmission as requiring multiple pass
location processing whereby the WLS produces a first, lower quality location estimate
and then subsequently produces a second, higher quality location estimate. The WLS
then produces the first location estimate and provides it to a first location application,
and then produces the second location estimate. The second location estimate may be a
more accurate estimate than the first location estimate and/or of a higher confidence
than the first location estimate. This method is suitable, but not limited, for use in
connection with locating a wireless transmitter involved in an emergency services call
and routing the call to a call center.

]57[

__________________
]11[]21[

203

171363
December 29, 2011-‫ג' בטבת התשע"ב‬

‫תהליך להפקת מוצרים של טיטניום‬

]54[

PROCESS FOR THE
PRODUCTION OF TITANIUM
PRODUCTS

]22[
]51[
]71[

11.10.2005
Int. Cl.(2010.01) A62D 01//00, C01G 23//04
JOMA INTERNATIONAL AS,
NORWAY
ASHER VITNER
‫אשר ויטנר‬
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
A method for the industrial purification of a titanium feed stream of purity P1, by the
formation of a titanium-double-salt precipitate of purity P2, and a titanium solution
with purity P3, wherein P2>P1>P3, said method comprising the steps of: forming,
from said feed, a medium comprising water, titanium ion, a cation selected from the
group consisting of ammonium, cations of alkali metals, protons and a combination
thereof, and an anion selected from the group consisting of OH, SO4, HSO4, and a
combination thereof, which formed medium is further characterized by the presence of
(a) a double-salt precipitate comprising titanium ion, at least one of said cations and at
least of said anions; and (b) a titanium solution; and wherein the concentration of said
anion in said titanium solution is higher than 15 wt% and the ratio between the
concentrations of said cation and said anion in said titanium solution is higher than 0.4
and lower than 1.6; and; separating at least a portion of said precipitate from said
solution

]72[
]74[
]57[

__________________
]11[]21[
]54[

APPARATUS ADAPTED TO
PERFORM AS COMPRESSOR,
MOTOR, PUMP AND INTERNAL
COMBUSTION ENGINE

]22[
]51[
]71[
]87[
]74[

22.04.2003
Int. Cl.(2010.01) F01C 01//067
DAS AJEE KAMATH, INDIA
WO/2004/094787
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,

204

171444
,‫ מנוע‬,‫מערכת שמותאמת לתפקיד כמדחס‬
‫משאבה ומנוע בעירה פנימית‬

,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
December 29, 2011-‫ג' בטבת התשע"ב‬

]57[

BEER-SHEVA 84152
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
A rotary apparatus adapted to perform as, compressor, pump, motor or an internal
combustion engine; said apparatus comprising of two vanes, two hollow cylindrical
sleeves, hollow cylindrical liner, cams and associated linkages, couplings, shaft, clutch
and braking/locking arrangement; said vanes are fitted on to the curved surface of the
sleeves, one vane on each sleeve, such that the vanes are radial to sleeve's curved
surface and at one of the ends of each sleeve so that the vane's surface protrudes out of
the sleeve's end; said sleeves placed such that their ends, fitted with vanes are placed
adjacent, with the vanes angularly displaced; said vanes are placed inside a liner; said
liner's inner surface is contoured along the path traced by vane edge while rotating
about the said axis; said inner surface allows rotation of the vanes about the said axis;
said vanes divide the said enclosure formed inside the liner into two sealed chambers;
enclosure; said two sleeves, are coupled and uncoupled with a shaft by means of
coupling arrangement actuated by cams or other timing devices; said cams or timing
devices are dependent on sleeve position; said cams or timing devices actuate said
braking/locking arrangements such that each vane is held at a predetermined position
alternately, and the vanes are free to rotate through an defined angle alternately; said
cams or timing devices allow both vanes to rotate simultaneously through an
predefined angle; said cams or timing devices defines the angle by which the vanes are
separated, rotated simultaneously or independently.

__________________
]11[]21[
]54[

205

USE OF A PHENOXYACETIC
ACID DERIVATIVE FOR
PREPARING A COMPOSITION
FOR TREATING HYPERACTIVE
BLADDER

171713
‫שימוש בתולדה של חומצה פנוקסיאצטית‬
‫להכנת תכשיר לטיפול בפעילות יתר של‬
‫שלפוחית השתן‬

December 29, 2011-‫ג' בטבת התשע"ב‬

]22[
]31[
]51[
]71[
]87[
]74[

]57[

24.03.2004
10320084.3
]32[ 05.05.2003
]33[
10323837.9
23.05.2003
Int. Cl.(2010.01) A61K 31//191, 31//192
KISSEI PHARMACEUTICAL CO.,
LTD., JAPAN
WO/2004/098586
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

DE
DE

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

The present invention relates to a new field of indication for phenoxyacetic acid
derivatives as described in European Patent Application EP 1095932. It has now been
found that the compounds described therein are suitable for the preparation of a
medicament for treating hyperactive bladder (overactive bladder). Accordingly, by
means of these active substances, a method is provided for treating this urological
syndrome.

__________________
]11[]21[

171722

]54[

ACCESS SYSTEM FOR THE
PROVISIONING OF DIFFERENT
COMMUNICATION SERVICES
AND METHOD FOR USING
SAME

]22[
]51[
]71[
]74[

01.11.2005
Int. Cl.(2010.01) H04M 03//42, H04Q 03//00
ECI TELECOM LTD.
ECI TELECOM LTD.,
30 HASIVIM ST.,
PETACH TIKVA 49517

]57[

206

‫מערכת גישה למתן שירותי תקשורת שונים‬
‫ושיטה לשימוש בה‬

‫ פתח תקוה‬,‫ טלקום בע"מ‬.‫ איי‬.‫ סי‬.‫אי‬
,‫ טלקום בע"מ‬.‫ איי‬.‫ סי‬.‫אי‬
30 ‫רחוב הסיבים‬
‫פתח תקוה‬
An access communication system is provided which comprises at least one
aggregation device comprising at least one automated switching matrix for connecting
a plurality of communication devices with a plurality of subscribers. When a new
subscriber is to be connected through the at least one aggregation device, the at least
one automated switching matrix is operative to enable the provisioning of a required
service to the new subscriber either by using one of these communication devices or
by communicating with a communication device installed at a different location and
operative to enable the provisioning of the service required by the new subscriber. By
December 29, 2011-‫ג' בטבת התשע"ב‬

a preferred embodiment the at least one aggregation device and automated switching
matrix and the plurality of communication devices are managed by a single managing
entity.

__________________
]11[]21[

172008
‫שימוש לקביעת יכולת של אנזים לווסות את‬
‫רמת הפוספורילציה של פוליפפטיד שעבר‬
‫ביוטניליזציה‬

]54[

METHOD FOR DETERMINING
THE ABILITY OF AN ENZYME TO
MODULATE THE
PHOSPHORYLATION STATUS OF
A BIOTINYLATED POLYPEPTIDE

]22[
]31[
]51[
]71[

27.04.2004
10323081.5
]32[ 22.05.2003
]33[ DE
Int. Cl.(2010.01) C07K 14//435, C12Q 01//48
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2004/104220
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The invention relates to the use of a polypeptide for determining the ability of an
enzyme, a functional fragment or a derivative thereof, to modulate the phosphorylation
status of the polypeptide, said invention being characterised in that the polypeptide is
biotinylated.

]87[
]74[

]57[

__________________
]11[]21[
]54[

METHOD FOR REMOVING
PIGMENTS FROM A PIGMENTED
SECTION OF SKIN

]22[
]31[
]51[

10.06.2004
156374
]32[ 10.06.2003
Int. Cl.(2010.01) A61B 17//00, 17//20

207

172326
‫שיטה להסרת פיגמנטים מחלק עור עם‬
‫פיגמנטציה‬

]33[

IL
December 29, 2011-‫ג' בטבת התשע"ב‬

]71[
]87[
]74[

]57[

HAWK MEDICAL TECHNOLOGIES
‫ ראשון לציון‬,‫הוק מדיקל טכנולוג'יס בע"מ‬
LTD
WO/2004/107995
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The present invention relates to a method for removing pigments from a pigmented
section of a skin by puncturing the skin at the pigmented section, with a skin
puncturing device which is provided with at least one needle, and then bandaging the
punctured section with a suitable adsorbing pad. The pad contains one or more
materials, such as saline, which will cause the pigments at the punctured section to
migrate into the outer layer of the skin.

__________________
]11[]21[

172354
‫אפוליפופרוטאין לשימוש בתבחיך לגילוי של‬
PrPSC

]54[

APOLIPOPROTEIN FOR USE IN
AN ASSAY FOR DETECTION OF
PRPSC

]22[
]31[
]51[
]71[

18.06.2004
03101795.7
]32[ 19.06.2003
]33[ EP
Int. Cl.(2010.01) G01N 33//68
MERCK SERONO S.A.,
SWITZERLAND
CLAUDIO SOTO-JARA, KINSEY
MAUNDRELL
WO/2004/111652
INTERPHARM LABORATORIES
,‫אינטרפארם מעבדות בע"מ‬
LTD.,
18 ‫רחוב הקישון‬
18 HAKISHON ST.,
‫יבנה‬151 .‫ד‬.‫ ת‬,
P.O.B. 151,
YAVNE 81101
The use of Apolipoprotein B, Apolipoprotein E, fragments and mimetics thereof is
provided for diagnostic, detection, prognostic and therapeutic applications in prion
diseases. More specifically, the invention provides the use of Apolipoprotein B or
fragments thereof for modulating or identifying modulators of the prion protein
replication which are implicated in thepathogenesis of transmissible spongiform
encephalopathics and other prion diseases.

]72[
]87[
]74[

]57[

208

December 29, 2011-‫ג' בטבת התשע"ב‬

50/17/4

The applications for division
from this application have
not yet been published

‫בקשות חלוקה מבקשה זו‬
9‫שטרם פורסמו‬

__________________
]11[]21[

172404

]54[

VEGF MINI TRAPS,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THE SAME AND USE OF THE
PHARMACEUTICAL
COMPOSITIONS FOR
PREPARING MEDICAMENTS

]22[
]31[
]51[
]71[

29.06.2004
10/609775
]32[ 30.06.2003
]33[ US
Int. Cl.(2010.01) A61K 38//17, C07K 14//71, 19//00, C12N 15//12, 15//62
REGENERON
PHARMACEUTICALS, INC., U.S.A.
WO/2005/000895
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬

]87[
]74[

]57[

‫ תכשירים רפואיים‬,VEGF ‫מלכודות מיני‬
‫המכילים אותן ושימושים של התכשירים‬
‫הרפואיים להכנת תרופות‬

Nucleic acid molecules and multimeric proteins capable of binding vascular
endothelial growth factor (VEGF). VEGF traps are disclosed which are therapeutically
useful for treating VEGF-associated conditions and diseases, and are specifically
designed for local administration to specific organs, tissues, and/or cells .

__________________
]11[]21[
]54[

209

FUSED COMPOUNDS
CONTAINING AN UREIDO
GROUP THAT INHIBIT
VANILLOID RECEPTOR
SUBTYPE 1 (VR1) RECEPTOR
FOR TREATING DISORDERS
CAUSED BY VANILLOID
RECEPTOR ACTIVITY AND

172457
‫תרכובות מאוחות המכילות קבוצת אוראידו‬
‫ של‬1 ‫המעכבות קולטן של ונילואיד תת–סוג‬
‫ לטיפול בהפרעות הנגרמות על–ידי‬,‫הקולטן‬
‫פעילות של קולטן וינלואיד ותהליך להכנתן‬

December 29, 2011-‫ג' בטבת התשע"ב‬

PROCESS FOR THEIR
PREPARATION
]22[
]31[
]51[
]71[
]87[
]74[

]57[

10.06.2004
10/459925
]32[ 12.06.2003
]33[ US
10/864068
09.06.2004
US
Int. Cl.(2010.01) A61K 31//416, 31//472, A61P 13//00, C07D 21/7/02, 23/1/56,
40/1/12, 40/3/12
ABBOTT LABORATORIES, U.S.A.
WO/2004/111009
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
124 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11490 .‫ד‬.‫ ת‬,
TEL AVIV 62038
The present invention discloses novel compounds of general formula (I), or a
pharmaceutically acceptable salt or prodrug thereof (in which X1 - X5, R5 - R8b, Z1 - Z2
and Ar1 are defined herein), a method for inhibiting the VR1 receptor in mammals
using these compounds, a method for controlling pain in mammals, and
pharmaceutical compositions including those compounds and a process for making
those compounds.

The applications for division
from this application have
not yet been published

5024/24502377550/5113

‫בקשות חלוקה מבקשה זו‬
9‫שטרם פורסמו‬

__________________
]11[]21[
]54[
]22[
210

INTRAVAGINAL DRUG
DELIVERY DEVICES

172620
‫מתקנים לאספקה תוך–נרתיקי של תרופות‬

09.07.2004
December 29, 2011-‫ג' בטבת התשע"ב‬

]31[
]51[
]71[
]87[
]74[

]57[

S0515
]32[ 10.07.2003
]33[ IE
Int. Cl.(2010.01) A61K 09//00, 45//08, 47//36, 47//38
WARNER CHILCOTT (IRELAND)
LIMITED, IRELAND
WO/2005/004837
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122

,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
The invention relates to an intravaginal drug delivery device comprising at least one
reservoir, the, or each, reservoir containing at least one pharmacologically active agent
dispersed in a carrier system; and a sheath discontinuously surrounding the at least one
reservoir, so that, in use, at least part of that reservoir is directly exposed to the vaginal
environment. Preferably, the sheath defines one or more holes or openings, the, or
each, hole or opening extending through the sheath to the at least one reservoir, so that
at least part of that reservoir is exposed, in use, to the vaginal environment.

__________________
]11[]21[

172783

]54[

RASGAP DERIVED PEPTIDE FOR
SELECTIVELY KILLING
CANCER CELLS

]22[
]31[
]51[
]71[

30.06.2004
60/483691
]32[ 30.06.2003
]33[
Int. Cl.(2010.01) A61K 38//17, C07K 14//47
UNIVERSITE DE LAUSANNE,
SWITZERLAND
CHRISTIAN WIDMANN, JIANGYANG YANG, DAVID MICHOD
WO/2005/000887
SOROKER-AGMON,
14 SHENKAR ST.,
HERZLIYA PITUAH 46725

]72[
]87[
]74[

]57[
211

‫ ההורג באופן‬RASGAP ‫פפטיד הנגזר מחלבון‬
‫סלקטיבי תאים סרטניים‬

US

,‫אגמון‬-‫סורוקר‬
14 ‫ רחוב שנקר‬,‫בית נולטון‬
‫הרצליה פיתוח‬
The present invention relates to a peptide consisting in the N2 sequence of the
December 29, 2011-‫ג' בטבת התשע"ב‬

RasGAP protein, a fragment thereof, or a variant thereof which enhances the ability of
a drug to selectively kill cells. Furthermore, it relates to a pharmaceutical composition
comprising as an active substance a pharmaceutically effective amount of said peptide.

__________________
]11[]21[

172928
‫התקן נעילה לכוונון גובה של מודול‬

]54[

LOCKING DEVICE FOR HEIGHT
ADJUSTMENT OF A MODULE

]22[
]31[
]51[
]71[
]87[
]74[

25.06.2004
20033053
]32[ 03.07.2003
]33[ NO
Int. Cl.(2010.01) A47C 03//28
STOKKE AS, NORWAY
WO/2005/002946
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
Device (1) for height adjustment of a module, such as a children's seat (3) on a stem
(2) in a trolley or a chair, characterized in that the locking device (1) comprises a
movable casing (4) which partly or completely surrounds the stem (2), a friction
element (5) and a handle (6) which rotates eccentrically in order to tighten the friction
element (5) against the stem (2) and providing friction between the locking device (1)
and the stem (2). The children's seat (3) may comprise a footrest (20) characterized in
that two rails (21) are received in guides (22) integrated in the seat, such that the
footrest (20) may be displaced telescopically in relation to the seat (3).

]57[

__________________
212

December 29, 2011-‫ג' בטבת התשע"ב‬

]11[]21[

172944
‫קרומית פולימרית מוליכה המכילה תמיסה יונית‬
‫לשימוש בתאי דלק ושיטה ליצורה‬

]54[

POLYMER ELECTROLYTE
MEMBRANES AND IONIC
LIQUID THEREIN FOR USE IN
FUEL CELLS AND METHOD
FOR ITS PREPARATION

]22[
]51[
]71[

02.01.2006
Int. Cl.(2010.01) H01M 08//10
BEN-GURION UNIVERSITY OF
‫אוניברסיטת בן גוריון בנגב הרשות למחקר‬
THE NEGEV RESEARCH AND
‫ באר שבע‬,‫ופיתוח‬
DEVELOPMENT AUTHORITY
ELI KORIN, ARMAND
‫ ארמון בטלהיים‬,‫אלי קורין‬
BETTELHEIM
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A method for preparing a Polymer Electrolyte Membrane (PEM), wherein said
method comprises the step of combining a polysiloxane-RTV matrix with an ionic
liquid component to form an electrically conductive membrane, said combination
being carried out by introducing said ionic liquid with a first anion in the
polysiloxane-RTV component and then exchanging said first anion with a second
anion, said second anion being provided in the form of a salt in aqueous solution.

]72[
]74[

]57[

__________________
]11[]21[
]54[

DEVICE AND METHOD FOR
SIMULTANEOUSLY
IDENTIFYING BLOOD GROUP
ANTIGENS

]22[
]31[
]51[
]71[

08.07.2004
103 30 982.9 ]32[ 09.07.2003
Int. Cl.(2010.01) G01N 33//80
MEDION DIAGNOSTICS AG,
SWITZERLAND
WO/2005/005991
REINHOLD COHN AND
PARTNERS,

]87[
]74[
213

172998
‫מתקן ושיטה לזיהוי בו–זמני של אנטיגנים של‬
‫סוג דם‬

]33[

DE

,‫ריינהולד כהן ושותפיו‬
December 29, 2011-‫ג' בטבת התשע"ב‬

'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[

The invention relates to a device for simultaneously, qualitatively or quantitatively
identifying a number of analytes in a liquid sample, comprising a membrane (2) with:
a charging zone (5) for applying the liquid sample; at least two indicator zones, which
can interact with the analyte(s), and at least one absorption area (3), which absorbs the
liquid after passing the indicator zones, whereby the indicator zones are located
between the charging zone (5) and an absorption area (3). The invention is
characterized in that the flowing directions from the charging zone (5) through the
respective indicator zones to an absorption area (3) (flow paths) are essentially
parallel, and at least two different flow paths exist. The invention also relates to a
method for identifying a number of analytes or the derivatives thereof in a liquid
sample, consisting in the application of the sample to the charging zone (5) of a
membrane (2) of the device according to one of cited claims 1 to 8, whereby this
sample is present in an amount sufficient for causing the sample liquid to flow through
the indicator zones toward the absorption area (3), and for causing the analytes or the
derivatives thereof in the sample liquid to form a complex in the indicator zones.

__________________
]11[]21[

173022
‫ שיטה לטיפול במצב‬,‫תרכובות טטראציקליניות‬
,‫המגיב לטטראציקליות במטופל שאינו אנושי‬
‫תכשיר פרמצבטי ושימוש בהן להכנת תרופוה‬

]54[

TETRACYCLINE COMPOUNDS, A
METHOD OF TREATING A
TETRACYCLINE RESPONSIVE
STATE IN A NON-HUMAN
SUBJECT, A PHARMACEUTICAL
COMPOSITION AND USE
THEREOF FOR THE
PREPARATION OF A
MEDICAMENT

]22[
]31[

25.06.2004
60/486017
]32[ 09.07.2003
]33[ US
60/525287
25.11.2003
US
60/530123
16.12.2003
US
60/566150
27.04.2004
US
Int. Cl.(2010.01) A61K 31//65, A61P 31//04, C07D 21/1/34

]51[
214

December 29, 2011-‫ג' בטבת התשע"ב‬

]71[
]87[
]74[

]57[

PARATEK PHARMACEUTICALS,
INC., U.S.A.
WO/2005/009944
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122

,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
The invention pertains to prodrugs of 9-aminomethyl substituted tetracycline
compounds, methods of using the compounds, and pharmaceutical compositions
containing them.

The applications for division
from this application have
not yet been published

5024/67502046750/4114

‫בקשות חלוקה מבקשה זו‬
9‫שטרם פורסמו‬

__________________
]11[]21[

173062
‫– אמינוטטרלינים מותמרים לייצור‬2–‫שימוש ב‬
‫תרופה לטיפול בדיכאון‬

]54[

USE OF SUBSTITUTED 2AMINOTETRALINS FOR THE
MANUFACTURE OF A
MEDICAMENT FOR THE
TREATMENT OF DEPRESSION

]22[
]31[
]51[

22.07.2004
10334187.0
]32[ 26.07.2003
]33[ DE
Int. Cl.(2010.01) A61K 31//341, 31//381, 31//40, A61P 25//24, C07D 20/7/335,
30/7/52, 33/3/20
UCB PHARMA GMBH, GERMANY
WO/2005/009425
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬

]71[
]87[
]74[

]57[

215

The invention relates to the use of a compound of general formula (I) and the
pharmaceutically acceptable salts, racemates or pure entiomers thereof for the
production of a medicament used to treat depression. The substituents are defined as in
the description.

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

173067
‫תערובת אבקות הניתנת לסינטור וקבלת חומר‬
‫מוצק בעל סיכה–עצמית‬

]54[

POWDER MIXTURE CAPABLE
OF BEING SINTERED TO
PRODUCE A SELF-LUBRICATING
SOLID SUBSTANCE

]22[
]31[
]51[

10.01.2006
0500287
]32[ 12.01.2005
]33[ FR
Int. Cl.(2010.01) B22F 01//00, 03//12, 05//00, C10M 10/3/04, 12/5/22, C22C 01//00,
01//04, 32//00, 38//00, 38//18, F16C 33//04
SNECMA SERVICES, FRANCE
SNECMA, FRANCE
EITAN MEHULAL LAW GROUP,
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
10 ABBA EBEN BLVD.,
,‫פטנטים‬
P.O.B. 2081,
10 ‫שדרות אבא אבן‬
HERZLIYA 46120
‫הרצליה‬2081 .‫ד‬.‫ ת‬,
A powder mixture suitable for sintering to form a self-lubricating solid material,
comprising a powder of a metal alloy that is a precursor for the matrix of said selflubricating solid material, particles of a first solid lubricant for insertion in said matrix
without reacting with said metal alloy during sintering of the powder, and particles of a
second solid lubricant for reacting with a component of said metal alloy during
sintering of the powder in order to form a lubricating phase, characterized in that the
particles of the first solid lubricant are particles of cerium trifluoride CeF 3.

]71[
]74[

]57[

__________________
]11[]21[
]54[

216

STRUCTURE AND METHOD OF
MAKING STRAINED
SEMICONDUCTOR CMOS
TRANSISTORS HAVING
LATTICE-MISMATCHED

173422
‫מבנה ושיטה להכנת טרנזיסטורים מתוחים‬
‫ בעלי אזורי מקור ותעלה שאין‬,CMOS ‫מסוג‬
‫ביניהם התאמה סימטרית‬

December 29, 2011-‫ג' בטבת התשע"ב‬

SOURCE AND DRAIN REGIONS
]22[
]31[
]51[
]71[
]87[
]74[

]57[

04.08.2004
10/604607
]32[ 04.08.2003
]33[
Int. Cl.(2010.01) H01L 21//20, 31//0328
IBM CORPORATION, U.S.A.
WO/2005/017964
IBM LABORATORIES,
HAIFA UNIVERSITY,
HAIFA 31905

US

,‫מעבדות יבמ מחלקת קנין רוחני‬
‫אוניברסיטת חיפה הר הכרמל‬
‫חיפה‬
A p-type field effect transistor (PFET) (10) and an n-type field effect transistor
(NFET) (12) of an integrated circuit are provided. A first strain is applied to the
channel region (20) of the PFET (10) but not the NFET (12) via a lattice-mismatched
semiconductor layer such as silicon germanium disposed in source and drain regions
(111) of only the PFET (10) and not of the NFET.(12) A process of making the PFET
(10) and NFET (12) is provided. Trenches are etched in the areas to become the source
and drain regions (111) of the PFET and a lattice-mismatched silicon germanium layer
(121) is grown epitaxially therein to apply a strain to the channel region of the PFET
adjacent thereto. A layer of silicon (14) can be grown over the silicon germanium layer
(121) and a salicide (68) formed from the layer of silicon to provide low-resistance
source and drain regions (111).

__________________
]11[]21[
]54[

ISOXAZOLINE DERIVATIVES AS
CASPASE INHIBITORS,
THERAPEUTIC COMPOSITIONS
COMPRISING SAME AND USE
THEREOF FOR PREVENTING
INFLAMMATION AND
APOPTOSIS

]22[
]31[

26.08.2004
10-20030059451

217

]32[

27.08.2003

173638
‫ תכשיר‬,‫נגזרות איזוקסאזולין כמעכב קאספאס‬
‫טיפולי המכיל אותו ושימוש בו למניעת דלקת‬
‫ואפופטוזיס‬

]33[

KR
December 29, 2011-‫ג' בטבת התשע"ב‬

]51[
]71[
]87[
]74[

]57[

Int. Cl.(2010.01) C07D 26/1/04, 41/3/04, 41/3/12, 41/3/14
LG LIFE SCIENCES LTD.,
REPUBLIC OF KOREA
WO/2005/021516
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
279 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬6451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
The present invention relates to an isoxazoline derivative as an inhibitor against
various caspases, a process for preparing the same, and a therapeutic composition for
preventing inflammation and apoptosis comprising the same

__________________
]11[]21[

173982
‫ מערכת ושיטה לניהול תקשורת קישור‬,‫מתקן‬
‫הפוך‬

]54[

APPARATUS, SYSTEM AND
METHOD FOR MANAGING
REVERSE LINK
COMMUNICATION

]22[
]31[

08.09.2004
60/501563
]32[ 08.09.2003
]33[ US
60/501450
08.09.2003
US
Int. Cl.(2010.01) H04B 07//005, 07//185, H04W 52//24, 52//26
QUALCOMM INCORPORATED,
U.S.A.
WO/2005/027371
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬2273 .‫ד‬.‫ ת‬,
In accordance with an exemplary embodiment of the invention, an apparatus, system,
and method efficiently manage reverse link resources by allowing a mobile station to
select between transmitting a payload a standard power level and transmitting a
smaller payload at a boosted power level. The mobile station, therefore, can
autonomously select a QoS (Quality of Service) level for physical layer packets. Based
on reverse link transmission information received from a base station, the mobile
station derives a reverse link transmission guideline defining the power levels and
associated payloads for at least a standard service and boosted service. The mobile
station selects a reverse link transmission power level from a plurality of power levels
including at least a standard reverse link transmission power level associated with a
standard payload size and a boosted reverse link transmission power level associated

]51[
]71[
]87[
]74[

]57[

218

December 29, 2011-‫ג' בטבת התשע"ב‬

with a boosted payload size where the standard payload size is greater than the boosted
payload size.

__________________
]11[]21[

173997
‫אטמים‬

]54[

SEALS

]22[
]31[
]51[
]71[

26.08.2004
0320858.4
]32[ 05.09.2003
]33[ GB
Int. Cl.(2010.01) A47B 88//04, F16J 15//02, F25D 23//08, 25//02
APPLIED DESIGN AND
ENGINEERING LIMITED, UNITED
KINGDOM
IAN DAVID WOOD
WO/2005/024315
SOROKER-AGMON,
,‫אגמון‬-‫סורוקר‬
14 SHENKAR ST.,
14 ‫ רחוב שנקר‬,‫בית נולטון‬
HERZLIYA PITUAH 46725
‫הרצליה פיתוח‬
A storage compartment comprises a container defining an access aperture closable by a
closure that can be sealed to the container around the aperture and that can be opened
by relative movement between the container and the closure in a lateral direction with
respect to the aperture, the container having a first sealing loop around the aperture and
the closure having a second sealing loop co-operable by alignment with the first
sealing loop to maintain a seal when the closure closes the aperture. The sealing loops
are moved into and out of mutual alignment by said relative movement between the
container and the closure and at least one of the sealing loops includes magnetic means
for attracting the other of the sealing loops to maintain a seal when the sealing loops
are mutually aligned.

]72[
]87[
]74[

]57[

219

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

174075
‫–בנזואיל–פיפרזין כמעכבי הספיגה‬1 ‫נגזרות של‬
‫של גליצין לטיפול בפסיכוזה‬

]54[

1-BENZOYL-PIPERAZINE
DERIVATIVES AS GLYCINE
UPTAKE INHIBITORS FOR THE
TREATMENT OF PSYCHOSES

]22[
]31[
]51[
]71[

31.08.2004
03019682.8
]32[ 09.09.2003
]33[ EP
Int. Cl.(2010.01) A61K 31//495, 31//496, A61P 25//28, C07D 29/5/18, 40/3/04
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND
WO/2005/023261
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The invention relates to compounds of formula (I) wherein Ar is substituted aryl or
unsubstituted or substituted 6-membered heteroaryl, containing one, two or three
nitrogen atoms, and wherein the aryl and the heteroaryl groups may be substituted by
one or more substituents selected from the group consisting of hydroxy, halogen, CN,
(C1C6)-alkyl, (C1-C6)-alkyl substituted by halogen, (C1-C6)-alkoxy, (C1-C6)-alkoxy
substituted by halogen, NR7R8, C(O)R9 or SO2R10; R1 is hydrogen or (C1-C6)-alkyl; R2
is halogen, (C1-C6) -alkyl, (C2-C6) -alkenyl, wherein a hydrogen atom may be replaced
by CN, C(O)-R9 or (C1-C6)-alkyl, or is (C2-C6)alkynyl, (C1-C6)-alkyl substituted by
halogen, -(CH2)n-(C3-C7)-cycloalkyl, -(CH2)n-heterocycloalkyl, -C(O)-R9, -(CH2)n-aryl
or -(CH2)n-5 or -6membered heteroaryl containing one, two or three heteroatoms,
selected from the group consisting of oxygen, sulphur or nitrogen wherein aryl,
cycloalkyl, heterocycloalkyl and heteroaryl are unsubstituted or substituted by one or
more substituents selected from the group consisting of hydroxy, halogen, (C 1-C6)alkyl, (C1-C6)-alkyl substituted by halogen or (C1-C6) alkoxy; R3, R4 and R6
independently from each other are hydrogen, hydroxy, halogen, (C 1-C6)-alkyl or (C1C6)-alkoxy; R5 is NO2, CN, C(O)R9, SO2R10 or NR11R12 ; R7 and R8 independently
from each other are hydrogen or (C1-C6)-alkyl; the other substituents are defined in the
claims; and to pharmaceutically acceptable acid addition salts thereof for the treatment
of psychoses, pain, neurodegenerative disfunction in memory and learning,
schizophrenia, dementia and other diseases in which cognitive processes are impaired,
such as attention deficit disorders or Alzheimer's disease.

]87[
]74[

]57[

220

December 29, 2011-‫ג' בטבת התשע"ב‬

‫__________________‬

‫‪174148‬‬

‫[‪]11[]21‬‬

‫מתקן עזר לקידוח ידני אנכי‬

‫גדעון אלון‪ ,‬קבוץ מעברות‬
‫גדעון אלון‪,‬‬
‫קבוץ מעברות‬

‫‪DEVICE FOR MANUAL‬‬
‫‪VERTICAL DRILLING‬‬

‫[‪]54‬‬

‫‪07.03.2006‬‬
‫‪Int. Cl.(2010.01) B23B 45//00‬‬
‫‪GIDEON ALON‬‬
‫‪GIDEON ALON,‬‬
‫‪KIBUTZ MAABAROT 40230‬‬

‫[‪]22‬‬
‫[‪]51‬‬
‫[‪]71‬‬
‫[‪]74‬‬

‫מתקן לקידוח קדח במשטח של חלק‪ ,‬הכולל‪ :‬בסיס בעל שני צדדים ‪ ,1‬עמוד חלול ‪ 2‬הבנוי להוביל תנועה אנכית ביחס לבסיס‬
‫וכולל מוביל מחליק ‪ ,4‬בית תפסנית למקדח ‪ 3‬הצמוד למוביל המחליק‪ ,‬תפסנית למקדח ‪ 5‬המותקנת בתוך בית התפסנית‬
‫והניתנת להנעה סיבובית על ידי מניע חיצונית‪ ,‬כאשר המהלך של המוביל המחליק בתוך העמוד החלול מאפשר למקדח‬
‫המהודק בתפסנית לבצע קידוח מעבר לבסיס‪ ,‬כאשר העמוד החלול מותקן על גבי אחד משני הצדדים העיקריים של הבסיס‬
‫והחלק לקידוח מיועד להיות מוצמד לצד האחר של הבסיס כאשר הבסיס כולל יחידת ואקום ‪ 6‬לצורך הצמדה אל המשטח‬
‫עבודה‪ ,‬וכאשר קו הקידוח של התפסנית אינו עובר דרך הבסיס‪.‬‬

‫[‪]57‬‬

‫__________________‬

‫‪174172‬‬

‫[‪]11[]21‬‬
‫‪MULTIMERIC COMPOUND THAT‬‬
‫‪BINDS PSGL-1 PROTEINS, USES‬‬
‫‪THEREOF AND KITS‬‬
‫‪COMPRISING THE SAME‬‬

‫[‪]54‬‬

‫‪09.09.2004‬‬
‫‪10/662906‬‬
‫‪]32[ 15.09.2003‬‬
‫‪]33[ US‬‬
‫‪Int. Cl.(2010.01) A61K 38//17, C07K 14//435, 14//705, 16//18, 16//28‬‬
‫‪ABGENOMICS COOPERATIEF U.A.,‬‬
‫‪THE NETHERLANDS‬‬
‫‪WO/2005/027831‬‬
‫‪REINHOLD COHN AND PARTNERS,‬‬
‫ריינהולד כהן ושותפיו‪,‬‬
‫‪26A HABARZEL ST.,‬‬
‫רחוב הברזל ‪26‬א'‬
‫‪RAMAT HACHAYAL 69710‬‬
‫ג' בטבת התשע"ב‪December 29, 2011-‬‬

‫[‪]22‬‬
‫[‪]31‬‬
‫[‪]51‬‬
‫[‪]71‬‬

‫מולקולה מולטימרית הקושרת חלבוני –‪PSGL‬‬
‫‪ ,1‬שימושים שלה וערכה המכילה אותה‬

‫[‪]87‬‬
‫[‪]74‬‬

‫‪221‬‬

]57[

‫רמת החייל‬
Multimeric compounds that bind to P-Selectin Glycoprotein 1 (PSGL-1) on the surface
of T cells or natural killer (NK) cells can be used to induce T cell or NK cell depletion
and/or to induce T cell or NK cell apoptosis. The multimeric compounds and methods
of the invention can be used to control unwanted T cell-or NK cell-mediated immune
responses in conditions such as inflammatory diseases, autoimmune diseases,
transplant rejection, and allergic diseases.

__________________
]11[]21[

174299
‫תכשירים‬, ] 3.1.0[ ‫תולדות ביציקליים‬
‫פרמצפטיים ושימוש בהם‬

]54[

BICYCLIC [3.1.0] DERIVATIVES,
PHARMACEUTICAL
COMPOSITIONS AND USE
THEREOF

]22[
]31[
]51[
]71[
]87[
]74[

14.10.2004
60/510846
]32[ 14.10.2003
]33[ US
Int. Cl.(2010.01) A61K 31//403, C07D 20/9/04, 41/3/12
PFIZER PRODUCTS, INC., U.S.A.
WO/2005/037216
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122

]57[

222

,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
The present invention relates to a series of substituted bicyclic [3.1.0]amines of the
Formula I: Wherein A, B, D, Q, V, W, X, Y, Z, R2, R3, R4, R5, R14, R15, R30.o, p, s, t
and q are as defined in the specification, their pharmaceutically acceptable salts,
pharmaceutical compositions thereof, and their use for the enhancement of cognition
and the treatment of the positive and negative symptoms of schizophrenia and other
psychoses in mammals, including humans.

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

174373
–)‫– (קרבוקסיאלקיל‬1 ‫תולדות‬
–‫ציקלופנטיל קרבונילאמינו–בנזאזאפין‬
‫ –חומצה אצטית מותמרת‬N
‫ תהליך וחומר ביניים‬,‫באמידומתיל‬
‫להכנתן ותרופות המכילות תרכובות אלו‬

]54[

AMIDOMETHYL SUBSTITUTED 1(CARBOXYALKYL)CYCLOPENTYLCARBONYLAMINOBENZAZEPINE-N-ACETIC ACID
DERIVATIVES, PROCESS AND
INTERMEDIATE PRODUCTS FOR THEIR
PREPARATION AND MEDICAMENTS
CONTAINING THESE COMPOUNDS

]22[
]31[

23.09.2004
10344848.9
]32[
26.09.2003
]33[ DE
04100065.4
12.01.2004
EP
Int. Cl.(2010.01) A61K 31//55, A61P 09//10, 09//12, 15//10, C07D 22/3/16, 40/1/12,
40/9/12
SOLVAY PHARMACEUTICALS GMBH,
GERMANY
WO/2005/030795
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬

]51[
]71[
]87[
]74[

]57[

Described are novel compounds with neutral endopeptidase (NEP) and/or human
soluble endopeptidase (hSEP) inhibitory activity of the general formula (I), wherein the
substituents R1, R2 , R3 and R4 have the meanings given in the description and also
medicaments containing these compounds, in particular medicaments suitable for
treating or preventing cardiovascular diseases, sexual dysfunction and/or adverse
conditions associated with apoptosis.

__________________
]11[]21[
223

174374
December 29, 2011-‫ג' בטבת התשע"ב‬

‫שימוש בתרכובות הדמיה להכנת הרכבים‬
‫למעקב אחרי מסה אוצורה של תאי בטא של‬
‫הלבלב‬

]54[

USE OF IMAGING COMPOUNDS
FOR THE PREPARATION OF
COMPOSITIONS FOR
MONITORING PANCREATIC
BETA CELL MASS OR
MORPHOLOGY

]22[
]31[
]51[
]71[

16.09.2004
60/503683
]32[ 17.09.2003
]33[ US
Int. Cl.(2010.01) A61K 10/3/10, 31//175, 31//426, 31//4439, 51//00, 51//04
BOARD OF REGENTS, THE
UNIVERSITY OF TEXAS SYSTEM,
U.S.A.
WO/2005/027981
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬

]87[
]74[

]57[

Compositions for imaging beta cells comprise chelator-antidiabetic agent conjugates
and optionally chelated metals.

__________________
]11[]21[
]54[

CRYSTALLINE ANHYDROUS
MALEATE SALT OF 5-[(Z)-(5FLUORO-2-OXO 1,2-DIHYDRO3H-INDOL-3-YLIDENE)
METHYL]-N-[(2S)-2-HYDROXY-3MORPHOLIN-4-YLPROPYL]-2,4DIMETHYL-1H-PYRROLE-3CARBOXAMIDE

]22[
]31[
]51[
]71[

20.09.2004
60/508104
]32[ 02.10.2003
Int. Cl.(2010.01) C07D 40/3/06
PHARMACIA & UPJOHN
COMPANY LLC, U.S.A.
WO/2005/033098
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,

]87[
]74[

224

174414
Z )–([–5 ‫מלח מאלאט אנהידרטי קריסטלי של‬
–H 3–‫–דיהידרו‬1,2 ‫–אוקסו‬2–‫(–פלואורו‬5
–N– [(S 2 ( –2–]‫–אילידן) מתיל‬3–‫אינדול‬
–2,4–]‫–אילפירופיל‬4–‫–מורפולינ‬3–‫הידרוקסי‬
‫–קרבוקסאמיד‬3–‫–פירול‬H–1–‫דימתיל‬

]33[

US

,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
December 29, 2011-‫ג' בטבת התשע"ב‬

]57[

BEER-SHEVA 84152
The invention relates to non-hygroscopic salts of 5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro3H--indol-3-ylidene)methyl]-N-[(2)-2-hydroxy-3-morpholin-4-ylpropyl]-2,4-dimethyl1 H-pyrrole-3--yarboxamide, shown in structural formula (1) such as maleate salts, and
to crystalline polymorphs of these salts. The invention further relates to pharmaceutical
compositions of 5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3--ylidene)methyl]-N[(2S)-2-hydroxy carboxamide salts, and meth roxy-3-morpholin-4-ylpropyl]-2,4dimethyl-1 H-pyrrole-3- ds of treating disorders such as cancer using such
compositions.

__________________
]11[]21[

174513
– ‫נגזרות מותמרות של דיבנזו–אזפין ובנזו‬
,‫דיאזפין המשמשות כמעכבי גמא–סקרטז‬
‫תהליך להכנתן ושימושן בהכנת תרופות לטיפול‬
‫במחלת האלצהיימר‬

]54[

SUBSTITUTED DIBENZOAZEPINE AND BENZODIAZEPINE DERIVATIVES
USEFUL AS GAMMA-SECRETASE
INHIBITORS, A PROCESS FOR
THEIR PREPARATION AND USE
THEREOF IN THE PREPARATION
OF MEDICAMENTS FOR
TREATING ALZHEIMER'S
DESEASE

]22[
]31[
]51[

27.09.2004
03022650.0
]32[ 06.10.2003
]33[ EP
Int. Cl.(2010.01) A61K 31//55, 31//5513, A61P 25//28, C07D 22/3/18, 24/3/12,
40/1/12, 40/3/12, 40/5/12, 40/9/12, 41/7/12, C07F 07//10
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND
WO/2005/040126
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The present invention relates to compounds of the general formula (I) Wherein R 1 is (CHR’)q-aryl or -(CHR')q-heteroaryl, which are unsubstituted or mono, di- or tri-

]71[
]87[
]74[

]57[
225

December 29, 2011-‫ג' בטבת התשע"ב‬

substituted by lower alkyl, lower alkoxy, CF3 or halogen, or is lower alkyl, lower
alkenyl, -(CH2)n-Si(CH3)3, -(CH2)n-O-lower alkyl, -(CH2)n-S-lower alkyl, -(CH2)qcycloalkyl, -(CH2)n-[CH(OH)]m-(CF2)p-CHqF(3-q), or is -(CH2)n-CR2-CF3, wherein the
two R radicals form together with the carbon atom a cycloalkyl ring; R' is hydrogen or
lower alkyl; n is 1, 2 or 3; in is 0 or 1; p is 0, 1, 2, 3, 4, 5 or 6; q is 0, 1, 2 or 3; R 2 is
hydrogen or lower alkyl; R3 is hydrogen, lower alkyl, -CH2CF2CF3, CH2CF3,
(CH2)2CF3, CF3, CHF2, CF3, CHF2, CH2F, or is aryl, optionally mono, di or trisubstituted by halogen, or is (CH2)nNR5R6, wherein R5 and R6 are independently from
each other hydrogen or lower alkyl; R4 is one of the following groups wherein R7is
hydrogen, lower akl, -(CH2)n-CF3 or -(CH2)n-cycloalkyl; R8 is hydrogen, lower alkyl, C(O)-phenyl, -C(O)-lower alkyl, -C(O)O-(CH2)n- cycloalkyl, -C(O)O-(CH2)n-lower
alkyl, -C(O)NH-(CH2)n-lower alkyl or -C(O)NH(CH2).-CyClOalkYl; R9 is hydrogen,
lower alkyl, -(CH2)n-cycloalkyl or -(CH2)n-CF3; and to pharmaceutically suitable acid
addition salts, optically pure enantiomers, racernates or diastereomeric mixtures
thereof for the treatment of Alzheimer's disease..

__________________
]11[]21[

174670
‫כלי חיתוך‬

]54[

CUTTING TOOL

]22[
]51[
]71[
]72[
]74[

30.03.2006
Int. Cl.(2010.01) B23B 27//00, 27//04, 27//08
ISCAR LTD.
‫ תפן‬,‫ישקר בע"מ‬
GIL HECHT
‫גיל הכט‬
ISCAR LTD.,
,‫ישקר בע"מ‬
P.O.B. 11,
‫תפן‬11 .‫ד‬.‫ ת‬,
TEFEN 24959
A cutting tool having a tool axis (A) establishing a forward-to-rear direction, the
cutting tool comprising a cutting insert and an insert holder, the cutting insert having
an insert axis (B), and a peripheral side surface comprising a first wall, a second wall,
a third wall and at least one operative cutting section, the insert holder comprises a
forward securing portion and a rear body portion, the forward securing portion
comprises a base and securing surface, the securing surface including a first support, a
second support and a third support which all extend transversely to the base, at least a
portion of the first support abuts at least a portion of the first wall along a first
abutment region, at least a portion of the second support abuts at least a portion of the
second wall along a second abutment region and at least a portion of the third support
December 29, 2011-‫ג' בטבת התשע"ב‬

]57[

226

abuts at least a portion of the third wall along a third abutment region, wherein: the
first and the second abutment regions diverge downwardly, the second and the third
abutment regions diverge rearwardly and the third wall generally faces upwardly.

__________________
]11[]21[

174681
‫שיטה לייצור מכשיר מיקרואלקטרוני ארוז‬
‫בוואקום‬

]54[

METHOD OF MANUFACTURING
A PACKAGED VACUUM
MICROELECTRONIC DEVICE

]22[
]31[
]51[
]62[
]71[
]87[
]74[

15.08.2001
09/652516
]32[ 31.08.2000
Int. Cl.(2008.04) H01J 1//62
DIVISION FROM 154517
INTEVAC, INC., U.S.A.
WO/2002/019365
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]57[

A method of manufacturing a packaged vacuum microelectronic device, said device
comprising a rectangular photocathode and a rectangular semiconductor die,
comprising: fabricating a housing of a ceramic material and forming a cavity within
said housing, wherein said die and said cavity exhibit rectangular shapes and said
housing comprises an electrical isolator; inserting said semiconductor die into said
housing; orienting said die within said housing whereby the volume of said housing is
efficiently employed, said die comprising a photodiode array; bonding the rectangular
photocathode to a surface of a transparent closure member; bonding a transparent
closure member to a sealing surface of said housing ,and drawing a vacuum in said
cavity.

227

]33[

US

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

174764
‫התקן לייזר מונוליטי במצב מוצק של לייזר‬
‫משאבת דיודה‬

]54[

LASER DIODE-PUMPED
MONOLITHIC SOLID STATE
LASER DEVICE

]22[
]31[
]51[
]71[
]87[
]74[

08.10.2004
0311809
]32[ 09.10.2003
Int. Cl.(2010.01) H01S 03//109
OXXIUS SA, FRANCE
WO/2005/036703
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]57[

The invention relates to an intracavity-doubled laser device, comprising a pumping
laser-diode, a Nd:YAG amplifying medium stimulated by a laser beam with a
fundamental wavelength emitted by the laser diode, the output face of said amplifying
medium being cut at the Brewster angle for said fundamental wavelength and a
birefringent frequency-doubling KNbO3 crystal. The device further comprises an
isotropic medium (3), inserted between the input face (8) of the birefringent crystal,
the amplifying medium (2) and the birefringent crystal (4), being fixed to each other
such as to provide a monolithic resonant cavity. Furthermore, the crystal axis 'c' of the
birefringent crystal includes a non-zero angle ?c with relation to the orthogonal
direction of polarisation of the fundamental wave defined by the Brewster surface.

228

]33[

FR

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

__________________
December 29, 2011-‫ג' בטבת התשע"ב‬

]11[]21[

174786
‫מולקולות חומצות גרעין המקודדות וריאנטים‬
‫ תכשירים ושיטות הכנה ושימוש‬,‫של הרגולין‬

]54[

NUCLEIC ACID MOLECULES
ENCODING HEREGULIN
VARIANTS, COMPOSITIONS AND
METHODS FOR THEIR
PRODUCTION AND USE

]22[
]31[
]51[
]62[
]71[
]87[
]74[

10.02.1998
08/799054
]32[ 10.02.1997
]33[ US
Int. Cl.(2010.01) A61K 38//17, C07K 14//47, 14//475, C12N 15//12
DIVISION FROM 130827
GENENTECH, INC., U.S.A.
WO/1998/035036
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬

]57[

A nucleic acid molecule encoding a heregulin variant having an amino acid sequence
not found in nature and the ability to bind an ErbB receptor, wherein said variant
comprisses a methionine residue in place of amino acid residues corresponding to
residue numbers 228 to 231 of native human heregulin-beta 1 (SEQ ID NO: 93)
numbered from the N-terminus and said heregulin variant comprises a portion that is at
least 70% identical to the portion from about residue 175 to about residue 230 of
native human heregulin-beta 1 (SEQ ID NO: 93), said heregulin variany having a
greater specificity for the ErbB4 receptor, relative to the ErbB3 receptor, than a
heregulin that differs from the heregulin variant only in that the heregulin comprises
said amino acid residues corresponding to residue numbers 228 to 231 in place of said
methionine.

__________________
]11[]21[
]54[

DERIVATIVES OF N[HETEROARYL (PIPERIDINE-2YL) METHYL] BENZAMIDE AND
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM

]22[

15.10.2004

229

174941
–2–‫–[הטרואריל(פפרידינ‬N ‫תולדות של‬
‫איל)מתיל] בנזאמיד ותכשירים רוקחיים‬
‫המכילים אותן‬

December 29, 2011-‫ג' בטבת התשע"ב‬

]31[
]51[
]71[
]87[
]74[

]57[

0312142
]32[ 17.10.2003
Int. Cl.(2010.01) C07D 41/7/06
SANOFI, FRANCE
WO/2005/037781
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122

]33[

FR

,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
The invention relates to compounds having general formula (I), wherein: R1 represents
H or an alkyl, cycloalkyl, cycloalkylalkyl, phenylalkyl, alkenyl, alkynyl group; R 2
represents a pyridinyl, furanyl, thienyl, thiazolyl or oxazolyl group, said group being
optionally substituted; and R3 represents H, one or more substituents selected from
among the halogen atoms and the trifluoromethyl, alkyl, cycloalkyl, alkoxy, phenyl,
cyano, acetyl, benzoyl, thioalkyl, alkylsulfonyl, carboxy or alcoxycarbonyl groups, or
a group having general formula NR4R5 or SO2NR4R5 or CONR4R5 in which R4 and R5
each represent H or an alkyl group or, together with the nitrogen atom bearing same,
form a pyrrolidine, piperidine or morpholine ring, said compound taking the form of a
base, an acid addition salt, a hydrate or a solvate. The invention also relates to the use
of the compound in therapeutics.

__________________
]11[]21[
]54[

POWDER INHALER

]22[
]31[
]51[
]71[

05.11.2004
10352277.8
]32[ 08.11.2003
Int. Cl.(2010.01) A61M 15//00
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH,
GERMANY

230

175017
‫משאף לאבקה‬
]33[

DE

December 29, 2011-‫ג' בטבת התשע"ב‬

]87[
]74[

WO/2005/044353
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]57[

The invention relates to an inhaler for the inhalation of powdery medicaments in a
capsule form. Said capsules are inserted, prior to use, into a capsule holder (3)
arranged inside the inhaler (3). After the capsule is inserted into the capsule holder, the
patient can press the actuating element (8) which can be displaced from a resting
position and which co-operates with at least one needle (9) pushed into the capsule
holder. The aim of the invention is to further improve said type of inhalers with respect
to operational comfort. Said aim is achieved by providing an embodiment of an inhaler
wherein the actuating element is embodied as a multifunctional actuating element (8a),
thereby enabling the cover (5) of the lower part (1) to pivot when the closing element
(6) is inserted into a first functional position, and enabling the mouth piece (4), which
is secured to the plate (2), to be removed from the plate in a second functional position
in such a manner that the mouth piece can be pivoted away from the lower part.

The applications for division
from this application have
not yet been published

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

5024224

‫בקשות חלוקה מבקשה זו‬
9‫שטרם פורסמו‬

__________________
]11[]21[
]54[

231

ANTAGONIST ANTI-CD40
MONOCLONAL ANTIBODY, AN
ISOLATED NUCLEIC ACID
ENCODING THE ANTIBODY, A
HYBRIDOMA CELL LINE
CAPABLE OF PRODUCING THE
ANTIBODY, USE OF THE

175225
‫ חומצת‬,CD40–‫נוגדן חד שבטי אנטגוניסט אנטי‬
‫ שורת תאי היברידומה‬,‫גרעין המקודדת לנוגדן‬
‫ שימושים בנוגדן‬,‫המסוגלת לייצר את הנוגדן‬
.‫ותכשירים רוקחיים המכילים אותו‬

December 29, 2011-‫ג' בטבת התשע"ב‬

ANTIBODY AND
PHARMACEUTICAL
COMPOSITIONS COMPRISING IT
]22[
]31[
]51[
]71[
]87[
]74[

]57[

04.11.2004
60/517337
]32[ 04.11.2003
]33[ US
60/525579
26.11.2003
US
60/565710
27.04.2004
US
Int. Cl.(2010.01) A61K 39//395, A61P 29//00, 35//02, 37//00, C07K 16//28, C12N
15//13
NOVARTIS VACCINES AND
DIAGNOSTICS, INC., U.S.A.
WO/2005/044854
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
Methods of therapy for treating diseases mediated by stimulation of CD40 signaling on
CD40-expressing cells are provided. The methods comprise administering a
therapeutically effective amount of an antagonist anti-CD40 antibody or antigenbinding fragment thereof to a patient in need thereof. The antagonist anti-CD40
antibody or antigen-binding fragment thereof is free of significant agonist activity, but
exhibits antagonist activity when the antibody binds a CD40 antigen on a human
CD40-expressing cell. Antagonist activity of the anti-CD40 antibody or antigenbinding fragment thereof beneficially inhibits proliferation and/or differentiation of
human CD40expressing cells, such as B cells.

__________________
]11[]21[

175521

]54[

PROCESS FOR THE
CULTIVATION OF
MICROORGANISMS OF THE
GENUS THRAUSTOCHYTRIALES

]22[
]31[
]51[
]71[

10.11.2004
10352837.7
]32[ 10.11.2003
]33[
Int. Cl.(2010.01) C12N 01//14, C12P 07//64
NUTRINOVA NUTRITION
SPECIALTIES & FOOD
INGREDIENTS GMBH, GERMANY
WO/2005/045050

]87[
232

‫תהליך לטיפוח מיקרואורגניזמים ממין‬
‫טראוסטוכיטריאלי‬

DE

December 29, 2011-‫ג' בטבת התשע"ב‬

]74[

]57[

PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The invention relates to an optimized method for the production of PUFAs by
cultivating microorganisms of the order thraustochytriales in a fermentation medium
that is pH-stabilized using calcium carbonate and comprises 3 to 15 g/L of CaCO 3,
whereupon the PUFAs are isolated from the microorganisms and/or the medium. The
invention particularly relates to novel optimized media having a different CaCO3
content. By using adequate quantities of CaCO3, the process can be significantly
simplified during fermentation while greater quantities of DHA can be obtained at an
increased oil content in the biomass, allowing thraustochytriales microorganisms to be
fermented without controlling the pH, thereby substantially improving and
significantly simplifying PUFA production.

__________________
]11[]21[

175572

]54[

CONDENSED HETEROCYCLES,
JAK SELECTIVE KINASE
INHIBITORS AND
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM

]22[
]31[
]51[
]71[

12.01.2005
2004900103
]32[ 12.01.2004
]33[ AU
Int. Cl.(2010.01) A61K 31//497, C07D 40/3/04, 41/3/14
YM BIOSCIENCES AUSTRALIA
PTY LTD., AUSTRALIA
WO/2005/066156
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A compound of the general formula (I) or pharmaceutically acceptable prodrugs, salts,
hydrates, solvates, crystal forms or diastereomers thereof, wherein A represents a
variety of six membered nitrogen containing heterocyclic rings, Q is a bond, halogen,
C1-4 alkyl, O, S, SO2, CO or CS and X1, X2, X3 and X4 are optionally substituted by 9
specific substituents or one can be nitrogen. Compositions comprising a carrier and at
least one compound of formula (I) are also provided. Further provided are methods of
treating tyrosine kinase-associated disease states by administering a compound of

]87[
]74[

]57[

233

‫ קינאז‬JAK ‫ מעכבי‬,‫הטרוציקלים דחוסים‬
‫סלקטיביים ותכשירים רפואיים המכילים אותם‬

December 29, 2011-‫ג' בטבת התשע"ב‬

formula (I) and methods of suppressing the immune system of a subject by
administering a compound of formula (I).

__________________
]11[]21[

175722
‫תהליך והתקן לייצור פרורים ואבקת גומי‬

]54[

PROCESS AND APPARATUS FOR
MANUFACTURING CRUMB AND
POWDER RUBBER

]22[
]31[
]51[
]71[

16.11.2004
10/714782
]32[ 17.11.2003
]33[ US
Int. Cl.(2010.01) B02C 19//18, B09B 05//00, B29B 17//04, C08J 11//04
LEHIGH TECHNOLOGIES, LLC,
U.S.A.
WO/2005/049656
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
A process and apparatus for manufacturing crumb and powder rubber. The process and
apparatus include a cooling step (12), effectuated by cooling means, wherein the
temperature or cryogenically cooled preprocessed rubber particles is controlled. The
process and apparatus also include a grinding step (20), effectuated by grinding means,
in which degree of grinding, and thus the product particle size range, is controlled.

]87[
]74[
]57[

__________________
]11[]21[
]54[
234

PROCESS FOR THE PURIFICATION

175765
‫תהליך לטיהור של גאבאפנטין‬
December 29, 2011-‫ג' בטבת התשע"ב‬

OF GABAPENTIN
]22[
]31[
]51[
]71[
]87[
]74[

14.12.2004
MI2003A002456 ]32[ 16.12.2003
Int. Cl.(2010.01) C07C 22/7/40, 22/9/28
ZAMBON GROUP S.P.A., ITALY
WO/2005/058797
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]57[

A process for the preparation of gabapentin comprising the passage of a salt of the
same through a ionic exchange resin of strong cationic type, the elution of the
gabapentin which has fixed onto the column and the crystallization from organic
solvent, characterized in that the resin is regenerated by using a mineral acid in a molar
quantity between 50 and 90%, is described.

]33[

IT

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

__________________
]11[]21[

175936
‫פולימרים מבוססים על סילוקסן או מרוכבים‬
‫לשימוש בחיישנים כימיים לגלות תרכובות‬
‫ניטראט‬

]54[

SILOXANE-BASED POLYMERS
OR COMPOSITES FOR USE IN
CHEMICAL SENSORS FOR
DETECTING NITRATE
COMPOUNDS

]22[
]31[
]51[
]71[

03.12.2004
0350984
]32[ 05.12.2003
]33[
Int. Cl.(2010.01) C08L 83//16, G01N 21//00
COMMISSARIAT A L'ENERGIE
ATOMIQUE, FRANCE
WO/2005/057198
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122

]87[
]74[

]57[

235

FR

,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
The invention relates to the use of at least one type of a polymer comprising a
repetitive structural unit of formula (I), wherein X and Y = a simple link or a linear C 1C50 group; R1 and R2 = H, CN, C(Z)3, CH(Z)2, CH2Z with Z = halogens; NH2, NHR3,
NR3R4 with R3, R4 = halogens, CH3 or a linear or branched, saturated or unsaturated
C2-C20 hydrocarbon chain, possibly comprising one or several heteroatoms and/or
chemical functions containing at least one heteroatom; at least one R1 and R2 different
December 29, 2011-‫ג' בטבת התשע"ב‬

from H; or a compound which comprises said polymer and one or several conductive
charges and is used as a sensitive material in a sensor for detecting nitrate compounds.
Said invention can be used for detecting explosive materials, controlling/monitoring
air pollution and the quality of environment and for monitoring industrial sites.

__________________
]11[]21[

176147
‫מתודולוגיה סינטתית לאלקילציה חיזורית‬
‫ של אינדולים‬C–3 ‫בעמדה‬

]54[

SYNTHETIC METHODOLOGY
FOR THE REDUCTIVE
ALKYLATION AT THE C-3
POSITION OF INDOLES

]22[
]31[
]51[
]71[
]87[
]74[

15.12.2004
60/529797
]32[ 16.12.2003
]33[
Int. Cl.(2010.01) C07B 37//04, C07D 20/9/18
WYETH LLC, U.S.A.
WO/2005/058820
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]57[

A process for the reductive alkylation at the C-3 position of an indole compound in
which the indole is treated with an aldehyde in the presence of a Lewis acid and a
silicon hydride reducing agent. The process is useful for alkylating the C-3 position of
indoles that contain acid-sensitive substituents at the N-1 position.

US

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

__________________

236

December 29, 2011-‫ג' בטבת התשע"ב‬

]11[]21[

176649
‫שתלים פולימרים המכילים בעדיפות תערובת‬
‫ לשחרור מבוקר של חומר‬PLG –‫ ו‬PEG ‫של‬
GNRH ‫ עדיף‬,‫פעיל‬

]54[

POLYMERIC IMPLANTS,
PREFERABLY CONTAINING A
MIXTURE OF PEG AND PLG, FOR
CONTROLLED RELEASE OF
ACTIVE AGENTS, PREFERABLY
A GNRH

]22[
]31[

23.12.2004
60/533301
]32[ 30.12.2003
]33[ US
60/563377
19.04.2004
US
60/575199
28.05.2004
US
Int. Cl.(2010.01) A61K 09//00, 09//16, 09//20, 38//24
DURECT CORPORATION, U.S.A.
JOHN W. GIBSON, ARTHUR J.
TIPTON
WO/2005/067889
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
124 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11490 .‫ד‬.‫ ת‬,
TEL AVIV 62038
Polymeric devices for controlled release of an active agent of interest are provided.
The active agent is provided within a biodegradable polymer system to supply a
polymeric device for controlled release of the active agent. The polymer system is a
copolymer or a polymer blend comprising a hydrophobic component and a hydrophilic
component, and the polymer system does not form a hydrogel when contacted with, or
immersed in an aqueous system, for example when the device is implanted in a
subject. When the device is administered to a subject, for example, when it is
implanted, the device releases the active agent in a controlled fashion without a lag
period, or with a minimal lag period. Methods for producing the polymeric devices are
also provided, as are methods of using the polymeric devices to provide for controlled
release of an active agent in a subject. Preferred hydrophobic component is a PLG.
Preferred hydrophilic Components are a PEG or a methoxyPEG. Preferred peptides are
LHRH, goserelin, leuprolide.

]51[
]71[
]72[
]87[
]74[

]57[

__________________
]11[]21[
]54[

237

MULTI-STAGE INK JET DIGITAL
PRINTING APPARATUS,
METHOD AND SYSTEM

177323
‫ בטכנולוגית‬,‫ רב שלבית‬,‫מכונת דפוס דיגיטאלית‬
‫הזרקת דיו – מערכת ושיטת הדפסה‬
December 29, 2011-‫ג' בטבת התשע"ב‬

]22[
]31[
]51[
]71[
]72[
]87[
]74[

]57[

10.02.2005
10/776163
]32[ 12.02.2004
]33[ US
162231
30.05.2004
IL
Int. Cl.(2010.01) B41J 02//135, 15//04, 33//34, D06B 01//00
KORNIT DIGITAL TECHNOLOGIES
-‫ ראש‬,‫קורנית דיגיטל טכנולוגיות בע"מ‬
LTD.
‫העין‬
OFER BEN-ZUR, YOSSI PEARL
‫ יוסי פרל‬,‫צור‬-‫עופר בן‬
WO/2005/076730
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬1995( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
A digital printing machine includes a rigid frame, a first linear motion X axis stage
mounted on the frame, a printing table assembly movable on each linear X axis stage,
a linear motion Y axis stage mounted on the frame perpendicular to the linear X axis
stages, above the printing table assemblies, and an array of inkjet nozzles mounted on
the linear Y axis stage for linear motion perpendicular to the X axis stage, also a
second linear motion X axis stage mounted on the frame parallel to the first axis stage
and arranged for operation independently of the first axis stage, and/or a curing unit
located above the printing table assembly and/or a pre-printing wetting assembly, for
printing over garments, by applying wetting composition on the printed material, prior
to printing.

__________________
]11[]21[
]54[

COMPOSITION COMPRISING
PROLIFERATING PRIMATE
PLURIPOTENT STEM CELLS

]22[
]31[

10.01.2001
60/175581
]32[ 11.01.2000
60/213740
22.06.2000
60/213739
22.06.2000
60/216387
07.07.2000
60/220064
21.07.2000
09/688031
10.10.2000
Int. Cl.(2010.01) C12N 05//0789
DIVISION FROM 141742
GERON CORPORATION, U.S.A.

]51[
]62[
]71[
238

177324
‫תכשיר המכיל תאי גזע רב עוצמתיים מתרבים‬
‫של יונק עליון‬

]33[

US
US
US
US
US
US

December 29, 2011-‫ג' בטבת התשע"ב‬

]87[
]74[

]57[

WO/2001/051616
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122

,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A composition comprising proliferating primate pluripotent stem cells which is
essentially free of feeder cells and further comprises a soluble preparation from
Engelbreth-Holm-Swarm tumor cells.

__________________
]11[]21[

177414
‫שיטה לייצור ציפוי קשה בעל עמידות גבוהה‬
‫לקורזיה על פריטים המיוצרים ממתכות או‬
‫סגסוגות הניתנות לאינוד‬

]54[

METHOD FOR PRODUCING A
HARD COATING WITH HIGH
CORROSION RESISTANCE ON
ARTICLES MADE OF
ANODIZABLE METALS OR
ALLOYS

]22[
]31[
]51[
]71[

05.07.2005
10/898152
]32[ 23.07.2004
]33[ US
Int. Cl.(2010.01) C25D 11//02
ALONIM HOLDINGS
‫ קיבוץ‬,‫אלונים אחזקות אגש"ח בע"מ‬
AGRICULTURAL COOPERATIVE
‫אלונים‬
SOCIETY LTD.
ILYA OSTROVSKY
‫איליה אוסטרובסקי‬
WO/2006/007972
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
‫ רחוב ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
7
7 JABOTINSKY ST.,
‫ גן‬-‫רמת‬
RAMAT GAN 52520
A method for coating, a composition suitable for coating and a coating generated with
the method of coating on anodizable metallic surfaces, especially on magnesium rich
and aluminum rich surfaces, is disclosed. The composition is an aqueous solution
including alkali metal or ammonium cations, phosphorus containing anions and silicon
containing anions as well as optionally a peroxide or a compound of Al, Ti, Zr or any
mixture of them. Preferably, the anodizing is carried out with a micro-arc oxidation
process.

]72[
]87[
]74[

]57[

__________________
239

December 29, 2011-‫ג' בטבת התשע"ב‬

]11[]21[

177561
‫–אמינוכוהולים‬3 ‫–מותמר‬1 ‫תהליך להכנת‬
‫טהורים מבחינה איננטומרית‬

]54[

PROCESS FOR THE
PREPARATION OF
ENANTIOMERICALLY PURE 1SUBSTITUTED-3AMINOALCOHOLS

]22[
]31[

21.02.2005
04003809.3
]32[ 19.02.2004
]33[ EP
04010043.0
28.04.2004
EP
Int. Cl.(2010.01) C07C 21/3/00, C07D 33/3/20, 33/3/22
LONZA LTD., SWITZERLAND
WO/2005/080370
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122

]51[
]71[
]87[
]74[

]57[

,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
Provided is a process for the preparation of enantiomerically pure 1-substituted-3aminoalcohols, particularly of (S)-(-)- and (R)-(+)-3-N-methylamino-l-(2-thienyl)-1propanol, by asymmetrically hydrogenating salts of a carboxylic acids with an
aminoketone of formula (II), wherein R1 is selected from the group consisting of 2thienyl, 2-furanyl and phenyl, each optionally substituted with one or more halogen
atoms and/or one or more C1-4-alkoxy groups, and wherein R2 is C1-4-alkyl or phenyl,
each optionally substituted with one or more halogen atoms and/or one or more C 1-4alkyl or C1-4-alkoxy groups, and wherein the corresponding aminoalcohols are
obtained by subsequent hydrolysis of their salts. Furthermore provided are salts of a
carboxylic acid with said aminoketones and the aminoalcohols obtained by
asymmetriacally hydrogenating said aminoketones, respectively.

__________________
]11[]21[
]54[
240

METHODS FOR PROTECTING
PLANTS USING ABAMECTIN AND

177563
‫שיטות להגנה על צמחים על ידי שימוש‬
‫באבאמקטין ותיאמטוקסאם‬
December 29, 2011-‫ג' בטבת התשע"ב‬

THIAMETHOXAM
]22[
]31[
]51[
]71[
]87[
]74[

]57[

07.06.2004
60/553516
]32[ 16.03.2004
]33[ US
Int. Cl.(2010.01) A01N 25//00, 43//00, 51//00
SYNGENTA PARTICIPATIONS AG,
SWITZERLAND
WO/2005/094585
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The present invention provides an at least binary composition for controlling
nematodes and insects or representatives of the order Acarina, which composition
comprises: (A) a nernaticidally effective amount of at least one macrolide, and (B) an
insecticidally effective amount of at least one insecticide selected from the
neonicotinoids.

__________________
]11[]21[

177591
‫שיטה לאיבחון סרטן השחלות על ידי השימוש‬
‫בביומרקרים‬

]54[

METHOD FOR DIAGNOSIS OF
OVARIAN CANCER COMPRISING
BIOMARKERS

]22[
]31[

18.01.2005
60/545581
]32[ 19.02.2004
]33[ US
60/545900
20.02.2004
US
Int. Cl.(2010.01) C12Q 01//68, G01N 33//48, 33//574
YALE UNIVERSITY, U.S.A.
WO/2005/083440
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122

]51[
]71[
]87[
]74[

]57[

241

,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
The claimed invention describes methods to diagnose or aid in the diagnosis of cancer.
The claimed methods are based on the identification of biomarkers which are
particularly well suited to discriminate between cancer subjects and healthy subjects.
These biomarkers were identified using a unique and novel screening method
described herein. The biomarkers identified herein can also be used in the prognosis
and monitoring of cancer. The invention comprises the use of leptin, prolactin, OPN
and IGF-II for diagnosing, prognosis and monitoring of ovarian cancer.
December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

177761
–‫גרגרי עמילן המכילים שמן לאספקת תוספי‬
‫תועלת למצע‬

]54[

OIL CONTAINING STARCH
GRANULES FOR DELIVERING
BENEFIT-ADDITIVES TO A
SUBSTRATE

]22[
]31[
]51[
]71[

17.03.2005
10/803586
]32[ 18.03.2004
]33[ US
Int. Cl.(2010.01) C11D 03//50
COLGATE-PALMOLIVE
COMPANY, U.S.A.
WO/2005/090538
SELIGSOHN GABRIELI & CO.,
,'‫זליגסון גבריאלי ושות‬
31 YAVNE ST.,
31 ‫רח' יבנה‬
P.O.B. 1426,
‫תל אביב‬1426 .‫ד‬.‫ ת‬,
TEL AVIV 61013
An oil containing starch granule is provided comprising: (a) a starch to form an
effective matrix for said granule; (b) a perfume oil comprising ingredients having a
calculated Clog P of at least 3, said Clog P being the calculated octanol to water
partition coefficient, said perfume oil being capable of providing a benefit-additive to a
substrate upon contact therewith, said substrate being selected from the group
consisting of fabrics, hard surfaces, hair and skin; and (c) an effective amount of a
defined organic compound for inhibiting the migration of said oil to the surface of said
starch granule.

]87[
]74[

]57[

__________________
242

December 29, 2011-‫ג' בטבת התשע"ב‬

]11[]21[

177778
‫–הידרוקסי‬4 ‫תכשירים יציבים כימית של‬
‫טאמוקסיפן‬

]54[

CHEMICALLY STABLE
COMPOSITIONS OF 4-HYDROXY
TAMOXIFEN

]22[
]31[

18.03.2005
04290762.6
]32[ 22.03.2004
]33[ EP
10/805530
22.03.2004
US
Int. Cl.(2010.01) A61K 31//138, A61P 35//00, C07C 21/7/64
LABORATOIRES BESINS
INTERNATIONAL, FRANCE
WO/2005/092310
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬

]51[
]71[
]87[
]74[

]57[

A class of chemically stable 4-hydroxy tamoxifen compositions is characterized by
roughly equal amounts of the Z-4-hydroxy tamoxifen and E-4-hydroxy tamoxifen
isomers, such that the potency of the compositions is not affected adversely by the
isomerization that occurs between these two forms. The inventive compositions are
useful for preventing or for treating medical conditions.

5023675

The applications for division
from this application have
not yet been published

‫בקשות חלוקה מבקשה זו‬
9‫שטרם פורסמו‬

__________________
]11[]21[
]54[

COMBINED PERIPHERAL AND
CENTRAL REWINDING MACHINE

]22[
]31[
]51[
]71[
]87[
]74[

15.03.2005
FI2004A000061 ]32[ 18.03.2004
Int. Cl.(2010.01) B65H 19//30
FABIO PERINI S.P.A., ITALY
WO/2005/087639
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,

243

177886
‫מכונת גלילה הקפית ומרכזית משולבת‬

]33[

IT

,‫פרל כהן צדק לצר‬
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
December 29, 2011-‫ג' בטבת התשע"ב‬

]57[

HERZLIYA 46733
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
The rewinding machine comprises: a first winding roller (11) and a second winding
roller (13) defining a nip (15) through which said cores are inserted and through which
said web material (N) is fed; and at least one pair of motorized engaging members
(57), to engage the ends of a winding core and transmit a rotational movement to the
core during at least part of the winding cycle of each log. The engaging members and
the first and second winding roller are produced and disposed so that the log being
formed is in contact with said first and said second winding roller. Moreover, a third
winding roller (17) is provided, defining a winding space with said first and said
second winding roller, said third winding roller being movable to allow increase and
completion of winding of each log in said winding space.

__________________
]11[]21[

178002
‫שימוש בכמות אפקטיבית של חומר בהכנת‬
,TH2 ‫תרופות לטיפול בהפרעה המתווכת על ידי‬
‫ או לטיפול‬TH1 ‫לקידום תגובה חיסונית של‬
‫באאוזינופיליה‬

]54[

USE OF A THERAPEUTICALLY
EFFECTIVE AMOUNT OF AN
AGENT IN THE PREPARATION
OF MEDICAMENTS FOR
TREATING A TH2-MEDIATED
DISORDER, PROMOTING A TH1
IMMUNE RESPONSE OR
TREATING EOSINOPHILIA

]22[
]31[

14.03.2005
60/552523
]32[ 12.03.2004
]33[ US
60/622559
27.10.2004
US
Int. Cl.(2010.01) A61K 38//17, A61P 01//00, 07//00, 11//00, 13//12, 35//00, 37//00,
C07K 14//705
THE BRIGHAM AND WOMEN'S

]51[
]71[
244

December 29, 2011-‫ג' בטבת התשע"ב‬

]87[
]74[

]57[

HOSPITAL, INC., U.S.A.
BETH ISRAEL DEACONESS
MEDICAL CENTER, U.S.A.
WO/2005/090573
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The invention relates to methods of modulating immune responses in a subject, such as
by administering to the subject agents which modulate tim-1, tim-2 or tim-4 activity,
or which modulate the physical interaction between tim-1 and tim-4 or between tim-2
and a tim-2 ligand. Immune responses include, but are not limited to, autoimmune
disorders, transplantation tolerance, and Thl and Th2-mediated responses and
disorders. The invention also relates to novel assays for identifying agents which
modulate the physical interaction between tim-1 and tim-4. In addition, the invention
relates to novel soluble tim-4 polypeptides and to nucleic acids which encode them.

__________________
]11[]21[
]54[

PERSONALIZED MULTIMEDIA
MESSAGING SYSTEM

]22[
]51[
]71[
]87[
]74[

23.03.2004
Int. Cl.(2010.01) H04L 12//58
NDS LIMITED, UNITED KINGDOM
WO/2005/091537
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122

]57[

245

178041
‫מערכת אישית להעברת הודעות מולטימדיה‬

,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A method for providing a personalized multimedia messaging service, wherein the
method includes obtaining an MMS message (800). Recipient according to
preferences of the at least one targeted recipient (900), thereby producing a
personalized MMS message (910), and transmitting the personalized MMS message to
the at least one targeted recipient indicate (1000) that the at least one targeted recipient
is not interested in receiving the personalized MMS message.

December 29, 2011-‫ג' בטבת התשע"ב‬

The applications for
division from this
application have not yet
been published

50222245022223

‫בקשות חלוקה מבקשה זו‬
9‫שטרם פורסמו‬

__________________
]11[]21[
]54[

SYSTEM AND METHOD FOR
DYNAMICALLY GENERATING A
SELECTABLE SEARCH
EXTENSION

]22[
]31[

30.07.2004
60/566947
]32[ 03.05.2004
10/887085
09.07.2004
Int. Cl.(2010.01) G06F 03//00, 17//30
MICROSOFT CORPORATION,
U.S.A.
WO/2005/111868
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]51[
]71[
]87[
]74[

]57[

246

178202
‫מערכת ושיטה ליצור דינאמי של שלוחת חיפוש‬
‫נבחרת‬

]33[

US
US

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

A system and related techniques accept user-inputted search terms to perform a search
for files within a file system hierarchy. A user searches a current level of a file system
(120) by entering a search term in a search term input box (112) of a user interface
(104). A search box (114) is dynamically created and may present an extension of the
search to a different level (122) in the file system in an attempt to locate more or
further matching files or hits. The extension of the search may be automatically
generated when an initial search fails to produce any results. When the user does select
the selectable search box, the user's search may be seamlessly extended to other files,
folders, trees or other points or levels in the files system. Search results may be
continuously or dynamically updated as the user enters more characters or other data.

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[
]54[

3- OR 4-MONOSUBSTITUTED
PHENOL AND THIOPHENOL
DERIVATIVES USEFUL AS H3
LIGANDS

]22[
]31[

19.04.2005
04291187.5
]32[ 07.05.2004
0504564.6
04.03.2005
Int. Cl.(2010.01) C07D 30/9/06
WARNER-LAMBERT COMPANY
LLC., U.S.A.
WO/2005/108384
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]51[
]71[
]87[
]74[

]57[

247

178433
‫תולדות פנול או תיאופנול חד–מותמרים בעמדה‬
H3 ‫ היעילות כליגנדים של‬4 ‫ או‬3

]33[

EP
GB

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

The invention relates to 3- or 4-monosubstituted phenol and thiophenol derivatives of
formula (1) and to processes for the preparation of, intermediates used in the
preparation of, compositions containing and the uses of, such derivatives. Said 3- or 4monosubstituted phenol and thiophenol derivatives are H3 ligands and are useful in
numerous diseases, disorders and conditions, in particular inflammatory, allergic and
respiratory diseases, disorders and conditions.

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

178446
‫בחירת ורכישת מערכת למתקן אלחוטי‬

]54[

SYSTEM SELECTION AND
ACQUISITION FOR A WIRELESS
DEVICE

]22[
]31[

09.03.2005
60/561019
]32[ 09.04.2004
]33[ US
11/043359
25.01.2005
US
Int. Cl.(2010.01) H04M 03//00, H04W 48//18, 88//06
QUALCOMM INCORPORATED,
U.S.A.
WO/2005/104513
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122

]51[
]71[
]87[
]74[

]57[

248

,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
Wireless devices with different capabilities may use a single file containing multiple
(e.g., two) PRLs for system selection and acquisition. A first PRL in the file has a first
(e.g., IS-683-A) format and includes PRL information for, e.g., 1x systems. A second
PRL has a second (e.g., IS-683-C) format and includes PRL information for, e.g., 1x
and 1xEV-DO systems or just 1xEV-DO systems. A legacy wireless device supporting
only IS-683-A would read and use the first PRL for system selection and acquisition
and ignore the second PRL. A wireless device supporting IS-683-C would read the
second PRL and (1) use the second PRL by itself if it contains PRL information for
both 1x and 1xEV-DO systems or (2) combine the first and second PRLs to generate a
combined PRL if the second PRL contains PRL information for only 1xEV-DO
systems.

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

178515
‫אוליגופפטידים להפחתת ריכוז גבוה של אוריאה‬
‫בדם‬

]54[

OLIGOPEPTIDES FOR
REDUCING ELEVATED BLOOD
UREA CONCENTRATION

]22[
]31[
]51[
]71[

08.04.2005
10/821256
]32[ 08.04.2004
]33[ US
Int. Cl.(2010.01) A61K 38//06, 38//07
BIOTEMPT, B.V., THE
NETHERLANDS
WO/2005/097163
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The invention includes a method of reducing urea concentration in a subject's serum.
Such a method comprises administering to the subject (e.g., a mammal such as a
human) a composition comprising an oligopeptide (or oligopeptides) having activity in
reducing urea concentration in the subject's serum as determined by a mouse renal
reperfusion test, wherein the oligopeptide comprises the sequence QGV or MTRV
(SEQ ID NO:1) (e.g., AQGV (SEQ ID NO:2) or MTRV (SEQ ID NO:1)).

]87[
]74[

]57[

__________________
]11[]21[

178694
‫שיטה ומערכת לדחיסת תיקים לאחסון ופעילות‬
‫על תיקים דחוסים‬

]54[

METHOD AND SYSTEM FOR
COMPRESSION OF FILES FOR
STORAGE AND OPERATION ON
COMPRESSED FILES

]22[
]31[
]51[
]71[
]87[
]74[

21.04.2005
60/565298
]32[ 26.04.2004
]33[ US
Int. Cl.(2010.01) G06F 05//10, 17//30, H03M 07//30
STOREWIZ INC., U.S.A.
WO/2005/103878
SUZANNE EREZ, IBM R&D
,R&D ‫ מעבדות יבמ‬,‫סוזן ארז‬
LABORATORIES,
December 29, 2011-‫ג' בטבת התשע"ב‬

249

]57[

HAIFA UNIVERSITY,
‫ הר הכרמל‬,‫אוניברסיטת חיפה‬
HAIFA 31905
‫חיפה‬
A method and system for creating, reading and writing compressed files (44) for use
with a file access storage. The compressed data of a raw file (41) are packed into
plurality of compressed units (46) and stored as compressed file (44). One or more
corresponding compressed units (46A) may be read and/or updated with no need of
restoring the entire file whilst maintaining de-fragmented structure of the compressed
file (44).

__________________
]11[]21[

179003
‫שיטה ומערכת לאיחסון זהויות ארעיות של‬
WLAN–I

]54[

METHOD OF AND SYSTEM FOR
STORAGE OF I-WLAN
TEMPORARY IDENTITIES

]22[
]31[

04.05.2005
60/568625
]32[ 06.05.2004
]33[ US
11/080918
15.03.2005
US
Int. Cl.(2010.01) H04L 09//32, 12//28, 29//06
TELEFONAKTIEBOLAGET L M
ERICSSON (PUBL), SWEDEN
WO/2005/109818
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
A temporary-identity-storage method for user equipment includes receiving
authentication challenge information and at least one temporary identity, processing
the authentication challenge information, and determining whether the processing step
results in successful authentication. The user equipment includes mobile equipment
and a subscriber identity module. Responsive to a determination that the authentication
was successful, the received at least one temporary identity is considered to be valid. If
the received at least one temporary identity is at least one pseudonym and an
appropriate data file to the store the at least one pseudonym is available in the
subscriber identity module, the at least one pseudonym is stored and any previously-

]51[
]71[
]87[
]74[
]57[

250

December 29, 2011-‫ג' בטבת התשע"ב‬

stored pseudonym is over-written in the subscriber identity module. If the received at
least one temporary identity is at least one pseudonym and an appropriate data file to
the store the at least one pseudonym is not available in the subscriber identity module,
the at least one pseudonym is stored and any previously-stored pseudonym is overwritten in the mobile equipment.

__________________
]11[]21[
]54[

ANTI-THEILERIOSIS VACCINE

]22[
]31[

12.05.2005
880/DEL/2004
]32[ 14.05.2004
DEL/2004/2103
26.10.2004
Int. Cl.(2010.01) A61K 39//002, 39//018
NATIONAL RESEARCH
DEVELOPMENT CORPORATION,
INDIA
WO/2005/109991
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]51[
]71[
]87[
]74[

]57[

251

179254
‫חיסון אנטי–תילריוסיס‬
]33[

IN
IN

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

A process for the preparation of anti-theileriosis vaccine comprising the steps of
isolating lymphoid cells infected with schizonts of Theileria annulata present in an
infected animal, culturing the infected cells in a growth medium, subjecting said
cultured cells to the step of in-vitro propagation by-serial passaging, developing cloned
curltures from a single cell by limiting dilution technique and further passaging these,
karyotyping the cells in the medium to ascertain the diploid character, and obtaining
viable cells with maximum infectivity rates, determining macroschizont nuclear
number, subjecting a number of viable cells with diploid character to the step of
cryoprotectant in liquid nitrogen in the presence of a cryoprotectant in the said growth
medium to obtain a suspension of viable cells, testing these cultures at different
passages and in varying dose levels in groups of calves for ascertaining their
December 29, 2011-‫ג' בטבת התשע"ב‬

pathogencity / antigenicity, determining passage level and dose for the safety and
efficacy of candidate vaccine, its safe use in new born calves and pregnant cows, time
taken to induce immunity, serological responses and erect on haematological
parameters, and testing its efficacy under wide field conditions in the susceptible stock.

__________________
]11[]21[

179370
‫ תכשירים‬,‫ תהליך לייצורן‬,‫נגזרות נפתלן‬
‫ ושימושן בהכנת‬,‫רפואיים המכילים אותן‬
‫תרופות‬

]54[

NAPHTHALENE DERIVATIVES,
PROCESS FOR THEIR
PREPARATION,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND USE THEREOF IN
THE PREPARATION OF
MEDICAMENTS

]22[
]31[
]51[

24.05.2005
04102460.5
]32[ 02.06.2004
]33[ EP
Int. Cl.(2010.01) A61K 31//445, 31//47, 31//5375, 31//541, 31//546, A61P 03//04,
C07D 21/1/44, 29/5/08, 40/1/12, 41/1/12, 41/3/12, 41/7/12
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND
WO/2005/117865
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The present invention relates to compounds of formula (I) wherein A, R 1 and R2 are as
defined in the description and claims, and pharmaceutically acceptable salts thereof, to
the preparation of such compounds and pharmaceutical compositions containing them.
The compounds are useful for the treatment and/or prevention of diseases which are
associated with the modulation of H3 receptors.

]71[
]87[
]74[

]57[

__________________
252

December 29, 2011-‫ג' בטבת התשע"ב‬

]11[]21[

179699
‫מדידות ביומטריות באמצעות הדמייה‬
‫מולטיספקטרלית‬

]54[

MULTISPECTRAL IMAGING
BIOMETRICS

]22[
]31[

26.05.2005
60/576364
]32[ 01.06.2004
]33[ US
60/600867
11.08.2004
US
60/610802
17.09.2004
US
60/654354
18.02.2005
US
11/115075
25.04.2005
US
11/115100
25.04.2005
US
11/115101
25.04.2005
US
Int. Cl.(2010.01) G06K 09//00
LUMIDIGM, INC., U.S.A.
WO/2006/093508
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
124 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11490 .‫ד‬.‫ ת‬,
TEL AVIV 62038
Methods and systems are provided for performing a biometric measurement on an
individual. A purported skin site of the individual is illuminated under a plurality of
distinct optical conditions during a single illumination session. Light scattered beneath
a surface of the purported skin site is received separately for each of the plurality of
distinct optical conditions. A multispectral image of the purported skin site is derived
from the received light. A biometric function is performed with the derived
multispectral image.

]51[
]71[
]87[
]74[

]57[

__________________
]11[]21[
253

179737
December 29, 2011-‫ג' בטבת התשע"ב‬

‫ תכשירים רפואיים המכילים‬,‫תולדות אינדול‬
‫אותן ושימושן בהכנת תרופות לטיפול או מניעת‬
H3 ‫מחלות הקשורות למודולציה של רצפטורי‬

]54[

INDOLE DERIVATIVES,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND USE THEREOF IN
THE PREPARATION OF
MEDICAMENTS FOR TREATING
OR PREVENTING DISEASES
ASSOCIATED WITH
MODULATION OF H3
RECEPTORS

]22[
]31[
]51[

13.06.2005
04102839.0
]32[ 21.06.2004
]33[ EP
Int. Cl.(2010.01) A61K 31//4439, A61P 03//04, 43//00, C07D 40/1/12, 40/1/14,
40/3/12, 40/3/14, 41/3/14
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND
WO/2005/123716
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The present invention relates to compounds of formula (I) wherein X, R 1, R2, R3, R4
and R5 are as defined in the description and claims, and pharmaceutically acceptable
salts thereof, to the preparation of such compounds and pharmaceutical compositions
containing them. The compounds are useful for the treatment and/or prevention of
diseases which are associated with the modulation of H3 receptors.

]71[
]87[
]74[

]57[

__________________
]11[]21[
]54[

]22[
254

TRANSMISSION OF OVERHEAD
INFORMATION FOR
BROADCAST AND MULTICAST
SERVICES IN A WIRELESS
COMMUNICATION SYSTEM

179802
‫תמסורת תקורה לשירותי שידור נתוני בקרה‬
‫ושירותי שידור מרובב במערכת תקשורת‬
‫אלחוטית‬

03.06.2005
December 29, 2011-‫ג' בטבת התשע"ב‬

]31[
]51[
]71[
]87[
]74[

]57[

60/577083
]32[ 04.06.2004
Int. Cl.(2010.01) H04L 01//00, 05//02
QUALCOMM INCORPORATED,
U.S.A.
WO/2005/122627
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122

]33[

US

,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
To transmit overhead information for broadcast and multicast services in a system that
utilizes multiple radio technologies, time slots used for OFDM in a super-frame are
initially ascertained. Overhead information for multiple streams to be sent in the time
slots used for OFDM is generated. The overhead information conveys the time slots
and the coding and modulation used for the streams and may be given in various
forms. Multiple records may be formed for the overhead information for the streams.
The overhead information for the streams is processed and time division multiplexed
with the data for the streams in the super-frame. Information indicating the time slots
used for OFDM in the super-frame may be sent separately or included in the overhead
information. An indicator may also be appended to each stream to indicate whether
there is any change in the overhead information for the stream in the next super-frame.

__________________
]11[]21[
]54[

APPARATUS AND PROCESS FOR
COOLING AND DE-STEAMING
CALCINED STUCCO

]22[
]31[
]51[
]71[

19.05.2005
10/891964
]32[ 15.07.2004
Int. Cl.(2010.01) F25D 23//12
UNITED STATES GYPSUM
COMPANY, U.S.A.
WO/2006/019456
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]87[
]74[

255

179810
‫התקן ותהליך לקירור והזרמה מחדש של טיח‬
‫קירות שנשרף‬

]33[

US

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
December 29, 2011-‫ג' בטבת התשע"ב‬

]57[

The present invention is an apparatus and process for cooling and de-steaming hot
calcined stucco used in the production of gypsum boards or bagged plaster. The
apparatus is a fluid bed stucco cooler and comprises a cooler housing having a plenum
having a stucco inlet and stucco outlet. The stucco cooler includes a rotating disk in the
plenum. The rotating disk includes nozzle for spraying fluid, and is attached to a
rotable shaft extending from the side of the cooler also includes a fluidization pad and
agitator to help to mix the air and the stucco powder to insure fluidization, prevent
channeling, and prevent the stucco powder from building up on the various
components. The air also forces steam from the hot calcined stucco out through an air
outlet located at the top of the stucco cooler, thereby de-steaming the stucco. The
stucco flows through the plenum and passes over the cooling coils, thereby cooling the
stucco as it reaches the stucco outlet.

__________________
]11[]21[

179893
‫בניות אבני חן שימושי במיוחד ליהלומים‬

]54[

GEMSTONE CONSTRUCTIONS
PARTICULARLY USEFUL FOR
DIAMONDS

]22[
]31[
]51[
]71[
]74[

06.12.2006
179471
]32[ 21.11.2006
]33[ IL
Int. Cl.(2010.01) A44C 17//02
JACKOB TSROR
‫גן‬- ‫ רמת‬,‫יעקב צרור‬
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬1995( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
A gemstone construction comprising: a plurality of individual gemstones assembled
together by a common frame to define a composite gemstone unit having a girdle, a
crown on one side of the girdle and a pavilion on the opposite side of the girdle; each
of said individual gemstones defining a segment of said composite gemstone unit and
December 29, 2011-‫ג' בטבת התשע"ב‬

]57[

256

including a girdle segment of the composite gemstone unit girdle, a crown segment of
the composite gemstone unit crown and a pavilion segment of the composite gemstone
unit pavilion; the girdle and crown segments of at least some of said individual
gemstones having an outer face to serve as the outer face of the composite gemstone
unit girdle and crown; the girdle segment of at least some of said individual gemstones
having at least one flat, smooth, inner face in contact with a corresponding flat,
smooth, inner face of the girdle segment of another individual gemstone in the
composite gemstone unit; said common frame engaging the girdle segments of said
individual gemstones to press the flat, smooth, inner faces of the individual gemstones
into firm contact with each other such that the composite gemstone unit appears
substantially seamless to the naked eye.

__________________
]11[]21[

180004
‫שיטה והתקן לריבוב מוגבר בהעברת אות ללויין‬

]54[

METHOD AND APPARATUS FOR
ENHANCED UPLINK
MULTIPLEXING

]22[
]31[

05.07.2005
60/588960
]32[ 19.07.2004
]33[ US
11/113763
25.04.2005
US
Int. Cl.(2010.01) H04B 07//00, 07//216, H04J 03//02, 03//16, H04W 28//16
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2006/019562
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬

]51[
]71[
]87[
]74[

]57[
257

A method and apparatus for enhanced uplink multiplexing are disclosed. A set of
December 29, 2011-‫ג' בטבת התשע"ב‬

combinations of MAC-d flows (and/or logical channels) that are allowed to be
multiplexed within a MAC-e PDU is defined for a WTRU. The WTRU MAC-e entity
selects a combination among a set of allowed combinations for multiplexing MAC-d
flows for each MAC-e PDU. Certain MAC-d flow combinations may be defined that
can not be blocked from transmission even when the WTRU is in a transmit power
restricted state. The amount of data from each logical channel or corresponding MACd flow that can be multiplexed within a MAC-e PDU may be defined to ensure
guaranteed data rates. When the WTRU is in a restricted power condition, an
indication of the restricted power condition may be passed to the Node-B with the EU
transmission.

The applications for division
from this application have
not yet been published

5024225

‫בקשות חלוקה מבקשה זו‬
9‫שטרם פורסמו‬

__________________
]11[]21[

180213
‫מקבע לקוורץ המשמש לעיבוד נתחי מוליכים‬
‫למחצה ושיטה לייצור של המקבע‬

]54[

QUARTZ GLASS JIG FOR
PROCESSING SEMICONDUCTOR
WAFERS AND METHOD FOR
PRODUCING THE JIG

]22[
]31[
]51[
]71[

30.03.2006
102005017739.5 ]32[ 15.04.2005
]33[ DE
Int. Cl.(2010.01) C03B 19//14, C03C 03//06, H01L 21//00
HERAEUS QUARZGLAS GMBH & CO.
KG, GERMANY
WO/2006/108766
FISHER WEILER JONES,
26 HABARZEL ST.,
RAMAT HACHAYAL 69710

]87[
]74[

]57[
258

,‫פישר וילר ג'ונס‬
26 ‫הברזל‬
‫רמת החייל‬

An ideal quartz glass for a wafer holder for application in an etching environment is
December 29, 2011-‫ג' בטבת התשע"ב‬

characterised both by high purity and also a high dry etching resistance. According to
the invention, such a quartz glass may be achieved, whereby the quartz glass is doped
with nitrogen, at least in a region near the surface, has an average content of metastable
hydroxy groups of less than 30 wt. ppm, the fictive temperature is less than 1250 °C
and the viscosity at a temperature of 1200 °C is at least 1013 dPas. A commercial
method for production of such a quartz glass comprises the following method steps:
fusion of a SiO2 raw material to give a quartz glass blank, whereby the SiO2 raw
material or the quartz glass blank is subjected to a dehydration process, heating of the
SiO2 raw material or the quartz glass blank to a nitriding temperature in the range
between 1050 °C and 1850 °C under an atmosphere containing ammonia, a
temperature treatment, by means of which the quartz glass of the quartz glass blank is
brought to a fictive temperature of 1250 °C or less and a surface treatment of the quartz
glass blank to give the quartz glass holder.

__________________
]11[]21[
]54[

SPOT TEST KIT FOR
EXPLOSIVES DETECTION

]22[
]31[

23.06.2005
60/583161
]32[ 24.06.2004
11/159451
22.06.2005
Int. Cl.(2010.01) G01N 01//02
THE REGENTS OF THE
UNIVERSITY OF CALIFORNIA,
U.S.A.
PHILIP F. PAGORIA, RICHARD E.
WHIPPLE, PETER J. NUNES, JOEL
DEL ECKELS, JOHN G. REYNOLDS,
ROBIN R. MILES, MARINA L.
CHIARAPPA-ZUCCA
WO/2006/093517

]51[
]71[
]72[

]87[
259

180219
‫ערכה לגילוי חומרי נפץ‬

]33[

US
US

December 29, 2011-‫ג' בטבת התשע"ב‬

]74[

]57[

,‫אגמון‬-‫סורוקר‬
14 ‫ רחוב שנקר‬,‫בית נולטון‬
‫הרצליה פיתוח‬
An explosion tester system comprising a body, a lateral flow membrane swab unit
adapted to be removeably connected to the body, a first explosives detecting reagent, a
first reagent holder and dispenser operatively connected to the body, the first reagent
holder and dispenser containing the first explosives detecting reagent and positioned to
deliver the first explosives detecting reagent to the lateral flow membrane swab unit
when the lateral flow membrane swab unit is connected to the body, a second
explosives detecting reagent, and a second reagent holder and dispenser operatively
connected to the body, the second reagent holder and dispenser containing the second
explosives detecting reagent and positioned to deliver the second explosives detecting
reagent to the lateral flow membrane swab unit when the lateral flow membrane swab
unit is connected to the body.
SOROKER-AGMON,
14 SHENKAR ST.,
HERZLIYA PITUAH 46725

__________________
]11[]21[

180331
‫ תכשירים‬,‫– פירידון‬2–‫–קרבמואיל‬3 ‫נגזרות של‬
‫רפואיים המכילים אותן ושימושים שלהן‬

]54[

3-CARBAMOYL-2 PYRIDONE
DERIVATIVES,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND USES THEREOF

]22[
]31[

28.10.2005
2004-313947 ]32[ 28.10.2004
]33[ JP
2005-159995
31.05.2005
JP
Int. Cl.(2010.01) A61K 31//435, 31//436, 31//4365, 31//4412, 31//4436, 31//4439,
31//444, 31//4545, 31//455, 31//4704, 31//496, 31//506, 31//517, 31//5377, 31//55,

]51[
260

December 29, 2011-‫ג' בטבת התשע"ב‬

]71[
]87[
]74[

]57[

31//675, A61P 17//04, 25//02, 37//08, 43//00, C07D 21/3/80, 21/3/82, 21/3/85, 21/5/54,
21/5/56, 22/1/16, 40/1/06, 40/1/12, 40/5/06, 40/5/12, 41/3/12, 41/7/12, 49/1/052,
49/5/04, C07F 09//58
SHIONOGI & CO., LTD., JAPAN
WO/2006/046778
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
1
A compound represented by the general formula (I): (wherein R is optionally
substituted C1-8 alkyl, etc.; R2 is C1-6 alkyl and R3 is C1-6 alkyl, etc., provided that R2
and R3 may be bonded to each other to form an optionally substituted 5- to 10membered nonaromatic carbocycle; R4 is hydrogen, etc.; and G is a group selected
among, e.g., groups represented by the formula (X) (wherein R5 is hydrogen, etc.; X1 is
a single bond, etc.; X2 is, e.g., optionally substituted C1-8 alkylene optionally having
one or two atoms or groups selected between -O- and -N(R6)- (R6 is hydrogen, etc.);
X3 is a single bond, etc.; Y is -O-, etc.; and Z is hydrogen, etc.)), a pharmaceutically
acceptable salt of the compound, or a solvate of either. These compounds have
cannabinoid receptor agonistic activity. Also provided are a medicinal composition, an
atopic dermatitis remedy, and an anti-itching agent, especially an anti-itching agent for
oral administration or for external use, which each contains any of those compounds as
an active ingredient.

__________________
]11[]21[
]54[

DYNAMIC CONFIGURATION OF
IP FOR A TERMINAL
EQUIPMENT ATTACHED TO A
WIRELESS DEVICE

]22[

28.06.2005

261

180338
‫תצורות דינמיות של פרוטוקולי אינטרנט לציוד‬
‫מסוף המחובר להתקן אלחוטי‬

December 29, 2011-‫ג' בטבת התשע"ב‬

]31[
]51[
]71[
]87[
]74[

]57[

10/882522
]32[ 30.06.2004
Int. Cl.(2010.01) H04L 29//12
QUALCOMM INCORPORATED,
U.S.A.
WO/2006/004753
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122

]33[

US

,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
Techniques for dynamically configuring IP and providing IP connectivity for a
terminal equipment '110' attached to a wireless device '120' are described. The
wireless device obtains from a wireless network '130' a dynamically assigned IP
address, an IP gateway's IP address, a subnet mask, or none or any combination
thereof. Wireless device determines a host IP address (which may be the dynamically
assigned IP address), a router IP address (which may be the gateway IP address or a
spoofed IP address), a server IP address (which may be the router IP address), and a
subnet mask (which may be obtained from the wireless network or spoofed by the
wireless device). Wireless device, acting as a DHCP server, provides IP configuration
for the terminal equipment, acting as a DHCP client. Wireless device thereafter
forwards IP packets exchanged between the terminal equipment and wireless network
and processes DHCP packets from the terminal equipment.

__________________
]11[]21[

180411

]54[

QUINAZOLINONE DERIVATIVES
AS PARP INHIBITORS,
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THEM, USES AND METHODS OF
PREPARATION THEREOF

]22[
]31[
]51[

28.06.2005
04076887.1
]32[ 30.06.2004
]33[ EP
Int. Cl.(2010.01) A61K 31//517, 31//5375, A61P 03//10, 09//00, 09//10, 13//12,
17//00, 19//10, 21//00, 25//00, 25//28, 31//18, 35//00, 43//00, C07D 23/9/88, 40/1/12,
40/3/12, 40/3/14, 40/5/14, 41/3/14, 41/7/14
JANSSEN PHARMACEUTICA, N.V.,
BELGIUM

]71[

262

‫ תכשירים‬,PARP ‫תולדות קווינאזולינון כמעכבי‬
‫ השימוש בהן ושיטות‬,‫רוקחיים המכילים אותן‬
‫להכנתן‬

December 29, 2011-‫ג' בטבת התשע"ב‬

]87[
]74[

WO/2006/003146
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]57[

The present invention provides compounds of formula (I), their use as PARP inhibitors
as well as pharmaceutical compositions comprising said compounds of formula (I)
wherein R1, R2, R3, L, X, Y and Z have defined meanings.

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

__________________
]11[]21[

180440

]54[

COMPACT SOURCE OF A HIGHBRIGHTNESS X-RAY BEAM

]22[
]31[
]51[
]71[
]74[

28.12.2006
0650007
]32[ 03.01.2006
Int. Cl.(2010.01) H01J 35//10
ALCATEL LUCENT, FRANCE
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]57[

Device for the emission of X-rays, comprising: a vacuum chamber (7), limited by a
sealed wall (1f), a vacuum pump (1), including in a sealed peripheral casing (1f) a
stator (1b), a rotor (1a) and means of slaving (10a-10e) the rotor, allowing its stable
rotation at very high speed, and connected to the vacuum chamber to generate and
maintain a vacuum, a cathode (3), in the vacuum chamber, adapted to generate an
electron flux (4), a rotating anode (2), in the vacuum chamber, driven in rotation
around a rotation axis (I-I), and receiving in its periphery (2a) the electron flux coming
from the cathode to emit X-rays (6) towards an output (11), the rotating anode is
connected to the rotor of the vacuum pump, arranged coaxially with the rotor, the
sealed peripheral casing of the vacuum pump itself constitutes all or part of the sealed
wall of the vacuum chamber, and characterized in that the device also comprises at
least two cooling elements (8, 9), fixed to the stator of the vacuum pump or to the
sealed peripheral casing, arranged respectively opposite each of the main radial faces
(2b, 2c) of the rotating anode to absorb the thermal energy from radiation emitted by

263

‫ בעלת בהירות גבוהה‬X ‫מקור דחוס לקרן‬

]33[

FR

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

December 29, 2011-‫ג' בטבת התשע"ב‬

the rotating anode in operation.

__________________
]11[]21[

180486
‫מלחים של תולדת בנזימידאזול עם אמינים‬
‫ותהליך לייצרם‬

]54[

SALTS OF BENZIMIDAZOLE
DERIVATIVE WITH AMINES AND
PROCESS FOR PRODUCTION
THEREOF

]22[
]31[
]51[
]71[

05.08.2005
2004-230094 ]32[ 06.08.2004
]33[ JP
Int. Cl.(2010.01) A61K 31//4439, A61P 01//04, C07D 40/1/12
EISAI R&D MANAGEMENT CO.,
LTD., JAPAN
WO/2006/013960
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬2273 .‫ד‬.‫ ת‬,
The invention provides (1) a process for the production of alkali metal salts of 2-[{4(3-methoxypropoxy)-3- methylpyridin-2-yl}methylsulfinyl]-1H-benzimidazole which
are useful as gastric acid secretion inhibitor, antiulcer agent, and other drugs and (2)
salts of 2-[{4-(3-methoxypropoxy) -3-methylpyridin-2-yl}methylsulfinyl]-1Hbenzimidazole with amines which are intermediates for the production of the alkali
metal salts and a process for the production of the same. Specifically, salts represented
by the general formula (I): wherein A+ is an isopropylammonium ion, a secbutylammonium ion, or a cyclopentylammonium ion.

]87[
]74[

]57[

264

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[
]54[

CORTICOTROPIN RELEASING
FACTOR (CRF) FOR TREATMENT
OF NEURAL DISORDERS

]22[
]31[

08.07.2005
0415359.9
]32[ 08.07.2004
0423386.2
21.10.2004
Int. Cl.(2010.01) A61K 38//17, 38//22
AIMSCO LIMITED, UNITED
KINGDOM
WO/2006/021814
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122

]51[
]71[
]87[
]74[

]57[

180487
‫גורם המשחרר קורטיקוטרופין לטיפול בהפרעות‬
‫עיצביות‬

]33[

GB
GB

,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
Analysis of a goat serum product with many therapeutic effects is described. The
product is identified as containing proopiomelanocortin (POMC) and Corticotropin
releasing factor (CRF) peptides, as well as breakdown products of these peptides. We
describe methods of treatment of diseases including cancers, multiple sclerosis, and
neural disorders using these peptides and their products, as well as medicaments
including such peptides and methods of producing the peptides.

__________________
]11[]21[
]54[

MINIATURE COILS ON CORE
WITH PRINTED CIRCUIT

]22[
]31[
]51[
]71[
]74[

02.01.2007
11/327058
]32[ 06.01.2006
Int. Cl.(2010.01) H04R 09//06
BIOSENSE WEBSTER, INC., U.S.A.
D. KLIGLER I.P. SERVICES LTD.,
P.O.B. 33111
TEL AVIV 61330

265

180516
‫סלילים מיניאטוריים על בסיס עם מעגל חשמלי‬
‫מודפס‬

]33[

US

,‫ קליגלר שירותי קניין רוחני בע"מ‬.‫ד‬
‫תל אביב‬33111 .‫ד‬.‫ ת‬,
December 29, 2011-‫ג' בטבת התשע"ב‬

]57[

A method for producing a coil assembly, comprising: overlaying printed circuit traces
on a core by printing the circuit traces onto the core, the traces comprising terminals
for coupling to conductive connections on a base on which the coil assembly is to be
mounted; wrapping two or more wires around the core and printed circuit traces so as
to define two or more coils, wrapped in different, respective directions, the wires
having respective ends; and coupling the ends of the wires to the printed circuit traces,
so as to connect the wires through the traces to the terminals.

__________________
]11[]21[
]54[

266

PROCESS FOR PREPARING NHYDROXY-4-{5-[4-(5-ISOPROPYL2-METHYL-1,3-THIAZOL-4-YL)-

180524
–5(–4[–5{–4–‫–הידרוקסי‬N ‫תהליך להכנת‬
–)‫–איל‬4–‫–תיאזול‬3,1–‫–מתיל‬2–‫איסופרופיל‬
‫פנוקסי]–פנטוקסי}–בנזאמידין‬
December 29, 2011-‫ג' בטבת התשע"ב‬

PHENOXY]-PENTOXY}BENZAMIDINE
]22[
]31[
]51[
]71[
]72[

]87[
]74[

]57[

05.07.2005
10-2004]32[ 05.07.2004
]33[ KR
0052070
Int. Cl.(2010.01) C07D 27/7/22
DONG WHA PHARMACEUTICAL
CO., LTD., REPUBLIC OF KOREA
JIN SOO LEE, SEOK HOON AHN,
YOUNG GOO JIN, JAE HOON
PARK, DONG HYUK SHIN, EUN
HEE CHO, HWAN BONG CHANG,
YOUNG HO JUNG
WO/2006/004368
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45087 .‫ד‬.‫ ת‬,
JERUSALEM 91450
This invention relates to an improved method of preparing N-hydroxy-4-{5- [4- (5isopropyl-2-methyl-l, 3-thiazol-4-yl) phenoxy] pentoxy}benzamidine .

__________________
]11[]21[

180758
–'3,'2–‫'–פלואורו‬2 ‫פוספונאטים של אנלוג של‬
‫ תכשירים‬,‫'–דידאוקסיאדנוזין‬3,'2–‫דידהידרו‬
‫המכילים אותם ושימושים בהם להכנת תרופות‬
HIV ‫לעיכוב‬

]54[

PHOSPHONATES OF A 2 FLUORO-2' ,3' -DIDEHYDRO-2' ,3'
-DIDEOXYADENOSINE
ANALOGUE, PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND USE THEREOF FOR
THE PREPARATION OF
MEDICAMENTS FOR INHIBITING
HIV

]22[
]31[
]51[

27.07.2005
60/591811
]32[ 27.07.2004
]33[ US
Int. Cl.(2010.01) A61K 31//662, 31//7076, 47//48, A61P 31//18, C07F 09//6561,
C07H 19//16
GILEAD SCIENCES, INC., U.S.A.
WO/2006/015261

]71[
]87[
267

December 29, 2011-‫ג' בטבת התשע"ב‬

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

]74[

REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]57[

The invention is related to phosphorus substituted anti-viral inhibitory compounds,
compositions containing such compounds, and therapeutic methods that include the
administration of such compounds, as well as to processes and intermediates useful for
preparing such compounds.

__________________
]11[]21[

180781
‫אנלוגים פוספונאטים של תרכובות מעכבות‬
HIV

]54[

PHOSPHONATE ANALOGS OF
HIV INHIBITOR COMPOUNDS

]22[
]31[
]51[
]71[
]87[
]74[

26.07.2005
60/591811
]32[ 27.07.2004
]33[ US
Int. Cl.(2010.01) A61K 31//662, 47//48, C07F 09//38
GILEAD SCIENCES, INC., U.S.A.
WO/2006/110157
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]57[

The invention is related to phosphorus substituted anti-viral inhibitory compounds,
compositions containing such compounds, and therapeutic methods that include the
administration of such compounds, as well as to processes and intermediates useful for
preparing such compounds.

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

__________________
]11[]21[
]54[

HYBRID DEVICE FOR CELL
THERAPIES

]22[
]31[

20.07.2005
60/591919

268

]32[

29.07.2004

180995
‫מתקן היברידי עבור ריפויי תא‬

]33[

US
December 29, 2011-‫ג' בטבת התשע"ב‬

]51[
]71[
]87[
]74[
]57[

Int. Cl.(2010.01) A61F 02//02, A61K 09//22, A61M 05//142, C12M 03//00
THE UNIVERSITY OF MIAMI,
U.S.A.
WO/2006/020288
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
A device for receiving implanted biological material includes a porous outer wall
defining an inner space, a fluid manifold assembly for selectively infusing at least one
immunosuppresive and growth factor media to said space, and a pump structure
operatively coupled to the manifold assembly. The device may comprise an additional
plunger body for being disposed in said space and so as to define a peripheral gap
between the plunger and the perforated wall of the device.

__________________
]11[]21[

181024

]54[

TRPV1 AGONISTS AND
FORMULATIONS CONTAINING
THEM

]22[
]31[
]51[

06.07.2005
MI2004A001566 ]32[ 30.07.2004
]33[ IT
Int. Cl.(2010.01) A61K 31//16, A61P 13//00, 25//00, C07C 23/5/26, 23/5/28, C07D
30/3/46
INDENA S.P.A., ITALY
WO/2006/010445
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬

]71[
]87[
]74[

]57[

‫ והרכבים הכוללים‬TRPV 1 ‫אגוניסטים של‬
‫אותם‬

The compounds of the general formula (I) in which X is represented by two hydrogen
atoms, a pi-bond, oxygen or methylene; R2 is a C6-C12 aryl, or arylalkyl residue; R3 is
hydrogen, 2-hydroxyethyl or 2-aminoethyl are useful for the treatment of pathologies
mediated by vanilloid receptors type I.

__________________
269

December 29, 2011-‫ג' בטבת התשע"ב‬

]11[]21[

181119
‫כיול דו–שלבי של גששים רפואיים‬

]54[

TWO-STAGE CALIBRATION OF
MEDICAL PROBES

]22[
]31[
]51[
]71[
]74[

01.02.2007
11/351135
]32[ 09.02.2006
]33[ US
Int. Cl.(2010.01) G01N 01//00, 27//00, G01Q 40//00
BIOSENSE WEBSTER INC., U.S.A.
D. KLIGLER I.P. SERVICES LTD.,
,‫ קליגלר שירותי קניין רוחני בע"מ‬.‫ד‬
P.O.B. 33111
‫תל אביב‬33111 .‫ד‬.‫ ת‬,
TEL AVIV 61330
Medical apparatus, comprising: a probe, having a proximal end and a distal
end, which is adapted for insertion into a body of subject, the probe
comprising: a sensor, which outputs a sensor signal ;a first microcircuit,
which stores first calibration data with respect to the sensor; and a first
connector at the proximal end of the probe, electrically coupled at least to the
sensor; a probe adapter, comprising: a second connector, which is arranged to
mate with the first connector; a signal processing circuit, which is coupled to
process the sensor signal so as to output a processed signal; a second
microcircuit, which stores second calibration data with respect to the signal
processing circuit; a microcontroller, which is arranged to receive the first and
second calibration data from the first and second microcircuits, respectively,
and to compute combined calibration data based on the first and second
calibration data; and a third connector, electrically coupled at least to the
signal processing circuit, and a console, comprising: a fourth connector,
which is arranged to mate with the third connector, and signal analysis
circuitry, which is coupled to receive at least the processed signal from the
fourth connector and is arranged to analyze the processed signal using the
combined calibration data provided by the probe adapter.

]57[

__________________
]11[]21[
]54[
270

METHOD AND APPARATUS
PROVIDING SINGLE BUMP,

181274
‫שיטה והתקן לארכיטקטורה רבת פיקסלי–צבע‬
‫בעלת שליטה יחידה‬
December 29, 2011-‫ג' בטבת התשע"ב‬

MULTI-COLOR PIXEL
ARCHITECTURE
]22[
]31[
]51[
]71[
]87[
]74[

17.11.2005
11/003637
]32[ 03.12.2004
Int. Cl.(2010.01) H01L 31//101
RAYTHEON COMPANY, U.S.A.
WO/2006/062721
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]57[

An infrared detector has a multi-layer structure to simultaneously detect IR energy in
different spectral bands without changing polarity of a bias imposed across the
detector. Two absorption layers are separated by a barrier layer that imposes an
electrical potential barrier to one of the absorption layers. Under low bias in one
direction, only one layer generates a photocurrent. Under a higher bias in the same
direction, both layers generate a photocurrrent. Additional absorption layers may be
added to detect additional bands of energy, where the additional absorption layers
generate photocurrent under a bias in another direction. Two, three, and four band
detection is disclosed. Where absorbing layers within a single unit cell absorb under
different bias direction, the barrier layer between those different bias direction layers
suppresses a diffusing electron current. A method for detecting and resolving energy
absorbing in two, three, and four different energy bands is also provided.

]33[

US

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

__________________
]11[]21[

181317
‫–דיאמינו חומצה שיקימית‬5 ,4 ‫תהליך להכנת‬

]54[

PROCESS FOR THE
PREPARATION OF 4,5-DIAMINO
SHIKIMIC ACID

]22[
]31[
]51[
]71[

24.08.2005
04104227.6
]32[ 02.09.2004
]33[ EP
Int. Cl.(2010.01) C07C 22/7/10, 22/7/18, 22/9/48
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND

271

December 29, 2011-‫ג' בטבת התשע"ב‬

]87[
]74[

WO/2006/024436
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]57[

The present invention relates to a process for the preparation of a 4,5-diamino shikimic
acid derivative of formula (I) and pharmaceutically acceptable addition salts thereof
wherein R1, R1’ are independent of each other H or alkyl, R2 is an alkyl and R3, R4 are
independent of each other H or an alkanoyl, with the proviso that not to both R3 and R4
are H. 4,5-diamino shikimic acid derivatives of formula I, especially the (3R,4R,5S)-5amino-4-acetylamino-3- (1-ethyl-propoxy)-cyclohex-l-ene-carboxylic acid ethyl ester
and its pharmaceutically acceptable additional salts are potent inhibitors of viral
neuraminidase.

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

__________________
]11[]21[

181462
‫תהליך לייצור תולדות אמינים בעלות פעילות‬
‫אופטית‬

]54[

PROCESS FOR PRODUCTION OF
OPTICALLY ACTIVE AMINE
DERIVATIVES

]22[
]31[
]51[
]71[

12.09.2005
2004-265307 ]32[ 13.09.2004
]33[ JP
Int. Cl.(2010.01) A61K 31//343, A61P 25//20, C07D 30/7/77
TAKEDA PHARMACEUTICAL
COMPANY LIMITED, JAPAN
WO/2006/030739
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬2273 .‫ד‬.‫ ת‬,
An industrial process for producing high-purity optically active amine derivatives in
high yield while inhibiting the formation of by-products, which comprises subjecting
(E)-2- (1, 6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-ylidene)ethylamine to asymmetric
reduction, catalytically reducing the obtained product at a reaction temperature of 40 to

]87[
]74[

]57[

272

December 29, 2011-‫ג' בטבת התשע"ב‬

100 C and a pH of 3 to 9, subjecting the obtained (S)-2-(1,6,7,8-tetrahydro -2H-indeno
[5,4-b]furan-8-yl)ethylamine to propionylation, and then crystallizing the reaction
mixture.

The applications for division
from this application have
not yet been published

50/532/

‫בקשות חלוקה מבקשה זו‬
9‫שטרם פורסמו‬

__________________
]11[]21[

181510
‫שיטת כיול של מיקום יחסי של מדידים במערכת‬
‫זיהוי ירי‬

]54[

METHOD FOR CALIBRATING
RELATIVE SENSOR POSITIONS
OF SENSORS IN A SHOOTER
DETECTION SYSTEM

]22[
]31[
]51[
]71[

11.08.2005
10/925876
]32[ 24.08.2004
]33[ US
Int. Cl.(2010.01) G01S 05//22
RAYTHEON BBN TECHNOLOGIES
CORP., U.S.A.
WO/2006/098755
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
Shockwave-only solutions that estimate shooter position and shot trajectory are
extremely sensitive to the quality and precision of the shock time-of-arrival (TOA)
measurements as well as the accuracy to which relative sensor positions in space are
known. Over the life of a long-deployed system, the sensor positions can shift and the
performance of some sensors may degrade for various reasons. Such changes can
degrade the performance of deployed shooter estimation systems. Disclosed are
systems and methods that can be used to calibrate sensor positions based on shock and
muzzle measurements processed from a series of shots fired from a known location
and in a known direction, as well as an approach for dynamically adapting shock-only
shooter estimation algorithms to compensate for sensor degradation and/or loss.

]87[
]74[

]57[

273

December 29, 2011-‫ג' בטבת התשע"ב‬

50/6575

The applications for division
from this application have
not yet been published

‫בקשות חלוקה מבקשה זו‬
9‫שטרם פורסמו‬

__________________
]11[]21[

181562
‫כרסום בעל פעילות משופרת‬

]54[

HIGH-PERFORMANCE END
MILL

]22[
]51[
]71[
]74[

26.02.2007
Int. Cl.(2010.01) B23C 01//00
HANITA METAL WORKS LTD.
‫ שלומי‬,‫חניתה מפעלי מתכת בע"מ‬
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A high-performance end mill comprising a shank portion and at least one cutting

]57[

portion divided into a plurality of teeth by flutes disposed between said teeth, the
radial teeth at the cutter extremity each having a cutting edge extending outwardly
from the centre of the tool's extremity and a gash cut profile wherein the maximum
axial depth of said gash cut measured in the direction parallel to the cutter axis is less
than 0.15D where D is the outer diameter of the cutter.

__________________

274

December 29, 2011-‫ג' בטבת התשע"ב‬

]11[]21[

181639
‫מערכת לאינטגרציה לאחר הקלטה ראשונית‬

]54[

POST PRODUCTION
INTEGRATION PLATFORM

]22[
]51[
]71[
]74[

28.02.2007
Int. Cl.(2010.01) G06K 01//00
MICHAEL BRUGGEMAN
‫ רמת גן‬,‫מייקל ברוגמן‬
APPELFELD ZER FISHER WEILER,
,‫אפלפלד זר פישר וילר חברת עורכי דין‬
LAW FIRM,
16 ‫ קומה‬.‫ר‬.‫ס‬.‫ מגדל ב‬2 ‫בן גוריון‬
B.S.R TOWER 1, FLOOR 16
‫ גן‬- ‫רמת‬
2 BEN GURION ST.
RAMAT GAN 52573
A system for integrating video, three-dimensional animation and sound file formats
into a unified environment for performing manipulations on said files, said system
comprising a unified visual manipulation working environment, wherein said
environment comprises: an import module for receiving a plurality of visual content
objects encoded with a respective original source format within a plurality of different
media formats, wherein the plurality of visual content objects comprises at least one
two-dimensional video stream and at least one three-dimensional, time varying
animated object; a unified timeline module for combining the plurality of visual
content objects in time synchronization to be played on a single timeline; a processing
module enabling separate manipulation of at least two selected visual content objects
within the plurality of visual content in a non destructive manner retaining the
respective original source format characteristics of each of the visual content objects;
and a Visual Three-Dimensional Integration Interface adapted to simultaneously
display a combination of the plurality of visual content objects in a three-dimensional
environment, the Visual Three-Dimensional Integration Interface adapted to integrate
and manipulate respective timelines of at least one visual content object within the
plurality of visual content objects and preview a two-dimensional representation of the
combination, wherein said Visual Three-Dimensional Integration Interface includes: a
two-dimensional video surface layer adapted to display the at least one twodimensional video stream, a three-dimensional animation view platform adapted to
display the at least one three-dimensional, time varying animated object, and a
consolidation layer for displaying the combination, wherein the three-dimensional
animation view platform is illustrated as a space between the consolidation layer and
the video surface layer and is adapted to manipulate in three dimensions, in response
to operator input, the at least one three-dimensional, time varying animated object
with respect to the at least one two-dimensional, video stream simultaneously
displayed on the two-dimensional video surface layer, and wherein frames of the
consolidation layer and of the video surface layer are locked together and are
manipulated via a scale control adapted to at least one of either increase and decrease a
relative size of images and three-dimensional time varying objects within confines of
the consolidation layer and the two-dimensional video surface layer as compared to
one another, and change a relative positioning of images and three-dimensional, time
varying objects displayed in the consolidation layer and the two-dimensional video
surface layer as compared to one another, the images and three-dimensional, time

]57[

275

December 29, 2011-‫ג' בטבת התשע"ב‬

varying object comprising three-dimensional animation objects sitting on the threedimensional animation platform and at least one two-dimensional video stream sitting
on the two-dimensional video surface layer.

__________________
]11[]21[

182170
‫שיטה לליטוש מתכות אצילות באמצעות הרכב‬
‫כימי–מכני עם תוסף פולימר‬

]54[

METHOD FOR POLISHING
NOBLE METALS WITH CMP
COMPOSITION CONTAINING A
POLYMER ADDITIVE

]22[
]31[
]51[
]71[

11.10.2005
10/963108
]32[ 12.10.2004
]33[ US
Int. Cl.(2010.01) B24B 37//00
CABOT MICROELECTRONICS
CORPORATION, U.S.A.
WO/2006/044417
SELIGSOHN GABRIELI & CO.,
,'‫זליגסון גבריאלי ושות‬
31 YAVNE ST.,
31 ‫רח' יבנה‬
P.O.B. 1426,
‫תל אביב‬1426 .‫ד‬.‫ ת‬,
TEL AVIV 61013
The invention provides a method of polishing a substrate comprising contacting a
substrate comprising a noble metal on a surface of the substrate with a chemicalmechanical polishing system comprising (a) a polishing component selected from the
group consisting of an abrasive, a polishing pad, and a combination thereof, (b) an
oxidizing agent, (c) an ethylene-oxide containing polymer, and (d) a liquid carrier, and
abrading at least a portion of the noble metal with the chemical-mechanical polishing
system to polish the substrate.

]87[
]74[

]57[

__________________
]11[]21[
]54[

METHOD AND APPARATUS FOR
SQUELCH GATING A
RECEIVING SIGNAL

]22[

27.03.2007

276

182301
‫שיטה והתקן למיתוג על ידי השתקה של סיגנל‬
‫נקלט‬

December 29, 2011-‫ג' בטבת התשע"ב‬

]31[
]51[
]71[
]74[

]57[

06 007 405.1 ]32[ 07.04.2006
145.8 000 07
04.01.2007
Int. Cl.(2010.01) H04B 01//10
ROHDE & SCHWARZ GMBH & CO.
KG, GERMANY
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O.B. 2081,
HERZLIYA 46120

]33[

EP
EP

‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬2081 .‫ד‬.‫ ת‬,

A method and an apparatus for squelch gating a receiving signal depending on the
level of phase noise in said receiving signal determines sampled amplitudes and
sampled phases of said receiving signal, determines sampled phase noise by
differentiating subsequent sampled phases, determines a squelch signal by rectifying
and averaging said sampled phase noise, determines a start point of gating after a
rising of said squelch signal above a higher threshold delayed by a first delay time,
determines an end point of gating after a dropping of said squelch signal below a lower
threshold delayed by a second delay time and gates said sampled amplitudes from said
start point of gating until said end point of gating.

__________________
]11[]21[

182396

]54[

SEMISYNTHESIS PROCESS FOR
THE PREPARATION OF 10DEACETYL-N-DEBENZOYLPACLITAXEL AND
INTERMEDIATES THEREFOR

]22[
]31[

07.10.2005
60/616840
]32[ 08.10.2004
]33[
04425752.5
08.10.2004
05007888.0
11.04.2005
Int. Cl.(2010.01) C07D 30/5/14, 41/1/12
INDENA S.P.A., ITALY
WO/2006/037653
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]51[
]71[
]87[
]74[

]57[

277

–N–‫– דיאצטיל‬10 ‫תהליך חצי–סינטטי להכנת‬
‫דיבנזואיל–פקליטקסל וחומרי ביניים עבורו‬

US
EP
EP

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

The invention relates to a process for the preparation of 10-deacetyl-Ndebenzoylpaclitaxel, a synthon useful for the preparation of taxanes with antitumour activity, and
December 29, 2011-‫ג' בטבת התשע"ב‬

intermediates for the preparation thereof. The invention also discloses a process for the
preparation of Docetaxel starting from said compound of formula (I).

50/607/

The applications for division
from this application have
not yet been published

‫בקשות חלוקה מבקשה זו‬
9‫שטרם פורסמו‬

__________________
]11[]21[
]54[

ROCKET-PROPELLED VEHICLE
COMPRISING KINETIC MEDIA
AND DECOMPOSABLE FOAM

]22[
]31[
]51[
]71[
]87[
]74[

19.10.2005
10/969724
]32[ 20.10.2004
Int. Cl.(2010.01) B64G 01//00
RAYTHEON COMPANY, U.S.A.
WO/2007/001419
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122

]57[

278

182473
‫כלי טייס ממונע רקטה המכיל רכיב קינטי וקצף‬
‫מתכלה‬

]33[

US

,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A high energy, e.g. ultraviolet (UV) catalyzed decomposing foam (124) encapsulating
kinetic media (122) forms a payload (120) to be boosted in space and provides an
ultra-light weight means for intercepting an incoming missile or other target (140,
142). The decomposed foam releases the kinetic media (at designed rates so as to
preserve a required density of media on target) to intercept the target and destroy it.
The use of the decomposing foam significantly lowers the weight and cost an improves
the probability of success of destroying the target.

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

182747
‫מערכת מיצלות הפוכות הכוללת מרכיב פעיל‬
‫טיפולי המסיס במים ותכשיר רפואי הכולל‬
‫אותה‬

]54[

REVERSE-MICELLAR SYSTEM
COMPRISING A HYDROSOLUBLE
THERAPEUTICALLY ACTIVE
AGENT AND PHARMACEUTICAL
COMPOSITION COMPRISING IT

]22[
]31[
]51[
]71[
]87[
]74[

02.11.2005
04025991.3
]32[ 02.11.2004
]33[ EP
Int. Cl.(2010.01) A61K 09//00, 09//107, 09//48, 38//00
MEDESIS PHARMA SA, FRANCE
WO/2006/048772
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The present invention relates generally to reverse-micellar system comprising a
hydrosoluble therapeutically active agent. Reverse micelles according to the invention
are particularly useful to deliver drugs. The present invention also relates to
pharmaceutical composition comprising said reverse micelles and methods for
preparing the same.

]57[

__________________
]11[]21[
]54[
279

METHOD FOR MANAGING

182824
‫שיטה לניהול משאבים בפלטפורמה לשירותי‬
‫ פלטפורמה‬,‫או ניהול רשת‬/‫טלקומוניקציה ו‬
December 29, 2011-‫ג' בטבת התשע"ב‬

RESOURCES IN A PLATFORM
FOR TELECOMMUNICATION
SERVICES AND/OR NETWORK
MANAGEMENT,
CORRESPONDING PLATFORM
AND COMPUTER PROGRAM
PRODUCT THEREFOR
]22[
]51[
]71[
]72[

]87[
]74[

]57[

280

‫ומוצר של תוכנת מחשב עבורה‬

28.10.2004
Int. Cl.(2010.01) H04L 12//24
TELECOM ITALIA S.P.A., ITALY
GIUSEPPE COVINO, ROSARIO
ALFANO, FABRIZIO BOBBIO,
GIUSEPPE CASSONE, DANILO
GOTTA, MARISA PORTA, MARCO
UGHETTI
WO/2006/045337
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
7 ‫ רחוב ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
‫ גן‬-‫רמת‬
7 JABOTINSKY ST.,
RAMAT GAN 52520
The invention relates to a method and system for managing resources in the
telecommunications services and networks. The method and system regard execution
of processes (WF1, ..., WFn) by distributed agents (A1, A2, A3) on processing
machines (H) to perform predetermined tasks on the network, and are characterized
by: setting target data including goals on processes (WF1, …, WFn) and constraints on
resource utilization to be met by the system; monitoring computational resources
utilization and processes execution by agents, and collecting performance data
representative of resource utilization and process execution; comparing the collected
performance data with the set data, a penalty being established when performance data
do not fulfil target data; and re-allocating resources for process execution by agents
(A1, A2, A3) so as to minimize the penalty determined on the basis of said
comparison.

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

183013
,‫סינתזה כימית מכוונת ע"י חומצת גרעין מבנית‬
‫הרכב ושיטה לביצוע החלפת מודולת נשא‬
‫האוליגונוקליאוטיד‬

]54[

STRUCTURAL NUCLEIC ACID
GUIDED CHEMICAL SYNTHESIS
COMPOSITION AND METHOD
OF PERFORMING
OLIGONUCLEOTIDE CARRIER
MODULE SUBSTITUTION

]22[
]31[

08.11.2005
04105597.1
]32[ 08.11.2004
]33[ EP
60/687849
07.06.2005
US
60/725347
11.10.2005
US
Int. Cl.(2010.01) C07B 61//00, C12N 15//10
VIPERGEN APS, DENMARK
WO/2006/048025
SELIGSOHN GABRIELI & CO.,
,'‫זליגסון גבריאלי ושות‬
31 YAVNE ST.,
31 ‫רח' יבנה‬
P.O.B. 1426,
‫תל אביב‬1426 .‫ד‬.‫ ת‬,
TEL AVIV 61013
Disclosed is a composition comprising a nucleic acid and a chemical compound, said
composition forming a star structure defining 3 or more stems extending from a
reaction center. The stems are formed by a nucleic acid duplex and the chemical
compound has been formed in the reaction center as the reaction product of 3 or more
chemical groups. The advantage of the composition is that a close proximity is
provided between the chemical groups in the reaction center, thereby promoting a
reaction. The invention also relates to a method for preparation of the composition.
The advantage of the method is that it does not require the pre-synthesis of a large
number of templates and that it is not dependent upon codon/anti-codon recognition
for an encoded molecule to be formed.

]51[
]71[
]87[
]74[

]57[

__________________
]11[]21[
281

183028
December 29, 2011-‫ג' בטבת התשע"ב‬

‫– פרופילאמינופנטאן‬2–)‫–איל‬2–‫–(בנזופוראנ‬1)–(
‫לשימוש בטיפול בתלות בסמים‬

]54[

(-)-1-BENZOFURAN-2-YL)-2PROPYLAMINOPENTANE FOR
USE IN THE TREATMENT OF
SUBSTANCE DEPENDENCE

]22[
]31[
]51[
]71[

21.11.2005
2004-339996 ]32[ 25.11.2004
]33[ JP
Int. Cl.(2010.01) A61K 31//343, A61P 25//00, C07D 30/7/81
FUJIMOTO CO., LTD., JAPAN
NATIONAL UNIVERSITY
CORPORATION KYUSHU
UNIVERSITY, JAPAN
WO/2006/057211
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬

]87[
]74[

]57[

To provide a therapeutic agent for drug dependence which prevents the flash-back of
or a relapse into a compulsive drug intake behavior based on the urge to, e.g., an
addictive substance such as amphetamine, opium, barbiturate type morphine,
psychedelic, cocaine, hemp, cannabis, alcohol, or volatile organic solvents. (-)-1(Benzofuran-2-yl)-2propylaminopentane or a pharmacologically acceptable acid
addition salt thereof is useful as a therapeutic agent for drug dependence which
prevents the flash-back of or a relapse into a compulsive drug intake behavior based on
the urge to, e.g., an addictive substance.

__________________
]11[]21[
]54[

ENDOPROSTHETIC ELEMENTS
FOR AN ANKLE JOINT

]22[
]31[
]51[
]71[

08.11.2005
A 1862/2004
]32[ 08.11.2004
Int. Cl.(2010.01) A61F 02//24, 02//42
ALPHAMED MEDIZINTECHNIK
FISCHER GMBH, AUSTRIA
WO/2006/047805
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733

]87[
]74[

282

183030
‫אלמנטים אנדופרוסטטיים עבור מחבר קרסול‬

]33[

AT

,‫פרל כהן צדק לצר‬
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
December 29, 2011-‫ג' בטבת התשע"ב‬

]57[

The invention relates to a talus component (1) for a multi-part ankle-joint prosthesis,
said component having an underside (3), which faces the bony talus after implantation.
Said component is characterised in that the underside that faces the bony talus is
configured as a concave ball segment.

__________________
]11[]21[

183054

]54[

LNA OLIGONUCLEOTIDES AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THE SAME

]22[
]31[

09.11.2005
60/626563
]32[ 09.11.2004
]33[ US
60/647186
25.01.2005
US
60/699721
15.07.2005
US
60/724621
07.10.2005
US
Int. Cl.(2010.01) C07H 21//00, 21//04, C12N 15//11
ENZON PHARMACEUTICALS, INC.,
U.S.A.
SANTARIS PHARMA A/S,
DENMARK
WO/2006/050734
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
The present disclosure relates to an LNA oligonucleotide consisting of a sequence
selected from the group consisting of 5'-(Tx GxGxcsasasasgscsastscscsTXGX T-3' and 5'(GX )TXTXascstsgscscststscsTXTX A-3', wherein capital letters designate a beta-D-oxyLNA nucleotide analogue, small letters designate a 2-deoxynucleotide, underline
designates either a beta-D-oxy-LNA nucleotide analogue or a 2-deoxynucleotide,
December 29, 2011-‫ג' בטבת התשע"ב‬

]51[
]71[

]87[
]74[
]57[

283

‫ ותכשירי רוקחות‬LNA ‫אוליגונוקלאוטידים‬
‫המכילים אותם‬

subscript 's' designates a phosphorothioate link between neighbouring
nucleotides/LNA nucleotide analogues, and subscript 'x' designates either a
phosphorothioate link or a phosphorodiester link between neighbouring
nucleotides/LNA nucleotide analogues, and wherein the sequence is optionally
extended by up to five 2-deoxynucleotide units. The LNA oligonucleotides are useful
for modulating the expression of hypoxia-inducible factor-la (HIF-1a), e.g. in the
treatment of cancer diseases, inhibiting angiogenesis, inducing apoptosis, preventing
cellular proliferation, or treating an angiogenic disease, e.g. diabetic retinopathy,
macular degeneration (ARMD), psoriasis, rheumatoid arthritis and other inflammatory
diseases.

__________________
]11[]21[

183157
‫תכשירים בסיסיים נטולי מים הניתנים ליצירה‬
‫עצמית של מיקרו–אמולסיות המכילים קו אנזים‬
‫ בריכוז גבוה‬Q10

]54[

HIGH CONCENTRATION SELFMICROEMULSIFIABLE
ANHYDROUS COENZYME Q10
BASE COMPOSITIONS

]22[
]51[
]71[
]87[
]74[

16.11.2004
Int. Cl.(2010.01) A61K 09//10, 09//48, 38//43
BIOAVAILABILITY, INC, U.S.A.
WO/2006/080903
EITAN MEHULAL LAW GROUP,
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
10 ABBA EBEN BLVD.,
,‫פטנטים‬
P.O.B. 2081,
10 ‫שדרות אבא אבן‬
HERZLIYA 46120
‫הרצליה‬2081 .‫ד‬.‫ ת‬,
A method and composition are presented for enhancing the dissolution and
bioavailable properties of CoQ10 nutritional supplements and/or therapeutic agents for
a human being and other mammals. The method includes preparing an anhydrous selfmicroemulsifying base composition by combining: CoQ10, a water-immiscible, and a
non-ionic surfactant, containing polyethylene glycol. For an orally administered
CoQ10 nutritional supplement in a capsule formulation, a unit dosage from the
composition is added to a dissolvable capsule, preferably a soft gelatin capsule, in
December 29, 2011-‫ג' בטבת התשע"ב‬

]57[

284

order to form the nutritional supplement. When a capsule containing the selfmicroemulsifying composition enters the digestive tract, the temperature of the body's
digestive juices warms the composition, causing any of the CoQ10 that may have recrystallized out of the composition to become re-dissolved into the composition before
the capsule dissolves. The re-dissolution of CoQ10 is bioavailable when the capsule
dissolves. Upon dissolution of the capsule, the self-microemulsifying composition
comes into contact with the digestive juices and naturally forms micellar-type
bioavaible microemulsions, consisting of micelles containing CoQ10. In addition to
the capsule formulation, the invention includes parenteral, liquid, topical and
ophthalmic formulations.

__________________
]11[]21[

183200
‫תכשיר רוקחי הכולל דפסיפפטידים קוטלי‬
‫טפילים פנימיים למניעת זיהום אנכי של יונק‬
‫לא אנושי עם טפילים פנימיים‬

]54[

PHARMACEUTICAL
COMPOSITION COMPRISING
ENDOPARASITICIDAL
DEPSIPEPTIDES FOR PREVENTING
VERTICAL INFECTION OF A NON
HUMAN MAMMAL WITH
ENDOPARASITES

]22[
]31[
]51[
]71[

03.11.2005
102004055316.5 ]32[ 16.11.2004
]33[
Int. Cl.(2010.01) A61K 38//15, A61P 33//00
BAYER ANIMAL HEALTH GMBH,
GERMANY
WO/2006/053641
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]87[
]74[

]57[

DE

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

The invention relates to the use of endoparasitic depsipeptides for the production of
medicaments for prevention of vertical endoparasite infections.

__________________

285

December 29, 2011-‫ג' בטבת התשע"ב‬

]11[]21[
]54[

TRACKING AND IMAGING
DATA FUSION

]22[
]51[
]71[

20.05.2007
Int. Cl.(2010.01) G06T 07//20
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD.
RON ZOHAR, DAVID REINITZ
DR. MARK FRIEDMAN LTD.,
MOSHE AVIV TOWER, 54TH
FLOOR,
7 JABOTINSKY ST.,
RAMAT GAN 52520

]72[
]74[

]57[

183320
‫מיזוג מידע ממעקב ומהדמיה‬

,‫רפא"ל מערכות לחימה מתקדמות בע"מ‬
‫חיפה‬
‫ דוד רייניץ‬,‫רון זוהר‬
,‫ד"ר מרק פרידמן בע"מ‬
7 ‫ רחוב ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
‫ גן‬-‫רמת‬

A method of monitoring a target, which includes tracking the target using a tracking
modality, thereby obtaining an estimated track of the target, imaging the target using
an imaging modality, thereby obtaining an image of the target, associating the
estimated track with the image, and displaying at least one datum related to the image
along with the estimated track.

__________________
]11[]21[
]54[

SURGICAL SYSTEM HAVING
PNEUMATIC MANIFOLDS WITH
INTEGRAL AIR CYLINDERS

]22[
]31[

20.05.2007
11/437301
]32[ 19.05.2006
11/477035
28.06.2006
Int. Cl.(2010.01) A61B 01//00
ALCON, INC., SWITZERLAND
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152

]51[
]71[
]74[

]57[

286

183323
‫מערכת פנאומטית ומורכבת לניתוחים בעלת‬
‫צילינדרי אויר אינטגרלים‬

]33[

US
US

,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
‫באר שבע‬5352 .‫ד‬.‫ ת‬,

A surgical system having all of the various pneumatic control sub-systems integrally
mounted on a common manifold. The various required control mechanisms such as
valves are likewise integrally mounted to the common manifold. Air cylinders for
valve actuation are directly installed into the manifolds, and pressurized air for the air
December 29, 2011-‫ג' בטבת התשע"ב‬

cylinders is supplied to the cylinders through the manifolds. Such a construction
eliminates the need to use external air tubing to supply the air cylinders with
pressurized air, thereby improving reliability and simplifying construction.

__________________
]11[]21[
]54[

INTRAOCULAR LENSES WITH
ENHANCED OFF-AXIS VISUAL
PERFORMANCE

]22[
]31[

21.05.2007
11/443766

287

]32[

31.05.2006

183368
‫תיקון סטיות כרומטיות בעדשות תוך עיניות‬

]33[

US
December 29, 2011-‫ג' בטבת התשע"ב‬

]51[
]71[
]74[

]57[

Int. Cl.(2010.01) G02C 07//06
ALCON, INC., SWITZERLAND
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A multi-element or multi-surface intraocular lens (10,22) (IOL), comprising: a
posterior optical surface (24b, 14a, 14b), and an anterior optical surface (24a, 12a,
12b), wherein at least one optical surface (24b, 14a, 14b) is adapted to provide
compensation for one aberration type and at least one optical surface (24a, 12a, 12b) is
adapted to provide compensation for another aberration type characterized in that a
combination of:the degree of asphericity of the optical surfaces; the Abbe number of
the lens material; the radii of curvature of the optical surfaces; the axial separation of
the optical surfaces; the degree of alignment of the optical axes of the optical surfaces,
are selected to cooperatively reduce, or substantially eliminate, the longitudinal
chromatic aberrations exhibited by the intraocular lens (10), and/or to cooperatively
provide compensation for the natural chromatic aberrations of the eye, whereby a
plurality of monochromatic, polychromatic and oblique aberrations may be
independently corrected and off-axis visual performance is enhanced by providing
customized IOLs exhibiting compensation for different aberrations and/or different
amounts of aberration correction.

__________________
]11[]21[
]54[

WEDGELOCK FOR ELECTRONIC
CIRCUIT CARD MODULE

]22[
]31[
]51[
]71[
]87[
]74[

10.11.2005
10/995535
]32[ 24.11.2004
Int. Cl.(2010.01) H05K 07//14
ELTA SYSTEMS LTD.
WO/2006/056971
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

288

183398
‫מנעול–טריז עבור כרטיס מודול של מעגל‬
‫אלקטרוני‬

]33[

US
‫ אשדוד‬,‫אלתא מערכות בע"מ‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
December 29, 2011-‫ג' בטבת התשע"ב‬

]57[

An arrangement is suggested for introducing a plate element, for which heat needs to
be dissipated by means of conduction, into a slot of a chassis which is adapted to
absorb the heat. The slot comprises a back wall adapted to contact the plate element
upon its insertion, an opposing front wall, and a base wall. The plate element
comprises margins adapted for carrying the arrangement. The arrangement comprises a
seat located on the margins. The arrangement further comprises a wedgelock moveably
attached to the seat, having two slot engaging surfaces adapted to contact the front and
base walls of the slot, and a seat engaging portion adapted to contact the seat. The
arrangement further comprises an actuating mechanism adapted to cause a movement
of the wedgelock in a direction toward the front wall and in a direction toward the base
wall of the slot until a tight contact is established between the slot engaging surfaces of
the wedgelock and the slot's front and base walls, while maintaining a tight contact
between the seat engaging portion of the wedgelock and the seat and between the
module and the back wall of the slot.

__________________
]11[]21[
]54[

COATED DRUG DELIVERY
FOMULATIONS

]22[
]31[
]51[
]71[

29.11.2005
10/999831
]32[ 30.11.2004
Int. Cl.(2010.01) A61K 09//127
WESTERN UNIVERSITY OF
HEALTH SCIENCES, U.S.A.
WO/2006/060325
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON ST.,

]87[
]74[
289

183490
‫פורמולציות מצופות לשחרור תרופות‬

]33[

US

,‫ד"ר יצחק הס ושותפיו‬
December 29, 2011-‫ג' בטבת התשע"ב‬

]57[

P.O.B. 6451,
279 ‫רחוב הירקון‬
TEL AVIV 61063
‫תל אביב‬6451 .‫ד‬.‫ ת‬,
The invention relates generally to methods of making formulations for delivering
biological agents to a patient. In one aspect, proliposomal drug-delivery systems for
medicaments are provided. In another aspect, coated proliposomal formulations for
poorly water soluble drugs, and methods for making the same, are provided. Certain
embodiments of the present invention provide enhanced stability and bioavailability
for pharmaceutical formulations.

50242/2

The applications for division
from this application have
not yet been published

‫בקשות חלוקה מבקשה זו‬
9‫שטרם פורסמו‬

__________________
]11[]21[

183492
‫ירוט חוקי של צלילי צילצול חזרה אישיים‬

]54[

LAWFUL INTERCEPTION OF
PERSONALIZED RING BACK
TONES

]22[
]31[
]51[
]71[

04.11.2005
04445128.4
]32[ 16.12.2004
]33[ EP
Int. Cl.(2010.01) H04M 03//22, 03//42, 19//02
TELEFONAKTIEBOLAGET L M
ERICSSON (PUBL), SWEDEN
WO/2006/063903
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
Systems and methods for legal interception of the transmission of personalized ring
back tones as they are sent from a network such as a mobile telephone network
associated with a subscriber to a caller in response to a call placed by the caller to the
subscriber to allow monitoring of personalized ring back tones and/or their associated
call content data. The personalized ring back tone is intercepted at an intercept access

]87[
]74[
]57[

290

December 29, 2011-‫ג' בטבת התשע"ב‬

point on the network, where the systems and methods of the invention then transmit
the intercepted personalized ring back tone to an authorized person or entity, such as a
law enforcement agency.

__________________
]11[]21[

183500
‫שיטה ומכשיר להעיר בן אדם‬

]54[

METHOD AND APPARATUS FOR
WAKING A PERSON

]22[
]31[
]51[
]71[
]87[
]74[

05.12.2005
60/632535
]32[ 03.12.2004
]33[
Int. Cl.(2010.01) G08B 06//00, H04B 03//36
SAFEAWAKE, LLC, U.S.A.
WO/2006/060679
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]57[

A system and method for waking a person includes the provision of tactile stimulation
in a repeating interrupted pattern upon the detection of an alarm signal indicative of an
event for which the person should be awakened. In one embodiment, a device for
waking a person comprises a circuit for generating a driver signal in response to an
alarm signal, the driver signal having a repeating interrupted pattern; an electrically
controlled switching device having a control input, a power input and a power output,
the power input being connectable to a power source, the control input being
connected to receive the driver signal from the circuit; and a tactile stimulation device
connected to the power output of the electrically controlled switching device, the
tactile stimulation device being configured to produce a tactile stimulation.

291

US

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

183594
‫ תהליכים‬,‫נגזרות של פניל–פיפראזין מתאנון‬
‫ תרופות המכילות אותן ושימושן בהכנת‬,‫לייצורן‬
‫תרופות לטיפול במחלת אלצהיימר‬

]54[

PHENYL-PIPERAZINE
METHANONE DERIVATIVES,
PROCESS FOR THEIR
PREPARATION, MEDICAMENTS
CONTAINING THEM AND USE
THEREOF IN THE
MANUFACTURE OF
MEDICAMENTS FOR THE
TREATMENT OF ALZHEIMER'S
DISEASE

]22[
]31[
]51[

01.12.2005
04106440.3
]32[ 09.12.2004
]33[ EP
Int. Cl.(2010.01) A61K 31//496, 31//498, A61P 25//28, C07D 27/7/82, 40/1/04,
40/3/04, 41/3/04, 41/7/04, 41/7/14
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND
WO/2006/061135
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The present invention relates to compounds of the general formula (I) wherein R 1 is
the group (A) or (B) or (C) or (D); R2 is a non aromatic heterocycle, or is OR' or
N(R')2; R' is lower alkyl, lower alkyl substituted by halogen or -(CH2)n-cycloalkyl; R'
is lower alkyl; R3 is NO2, CN or SO2R'; R4 is hydrogen, hydroxy, halogen, NO2, lower
alkyl, lower alkyl, substituted by halogen, lower alkoxy, SO2R' or C(O)OR'; R5/R6/R7
are hydrogen, halogen, lower alkyl or lower alkyl, substituted by halogen; X 1/X1’ are
CH or N, with the proviso that X1/X1’ are not simultaneously CH; X2 is O, S, NH or
N(lower alkyl); n is 0, l or 2; and to pharmaceutically active acid addition salts and to
December 29, 2011-‫ג' בטבת התשע"ב‬

]71[
]87[
]74[

]57[

292

their use in the treatment of neurological and neuropsychiatric disorders.

__________________
]11[]21[
]54[

PROCESS FOR PREPARATION OF
HIGH-PURITY MELOXICAM AND
MELOXICAM POTASSIUM SALT

]22[
]31[
]51[
]71[

16.12.2005
P0402634
]32[ 18.12.2004
Int. Cl.(2010.01) C07D 41/7/12
EGIS GYOGYSZERGYAR NYRT,
HUNGARY
WO/2006/064298
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]87[
]74[

]57[

183739
‫תהליך להכנת מלוקסיקם ומלח אשלגן של‬
‫מלוקסיקם בדרגת ניקיון גבוהה‬

]33[

HU

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

The invention provides a process for the preparation of high purity meloxicam of the
Formula (II). The meloxicam raw product is reacted with the solution of potassium
hydroxide or potassium carbonate, whereby high purity meloxicam potassium sait
monohydrate is produced. Said sait is subsequently treated with minerai or organic
acid to yield high-purity meloxicam.

__________________
]11[]21[
]54[

DOOR AND WINDOW FRAME

]22[
]31[

07.06.2007
TO2006A000435

293

]32[

15.06.2006

183773
‫מסגרת של דלת וחלון‬
]33[

IT
December 29, 2011-‫ג' בטבת התשע"ב‬

]51[
]71[
]74[

]57[

Int. Cl.(2010.01) E05C 09//18
SAVIO S.P.A., ITALY
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
Door and window frame, comprising: a movable quadrangular frame formed by four
section bars each having an outer side provided with a longitudinal groove, in which
the longitudinal groove comprises a base, two parallel lateral walls and two edges
oriented towards each other and defining an undercut engagement area at each of said
lateral walls, a first undercut engagement area being adjacent to a first face of the
frame and a second undercut engagement area being adjacent to a second face of the
frame, and a drive assembly comprising a plurality of actuating members and a
plurality of transmission rods that engage respective longitudinal grooves, each of said
actuating members and each of said transmission rods having a single tenon that
engages only one of said undercut engagement area, characterised in that the tenons of
the actuating member and of the transmission rods all engage said first undercut
engagement area of the respective groove.

__________________
]11[]21[

183776
‫שיטה להרכבת מתקן הנעה על מסגרת של‬
‫דלת או חלון‬

]54[

METHOD FOR MOUNTING A DRIVE
ASSEMBLY FOR DOOR AND
WINDOW FRAMES

]22[
]31[
]51[
]71[
]74[

07.06.2007
TO2006A000434 ]32[ 15.06.2006
]33[ IT
Int. Cl.(2010.01) E05D 15//52
SAVIO S.P.A., ITALY
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
Drive assembly for door and window frames, comprising at least one actuating
member and at least one transmission rod fastened to the actuating member. The
transmission rod comprises a central portion and two lateral portions positioned at
opposite sides relative to the central portion and forming two channel-shaped
longitudinal guides, the central portion having a longitudinal groove positioned
between the longitudinal guides, the longitudinal groove of the central portion being
closed by a base. The transmission member has a connecting portion including two
longitudinal ribs with ends shaped in such a way as to establish a telescopic coupling

]57[

294

December 29, 2011-‫ג' בטבת התשע"ב‬

with the longitudinal guides of the transmission rod and a central portion positioned
between said ribs and provided with a threaded hole in which is inserted a screw
having a tip that is able to cut a hole in the base of the transmission rod at said
longitudinal groove.

__________________
]11[]21[

183777
‫שיטה להרכבת איבר תומך על מסגרת של דלת‬
‫או חלון‬

]54[

METHOD FOR MOUNTING AN
AUXILIARY MEMBER ON A DOOR
OR WINDOW FRAME

]22[
]31[
]51[
]71[
]74[

07.06.2007
TO2006A00434 ]32[ 15.06.2006
]33[ IT
Int. Cl.(2010.01) E05D 15//52
SAVIO S.P.A., ITALY
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
Method for mounting an auxiliary member (130) on a window or door frame (10)
already installed and whereon is mounted a drive assembly (22) comprising at least
one actuating member (24, 25, 26, 27, 28) and at least one transmission rod (30, 32)
mounted in at least one slot (18, 20) of the frame (10). The method comprises the steps
of: providing, between the auxiliary member (130) and said rod (30, 32), a coupling
that is slidable in a longitudinal direction and fixed in any direction orthogonal to the
direction of sliding, and forming a through hole (118) in the rod by means of a screw
(106) carried by the auxiliary member (130), and fastening the auxiliary member to
said rod (30, 32) by the engagement of a tip (110) of said screw (106) with said
through hole (118).

]57[

295

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

183881
–‫מערכת ביוריאקטור עבור טיפול ביולוגי רב‬
‫שלבי במי–שופכין‬

]54[

BIOREACTOR SYSTEM FOR
MULTI-STAGE BIOLOGICAL
WASTEWATER TREATMENT

]22[
]31[
]51[
]71[

11.12.2005
11/008922
]32[ 13.12.2004
]33[ US
Int. Cl.(2010.01) C02F 03//06
AQUARIUS TECHNOLOGIES INC.,
U.S.A.
EFIM MONOSOV, ROMAN
NIKOLEVSKY, VLADIMIR PUZIY,
MARIA MONOSOV
WO/2006/064494
SHALOM LAMPERT IP &
,‫והנדסה בע"מ‬.‫פ‬.‫שלום למפרט אי‬
ENGINEERING LTD.,
59 ‫יקינטון‬
59 YAKINTON ST.
‫מעלות‬1078 .‫ד‬.‫ ת‬,
P.O.B. 1078
MAALOT 21520
A bioreactor system including at least one flexible substrate (10) for supporting
biomass growth having a plurality of threads (50) an at least two cross support
elements (52), wherein openings defined by adjacent threads and adjacent cross
support openings have an aspect ratio exceeding 50:1.

]72[
]87[
]74[

]57[

__________________
]11[]21[
]54[
296

DEVICE FOR DETECTING AND

183891
‫מכשיר לגילוי וספירה של יריות הנורות על ידי‬
‫ וכלי ירי‬,‫כלי ירי אוטומטי או חצי אוטומטי‬
December 29, 2011-‫ג' בטבת התשע"ב‬

‫המצויד במכשיר‬

COUNTING SHOTS FIRED BY AN
AUTOMATIC OR SEMIAUTOMATIC FIRE ARM, AND
FIRE ARM EQUIPPED WITH
SUCH A DEVICE
]22[
]31[
]51[
]71[
]74[

13.06.2007
2006/0396
]32[ 18.07.2006
Int. Cl.(2010.01) F41A 09//53
FN HERSTAL S.A., BELGIUM
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]57[

A device adapted to form a typical signature for a fire arm and for the type of
ammunition comprises an accelerometer with a pass band which is sensitive to shocks
in the axial direction of a barrel and a microprocessor for analyzing a signal of the
accelerometer while firing. The microprocessor is equipped with an algorithm to count
the number of shots to be fired, based on the discernment and recording of a shot to be
fired on the basis of the detection, in the signal of the accelerometer, of all or part of
the characteristic elements of the acceleration signature which is typical in the type of
fire arm and of in different types of ammunition to be used. These characteristic
elements are recorded beforehand in a memory of the device.

]33[

BE

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

__________________
]11[]21[
]54[

297

METHOD AND SYSTEM FOR
SYSTEM DISCOVERY AND USER
SELECTION

184083
‫שיטה ומערכת לגילוי מערכת ובחירת משתמש‬

December 29, 2011-‫ג' בטבת התשע"ב‬

]22[
]31[
]51[
]71[
]87[
]74[

]57[

17.01.2006
60/645367
]32[ 18.01.2005
11/318700
27.12.2005
Int. Cl.(2010.01) H04W 36//14, 88//06
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2006/078627
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]33[

US
US

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

The invention includes a method and apparatus for mobility handling across different
wireless technologies by efficiently performing alternate network discovery and
enabling a mobile station to select the most desirable candidate radio access
technology, depending on parameters such as location and network policy settings.

__________________
]11[]21[
]54[

TRANSDERMAL THERAPEUTIC
SYSTEM COMPRISING TWO
COMPARTMENTS WITH
ACTIVATABLE OVERSATURATION
AND CONTROLLED PERMEATION
PROMOTION AND PROCESS FOR
MANUFACTURING THE SAME

]22[
]31[
]51[
]71[

08.12.2005
102004062614.6 ]32[ 24.12.2004
Int. Cl.(2010.01) A61K 09//70
LTS LOHMANN THERAPIE-SYSTEME
AG, GERMANY
WO/2006/072329
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,

]87[
]74[
298

184145
‫מערכת לריפוי דרך העור המכילה שני תאים‬
‫בעלת אפשרות הפעלה של רווית יתר וקידום‬
.‫חדירה מבוקרת ותהליך לייצורה‬

]33[

DE

,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
December 29, 2011-‫ג' בטבת התשע"ב‬

]57[

P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The invention relates to a transdermal therapeutic system (TTS) that is essentially
composed of two compartments and that is provided with activatable oversaturation
and controlled permeation promotion. The invention more particularly relates to a
TTS, wherein an oversaturated active ingredient solution is produced in an activesubstance-containing polymer matrix when the system is applied to the skin, caused by
the controlled supply of one or several substances promoting permeation of the
pharmaceutical active ingredient; the two compartments which make up the inventive
transdermal therapeutic system; and the production of said transdermal therapeutic
system from the two compartments.

__________________
]11[]21[

184161
‫מתקן ושיטה לטיפול במוצר נוזלי‬

]54[

DEVICE AND METHOD FOR
TREATMENT OF A LIQUID
PRODUCT

]22[
]31[
]51[
]71[

22.12.2005
20040137687 ]32[ 23.12.2004
]33[ RU
Int. Cl.(2010.01) A23L 03//015, B05B 17//00
MILLISECOND TECHNOLOGIES
CORPORATION, U.S.A.
WO/2006/067604
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
279 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬6451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
A method and device related to a liquid product pressure and (optionally) temperature
treatment method reduces the level of microorganisms in the liquid product to a
preselected level. Utilizing the method, liquid product is diffused in a chamber with
the speed of pressure variation of liquid product in one embodiment of about 10 9
Pa/sec. The preferred speed of the diffused drops is about 10m/sec. The liquid product
can optionally be heated before or during diffusion, and is preferably heated as a
diffused liquid product by mixing it with superheated steams The device includes a
chamber and a diffuser in communication with the chamber. Optionally, the device
may include a heating apparatus, such as a steam generator connected via a pressure
control valve to a steam super heater, a cooling chamber connected via a pressure
control valve with a condenser, a vacuum pump in communication with the chamber,
units for condensation and collecting finished products and a vacuum control unit in
communication with the chamber.

]87[
]74[

]57[

299

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

184200
‫משטח ביניים המתאים במיוחד למבנה‬
‫אורתוגגונלי של מערכת אלקטרונית‬

]54[

MIDPLANE ESPECIALLY
APPLICABLE TO AN
ORTHOGONAL ARCHITECTURE
ELECTRONIC SYSTEM

]22[
]31[

23.12.2005
60/638973
]32[ 24.12.2004
]33[ US
11/173927
01.07.2005
US
Int. Cl.(2010.01) H01R 13//648
AMPHENOL CORPORATION, U.S.A.
THOMAS COHEN, MARK W.
GAILUS, JOHN R. DUNHAM
WO/2006/071890
DR. DAVID AGRANOV,
,‫ד"ר דוד אגרנוב‬
P.O.B. 15,
‫אבא‬-‫אלוני‬15 .‫ד‬.‫ ת‬,
ALONEY-ABA
36005
A midplane has a first side to which contact ends of a first differential connector are
connected and a second side opposite the first side to which contact ends of a second
differential connector are connected. The midplane includes a plurality of vias
extending from the first side to the second side, with the vias providing first signal
launches on the fist side and second signal launches on the second side. The first signal
launches are provided in a plurality of rows, with each row having first signal launches
along a first line and first signal launches along a second line substantially parallel to
the first line. The second signal launches are provided in a plurality of columns, with
each column having second signal launches along a third line and second signal
December 29, 2011-‫ג' בטבת התשע"ב‬

]51[
]71[
]72[
]87[
]74[

]57[

300

launches along a fourth line substantially parallel to the third line.

__________________
]11[]21[

184310

]54[

PROCESS FOR PREPARING 2METHYL-1-(2-METHYLPROPYL)1H-IMIDAZO[4,5C][1,5]NAPHTHYRIDIN-4-AMINE

]22[
]31[

28.12.2005
60/641129
]32[ 30.12.2004
]33[ US
60/708679
16.08.2005
US
Int. Cl.(2010.01) C07D 47/1/12
MEDA AB, SWEDEN
WO/2006/074046
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
The invention provides various processes for preparing 2-methyl-1-(2-methylpropyl)1H-imidazo[4,5-c][1,5]naphthyridin-4-amine.

]51[
]71[
]87[
]74[
]57[

–H1–)‫–מתילפרופיל‬2(–1–‫–מתיל‬2
‫–אמין‬4–‫]נפתירידין‬C][5,1–5,4[‫אימידאזו‬

__________________

301

December 29, 2011-‫ג' בטבת התשע"ב‬

]11[]21[

‫מחסום רכב עם תאורה‬

]54[

VEHICLE BARRIER WITH
LIGHT

]22[
]51[
]71[
]72[
]74[

02.07.2007
Int. Cl.(2010.01) F21V 33//00
GAMASONIC LTD.
LAZAR IZARDEL
DEKEL PATENT LTD.,
18 MENUHA VENAHALA ST.,
REHOVOT 76209

]57[

184362

‫ אביב‬-‫ תל‬,‫גמסוניק בע"מ‬
‫לזר איזרדל‬
,‫דקל פטנט בע"מ‬
27 ‫חדר‬, 18 ‫מנוחה ונחלה‬
‫רחובות‬
An assembly comprising: a vehicle barrier arranged for moving from a first
position that permits a vehicle to move past the vehicle to a second position
that prevents a vehicle from moving past the vehicle barrier; and a light
mounted on said vehicle barrier that moves with said vehicle barrier, wherein
when said vehicle is in the first position said light is illuminated in a first
color and in the second position said light is illuminated in a second color.

__________________
]11[]21[

184438
‫ תכשירים‬,‫ תהליך להכנתם‬,‫מקרולידים‬
‫רוקחיים המכילים אותם ושימושם בהכנת‬
‫תרופות לטיפול במחלות דלקתיות‬

]54[

MACROLIDES, PROCESS FOR
THEIR PREPARATION,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THE SAME AND USE THEREOF
IN THE MANUFACTURE OF
MEDICAMENTS FOR THE
TREATMENT OF
INFLAMMATORY DISEASES

]22[
]31[

13.01.2006
60/643841
]32[ 13.01.2005
]33[ US
60/715828
09.09.2005
US
Int. Cl.(2010.01) A61K 31//7042, 31//7048, 31//7052, A61P 29//00, C07H 17//08
GLAXO GROUP LIMITED, UNITED
KINGDOM
WO/2006/087644
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬

]51[
]71[
]87[
]74[
302

December 29, 2011-‫ג' בטבת התשע"ב‬

]57[

P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The present invention relates to novel semi-synthetic macrolides having antiinflammatory activity. More particularly, the invention relates to 14- and 15-membered
macrolides substituted at the 4' position, to their pharmaceutically acceptable
derivatives, to processes and intermediates for their preparation, to pharmaceutical
compositions containing them and to their activity and use in the treatment of
inflammatory diseases and conditions in humans and animals, especially those diseases
associated with excessive secretion of TNF-alpha, IL-1, IL-8, IL-2 or IL-5; and/or
inhibitor of excessive lymphocyte proliferation; and/or excessive granulocyte
degranulation.

__________________
]11[]21[

184877
‫סילון פלזמה בלחץ אטמוספרי‬

]54[

ATMOSPHERIC-PRESSURE
PLASMA JET

]22[
]31[
]51[
]71[

06.02.2006
05447017.4
]32[ 04.02.2005
]33[ EP
Int. Cl.(2010.01) H05H 01//24
VLAAMSE INSTELLING VOOR
TECHNOLOGISCH ONDERZOEK
(VITO), BELGIUM
WO/2006/081637
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The present invention is related to a plasma jet apparatus for performing plasma
processing of an article, comprising: - An elongated central electrode (2,15), - An
elongated cylindrical outer electrode (1) or two outer electrodes (15,16) surrounding
said central electrode and being coaxial with said central electrode, or two electrodes
substantially parallel to the central electrode, - An electrical insulator (3) or insulators
(18,19) disposed between said outer electrode(s) and said central electrode, wherein a
discharge lumen having a distal end and a proximal end is defined between said central
electrode and said electrical insulator(s), - A supply opening (6) disposed at said distal
end of said discharge lumen for supplying a plasma producing gas to said discharge
lumen, - A power source (9) for providing a voltage between said central electrode and
said outer electrode characterised in that said electrical insulator has a radial or
outward extension (40,20) at said proximal end beyond the outer surface of said outer
electrode(s).

]87[
]74[

]57[

303

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[
]54[

METHOD OPTIMISING RADIO
CONNECTIONS IN MOBILE
TELECOMMUNICATIONS
NETWORKS

]22[
]31[
]51[
]71[

25.01.2006
0501754.6
]32[ 27.01.2005
Int. Cl.(2010.01) H04L 12//28
HUTCHISON WHAMPOA THREE G
IP (BAHAMAS) LIMITED,
BAHAMAS
WO/2006/079802
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]87[
]74[

]57[

304

184887
‫שיטה לייעול חיבורי רדיו ברשתות‬
‫טלקומוניקציה ניידות‬

]33[

GB

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

A method of optimising radio connections in cellular mobile communications network
on the basis of the user equipment and data service being used. The network allocates
Access Point Names to various user equipment/data service combinations. In turn the
Access Point Names are allocated Quality Service parameters which are appropriate to
the corresponding user equipment and data service. When a user terminal requests a
data service with a particular Access Point Name, the radio connection is established
with a Quality of Service which is appropriate to the user equipment and data service
currently being used.

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

184983
–‫–פוריל)פירימידינ‬2(–4–‫–אמינו‬2[–5 ‫גביש של‬
‫)–און ותהליכים‬H 1(2–‫–מתילפירידינ‬1–]‫–איל‬5
‫לייצורו‬

]54[

CRYSTAL OF 5-[2-AMINO-4-(2FURYL)PYRIMIDIN-5-YL]-1METHYLPYRIDIN-2(1H)-ONE
AND PROCESSES FOR
PRODUCING THE SAME

]22[
]31[
]51[
]71[

20.03.2006
60/663580
]32[ 21.03.2005
]33[ US
Int. Cl.(2010.01) A61K 31//506, C07D 40/5/14
EISAI R&D MANAGEMENT CO.,
LTD., JAPAN
HITOSHI HARADA, HIROSHI
ISHIHARA, YOSHIAKI SATO,
HIROYUKI CHIBA, TEIJI
TAKIGAWA
WO/2006/101081
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45087 .‫ד‬.‫ ת‬,
JERUSALEM 91450
Crystal of 5-[2-amino-4-(2-furyl)pyrimidin-5-yl]-1- methylpyridin-2(1H)-one
exhibiting, in powder X-ray diffractometry, diffraction peaks at diffraction angles
(2&thetas;±0.2°) of 12.8°, 18.1° and/or 23.5°. This crystal excels in photostability,
thereby being suitable for use as an active ingredient of preventive/therapeutic agents
for diseases, such as costiveness.

]72[

]87[
]74[

]57[

305

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

185100
‫מכלול לשימוש חד–פעמי המכיל גורם מנקב עור‬

]54[

DISPOSABLE ASSEMBLY
CONTAINING A SKIN PIERCING
ELEMENT

]22[
]31[
]51[
]71[

07.02.2006
0502840.2
]32[ 07.02.2005
]33[
Int. Cl.(2010.01) A61B 05//15, A61M 37//00
GLIDE PHARMACEUTICAL
TECHNOLOGIES LIMITED, UNITED
KINGDOM
WO/2006/082439
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]87[
]74[

]57[

GB

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

The invention relates to devices used in the fields of drag delivery or sampling. More
particularly, it relates to a disposable assembly which is fitted to an actuator device
which causes the skin piercing element to enter the skin to deliver a drug (or other
substance) or take a sample. Preferably the assembly is 'made safe' after actuation,
such that the disposable assembly can't be reused and more preferably still the skin
piercing element is safely housed in the assembly such that it does not constitute a
'sharps' risk.

__________________
]11[]21[
]54[

REPLICATION-DEFICIENT RNA
VIRUSES AS VACCINES

]22[
]31[

10.02.2006
10 2005 006

306

]32[

11.02.2005

185147
‫ נטולי יכולת שכפול כחיסונים‬RNA ‫וירוסי‬

]33[

DE
December 29, 2011-‫ג' בטבת התשע"ב‬

]51[
]71[

]87[
]74[

]57[

388.8
Int. Cl.(2010.01) A61K 48//00, C07K 14//005, 14//115, C12N 15//86
MAX-PLANCK-GESELLSCHAFT
ZUR FOERDERUNG DER
WISSENSCHAFTEN E.V.,
GERMANY
WO/2006/084746
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The invention relates to a genome replication-deficient and transcription-competent
negative strand RNA virus which can be used for expressing transgenes and especially
for developing vaccines. The viral genome contains a mutation in at least one of the
genes N, L, or P.

__________________
]11[]21[
]54[

RADIO TRANSMISSION SYSTEM
AND METHOD FOR THE
OPERATION THEREOF

]22[
]31[

06.02.2006
102005006909.6 ]32[ 15.02.2005
102005030108.8
28.06.2005
Int. Cl.(2010.01) H04L 29//06
ROHDE & SCHWARZ GMBH & CO.
KG, GERMANY
WO/2006/087118
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O.B. 2081,
HERZLIYA 46120

]51[
]71[
]87[
]74[

]57[

307

185228
‫מערכת לשידור רדיו ושיטה להפעלתו‬

]33[

DE
DE

‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬2081 .‫ד‬.‫ ת‬,
The invention relates to a radio transmission system comprising a plurality of
processing layers for the transmission of data packets between various radio appliances
in a radio channel. A first functional unit (11) in a physical radio transmission layer
analyses the radio channel and determines the quality (QoC) of the radio channel. A
second functional unit (12) in a back-up layer controls the access to the radio channel
according to the actual quality (QoC) of the radio channel and the priority of the data
packets to be transmitted according to the quality (QoS) of the service carried out by
December 29, 2011-‫ג' בטבת התשע"ב‬

the data packets. A third functional unit (14) in a switching layer controls the switching
of the data packets. A control unit (13) then releases the data packets for switching by
means of the third functional unit (14) only when the quality (QoS) of the service
carried out by the data packets corresponds sufficiently with the quality (QoC) of the
radio channel determined in the first functional unit (11).

__________________
]11[]21[

185534
‫מערכת ושיטה למדידת תכולה של מיכל‬

]54[

SYSTEM AND METHOD FOR
MEASURING CONTENT OF A BIN

]22[
]31[
]51[
]71[

27.02.2006
60/656373
]32[ 28.02.2005
]33[ US
Int. Cl.(2010.01) G01F 17//00, 23//296
A.P.M. AUTOMATION SOLUTIONS
-‫ תל‬,‫ פתרונות אוטומציה בע"מ‬.‫מ‬.‫פ‬.‫א‬
LTD.
‫אביב‬
OFIR PERL, YOSSI ZLOTNICK
‫ יוסי זלוטניק‬,‫אופיר פרל‬
WO/2006/090394
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
‫ רחוב ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
7
7 JABOTINSKY ST.,
‫ גן‬-‫רמת‬
RAMAT GAN 52520
A system for measuring a height of a content of a bin, comprising: (a) at least one
transmitter for transmitting a pulse of acoustic energy towards an upper surface of the
content; (b) an array of at least three non-collinear receivers for receiving an echo of
said pulse, each said receiver producing a respective signal in response to said echo;
and (c) a processing apparatus, for jointly transforming said signals into at least one
measured distance from said array to said upper surface, that includes:
i. for each said receiver, a correlator for correlating a waveform of

]72[
]87[
]74[

]57[

308

December 29, 2011-‫ג' בטבת התשע"ב‬

said pulse with said respective signal, thereby producing a correlated signal, and
ii. a beamformer for computing at least one direction of arrival of said
correlated signals from said upper surface to said array.

__________________
]11[]21[

185631
‫שיטה וערכה לקביעת הרגישות של דוגמא‬
‫ביולוגית לשילוב של ארלוטיניב וגורם כימותרפי‬

]54[

METHOD AND KIT FOR
DETERMINING THE
SENSITIVITY OF A BIOLOGICAL
SAMPLE TO A COMBINATION OF
ERLOTINIB AND A
CHEMOTHERAPEUTIC AGENT

]22[
]31[

10.05.2006
05010244.1
]32[ 11.05.2005
]33[ EP
05011070.9
23.05.2005
EP
Int. Cl.(2010.01) G01N 33//573, 33//574
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND
WO/2006/119980
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The present invention relates to a method of determining whether a biological sample
comprising human lung cancer cells is sensitive to a combination of an epidermal
growth factor receptor inhibitor and a chemotherapeutic agent by determining the
overexpression of a phosphorylated AKT protein and/ or a phosphorylated MAPK
protein in the biological sample. The invention is also related to methods for deriving a
candidate agent or for selecting a composition for inhibiting the progression of lung
cancer in a patient wherein a phosphorylated Akt protein and/ or a phosphorylated
MAPK protein is used.

]51[
]71[
]87[
]74[

]57[

309

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[
]54[

COUPLER WITH EDGE AND
BROADSIDE COUPLED
SECTIONS

]22[
]31[
]51[
]71[
]87[
]74[

01.03.2006
11/075608
]32[ 08.03.2005
Int. Cl.(2010.01) H01P 05//18
WERLATONE, INC., U.S.A.
WO/2006/096445
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122

]57[

185696
‫מחבר עם קצה וחלקי צד רחב מוצמד‬

]33[

US

,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
Couplers (40) are disclosed that include first and second mutually coupled conductors
(48, 50). The coupled conductors may be regular or irregular in configuration, and for
example, may be linear, including rectilinear or with one or more curves, bends or
turns (78), such as forming a ring, coil, spiral (74, 76) or other loop (70, 72). One or
more sections (42, 44 46) of a coupler (40) may be on different levels and separated by
a dielectric medium, such as air or a dielectric substrate. Coupled conductors (48, 50)
may be facing each other on the same or spaced-apart dielectric surfaces, such as
opposing surfaces of a common substrate, and each conductor (48, 50) may include
one or more portions (48c, 48d, 48e, 50c, 5Od, 5Oe) on each side or surface of a
substrate. In some examples, a coupler (40) may include plural coupled sections (42,
44, 46), with conductors (48, 50) in one section (44) being only broadside coupled, and
conductors (48, 50) in another section (42) being edge-coupled.

__________________
]11[]21[
]54[
310

BOX AND LID

185874
‫קופסה ומכסה‬
December 29, 2011-‫ג' בטבת התשע"ב‬

]22[
]31[
]51[
]71[
]87[
]74[

]57[

07.03.2006
0500579-8
]32[ 11.03.2005
]33[ SE
60/660469
11.03.2005
US
Int. Cl.(2010.01) A24F 23//02, B65D 43//08
GALLAHER SNUS AB, SWEDEN
WO/2006/096117
EITAN MEHULAL LAW GROUP,
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
10 ABBA EBEN BLVD.,
,‫פטנטים‬
P.O.B. 2081,
10 ‫שדרות אבא אבן‬
HERZLIYA 46120
‫הרצליה‬2081 .‫ד‬.‫ ת‬,
A box comprising an open container (2) and a lid (3) for closing the open container
(2), the box (1) in a closed state comprising two base surfaces (4, 5), one of which
consists of the bottom wall (4) of the open container and the other of the top wall (5) of
the lid (3), together with at least one lateral surface, which is formed by a container
side (6) and a lid side (7). When the box (1) is in the closed state the container side (6)
and the lid side (7) at least partial overlap one another. An inward facing, inclined slide
surface (19) is furthermore arranged on the inside of the top wall (5) of the lid (3) in
order, when closing the open container (2), to allow displacement of the lid (3) into the
correct closing position relative to the container (2). The slide surface (19) runs along
and adjacent to the lid side (7) at an angle relative to the top wall (5) and the lid side
(7) and is remote from the lid side (7).

__________________
]11[]21[

185888
‫שמן עמיד בפני חום המאפשר סינרגיה המכיל‬
DHA–‫ ו‬EPA ‫ מסוג‬3 ‫חומצות אומגה‬

]54[

SYNERGISTICALLY HEAT
STABLE OIL MEDIA
COMPRISING
EICOSAPENTAENOIC ACID
(EPA) AND
DOCOSAHEXAENOIC ACID
(DHA)

]22[
]51[

11.03.2005
Int. Cl.(2010.01) A23D 09//00, 09//06, A61P 03//06, 09//10, C11B 05//00

311

December 29, 2011-‫ג' בטבת התשע"ב‬

]71[
]87[
]74[

]57[

RECON OIL INDUSTRIES
PRIVATE LIMITED, INDIA
WO/2006/095357
FISHER WEILER JONES,
26 HABARZEL ST.,
RAMAT HACHAYAL 69710

,‫פישר וילר ג'ונס‬
26 ‫הברזל‬
‫רמת החייל‬

A synergistically heat stable therapeutically active triglyceride and cholesterol
controlling oil composition including the usually highly unsaturated Eicosa Pentaenoic
Acid (EPA) and Docosa Hexaenoic Acid (DHA). The invention avoids limitations of
presently available impure sources of EPA / DHA such as fish oil, algae and the like
and provides for a synergistically stable edible oil formulation involving the Eicosa
Pentaenoic Acid and Docosa Hexaenoic acid of at least 50% to less than 100% purity
in a free of any encapsulated / protected form in combination with synergistically
stability contributing oil constituents / ingredients. The invention also provides for
benefit applications / uses of the surprising and unexpected heat stability of the
beneficial actives EPA and DHA. The invention is therefore directed to serve in
possible provision of variety of alternative media including heat stable media for
regular consumption of EPA / DHA and provide for maintenance of safe and healthy
lifestyle.

__________________
]11[]21[

186203
‫מערכת לניטור טמפרטורות נמוכות עבור‬
‫מחסומים מתחת לפני השטח‬

]54[

LOW TEMPERATURE
MONITORING SYSTEM FOR
SUBSURFACE BARRIERS

]22[
]31[
]51[
]71[

21.04.2006
60/674081
]32[ 22.04.2005
]33[ US
Int. Cl.(2010.01) E21B 47//06, 47//12, G01K 11//32
SHELL INTERNATIONALE
RESEARCH MAATSCHAPPIJ B.V.,
THE NETHERLANDS
WO/2006/115945
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]87[
]74[

]57[

312

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

The invention provides a system for monitoring temperature of a subsurface low
temperature zone, that includes a plurality of freeze wells (114) configured to form the
low temperature zone; at least one monitor well; one or more lasers; a fiber optic cable
December 29, 2011-‫ג' בטבת התשע"ב‬

(146) coupled to at least one laser (142), and an analyzer (144) coupled to the fiber
optic cable. A portion of the fiber optic cable is positioned in at least one monitor well.
At least one laser is configured to inject light pulses into at least one end of the fiber
optic cable. The analyzer is configured to receive return signals from the light pulses.
The invention also provides methods for monitoring temperature of a subsurface low
temperature zone.

__________________
]11[]21[
]54[

METHODS AND SYSTEMS FOR
PRODUCING FLUID FROM AN IN
SITU CONVERSION PROCESS

]22[
]31[
]51[
]71[

21.04.2006
60/674081
]32[ 22.04.2005
Int. Cl.(2010.01) E21B 36//00, 43//24
SHELL INTERNATIONALE
RESEARCH MAATSCHAPPIJ B.V.,
THE NETHERLANDS
WO/2006/116092
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]87[
]74[

]57[

313

186206
‫שיטות ומערכות ליצור נוזל מתהליך היפוך פנימי‬

]33[

US

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

The invention provides systems that include a plurality of heat sources (102)
configured to heat a portion of a formation; at least one production well (106) in the
formation, a pump system, and a production conduit coupled to the pump system. The
bottom portion of the production well is a sump positioned in an underburden of the
formation that is below the heated portion of the formation. Fluids are allowed to flow
from the heated portion of the formation flow into the sump. The pump system in
combination with the production conduit transport fluids in the sump out of the
formation. The invention also provides methods to remove a portion of the fluids from
the formation.

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[
]54[

VARYING PROPERTIES ALONG
LENGTHS OF TEMPERATURE
LIMITED HEATERS

]22[
]31[
]51[
]71[

21.04.2006
60/674081
]32[ 22.04.2005
Int. Cl.(2010.01) E21B 36//04, 43//24
SHELL INTERNATIONALE
RESEARCH MAATSCHAPPIJ B.V.,
THE NETHERLANDS
WO/2006/116130
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]87[
]74[

]57[

314

186207
‫שינוי תכונות לאורכם של מחממים אורכיים‬
‫בעלי טמפרטורה מוגבלת‬

]33[

US

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

A system for heating a subsurface formation is described. The system includes an
elongated heater in an opening in the formation. The elongated heater includes two or
more portions along the length of the heater that have different energy outputs. At least
one portion of the elongated heater includes at least one temperature limited portion
(240) with at least one selected temperature at which the portion provides a reduced
heat output. The heater is configured to provide heat to the formation with the different
energy outputs . The heater heats one or more portions of the formation at one or more
selected heating rates.

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[
]54[

IN SITU CONVERSION PROCESS
SYSTEMS UTILIZING
WELLBORES IN AT LEAST TWO
REGIONS OF A FORMATION

]22[
]31[
]51[
]71[

21.04.2006
60/674081
]32[ 22.04.2005
Int. Cl.(2010.01) E21B 36//04, 43//24
SHELL INTERNATIONALE
RESEARCH MAATSCHAPPIJ B.V.,
THE NETHERLANDS
WO/2006/116133
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]87[
]74[

]57[

315

186211
‫מערכות לתהליך המרה במקומו המקורי‬
‫המשתמשות בקודח בארות בלפחות שני איזורים‬
‫של הפורמציה‬

]33[

US

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

A system for heating a subsurface formation is described. The system includes a
plurality of elongated heaters (244) located in a plurality of openings in the formation.
At least two of the heaters are substantially parallel to each other for at least a portion
of the lengths of the heaters. At least two of the heaters have first end portions (234) in
a first region of the formation and second end portions (238) in a second region of the
formation. A source of time-varying current (254) is configured to apply time-varying
current to at least two of the heaters. The first end portions of the heaters are
configured to be applied with substantially the same voltage. The second portions of
the heaters are configured to be applied with substantially the same voltage.

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

186214
‫תהליך המרה פנימי המנצל מערכת חימום‬
‫פנימית סגורה‬

]54[

IN SITU CONVERSION PROCESS
UTILIZING A CLOSED LOOP
HEATING SYSTEM

]22[
]31[
]51[
]71[

21.04.2006
60/674081
]32[ 22.04.2005
]33[ US
Int. Cl.(2010.01) C10L 03//08, E21B 36//00, 36//04, 43//24
SHELL INTERNATIONALE
RESEARCH MAATSCHAPPIJ B.V.,
THE NETHERLANDS
WO/2006/116096
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]87[
]74[

]57[

316

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

The invention provides an in situ conversion system for producing hydrocarbons from
a subsurface formation, that includes: a plurality of u-shaped wellbores in the
formation; piping positioned in at least two of the u-shaped wellbores; a fluid
circulation system coupled to the piping, and an electrical power supply. The fluid
circulation system is configured to circulate hot heat transfer fluid through at least a
portion of the piping to form at least one heated portion of the formation. The electrical
power supply is configured to provide electrical current to at least a portion of the
piping (220) located below an overburden in the formation to resistively heat at least a
portion of the piping and the heat transfers from the piping to the formation. The
invention also provides methods of using the in situ conversion system to produce
hydrocarbons from the subsurface formation.

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

186288
‫מערכת להקרנת וידיאו במהירות משתנה‬

]54[

TRICK MODE SYSTEM

]22[
]31[
]51[
]71[
]87[
]74[

18.01.2006
60/669134
]32[ 07.04.2005
]33[ US
Int. Cl.(2010.01) H04J 01//02, H04L 09//08, H04N 05//783, 07//167
NDS LIMITED, UNITED KINGDOM
WO/2006/106498
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A method is described for trick mode playback (10), the method including selecting a
key- frame in recording (20) substantially in the vicinity of a trick mode playback
starting position (30), preparing a decryption key associated with a key period
including the selected key-frame, sending the prepared decryption key to a
descrambler (70), thereby enabling decryption of video beginning at the selected keyframe, sending a first number P seconds of decrypted video frames, starting a the
selected key-frame, at a predetermined speed for a predetermined number of seconds,
to a video decoder, in parallel to the sending P seconds of video frames, choosing at
least a second video section (50) to stream to the video decoder, sending a decryption
key associated with the chosen second video section to the descrambler (70), and
repeating the steps of selecting, preparing, sending the prepared decryption key, and
sending a first number P seconds of decrypted video frames.

]57[

317

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

186384
,‫תמיסות מימיות של מבהירים אופטיים‬
‫שימוש בהן עבור הרכבי ציפוי לנייר וכן תהליכי‬
‫ציפוי נייר העושים בהן שימוש‬

]54[

AQUEOUS SOLUTIONS OF
OPTICAL BRIGHTENERS, USE
THEREOF FOR COATING
COMPOSITIONS FOR PAPER AND
PAPER COATING PROCESSES
USING SAME

]22[
]31[
]51[
]71[

05.04.2006
05007691.8
]32[ 08.04.2005
]33[
Int. Cl.(2010.01) C07D 40/3/12, D21H 21//30
CLARIANT FINANCE (BVI)
LIMITED, BRITISH VIRGIN
ISLANDS
WO/2006/108785
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]87[
]74[

]57[

EP

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

The instant invention relates to storage stable aqueous solutions of stilbene optical
brighteners with polyvinyl alcohols which can be directly used by the papermaker in
that they may be diluted with water and/or be metered directly into a coating
composition, to provide coated papers of a particularly high whiteness.

__________________

318

December 29, 2011-‫ג' בטבת התשע"ב‬

]11[]21[

186491
‫ אדרנו–קולטן לטיפול‬2–‫אגוניסטים של בטא‬
‫במחלת–עור הקשורה לרקמה מחברת‬

]54[

BETA-2 ADRENOCEPTOR
AGONISTS FOR TREATING
CONNECTIVE TISSUE DISEASES
OF THE SKIN

]22[
]31[
]51[
]71[
]87[
]74[

12.04.2006
PA200500529 ]32[ 13.04.2005
Int. Cl.(2010.01) A61K 45//00
ASTION PHARMA A/S, DENMARK
WO/2006/108424
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]57[

The present invention provides effective and safe medicaments for the treatment of
connective tissue diseases of the skin, particularly with respect to the treatment of
cutaneous forms of Lupus Erythematous. The medicaments comprise as the
therapeutically active ingredient a beta2 adrenoceptor agonist. The invention
furthermore relates to dermatological compositions without skin sensitization
properties and which contain enantiomerically pure or enriched R-enantiomers of a
beta2 adrenoceptor agonist.

]33[

DK

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

__________________
]11[]21[

186517
‫מעקה רב–סריגי לבטיחות כלי רכב‬

]54[

VEHICLE SAFETY MULTI-RAIL
PARAPET

]22[
]31[

04.04.2006
0507358.0
]32[ 12.04.2005
]33[ GB
0520191.8
05.10.2005
GB
Int. Cl.(2010.01) E01D 19//10, E01F 13//00, 15//00
VARLEY AND GULLIVER
LIMITED, UNITED KINGDOM
WO/2006/109019
SELIGSOHN GABRIELI & CO.,
,'‫זליגסון גבריאלי ושות‬
31 YAVNE ST.,
31 ‫רח' יבנה‬
P.O.B. 1426,
‫תל אביב‬1426 .‫ד‬.‫ ת‬,
TEL AVIV 61013
A vehicle safety parapet comprises a plurality of rails (18, 24, 28) supported at varying

]51[
]71[
]87[
]74[

]57[
319

December 29, 2011-‫ג' בטבת התשע"ב‬

heights on uprights (12). A first of the rails comprises a steel box-section supported at
each upright by bracketing means (20) configured to collapse when a horizontal impact
load is applied to the rail, such that the first rail is displaced towards the upright. At
least one other rail extends from the uprights by a greater distance than the first rail
when the bracketing means has collapsed.

__________________
]11[]21[

186577
‫שיטה והתקן לחיזוי יחס אות להפרעה‬

]54[

SIR PREDICTION METHOD AND
APPARATUS

]22[
]31[
]51[
]71[

10.04.2006
11/105797
]32[ 14.04.2005
]33[ US
Int. Cl.(2010.01) H04B 17//00, H04W 52//22
TELEFONAKTIEBOLAGET L M
ERICSSON (PUBL), SWEDEN
WO/2006/108587
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
The present invention provides a method and apparatus for generating SIR estimates
early in a time interval that include the benefits of interference suppression without
requiring the computation of specific interference suppression elements. In particular,
the present invention generates an SIR estimate for a RAKE receiver during a current
time interval based on channel estimates generated based on the received signal(s). By
applying an offset derived during a previous time interval to the RAKE SIR estimate,
the present invention generates a second SIR estimate for a generalized RAKE
receiver.

]87[
]74[
]57[

320

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

186680
‫שיטה לייצור מלחי מתכת טריאלקלים של‬
‫–חומצה דיאתנואית עם‬N,N–‫מתילגליצין‬
‫תכולה נמוכה של תוצרי לוואי‬

]54[

METHOD FOR PRODUCING
METHYLGLYCINE-N,NDIETHANOIC ACID
TRIALKALIMETAL SALTS WITH A
LOW BY-PRODUCT CONTENT

]22[
]31[
]51[
]71[
]87[
]74[

02.05.2006
102005021055.4 ]32[ 06.05.2005
Int. Cl.(2010.01) C07C 22/7/26
BASF SE, GERMANY
WO/2006/120129
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]57[

The invention relates to a method for producing a light-coloured methylglycine-N,Ndiethanoic acid trialkali metal salt with a low by-product content, by the alkaline
hydrolysis of methylglycine diacetonitrile, said method comprises steps that are carried
out in the order (a) to (f): (a) mixing of the methylglycine diacetonitrile with an
aqueous alkali lye at a temperature of = 30 °C; (b) the aqueous alkali methylglycine
diacetonitrile suspension is then reacted at a temperature ranging between 10 and 30
°C for a period of 0.1 to 10 h, to form a solution; (c) the solution obtained in step (b) is
then reacted at a temperature ranging between 30 to 40 °C for a period of 0.1 to 10 h;
(d) optionally the solution obtained in step (c) is reacted at a temperature ranging
between 50 and 80 °C for a period of between 0.5 and 2 h; (e) optionally the solution
obtained in step (c) or (d) is reacted at a temperature ranging between 110 and 200 °C
for a period of between 5 and 60 min; (f) hydrolysis and isolation of ammonia from the
solution obtained in step (c), (d) or (e) by stripping at a temperature of between 90 and
105 °C.

321

]33[

DE

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[
]54[

COVERING FOR AN
ENDOPROSTHETIC DEVICE FOR
ANEURYSM TREATMENT

]22[
]31[
]51[
]71[
]72[
]87[
]74[

03.03.2006
60/673304
]32[ 19.04.2005
Int. Cl.(2010.01) A61F 02//06
MEDINOL LTD.
JACOB RICHTER
WO/2006/111801
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O.B. 2081,
HERZLIYA 46120

]57[

322

186786
‫מכסה להתקן תותב פנימי עבור טיפול במפרצת‬

]33[

US
‫אביב‬-‫ תל‬,‫מדינול בע"מ‬
‫יעקב ריכטר‬

‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬2081 .‫ד‬.‫ ת‬,
The present invention relates to covered endoprosthetic devices. Covered
endoprosthetic devices comprise an endoprosthesis and a sheath. The sheath comprises
a central portion and outer portions, wherein the central portion preferentially restricts
or causes a restriction of blood flow. Blood flow can be reduced by the central portion
of the sheath by varying the permeability of the sheath or by having projections on the
sheath that slow blood flow. Permeability may be provided by perforations or holes in
the material of the sheath or by varying the polymer structure that makes up the sheath
itself. The outer portions of the sheath do not substantially reduce blood flow. Methods
of using sheath-covered endoprosthetic devices of the invention to treat aneurysms,
especially aneurysms in proximity to small perforator vessels or arteries, are also
encompassed.

December 29, 2011-‫ג' בטבת התשע"ב‬

The applications for division
from this application have
not yet been published

50/645050/6452

‫בקשות חלוקה מבקשה זו‬
9‫שטרם פורסמו‬

__________________
]11[]21[

186988
‫תהליך ומערכת לתכנון מחדש חוץ–תאי של‬
‫תאים באופן גנטי ואפיגנטי והשימוש בתא‬
‫מתוכנן מחדש להכנת תכשיר רוקחות‬

]54[

PROCESS AND SYSTEM FOR
GENETIC AND EPIGENETIC IN
VITRO REPROGRAMMING OF
CELLS AND USE OF A
REPROGRAMMED CELL IN THE
PREPARATION OF A
PHARMACEUTICAL
COMPOSITION

]22[
]31[

04.05.2006
0551180
]32[ 04.05.2005
]33[ FR
0553058
07.10.2005
FR
0553533
21.11.2005
FR
Int. Cl.(2010.01) A61K 08//98, A61L 27//38, 27//50, A61Q 19//08, C12N 05//16
FRED ZACOUTO, FRANCE
WO/2007/000523
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬

]51[
]71[
]87[
]74[

]57[

323

The invention relates to an epigenetic and genetic treatment method and system. The
invention can be used to rejuvenate an adult cell nucleus without passing through an
embryonic stage and to obtain a tissue that is genetically-rejuvenated and autologous in
December 29, 2011-‫ג' בטבת התשע"ב‬

relation to the original nucleus, comprising the temporary introduction of a nucleus
into an enucleated oocyte (genetic rejuvenation), followed by oocyte extraction prior to
cell division. The treated nucleus can then be introduced into an adult cytoplasm
originating from the nucleus. In this way, cell divisions from the rejuvenated nucleus
take place in an adult autologous cytoplasm and the resulting cells immediately take
the form of adult, differentiated and functional cells. The rejuvenated autologous tissue
thus created can then be grafted without rejection to the adult tissue of the organism
from the treated nucleus.; Throughout the inventive procedure, the treated cytoplasms
and nuclei remain permanently in the adult state and no artificial cell differentiation is
necessary. In this way, the invention is different from standard deep cloning in which
the treated cells must return to the embryonic stage and which involves artificial cell
differentiation. In addition, the tissues derived from standard cloning are not
immunologically compatible with the original adult tissues from the treated nucleus
since the cell division thereof takes place in the oocyte which represents a foreign
cytoplasm to the nucleus. Moreover, standard cloning enables the creation of whole
organisms unlike the inventive method and system which can only be used to treat a
single tissue.; The possible applications of the invention include, for example, the
repair of necrotic tissues, such as a myocardial infarction, and damaged tissues, such as
the retina (RMD), heart failure, renal failure, liver failure and osteoporosis, the
treatment of cancers that occur with age, such as prostate cancer, rectal cancer, colon
cancer, etc. The anodyne implantation of a small volume of autologous, rejuvenated,
still-healthy cells from the affected organ should inhibit the aforementioned cancers
and the metastases thereof.

__________________
]11[]21[

187048
‫נעל‬

]54[

SHOE

]22[
]31[
]51[
]71[
]74[

30.10.2007
095140135
]32[ 30.10.2006
]33[ TW
Int. Cl.(2010.01) A43B 09//06, 13//00, 13//28, 15//00, B29D 35//00, 35//06
CHEN MING-TE, TAIWAN R.O.C.
DR. YORAM TSIVION,
,‫ד"ר יורם צביון‬
2 HATOCHEN ST.
‫ פארק התעשיה‬,2 ‫רח' הטוחן‬
P.O.B. 3148,
‫קיסריה‬3148 .‫ד‬.‫ ת‬,
CAESAREA 38900
A shoe, comprising: a vamp (200), comprising a lateral vamp (210) and a bottom vamp
(220); a connecting medium apparatus (230), comprising a first plane (231) enclosing
said lateral vamp, a second plane (232) connected to said first plane and extending
outward, a third plane (233) connected to said second plane and extending downward,
and a fourth plane (234) connected to said third plane and extending inward, wherein
said second plane comprises a plurality of holes (235); and an outsole (240) enclosing
said connecting medium apparatus and said bottom vamp, wherein a material forming

]57[

324

December 29, 2011-‫ג' בטבת התשע"ב‬

said outsole fills a gap between said fourth plane of said connecting medium apparatus
and said bottom vamp and said holes in said second plane.

__________________
]11[]21[

187093
‫גלגל המונע בכח לרכב צבאי‬

]54[

POWER-DRIVEN WHEEL FOR A
MILITARY VEHICLE

]22[
]31[

01.11.2007
TO2006A
]32[ 15.12.2006
]33[ IT
000894
Int. Cl.(2010.01) B60K 07//00, 17//04
OTO MELARA S.P.A., ITALY
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The application relates to a power-driven wheel for a military vehicle, comprising an
axial-flow electric motor and a hub connected functionally to said motor and rotating
about an axis. The motor comprises an output member housed partially inside said
hub. Further, the wheel is provided with an epicyclic reducer interposed functionally
between said hub and said output member.

]51[
]71[
]74[

]57[

__________________

325

December 29, 2011-‫ג' בטבת התשע"ב‬

]11[]21[

187519
‫רכיבי מכלל סיבובי לטורבינה‬

]54[

ROTOR ASSEMBLY FOR A
TURBINE

]22[
]31[
]51[
]71[

20.11.2007
11/564064
]32[ 28.11.2006
]33[ US
Int. Cl.(2010.01) B23P 15//02, 15//04, F04D 29//38
GENERAL ELECTRIC COMPANY,
U.S.A.
SELIGSOHN GABRIELI & CO.,
,'‫זליגסון גבריאלי ושות‬
31 YAVNE ST.,
31 ‫רח' יבנה‬
P.O.B. 1426,
‫תל אביב‬1426 .‫ד‬.‫ ת‬,
TEL AVIV 61013
A rotor assembly for a turbine, said rotor assembly comprising:
a first portion (210) of a rotor component forged from a first material, said first
material being alpha/beta processed; and a second portion (230) of said rotor
component separately forged from a second material that is the same material as said
first material, said second portion being beta processed, wherein said first material and
said second material comprise titanium-based alloys and said second portion is welded
to said first portion at a first axial position.

]74[

]57[

__________________
]11[]21[
]54[

326

PHARMACEUTICAL
COMPOSITIONS CONTAINING
AN INTERLEUKIN-6
ANTAGONIST FOR TREATMENT
OF STILL'S DISEASE

187604
‫תכשירי רוקחות המכילים אנטגוניסט‬
‫ לטיפול במחלת סטיל‬6 – ‫לאינטרלוקין‬

December 29, 2011-‫ג' בטבת התשע"ב‬

]22[
]31[
]51[
]62[
]71[
]87[
]74[
]57[

02.04.2002
2001-103627 ]32[ 02.04.2001
]33[ JP
2001-109131
06.04.2001
JP
Int. Cl.(2010.01) A61K 38//20, 39//395, 45//00, A61P 19//02, C07K 16//28
DIVISION FROM 158079
CHUGAI SEIYAKU KABUSHIKI
KAISHA, JAPAN
WO/2002/080969
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
A therapeutic agent for treatment of Still's disease comprising an antibody against
interleukin-6 (IL-6) receptor as an active ingredient .

236/57

The parent application from which
this application has been divided has
not yet been published

‫בקשת הורה לבקשה זו שטרם פורסמה‬

__________________
]11[]21[

187667
‫שיטה ומערכת לניווט של מחט אל איבר בגוף של‬
‫מטופל‬

]54[

SYSTEM AND METHOD FOR
NAVIGATING A SURGICAL
NEEDLE TOWARD AN ORGAN
OF THE BODY OF A PATIENT

]22[
]31[
]51[
]71[
]74[

26.11.2007
60/861118
]32[ 27.11.2006
]33[ US
Int. Cl.(2010.01) A61B 17//34, 19//00
MEDIGUIDE LTD.
‫ חיפה‬,‫מדיגייד בע"מ‬
BOROCHOV, KORAKH & CO.,
,'‫בורוכוב קורח ושות‬
15TH FLOOR, ATIDIM TOWER,
‫מגדל כלל עתידים‬
KIRYAT ATIDIM,
‫אביב‬-‫תל‬58100 .‫ד‬.‫ ת‬,
P.O.B. 58100,
TEL AVIV 61580
System (100) for navigating a surgical needle (106) toward a target organ of the body
of a patient, the system comprising: a removable mandrel (108) located within said
surgical needle, said removable mandrel to be moved in and moved out of said surgical
needle; a medical positioning system (MPS) sensor (110) located at the tip of said
removable mandrel; an electromagnetic field generator (104) for generating an
electromagnetic field; and an MPS (102) coupled with said MPS sensor and with said
electromagnetic field generator, said MPS sensor producing an output according to
said electromagnetic field, said MPS determining the position of said tip of said
December 29, 2011-‫ג' בטבת התשע"ב‬

]57[

327

removable mandrel in a coordinate system respective of said MPS, according to said
output of said MPS sensor, said MPS producing an indication respective of said
position, to enable navigation of said surgical needle toward said target organ.

__________________
]11[]21[
]54[

GRATING-BASED SENSOR
COMBINING LABEL-FREE
BINDING DETECTION AND
FLUORESCENCE
AMPLIFICATION AND READOUT
SYSTEM FOR SENSOR

]22[
]31[

20.07.2006
60/707579
]32[ 11.08.2005
60/713694
02.09.2005
60/778160
28.02.2006
60/790207
07.04.2006
Int. Cl.(2010.01) G01N 21//55
SRU BIOSYSTEMS, INC., U.S.A.
WO/2007/019024
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122

]51[
]71[
]87[
]74[

]57[

328

187808
‫חיישן מבוסס גריד המשלב זיהוי כריכה ללא‬
‫תגית והגברת נגיהת אור ומערכת קריאה עבור‬
‫חיישן‬

]33[

US
US
US
US

,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A grating-based sensor is disclosed that has a grating structure constructed and
designed for both evanescent resonance (ER) fluorescence detection and label-free
detection applications. Some embodiments are disclosed which are optimized for ER
detection in an air mode, in which the sample is dry. Other embodiments are optimized
for ER detection in liquid mode, in which the sample is suspended in liquid medium
such as water. One and two-dimensional gratings are also disclosed, including gratings
characterized by unit cells with central posts, central holes, and two-level, twodimensional gratings. A readout system for such sensors is also disclosed. One
embodiment includes a first light source optimized for collecting label -free detection
data, a second light source optimized for collecting ER fluorescence amplification
data, and at least one detector. In one embodiment, the detector is an imaging system
December 29, 2011-‫ג' בטבת התשע"ב‬

and includes a CCD camera for collecting both ER and label-free data. In other
embodiments, the at least one detector takes the form of a spectrometer for collection
of label-free data and a photomultiplier for collecting ER data. In other embodiments,
a single light source such as a tunable laser or broad band light source is used.

__________________
]11[]21[

187813
‫הרכב פרמצבטי לשמירה על רמה קבועה של‬
24 ‫ עד‬12 ‫סטרואיד ניורואקטיבי בפלסמה למשך‬
‫שעות לאחר השימוש‬

]54[

PHARMACEUTICAL
COMPOSITION PROVIDING A
STEADY STATE PLASMA LEVEL
OF A NEUROACTIVE STEROID
FOR 12-24 HOURS FOLLOWING
ADMINISTRATION

]22[
]31[
]51[
]71[

09.06.2006
60/688905
]32[ 09.06.2005
]33[ US
Int. Cl.(2010.01) A61K 09//16, 09//20, 31//58, A61P 25//00
EURO-CELTIQUE S.A.,
LUXEMBOURG
WO/2006/131392
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
124 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11490 .‫ד‬.‫ ת‬,
TEL AVIV 62038
The present invention relates to pharmaceutical compositions of the neuroactive
steroid 3alpha-hydroxy-3beta-methoxymethyl-21-(1′-imidazolyl)-5alpha-pregnan-20one or a pharmaceutically-acceptable salt or solvate thereof., with properties desirable
for use in treating mood disorders and the like. The pharmaceutical compositions
provide sustained therapeutic plasma levels of 3alpha-hydroxy- 3beta-methoxymethyl21-(1′-imidazolyl)-5alpha-pregnan-20-one. The present invention also relates to
methods of treating these disorders by administering the pharmaceutical compositions.

]87[
]74[

]57[

329

December 29, 2011-‫ג' בטבת התשע"ב‬

The applications for division
from this application have
not yet been published

50242725022222

‫בקשות חלוקה מבקשה זו‬
9‫שטרם פורסמו‬

__________________
]11[]21[

187840
‫נגזרות של חומצות תיאזול קרבוקסיליות‬
‫ושימושיהן בטיפול בהפרעות במערכת העצבים‬
‫ההיקפית‬

]54[

THIAZOLE CARBOXYLIC ACIDS
DERIVATIVES AND THEIR USE
IN THE TREATMENT OF
PERIPHERAL NERVE SYSTEM
DISORDERS

]22[
]31[
]51[
]71[

02.06.2006
2005-164458 ]32[ 03.06.2005
]33[ JP
Int. Cl.(2010.01) A61K 31//426, 45//00, C07D 27/7/20
ONO PHARMACEUTICAL CO.,
LTD., JAPAN
WO/2006/129788
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]87[
]74[

]57[

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

An EP2 agonist which may have an EP3 agonistic effect has an effect of regenerating
and/or protecting nerves, and is therefore useful as a therapeutic agent for a disease of
the peripheral nervous system, such as a lower or upper motor neuron disease, a nerve
root disease, plexopathy, thoracic outlet compression syndrome, peripheral
neuropathy, neurofibromatosis and neuromuscular transmission disease. An EP2
agonist which has an EP3 agonistic effect is a safe and effective agent for the
regeneration and/or protection of nerves which has little influence on the circulatory
system.

The applications for division
from this application have
not yet been published

50/5103

‫בקשות חלוקה מבקשה זו‬
9‫שטרם פורסמו‬

__________________
]11[]21[
330

188067
December 29, 2011-‫ג' בטבת התשע"ב‬

‫התקן לשבירה לרסיסים והסרת גושים מצינורות‬
‫וחללים בגוף‬

]54[

DEVICE FOR FRAGMENTING
AND REMOVING
CONCRETIONS FROM BODY
DUCTS AND CAVITIES

]22[
]51[
]71[
]74[

12.12.2007
Int. Cl.(2010.01) A61B 17//22, 18//26
LITHOTECH MEDICAL LTD.
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]57[

A medical device and method for breaking a concretion in a body into smaller pieces
and removing the pieces from the body are described. The device comprises a dilator
sheath, a lithotripsy probe, a tubular member, and a retrieval basket. The dilator sheath
is adapted to penetrate into a passage of the body to reach the location where the
concretion is located. The lithotripsy probe is configured for shattering the concretion
into smaller pieces. The tubular member is mounted within the dilator sheath adapted
to permit the lithotripsy probe to be inserted into the tubular member. The retrieval
basket is coupled to the tubular member, and configured for entrapping the concretion
and the smaller pieces for their extraction from the body. The retrieval basket
comprises a structure constituted by a plurality of filaments extending from a basket
proximal end towards a basket distal end, and then returning to the proximal end after
forming a plurality of filament loops in the basket distal portion, and a plurality of
filament strands at the basket proximal portion.

‫ קצרין‬,‫ליתוטק מדיקל בע"מ‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

__________________
]11[]21[

188199
‫ תהליך הכנתה‬,‫תרכובת ציקלובוטאן מותמרת‬
‫ושימושה הרפואי‬

]54[

SUBSTITUTED CYCLOBUTANE
COMPOUND, ITS PREPARATION
PROCESS AND ITS MEDICAL USE

]22[
]31[
]51[
]71[

21.06.2006
200510027131.X ]32[ 24.06.2005
]33[ CN
Int. Cl.(2010.01) A61K 31//4412, C07C 69//74, C07D 40/1/08
SHANGHAI INSTITUTE OF MATERIA
MEDICA, CHINESE ACADEMY OF
SCIENCES, CHINA
ZHOU CAIHONG, MINGWEI WANG,
NA LI, GUANGXING WANG, XIN XIE,
QING LIU, FAJUN NAN
WO/2006/136101

]72[
]87[
331

December 29, 2011-‫ג' בטבת התשע"ב‬

]74[

]57[

,‫אגמון‬-‫סורוקר‬
14 ‫ רחוב שנקר‬,‫בית נולטון‬
‫הרצליה פיתוח‬
Substituted cyclic compounds of formula (I) or formula (II) are provided. The
preparation methods of said compounds and the uses of glucagons like peptide-1
receptor (GLP-1R) regulators in the prophylaxis or treatment of metabolic disorder,
which include but not limit to diabetes, insulin-resistance and obesity etc., are also
provided.
SOROKER-AGMON,
14 SHENKAR ST.,
HERZLIYA PITUAH 46725

__________________
]11[]21[

188228
‫לאמינאט עמיד לירי וערכת טראומה‬

]54[

BULLET PROOF LAMINATE AND
TRAUMA PACK

]22[
]31[
]51[
]71[
]87[
]74[

16.06.2006
05013518.5
]32[ 23.06.2005
Int. Cl.(2010.01) B32B 05//26
TEIJIN ARAMID GMBH, GERMANY
WO/2006/136323
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]57[

The invention relates to a trauma pack comprising at least one panel of a plastic
material and at least one textile fabric layer affixed to the panel and made of yarns with
fibres having a tensile strength of at least 900 MPa, wherein the plastic material of the
panel is a self-reinforced thermoplastic material made of filaments, fibres, tapes or
strips of a polyolefin polymer, and wherein at least one textile fabric layer is bonded
over its entire surface to the self-reinforced thermoplastic material.

332

]33[

EP

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

188246
‫ראש מברשת למברשת שיניים‬

]54[

BRUSH HEAD FOR A
TOOTHBRUSH

]22[
]31[
]51[
]71[

03.08.2006
1307/05
]32[ 08.08.2005
]33[ CH
Int. Cl.(2010.01) A46B 09//00, 09//04, A46D 01//00
GABA INTERNATIONAL AG,
SWITZERLAND
WO/2007/016802
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]87[
]74[

]57[

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

Disclosed is a brush head (1) for a toothbrush, comprising a grip part (11), a head part
(12), and a bristle area with bunches of bristles (201, 202, 203, 204, 301, 302, 303,
304, 401, 402, 501, 502, 601, 602, 701, 702) that are inserted therein. At least one of
said bunches of bristles (301, 302, 303, 304) is inclined. The inventive brush head (1)
is characterized in that at least some of the bristles in at least one of the inclined
bunches of bristles (301, 302, 303, 304) are pointed.

__________________
]11[]21[
333

188264
December 29, 2011-‫ג' בטבת התשע"ב‬

‫תרבית תרחיף של תאי גזע עובריים ממקור אנוש‬

]54[

SUSPENSION CULTURE OF
HUMAN EMBRYONIC STEM
CELLS

]22[
]31[
]51[
]71[
]87[
]74[

20.06.2006
60/693266
]32[ 22.06.2005
Int. Cl.(2010.01) C12N 05//02
GERON CORPORATION, U.S.A.
WO/2007/002086
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122

]57[

]33[

US

,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
This disclosure provides an improved system for culturing human embryonic stem
cells. The cells are cultured in suspension so as to maximize the production capacity of
the culture environment. The new culture system of this invention allows for bulk
proliferation of hES cells in a more cost-effective manner, which facilitates
commercial production of important products for use in human therapy.

__________________
]11[]21[

188469
–‫מחסנית לערבוב סטרילי של תרכובת דו‬
‫ במיוחד לשרפים אקריליים בעלי שני‬,‫פאזית‬
‫מרכיבים‬

]54[

CARTRIDGE FOR STERILE
MIXING OF A TWO-PHASE
COMPOUND, PARTICULARLY FOR
TWO-COMPONENT ACRYLIC
RESINS

]22[
]31[
]51[
]71[
]72[

16.05.2006
VI2005A000187 ]32[ 28.06.2005
]33[
Int. Cl.(2010.01) A61B 17//56, A61F 02//46
TECRES S.P.A., ITALY
GIOVANNI FACCIOLI, RENZO

334

IT

December 29, 2011-‫ג' בטבת התשע"ב‬

]87[
]74[

]57[

SOFFIATTI
WO/2007/000631
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45087 .‫ד‬.‫ ת‬,
JERUSALEM 91450
The present invention has its application in the field of devices and methods for the
product physical and chemical mixing and refers particularly to a cartridge for sterile
mixing of a two-phase compound. The cartridge consists of a first tubular body (2)
defining a first collection chamber (3) for a solid phase, a second tubular body (4)
defining a second collection chamber (5) for a liquid phase, means for transferring (6)
the liquid phase from the second (5) to the first chamber (3), means for mixing (7) the
phases. The means for mixing (7) comprise agitator means (8) acting on the mixture
inside the first chamber (3) with the first tubular body (2) in substantially stationary
conditions, so as to favour the dispersion of the solid phase inside the liquid phase thus
obtaining a compound with uniform physical and mechanical properties.

__________________
]11[]21[
]54[

SURGICAL FASTENERS AND
DEVICES FOR SURGICAL
FASTENING

]22[
]31[
]51[
]71[

06.07.2006
60/696516
]32[ 06.07.2005
Int. Cl.(2010.01) A61B 17//064
I.B.I. ISRAEL BIOMEDICAL
INNOVATIONS LTD.

335

188582
‫מהדקים ניתוחיים והתקני הידוק‬

]33[

US

‫איי ישראל ביומדיקל אינוביישנס‬.‫בי‬.‫איי‬
‫בע"מ‬
December 29, 2011-‫ג' בטבת התשע"ב‬

]87[
]74[

WO/2007/004228
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]57[

The invention provides a surgical fastener. The fastener has a first element defining an
axis of the fastener, and or more prongs attached to the first element at hinge regions.
Deploying the fastener involves bending the prongs at the hinges so as to increase the
distance of the prong tips from the axis and locking the fastener in this deployed
configuration. The invention also provides a surgical fastening device and a method
for attaching a surgical fastener to a site of a body tissue.

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

__________________
]11[]21[

188600
‫תהליך להכנת אסאומאפראזול‬

]54[

METHOD FOR PREPARING
ESOMEPRAZOLE

]22[
]31[

11.07.2006
10-2005]32[ 28.07.2005
]33[ KR
0068761
Int. Cl.(2010.01) A61P 01//04, C07D 40/1/12
HANMI HOLDINGS CO., LTD.,
REPUBLIC OF KOREA
WO/2007/013743
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
Optically pure esomeprazole and its salt can be simply prepared by dissolving (S)-(-)binol, a weak base and the racemic form of omeprazole in a mixture of a watercompatible organic solvent and water at a high temperature, cooling the mixed solution

]51[
]71[
]87[
]74[
]57[

336

December 29, 2011-‫ג' בטבת התשע"ב‬

to crystallize the inclusion complex of esomeprazole and (S)-(-)-binol, and removing
the (S)-(-)-binol moiety from the crystallized inclusion complex.

__________________
]11[]21[

188641
‫מערכות התאמה מותאמות במיוחד לשם תיקון‬
‫תנוחות כיסא‬

]54[

FITTING SYSTEMS ADAPTED
ESPECIALLY FOR FIXING SEAT
POSITIONS

]22[
]31[
]51[
]71[
]87[
]74[

25.07.2006
60/702133
]32[ 25.07.2005
]33[
Int. Cl.(2010.01) B60N 02//08, B64D 11//06
WEBER AIRCRAFT LP, U.S.A.
WO/2007/014184
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122

]57[

US

,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
Fitting systems and assemblies are detailed. The assemblies are designed principally
(although not necessarily exclusively) for use with aircraft seats and supply positive
adjustable positioning of a seat or other object, typically actuated with a single turn (or
less) of a single tool

__________________
]11[]21[

188645

]54[

FOOT MEASURING DEVICE

]22[
]51[
]71[
]72[

07.01.2008
Int. Cl.(2010.01) A43D 01//00, 01//02, 01//06
FITRACKS INC., U.S.A.
ELIAHO GERBY, NOAM
DANENBERG, YUVAL BECHOR

337

‫מכשיר למדידת כף רגל‬

‫ יובל בכור‬,‫ נועם דננברג‬,‫אליהו ג'רבי‬
December 29, 2011-‫ג' בטבת התשע"ב‬

]74[

]57[

LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
An apparatus for measuring the dimensions of human feet, comprising: (a) a base (20)
which comprises and supports electrical and optical components; (b) a cover, which
fits over said base to protect said components, and defines the borders of two
essentially rectangular wells in the upper surface of said base, into which said feet to
be measured are placed; (c) pressure pads containing a sensor matrix, which are used
to provide structural and additional information of said feet; (d) a multitude of
emmiter/detector pairs )24,24',25,25'(, which are used to make length and width
measurements of said feet; (e) computational means, which calculate said dimensions
from said measurements; and (f) display means, which display said dimensions, said
structural information and other pre-determined information characterized in that said
computational means comprises an algorithm which uses information supplied by said
pressure pads to correct errors in said length and width measurments caused by
misplacement of said feet in said wells and said emitters and corresponding detector
are provided in two contiguous levels, wherein the upper is offset by one half of the
width of an individual emitter/detector.

__________________
]11[]21[
]54[

METHOD AND DEVICE FOR
AUTONOMOUS
DETERMINATION OF THE
LOCATION COORDINATES OF A
MOVING OBJECT

]22[
]51[
]71[

08.01.2008
Int. Cl.(2010.01) G01C 21//00
MICHAEL NAUMOV
GEORGE NAUMOV
MICHAEL NAUMOV,

]74[
338

188649
‫השיטה לקביעה אוטונומית של קואורדינטות‬
‫המיקום של אובייקט בתנועה והמכשיר ליישומו‬

‫ תל אביב‬,‫מיכאל נאומוב‬
‫ אביב‬-‫ תל‬,‫גאורגי נאומוב‬
,‫מיכאל נאומוב‬
December 29, 2011-‫ג' בטבת התשע"ב‬

3 ‫חצור‬
‫תל אביב‬

3 HATZOR ST.,
TEL AVIV
]57[

Method of autonomous determination of the location of the coordinates of a moving
object comprising the following stages: determination of the true course;
determination of the projections of the linear acceleration vector onto the lines of
crossing the horizontal plane and the planes going through the vertical axis of the
moving object and through, correspondingly, the longitudinal and traverse axis of said
object through its lines parallel to said axes; determination of the projections of the
ground speed vector onto said lines of crossing; determination of the location of the
coordinates of the moving object by means of said projections.

__________________
]11[]21[

188670
‫נגזרות פירידין ונגזרות פירימידין ושיטות‬
‫לשימוש בהן‬

]54[

PYRIDINE AND PYRIMIDINE
DERIVATIVES AND METHODS
OF USE THEREOF

]22[
]31[
]51[

21.08.2006
60/710671
]32[ 24.08.2005
]33[ US
Int. Cl.(2010.01) A61K 31//4409, 31//496, 31//506, 31//5377, A61P 35//00, 35//04,
43//00, C07D 21/3/75, 23/9/47, 40/1/12
EISAI R&D MANAGEMENT CO.,
LTD., JAPAN
TOMOHIRO MATSUSHIMA,
HIROSHI OBAISHI, KEIKO
TAKAHASHI, SETSUO FUNASAKA,
SHUJI SHIROTORI
WO/2007/023768
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45087 .‫ד‬.‫ ת‬,
JERUSALEM 91450
A compound represented by the general formula: (I) (wherein R 1 means a 3- to 10membered nonaromatic heterocyclic group or the like; R2 and R3 mean a hydrogen
atom; R4, R5, R6 and R7 are the same or different and mean a hydrogen atom, a halogen
atom, a C1-6 alkyl group or the like; R8 means a hydrogen atom or the like; R9 means a
3- to 10-membered nonaromatic heterocyclic group or the like; n means an integer of 1
to 2; and X means a group represented by the formula -CH= or a nitrogen atom), a salt
thereof or a hydrate thereof has an excellent hepatocyte growth factor receptor (HGFR)
inhibitory action, and exhibits an anti-tumor action, angiogenesis inhibitory action or
cancer metastasis inhibitory action.

]71[
]72[

]87[
]74[

]57[

339

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[
]54[

SYSTEMS, METHODS AND
MEDIA FOR TRANSITIONING
COMPRESSION LEVELS IN A
STREAMING IMAGE SYSTEM

]22[
]31[
]51[
]71[
]87[
]74[

13.07.2006
11/184345
]32[ 19.07.2005
Int. Cl.(2010.01) H04N 07//50
IBM CORPORATION, U.S.A.
WO/2007/009941
IBM LABORATORIES,
HAIFA UNIVERSITY,
HAIFA 31905

]57[

340

188757
,‫ שיטה ואמצעי להעברת רמות דחיסה‬,‫מערכת‬
‫במערכת של צורה זורמת‬

]33[

US

,‫מעבדות יבמ מחלקת קנין רוחני‬
‫אוניברסיטת חיפה הר הכרמל‬
‫חיפה‬
Systems, methods and media for transitioning compression levels of a streaming image
system are disclosed. One embodiment provides a method for transitioning
compression levels between image frames in a streaming image system. Embodiments
may include receiving by a smoothing module a request for a new compression level
associated with an image frame. Embodiments may also generally include performing
by the smoothing module a smoothing heuristic by generating a multi-frame
smoothing routine based on an initial compression level, a target compression level,
and a number of frames to achieve the target compression level. Embodiments may
also include setting by the smoothing module the new compression level for the image
frame based on the generated multi-frame smoothing routine. Further embodiments
may include transmitting by the smoothing module an indication of the new
compression level to a content encoder.

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

189030
‫תכשירים המכילים פטריית זנב תרנגול הודו‬
‫ או תמצית שלה‬FERM BP–10633 ‫מיזן‬

]54[

COMPOSITIONS COMPRISING
TURKEY TAIL MUSHROOM
STRAIN FERM BP-10633 OR ITS
EXTRACT

]22[
]31[
]51[
]71[

28.07.2006
2005-218554 ]32[ 28.07.2005
]33[ JP
Int. Cl.(2010.01) A01G 01//04, A01H 15//00, A61K 36//07, C12N 01//14
NIKKEN SOHONSHA
CORPORATION, JAPAN
WO/2007/013588
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152

]87[
]74[

]57[

341

Disclosed is a strain of turkey tail mushroom (Trametes versicolor) having excellent
biological activities (Accession number: FERM BP-10633). The strain is excellent in
platelet aggregation inhibitory effect, chemokine gene expression inhibitory effect,
anti-mutagenic effect, anti-tumor effect, anti-hypertensive effect and
immunomodulating effect. When the strain is used in combination with a microalga or
other basidiomycete, the effect of the strain is improved synergistically. The strain has
a high safety, is less likely to cause an adverse side effect even when used
continuously for a prolonged period of time, and can be used effectively in a beverage,
cosmetic, pharmaceutical or the like that is intended to be used for the
prevention/improvement of an inflammation, an allergy, a tumor or other disease. The
strain has extremely increased hypha growth property and shows extremely higher
physiological functions compared to conventional strains and therefore can be used
stably.

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[
]54[

DEVICE FOR THE TREATMENT
AND IN PARTICULAR
GALVANIZING OF SUBSTRATES

]22[
]31[
]51[
]71[

03.08.2006
102005038450.1 ]32[ 03.08.2005
Int. Cl.(2010.01) C25D 17//06
GEBR. SCHMID GMBH & CO.,
GERMANY
WO/2007/014778
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733

]87[
]74[

]57[

189168
‫ בפרט לגלוונם‬,‫התקן לטיפול במצעים‬

]33[

DE

,‫פרל כהן צדק לצר‬
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬12704 .‫ד‬.‫ ת‬,

The invention relates to a contacting device for a galvanization apparatus (11),
comprising contacting rollers (20) with a continuous rigid external face (26, 27) which
is joined to a jacket section (22). The jacket section (22) is provided with an inner
opening (23) that is wider than a rotating shaft (30) on which the contacting roller (20)
sits. This allows the contacting roller (20) to be moved in a radial direction, electric
contacting and securing of a basic position being obtained via springs (32). The
movability of the contacting roller (20) ensures good contact as the contacting roller
(20) rests against substrates (16) even when the substrates (16) are uneven. The contact
pressure can be relatively small.

__________________
]11[]21[
]54[
342

INTERRUPT CONTROLLER

189206
‫הפרעה להפקת תועלת של תיכנות ערכי עדיפות‬
December 29, 2011-‫ג' בטבת התשע"ב‬

‫של בקר‬

UTILISING PROGRAMMABLE
PRIORITY VALUES
]22[
]31[
]51[
]71[
]87[
]74[

]57[

24.10.2006
0526007.0
]32[ 21.12.2005
Int. Cl.(2010.01) G06F 13//24
ARM LIMITED, UNITED KINGDOM
WO/2007/071894
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122

]33[

GB

,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
An interrupt controller (2) is provided with priority registers (6) storing priority values
P0-P9 used to determine prioritisation between received interrupt signals I 0-I9. A
priority value accessing circuit (10) provides multiple mappings to the priority values
stored in dependence upon the priority value manager (16, 18), seeking to make an
access. In this way, a first priority value manager (18), such as a secure operating
system, can be given exclusive access to the highest priority values whilst a second
priority value manager (16), such as a non-secure operating system, can be given
access to a range of priority values as stored which are of a lower priority and yet as
written or read by the non-secure operating system appear to the non-secure operating
system to have a different, such as higher, priority level.

__________________
]11[]21[
]54[

METHOD AND DEVICE FOR
AUTONOMOUS
DETERMINATION OF THE
ANGLE OF DRIFT OF A MOVING
OBJECT

]22[
]51[

05.02.2008
Int. Cl.(2010.01) G01C 21//00

343

189284
‫השיטה והמכשיר לקביעה אוטונומית של זווית‬
‫הסחיפה של אובייקט בתנועה‬

December 29, 2011-‫ג' בטבת התשע"ב‬

]71[
]74[

]57[

‫ אביב‬-‫ תל‬,‫מיכאל נאומוב‬
‫ אביב‬-‫ תל‬,‫גאורגי נאומוב‬
,‫מיכאל נאומוב‬
3 ‫חצור‬
‫ אביב‬-‫תל‬

MICHAEL NAUMOV
GEORGE NAUMOV
MICHAEL NAUMOV,
3 HATZOR ST.,
TEL AVIV 69016

The present technical solution provided is intended for the accurate determination of
angle of drift only by the means located inside the moving object, without applying
any radiations and gyroscopes as well as without using any sources of information and
orientation on the Earth and on any other heavenly bodies. The determination of such
kind is provided for the first time and is considered to be of paramount importance for
navigational and meteorological purposes. The present solution is based on the
determination of the horizontal projections of the linear acceleration vector by means
of the sensors of said acceleration.

__________________
]11[]21[
]54[

TECHNOLOGY FOR PROVIDING
TELECOMMUNICATION
SERVICES TO MULTIPLE
OPTICAL COMMUNICATION
LINES BY EQUIPMENT HAVING
REDUNDANCY

]22[
]51[
]71[
]74[

07.02.2008
Int. Cl.(2010.01) H04Q 11//00
ECI TELECOM LTD.
ECI TELECOM LTD.,
30 HASIVIM ST.,
PETACH TIKVA 49517

]57[

344

189342
‫טכנולוגיה למתן שרותי תקשורת למספר קווי‬
‫תקשורת באמצעות ציוד עודף‬

‫ פתח תקוה‬,‫ טלקום בע"מ‬.‫ איי‬.‫ סי‬.‫אי‬
,‫ טלקום בע"מ‬.‫ איי‬.‫ סי‬.‫אי‬
30 ‫רחוב הסיבים‬
‫פתח תקוה‬
A system for serving N optical communication lines by a redundant set of modules in
an optical network; where the set of modules comprises N >1 main modules and one
backup module, N optical splitters, 2N fiber connections and a control means. In the
system, each of the N optical splitters is connected to two different modules of the set
by two respective fiber connections out of the 2N connections, while each of the N
optical splitters is also coupled to one of the N optical communication lines. The
arrangement is such that the control means selectively activates/inactivates any of the
fiber connections for respectively enabling/blocking transfer of data therealong; the
control means thus ensures that each specific line of the N optical communication
lines is always served by either one or another of two different modules.
December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[
]54[

LOGICAL BRIDGING SYSTEM
AND METHOD

]22[
]31[

13.02.2008
60/889809
]32[ 14.02.2007
60/916065
04.05.2007
Int. Cl.(2010.01) H04L 12//28
MARVELL ISRAEL (M.I.S.L) LTD.

]51[
]71[
]74[

]57[

189514
‫מערכת גישור לוגית ושיטה‬

]33[

US
US

,‫אל) בע"מ‬.‫אס‬.‫איי‬.‫מארוול ישראל (אמ‬
‫יוקנעם‬
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A bridge for routing data packets on a network, the bridge comprising: a physical
ingress port to receive a data packet from the network; a classification engine to assign
source logical port information to the data packet based on characteristics of the data
packet, wherein an assigned logical ingress port is decoupled from the physical ingress
port; a bridging engine downstream of the classification engine to learn the source
logical port information and to forward the data packet to a logical egress port based
on a destination address of the data packet; and a logical port mapping engine to map
the logical egress port to a physical egress port at which the data packet is to be
egressed.

The applications for division
from this application have
not yet been published

5024/7/

‫בקשות חלוקה מבקשה זו‬
9‫שטרם פורסמו‬

__________________
]11[]21[
]54[

345

OXAZOLO/THIAZOLO-PYRIDINE
DERIVATIVES AND BENZOOXAZOLE/THIAZOLE
DERIVATIVES, PROCESS FOR
THEIR PREPARATION AND
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THE SAME

189664
‫תיאזולו– פירידין ותולדות‬/‫תולדות אוקסזול‬
,‫ תהליך לייצורן‬,‫תיאזול‬/‫בנזו–אוקסזול‬
‫ותכשירים רוקחיים הכוללים אותן‬

December 29, 2011-‫ג' בטבת התשע"ב‬

]22[
]31[
]51[
]71[
]87[
]74[

]57[

21.08.2006
05108035.6
]32[ 02.09.2005
]33[ EP
Int. Cl.(2010.01) A61K 31//423, 31//424, 31//428, 31//429, A61P 03//00, 17//00,
19//02, C07D 41/3/12, 41/7/12, 49/8/04, 51/3/04
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND
WO/2007/025897
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
This invention is concerned with compounds of the formula (I) wherein X, A, B, R 1,
R2 and G are as defined in the description and claims, and pharmaceutically acceptable
salts thereof. The invention further relates to pharmaceutical compositions containing
such compounds, to a process for their preparation and to their use for the treatment
and/or prevention of diseases which are associated with the modulation of SST
receptors subtype 5.

__________________
]11[]21[

189666
‫בנזאמידים מותמרים בפירידינאמינוסולפוניל‬
P450 3A4 (4A3 ‫כמעכבים של ציטוכרום‬
)CYP

]54[

PYRIDINAMINOSULFONYL
SUBSTITUTED BENZAMIDES AS
INHIBITORS OF CYTOCHROME
P450 3A4 (CYP3A4)

]22[
]31[

11.09.2006
60/720151
]32[ 23.09.2005
]33[ US
60/723115
03.10.2005
US
60/725469
11.10.2005
US
60/762256
25.01.2006
US
60/821664
07.08.2006
US
Int. Cl.(2010.01) A61K 31//4406, A61P 39//00, C07D 21/3/00
PFIZER PRODUCTS, INC., U.S.A.
WO/2007/034312

]51[
]71[
]87[
346

December 29, 2011-‫ג' בטבת התשע"ב‬

]74[

]57[

LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The present invention provides compounds of formula (I), or pharmaceutically
acceptable salts or solvates thereof, methods for their preparation, methods for their
use, and pharmaceutical formulations comprising them.

__________________
]11[]21[

189716
‫שיטה ומערכת להשגת גישה לערוץ גישה‬
FDMA– ‫אקראי לקשר מהארץ ללוויין במערכת‬
SC

]54[

METHOD AND APPARATUS FOR
ACCESSING AN UPLINK
RANDOM ACCESS CHANNEL IN
A SINGLE CARRIER FREQUENCY
DIVISION MULTIPLE ACCESS
SYSTEM

]22[
]31[
]51[
]71[

22.08.2006
60\710599
]32[ 23.08.2005
]33[ US
Int. Cl.(2010.01) H04B 07//204, H04J 01//00, H04W 52//48, 52//50, 74//08
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2007/024791
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬

]87[
]74[

]57[

347

A method and apparatus for accessing a contention-based uplink random access
channel (RACH) in a single carrier frequency division multiple access (SC-FDMA)
system are disclosed. A wireless transmit/receive unit (WTRU) randomly selects a
RACH subchannel and a signature among a plurality of available RACH subchannels
and signatures. The WTRU transmits a preamble using the selected signature via the
December 29, 2011-‫ג' בטבת התשע"ב‬

selected RACH subchannel at a predetermined or computed transmission power. A
base station monitors the RACH to detect the preamble and sends an acquisition
indicator (AI) to the WTRU when a signature is detected on the RACH. When
receiving a positive acknowledgement, the WTRU sends a message part to the base
station. If receiving a negative acknowledgement or no response, the WTRU
retransmits the preamble.

__________________
]11[]21[

189804
‫רפידה תחתית נגד פצעי לחץ ותוכנית לרפידה‬
‫של מיטה המכילה רפידה תחתית נגד פצעי‬
‫לחץ‬

]54[

ANTIDECUBITAL UNDERLAY PAD
AND BED PAD DESIGN
COMPRISING AN ANTIDECUBITAL
UNDERLAY PAD

]22[
]31[
]51[
]71[
]72[
]87[
]74[

24.07.2006
102005041520.2 ]32[ 31.08.2005
]33[ DE
Int. Cl.(2010.01) A47C 27//00, A61G 07//057
OPED AG, SWITZERLAND
DANIELA HAPPEL
WO/2007/025611
HENRY SINAI,
,‫הנרי סיני‬
IP-PARTNERSHIP
4 ‫המייסדים‬
P.O.B 669
‫רעננה‬669 .‫ד‬.‫ ת‬,
RAANANA 43350
An antidecubital underlay pad having a receiving casing with a top side of the casing
and a bottom side of the casing, the casing being segmented along a plurality of
segmentation axes to form underlay segments, such that the underlay segments are
provided with a moulded body filling comprising a plurality of moulded bodies and are
bordered by segmentation lines running along the segmentation axes, characterized in
that the segmentation lines (11) have multiple changes in direction in their course
along the segmentation axes (13) and at least the top side (16) of the casing is designed
to be elastic at least in a supporting area and is pre-stressed by the moulded body
filling.

]57[

348

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

189823
‫שיטה ומערכת להכנת אריג בטכניקת‬
SPUNBOND

]54[

METHOD AND APPARATUS FOR
MAKING A SPUNBOND WEB

]22[
]31[
]51[
]71[

28.02.2008
07004747/7
]32[ 08.03.2007
]33[ EP
Int. Cl.(2010.01) D01D 05//088, 05//098, D04H 01//00, 03//16
REIFENHAUSER GMBH & CO. KG
MASCHINENFABRIK, GERMANY
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬

]74[

]57[

A method for the manufacture of a spunbond non-woven web fabric from filaments, in
particular of a thermoplastic plastic, wherein the filaments are spun from at least one
spinning device, wherein the filaments are subsequently cooled in a cooling chamber
and then stretched in a stretching unit, wherein the filaments are subsequently guided
through at least one diffuser and are then deposited on a deposition belt to form the
non-woven fabric web, wherein the non-woven fabric web is guided out of the wetting
unit and is subsequently initially consolidated by means of a high pressure water jet
treatment on the deposition belt, and wherein the non-woven fabric web is
subsequently drawn off from the deposition belt and is further treated.

__________________
]11[]21[
]54[

349

MODULAR ELEMENTS,
NETWORK, SUPPORTING
STRUCTURE, CONSTRUCTION

189909
‫ מבנה‬,‫ מבנה תומך‬,‫ רשת‬,‫אלמנטים מודולאריים‬
‫ותהליך לייצורם‬

December 29, 2011-‫ג' בטבת התשע"ב‬

AND PROCESS FOR OBTAINING
THEM
]22[
]31[
]51[
]71[
]87[
]74[
]57[

07.08.2006
A200500806
]32[ 22.09.2005
]33[ RO
Int. Cl.(2010.01) E04B 02//00, 02//26, E04C 02//26
LAURENTIU DUMITRU BREAZ,
ROMANIA
WO/2007/081233
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
The invention relates to modular elements made of insulating materials for
constructions, provided with at least one network element in the interior; to a network
obtained by connecting modular elements; to a supporting structure achieved by
casting a hardening material in the network achieved by connecting the modular
elements and joining them through the supporting structure, as well as to the process
for obtaining thereof. The modular element has an interior network element made up
of at least two main half-joints and optionaly it may have one or more secondary halfjoints, connected through vertical and oblique channels. The network obtained by
assembling the modular elements is made up of main and secondary joints, connected
trough vertical, horizontal and oblique channels. The unitary supporting structure is
obtained by casting a material that will be harden in the unitary network for the entire
construction. The process for obtaining the construction according to the invention
consists of the following: connection of modular elements and the casting of material
that hardens in the network defined through the connection of modular elements and
the creation of a unitary supporting structure.

__________________
]11[]21[
350

189972
December 29, 2011-‫ג' בטבת התשע"ב‬

‫פורמולציה המכילה היילורונן והשימוש בה‬
‫להכנת תרופה ומנעיה של מחלות תאיות‬

]54[

FORMULATION COMPRISING
HYALURONAN AND USE
THEREOF FOR PREPARING A
MEDICAMENT FOR TREATMENT
OR PROPHYLAXIS OF
CELLULAR DISEASES IN A
SUBJECT

]22[
]31[

04.09.2006
60/715293
]32[ 07.09.2005
]33[ US
60/788589
31.03.2006
US
Int. Cl.(2010.01) A61K 31//726, 31//728, 39//395, A61P 35//00
ALCHEMIA ONCOLOGY PTY
LIMITED, AUSTRALIA
WO/2007/028196
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬

]51[
]71[
]87[
]74[

]57[

The present invention relates generally to treatment and prophylactic protocols for
cellular diseases or disorders, such as diseases and disorders associated with abnormal
cellular proliferation. More particularly, the present invention provides compositions
comprising therapeutic antibodies and hyaluronan and their use in the treatment or
prophylaxis of cellular diseases and disorders.

__________________
]11[]21[

190011
‫מנעול רב שימושי‬

]54[

MULTIFUNCTIONAL LOCK

]22[
]31[

20.07.2006
200520075364.2 ]32[ 09.09.2005
]33[ CN
200620068971.0
25.01.2006
CN
Int. Cl.(2010.01) E05B 29//04
MALAFON ELECTRONIC (SUZHOU)
CO. LTD., CHINA
VINCENT GAN, YANG SHEN
WO/2007/028308
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45087 .‫ד‬.‫ ת‬,
JERUSALEM 91450
A multifunctional lock comprises a lock shell (1), a lock bar (3), movable tooth pieces
(4), a support (5) for sliding blocks, sliding blocks (6) and a guide slot unit (8) for the
December 29, 2011-‫ג' בטבת התשע"ב‬

]51[
]71[
]72[
]87[
]74[

]57[
351

insertion of a key. Wherein, an elastic element is provided between the lock bar and
the support, the sliding blocks at least partially extend into the keyway of the unit.
When the lock is unlocked, a projection of the unit has two operating positions, in one
of which the projection is received into the cut of the shell and the upper teeth of the
tooth pieces disengage from the bottom teeth of the sliding blocks, in another it is out
of the cut and the upper teeth engage with the bottom teeth. The key of the lock can be
changed many times.

__________________
]11[]21[

190071
‫מכלול איבר תמיכה‬

]54[

SUPPORT MEMBER ASSEMBLY

]22[
]31[
]51[
]71[
]87[
]74[

12.09.2006
200505952-2 ]32[ 16.09.2005
]33[
Int. Cl.(2010.01) E04B 02//00, 02//06, 02//58
DYNTEK PTE LTD., SINGAPORE
WO/2007/032746
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]57[

A support member system (100) is disclosed herein. In a preferred embodiment, the
system (100) comprises an elongate support member (102, 103) having an effective
length, an elongate member engagement portion (130, 135) arranged to engage with
one end of the elongate support member (102, 103) to extend the member's effective
length, and a base portion (110) for engaging with a support structure (8, 9). The base
portion (110) including connection means (114, 116) for releasably connecting the
base portion (110) selectively to the elongate member engagement portion (130, 135)
December 29, 2011-‫ג' בטבת התשע"ב‬

352

SG

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

or to the elongate support member (102, 103).

__________________
]11[]21[

190088

]54[

PROTEIN A PRODUCTION AND
PURIFICATION WITHOUT USING
ANIMAL DERIVED
COMPONENTS

]22[
]31[
]51[
]71[

14.09.2006
60/718759
]32[ 20.09.2005
]33[ US
Int. Cl.(2010.01) C07K 14//195, 14//31, C12N 01//20
AVANTOR PERFORMANCE
MATERIALS, INC., U.S.A.
WO/2007/035410
EITAN MEHULAL LAW GROUP,
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
10 ABBA EBEN BLVD.,
,‫פטנטים‬
P.O.B. 2081,
10 ‫שדרות אבא אבן‬
HERZLIYA 46120
‫הרצליה‬2081 .‫ד‬.‫ ת‬,
Purification of vegetarian (non-animal derived) Protein A using a multidimensional
purification process to remove undesirable non-animal derived components.

]87[
]74[

]57[

‫ ללא שימוש ברכיבים‬A ‫ייצור וטיהור חלבון‬
‫נגזרים מבעלי חיים‬

__________________
]11[]21[
]54[
353

APPARATUS FOR CLEANING
SUBSTRATE USING MEGASONIC

190454
‫התקן לניקוי פני שטח באמצעות כח מגהסוני‬
December 29, 2011-‫ג' בטבת התשע"ב‬

POWER
]22[
]31[
]51[
]62[
]71[
]72[

]87[
]74[

]57[

30.09.2003
10/261839
]32[ 30.09.2002
10/611140
30.06.2003
Int. Cl.(2010.01) H01L 21//00
DIVISION FROM 161550
LAM RESEARCH CORPORATION,
U.S.A.
JOHN M. DE LARIOS, JAMES P.
GARCIA, CARL A. WOODS,
MICHAEL RAVKIN, FRITZ
REDEKER, JOHN BOYD, AFSHIN
NICKHOU
WO/2004/030052
JMB, FACTOR & CO. LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450

]33[

US
US

,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
‫ הר חוצבים‬,‫רחוב המרפא‬
‫ירושלים‬45087 .‫ד‬.‫ ת‬,

A head used in a substrate preparation apparatus, having a head surface, the head
configured to be disposed proximate to a surface of a substrate, comprising: at least
one first source inlet for delivering a first fluid to the surface of the substrate through
the head; at least one second source inlet for delivering a second fluid to the surface of
the substrate through the head, the second fluid being different than the first fluid; at
least one source outlet for removing each of the first fluid and the second fluid from
the surface of the substrate, at least a portion of the at least one source outlet being
located in between the at least one first source inlet and the at least one second source
inlet; and a transducer disposed in the head for applying acoustic energy at a location
between the at least one of a first source inlet and the source outlet; wherein the head
surface has flat surface regions, and the head surface is defined so that the at least one
of the first source inlet, the second source inlet and the source outlet are defined by
discrete holes that reside at the head surface and extend through the flat surface regions
of the head surface.

__________________
]11[]21[
]54[

METHOD FOR THE DIAGNOSIS OF
THROMBOEMBOLIC AND
CORONARY HEART DISEASES

]22[
]31[

30.09.2006
102005048899.4

354

]32[

12.10.2005

190585
‫שיטה לאבחון תסחיפי קרישה ומחלות‬
‫בעורקים הכליליים של הלב‬

]33[

DE
December 29, 2011-‫ג' בטבת התשע"ב‬

]51[
]71[
]87[
]74[

]57[

Int. Cl.(2010.01) C12Q 01//68
SANOFI AVENTIS, FRANCE
WO/2007/042165
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The invention relates to a method for the In-vitro diagnosis of thromboembolic
disorders and/or coronary heart diseases. The nucleotide in position 470 of a nucleic
acid, coded for human EGLN2-protein, or the amino acid in position 58 of the human
EGLN2-protein of a sample from a person is determined.

__________________
]11[]21[

190673
‫מלח–דו–מימן פוספאט של אנטגוניסט לרצפטור‬
D2 ‫פרוסטגלאנדין‬

]54[

DIHYDROGEN PHOSPHATE
SALT OF A PROSTAGLANDIN D2
RECEPTOR ANTAGONIST

]22[
]31[
]51[
]71[

12.10.2006
60/726290
]32[ 13.10.2005
]33[ US
Int. Cl.(2010.01) A61K 31//505, C07D 23/9/46, 23/9/47
AVENTIS PHARMACEUTICALS
INC., U.S.A.
WO/2007/047378
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The present invention is directed to the dihydrogen phosphate salt of 2-(3-{6-[2-(2,4dichloro-phenyl)-ethylamino]-2-methoxy-pyrimidin-4-yl}-phenyl)-2-methyl-propionic
acid of Formula (III), a pharmaceutical composition comprising a pharmaceutically
effective amount of the compound of Formula (III), and a pharmaceutically acceptable
carrier; and a method of treating a patient suffering from a PGD2-mediated disorder
including, but not limited to, allergic disease (such as allergic rhinitis, allergic
conjunctivitis, atopic dermatitis, bronchial asthma and food allergy), systemic
mastocytosis, disorders accompanied by systemic mast cell activation, anaphylaxis
shock, bronchoconstriction, bronchitis, urticaria, eczema, diseases accompanied by
itch (such as atopic dermatitis and urticaria), diseases (such as cataract, retinal
detachment, inflammation, infection and sleeping disorders) which is generated
secondarily as a result of behavior accompanied by itch (such as scratching and
beating), inflammation, chronic obstructive pulmonary diseases, ischemic reperfusion
December 29, 2011-‫ג' בטבת התשע"ב‬

]87[
]74[

]57[

355

injury, cerebrovascular accident, chronic rheumatoid arthritis, pleurisy, ulcerative
colitis and the like, by administering to said patient a pharmaceutically effective
amount of the compound of Formula (III).

__________________
]11[]21[

190731
‫ייצור של אוליגודנדרוציטים מתאי גזע שהופקו‬
‫משלייה‬

]54[

PRODUCTION OF
OLIGODENDROCYTES FROM
PLACENTA-DERIVED STEM
CELLS

]22[
]31[
]51[
]71[

13.10.2006
60/727601
]32[ 13.10.2005
]33[ US
Int. Cl.(2010.01) C12N 05//0735
ANTHROGENESIS CORPORATION,
U.S.A.
WO/2007/047465
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
124 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11490 .‫ד‬.‫ ת‬,
TEL AVIV 62038
The present invention provides methods and compositions for the production of glial
cells and oligodendrocytes from placenta stem cells. The invention further provides for
the use of these glia and oligodendrocytes in the treatment of, and intervention in, for
example, trauma, ischemia and degenerative disorders of the central nervous system
(CNS), particularly in the treatment of demyelinating diseases such as multiple
sclerosis.

]87[
]74[

]57[

356

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[
]54[

METHOD OF PRODUCING
HUMAN STEM CELLS BY
PARTHENOGENIC ACTIVATION
OF HUMAN OOCYTES

]22[
]31[

19.10.2006
60/729177
]32[ 21.10.2005
60/733309
02.11.2005
60/758443
11.01.2006
60/813799
14.06.2006
Int. Cl.(2010.01) C12N 05//0735
INTERNATIONAL STEM CELL
CORPORATION, U.S.A.
WO/2007/047979
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]51[
]71[
]87[
]74[

]57[

357

190869
‫שיטה לייצור תאי גזע ממקור אנושי על ידי‬
‫שפעול רביית בתולים של בייציות ממקור אנושי‬

]33[

US
US
US
US

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

)Methods of producing human stem cells are disclosed for parthenogenetically
activating human oocytes by manipulation of O2 tension, including manipulation of
Ca2+ under high O2 tension and contacting oocytes with serine threonine kinase
inhibitors under low O2 tension, isolating inner cell masses (ICMs) from the activated
oocytes, and culturing the cells of the isolated ICMs under high O 2 tension. Moreover,
methods are described for the production of stems cells from activated oocytes in the
absence of non-human animal products, including the use of human feeder
cells/products for culturing ICM/stem cells. Stem cells produced by the disclosed
methods are also described.

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

191066
‫שיטה והתקן לטיפול במים למניעת אורגניזם‬
‫מימיים‬

]54[

METHOD AND APPARATUS FOR
WATER TREATMENT TO
ELIMINATE AQUATIC
ORGANISMS

]22[
]31[
]51[
]71[

27.10.2006
2005/10473
]32[ 28.10.2005
]33[ ZA
Int. Cl.(2010.01) C02F 01//36
RESOURCE BALLAST
TECHNOLOGIES (PROPRIETARY)
LIMITED, SOUTH AFRICA
WO/2007/049139
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
A method and apparatus for treating water such as ballast water in ships in order to
eliminate aquatic organisms in the water. The water is led under pressure through a
conduit into a chamber of greater cross-section than that of the conduit so that an
abrupt reduction in pressure occurs. Cavitation ensues, leading to the release of
dissolved gases. Ultrasonic vibration is generated and is applied to the water, exerting
a pounding effect that weakens or destroys the organisms present. Other means may be
used to generate further mechanical, electrical, and chemical forces in the water which
attack the organisms.

]87[
]74[

]57[

__________________
]11[]21[
]54[
358

ISOLATED ANTIBODY WHICH

191077
)NTD( ‫–טרמינלי‬N ‫נוגדן מבודד הנקשר לאזור‬
December 29, 2011-‫ג' בטבת התשע"ב‬

BINDS TO THE N-TERMINAL
DOMAIN (NTD) OF Γ-HRG, INVITRO METHODS FOR
DETECTING AND PURIFYING ΓHRG USING SUCH ANTIBODY
AND USE OF SUCH ANTIBODY IN
THE PREPARATION OF
MEDICAMENTS
]22[
]31[
]51[
]62[
]71[
]87[
]74[

]57[

‫ לגילוי‬IN–VITRO ‫ שיטות‬,γ–HRG ‫של‬
‫ העושות שימוש בנוגדן כזה‬γ–HRG ‫ולטיהור‬
‫ושימוש בנוגדן כזה להכנת תרופות‬

08.07.1997
60/021640
]32[ 12.07.1996
]33[ US
Int. Cl.(2010.01) A61K 39//395, C07K 16//22, C12N 15//12, 15//13
DIVISION FROM 127892
GENENTECH, INC., U.S.A.
WO/1998/002541
S. HOROWITZ & CO.,
,'‫ הורוביץ ושות‬.‫ש‬
31 AHAD HAAM ST.,
31 ‫רחוב אחד העם‬
P.O.B. 2499,
‫תל אביב‬2499 .‫ד‬.‫ ת‬,
TEL AVIV 65202
An isolated antibody which binds to the N-terminal domain (NTD) of γ-HRG, which
has the ability to bind to the ErbB3 and/or ErbB4 receptor and comprises an amino
acid sequence selected from the group consisting of:
(a) the amino acid sequence for γ-HRG in SEQ ID No:2;
(b) naturally occuring allelic variants or isoforms of 9a) having at least 80% amino
acid sequence identity with human γ-HRG of SEQ ID No:2; and
(c) the amino acid sequence of (a) or (b) which has only one or two amino acid
substitutions.

__________________
]11[]21[
]54[

359

POLYPEPTIDES COMPRISING A
CONSECUTIVE SEOUENCE OF
THE Γ-HRG, N-TERMINAL
DOMAIN, NUCLEIC ACIDS,
VECTORS, HOST CELLS,
PHARMACEUTICAL
COMPOSITIONS, METHODS FOR
PRODUCING AND USE OF SUCH
POLYPEPTIDES

191078
–N ‫פוליפפטידים הכוללים רצף עוקב של אזור‬
,‫ וקטורים‬,‫ חומצות גרעין‬,γ–HRG ‫טרמינלי של‬
‫ שיטות לייצור‬,‫ תכשירי רוקחות‬,‫תאי מאכסן‬
‫ושימוש בפוליפפטידים כאלה‬

December 29, 2011-‫ג' בטבת התשע"ב‬

]22[
]31[
]51[
]62[
]71[
]87[
]74[

]57[

08.07.1997
60/021640
]32[ 12.07.1996
]33[ US
Int. Cl.(2010.01) A61K 38//18, C07K 14//47, 14//475, C12N 15//12, 15//16, 15//63,
15//70, 15//74, 15//79
DIVISION FROM 127892
GENENTECH, INC., U.S.A.
WO/1998/002541
S. HOROWITZ & CO.,
,'‫ הורוביץ ושות‬.‫ש‬
31 AHAD HAAM ST.,
31 ‫רחוב אחד העם‬
P.O.B. 2499,
‫תל אביב‬2499 .‫ד‬.‫ ת‬,
TEL AVIV 65202
An isolated polypeptide comprising a consecutive sequence of at least thirty amino
acids of the gamma-HRG N-terminal domain (NTD) of SEQ ID NO:4.

__________________
]11[]21[

191417
‫קומבינציות של מפעילי קולטן מסוג פרוקסיזום‬
‫) ומעכבי ספיגת‬PPAR( ‫פרוליפרטור–אקטיבטד‬
‫סטרול‬

]54[

COMBINATIONS OF
PEROXISOME PROLIFERATORACTIVATED RECEPTOR (PPAR)
ACTIVATOR(S) AND STEROL
ABSORPTION INHIBITOR(S)

]22[
]31[

25.01.2002
60/264396
]32[ 26.01.2001
]33[ US
60/323839
21.09.2001
US
Int. Cl.(2010.01) A61K 31//397, 31//70, 45//06, 47//12, 47//20, 47//34, 47//38, A61P
03//04, 03//10, 09//04, 09//10, C07D 20/5/08, 20/5/12, 40/1/04, 40/3/12, 40/5/10,
40/9/04, 41/3/10, C07H 03//04, 17//02
DIVISION FROM 156445
SCHERING CORPORATION, U.S.A.
WO/2002/058732
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
124 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11490 .‫ד‬.‫ ת‬,
TEL AVIV 62038
The present invention provides compositions, therapeutic combinations and methods
including: (a) at least one peroxisome proliferator-activated receptor activator; and (b)
at least one substituted azetidinone or substituted b-lactam sterol absorption inhibitor
which can be useful for treating vascular conditions, diabetes, obesity and lowering
plasma levels of sterols.

]51[
]62[
]71[
]87[
]74[

]57[

360

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

191606
‫התקן להעמסת מערכת כלי נשק של שלדת כלי‬
‫רכב‬

]54[

DEVICE FOR MOUNTING A
WEAPON SYSTEM ON A
VEHICLE CHASSIS

]22[
]31[
]51[
]71[
]87[
]74[

13.11.2006
0511826
]32[ 21.11.2005
Int. Cl.(2010.01) F41A 23//34
NEXTER SYSTEMS, FRANCE
WO/2007/057550
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]57[

The invention relates to a device for mounting a weapon system on a vehicle chassis,
which device comprises a false chassis (12) which bears the weapon system and is
secured to the chassis (4) by a connection means (17). This device is characterized in
that the connection means comprises at least two attachment points (17) formed by
lugs (18) secured to the chassis (4), which lugs each bear a rod (20) on which a block
(22) secured to the false chassis (12) is mounted, which block is able both to move
translationally and pivot with respect to the rod (20).

]33[

FR

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

__________________
]11[]21[
]54[
361

MCD SHELL

191614
MCD ‫מעטפת‬
December 29, 2011-‫ג' בטבת התשע"ב‬

]22[
]31[
]51[
]71[
]72[
]87[
]74[

]57[

10.10.2006
0502564-8
]32[ 23.11.2005
]33[ SE
Int. Cl.(2010.01) F42B 12//76
BAE SYSTEMS BOFORS AB,
SWEDEN
TORSTEN RONN
WO/2007/061350
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The present invention relates to a method for firing explosive-filled, fragmentation
shells (1) that disperse fragments on the pre-programmed detonation of their own
explosive (7) so as to reduce the risk of accidental injury to unprotected personnel and
damage to materiel, which at the moment of firing are undeservedly situated between
the firing weapon and the target. The invention also encompasses shells (1) produced
or modified according to said method.

__________________
]11[]21[

191679
‫שיטה לאבחון מחוץ לגוף של מחלת דלקתית של‬
‫המעיים‬

]54[

IN VITRO METHODS FOR
DIAGNOSING INFLAMMATORY
BOWEL DISEASE

]22[
]31[
]51[
]71[

30.11.2006
11/293616
]32[ 01.12.2005
]33[ US
Int. Cl.(2010.01) C12N 05//16, C12Q 01//68, G01N 33//53
PROMETHEUS LABORATORIES
INC., U.S.A.
WO/2007/064964
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
The present invention provides methods, systems, and code for accurately classifying
whether a sample from an individual is associated with inflammatory bowel disease
(IBD) or a clinical subtype thereof. In particular, the present invention is useful for

]87[
]74[
]57[

362

December 29, 2011-‫ג' בטבת התשע"ב‬

classifying a sample from an individual as an IBD sample using a statistical algorithm
and/or empirical data. The present invention is also useful for differentiating between a
clinical subtype of IBD such as Crohn's disease (CD) and ulcerative colitis (UC) using
a statistical algorithm and/or empirical data. Thus, the present invention provides an
accurate diagnostic prediction of IBD or a clinical subtype thereof and prognostic
information useful for guiding treatment decisions.

__________________
]11[]21[
]54[

DEWPOINT COOLING DEVICE

]22[
]31[
]51[
]71[

28.11.2006
1030538
]32[ 28.11.2005
Int. Cl.(2010.01) F24F 05//00
OPTIMAIR HOLDING B.V.I.O., THE
NETHERLANDS
WILLEM MEIJER, THE
NETHERLANDS
WO/2007/061298
FISHER WEILER JONES,
26 HABARZEL ST.,
RAMAT HACHAYAL 69710

]87[
]74[

]57[

363

191720
‫מכשיר קירור ליצירת תנאי נקודת הטל‬
]33[

NL

,‫פישר וילר ג'ונס‬
26 ‫הברזל‬
‫רמת החייל‬

The invention relates to a device for cooling an airflow, comprising at least one
cooling channel with an inflow opening for the airflow for cooling and an outflow
opening for the cooled airflow, at least one evaporating channel separated from the
cooling channel by a transfer wall and having an inflow opening, which is connected
to the outflow opening of the cooling channel, and an outflow opening, means for
wetting the side of the transfer wall directed toward the evaporating channel, and
means for dehumidifying the airflow in the cooling channel. The dehumidifying means
can comprise a polymer with lower critical solution temperature (LCST polymer) with
which the side of the transfer wall directed toward the cooling channel can be covered
or from which it can be manufactured. The cooling device can further have means for
December 29, 2011-‫ג' בטבת התשע"ב‬

regenerating the dehumidifying means.

__________________
]11[]21[

191738
‫התקן לנעילת חיבור צינורות‬

]54[

PIPE JOINT LOCKING DEVICE

]22[
]31[
]51[
]71[
]87[
]74[

11.10.2006
2005-352883 ]32[ 07.12.2005
]33[ JP
Int. Cl.(2010.01) F16K 35//00, F16L 15//00, 19//00, 35//00
FUJIKIN INCORPORATED, JAPAN
WO/2007/066452
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
A pipe joint locking device that can prevent a pipe joint from being erroneously
loosened after tightening and in which sealing ability at a seal section of the pipe joint
is not impaired even force rotating a pipe member is applied to it. The pipe joint
locking device has a first structure member (11) and a second structure member (12).
The first structure member (11) has an installation section (21) attached to an
externally threaded joint member (2) such that the installation section is not rotatable
relative to the joint member, a cover section (22) engaged from below to the outer
perimeter surface of a cap nut (5), and a connection section (23) engaged from below
to a pipe member (3). The second structure member (12) has a cover section (31)
engaged from above to the outer perimeter surface of the cap nut (5) and a connection
section (32) engaged from above to the pipe member (3). The connection section (23)
of the first structure member (11) and the connection section (32) of the second
structure member (12) are connected such that they are fixed to a portion (3a)
projecting from the cap nut (5) of the pipe member (3).

]57[

364

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

191824

]54[

ANTI IL-22 ANTIBODY AND ITS
USE IN THE PREPARATION OF
PHARMACEUTICAL
COMPOSITIONS FOR
ALLEVIATING DISORDERS
CHARACTERIZED BY SKIN
INFLAMMATION

]22[
]31[

30.11.2006
60/741640
]32[ 02.12.2005
]33[ US
60/822597
16.08.2006
US
Int. Cl.(2010.01) A61K 38//20, 39//395, A61P 29//00, 35//00, 37//00, C07K 16//18,
16//24, 16//28
GENENTECH, INC., U.S.A.
WO/2007/126439
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬

]51[
]71[
]87[
]74[

]57[

365

‫ והשימוש בו להכנת תכשיר‬IL–22 ‫נוגדן כנגד‬
‫רוקחי לטיפול בהפרעות הקשורות בדלקת עור‬

Compositions and methods are provided for the diagnosis and treatment of
inflammation and autoimmune disorders, such as psoriasis. Compositions and methods
for modulating IL-23 or IL-22 signaling are provided.

December 29, 2011-‫ג' בטבת התשע"ב‬

5022276

The applications for division
from this application have
not yet been published

‫בקשות חלוקה מבקשה זו‬
9‫שטרם פורסמו‬

__________________
]11[]21[

191839
‫שיטה להרכבת בקרת שליטה לדלתות וחלונות‬

]54[

METHOD FOR MOUNTING A
CONTROL ASSEMBLY FOR
DOORS AND WINDOWS

]22[
]31[
]51[
]71[
]74[

29.05.2008
07425450.9
]32[ 23.07.2007
]33[ EP
Int. Cl.(2010.01) E05B 63//00
SAVIO S.P.A., ITALY
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
Method for mounting a control assembly (12) for doors or windows, in which the door
or window comprises a frame including a metallic section bar (10) having an outer
wall (24) and a longitudinal groove (30) with an undercut section and an open edge
contained in a plane that is orthogonal to said outer face and in which the control
assembly comprises: a handle (14) having a base (32), a rotatable grip (34) and a
rotatable control pin (36) rotatably connected to the grip, a transmission device (16)
having an input member (56) able to be coupled with the control pin of the handle and
at least one carriage (74) movable in rectilinear direction and connected to the input
member by means of a mechanism (60, 62, 68, 70, 72) able to transform the rotary
motion of the input member into a rectilinear motion of said carriage, a rod (18) able to
slidably engage said groove and a connecting member (20) able to be fastened to the
rod, characterised in that the method comprises the steps of: positioning said rod in
said groove with said connecting member positioned slidably on the rod, applying the
transmission mechanism to the section bar, mutually connecting said carriage and said
connecting member so that the connecting member is fixed to said carriage for
movements in the longitudinal direction of the groove and after mutually connecting
said carriage and the connecting member, fastening the connecting member to the rod.

]57[

__________________

366

December 29, 2011-‫ג' בטבת התשע"ב‬

]11[]21[

191897
‫שיטה לגילוי רעלים מבוססת על ביוסנסור‬
‫ומערכות לאנאליזה של איכות מים ואוויר‬
‫המבוססות עליה‬

]54[

BIOSENSOR-BASED METHOD
FOR THE DETECTION OF
TOXINS AND WATER AND AIR
QUALITY ANALYSIS SYSTEMS
BASED THEREON

]22[
]31[
]51[
]71[
]87[
]74[

13.12.2006
11/302844
]32[ 14.12.2005
]33[ US
Int. Cl.(2010.01) C12Q 01//02, 01//22
UT-BATTELLE, LLC, U.S.A.
WO/2007/070828
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A water or air quality analysis system (10) and related method is biosensor-based for
detecting toxins. The water or air to be analyzed includes a plurality of photosynthetic
organisms therein, wherein toxins including chemical, biological or radiological agents
alter a nominal photosynthetic activity of the photosynthetic organisms. A
photodetector (12) is for measuring photosynthetic activity of the plurality of
photosynthetic organisms. An electronics package (30) includes a processor coupled to
the photodetector for analyzing the photosynthetic activity to indicate a presence of a
toxin in the water or air. The analysis includes obtaining at a first time a measured
photosynthetic activity curve for the photosynthetic organisms, and comparing the
measured curve to a reference photosynthetic activity curve to determine differences
therebetween. The presence of specific toxins, or precursors thereof, are then identified
if present in the air or water using the differences.

]57[

__________________
367

December 29, 2011-‫ג' בטבת התשע"ב‬

]11[]21[
]54[

PROVIDING AN ADDRESS
FORMAT COMPATIBLE WITH
DIFFERENT ADDRESSING
FORMATS USED FOR
ADDRESSING DIFFERENT SIZED
ADDRESS SPACES

]22[
]31[
]51[
]71[
]87[
]74[

16.04.2007
11/381712
]32[ 04.05.2006
Int. Cl.(2010.01) G06F 03//06
IBM CORPORATION, U.S.A.
WO/2007/128652
IBM LABORATORIES,
HAIFA UNIVERSITY,
HAIFA 31905

]57[

191952
‫ התואם לפורמטים‬,‫קביעת פורמט לכתובת‬
‫אחרים של תכובות בהן נעשה שימוש לפניה‬
‫למרחבי כתובות בעלי גודל שונה‬

]33[

US

,‫מעבדות יבמ מחלקת קנין רוחני‬
‫אוניברסיטת חיפה הר הכרמל‬
‫חיפה‬
Provided are a method, system, and article of manufacture for providing an address
format compatible with different addressing formats used for addressing different sized
address spaces. An address format is used in an operating system to address storage
space in a storage device comprising a first region and a second region of storage
space. A first group of applicat ions uses the address format to only address the storage
space in the first region and is not coded to use the address format to access the second
region and a second group of applications uses the address format to address the
storage space in the first and second regions.

__________________

368

December 29, 2011-‫ג' בטבת התשע"ב‬

]11[]21[

192005
‫מערכת גיר שימושית במיוחד כמערכת גיר‬
‫משתנה המשכית‬

]54[

TRANSMISSION SYSTEM
PARTICULARLY USEFUL AS A
CONTINUOUSLY VARIABLE
TRANSMISSION

]22[
]31[
]51[
]71[
]72[
]87[
]74[

10.12.2006
60/597567
]32[ 10.12.2005
]33[ US
Int. Cl.(2010.01) B62M 09//00, 09//06, F16H 15//00, 15//42
CVTRON LTD.
‫ ת"א‬,‫סויטרון בע"מ‬
RAN SIMAN-TOV
‫טוב‬-‫רן סימן‬
WO/2007/066342
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬1995( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
A transmission system includes first and second transmission members to be
selectively coupled to each other or decoupled from each other The first transmission
member includes at least one gripping device having a plurality of spaced gπpping
elements, and the said second transmission member includes a plurality of coupling
elements receivable in an interleaved manner between the gπpping elements of the
gripping device The gπpping elements of the gripping device being displaceable by a
lateral compressive force (a) to displace them towards each other to firmly grip the
coupling elements of the second transmission member and thereby to establish a
nonslip coupling between the two transmission members, and (b) away from each
other to decouple the two transmission members from each other In a described
preferred embodiment, the first transmission member includes a pair of rotatable
conical members over which the second transmission member is wound.

]57[

__________________
]11[]21[

192011
‫מערכת ושיטה לניהול תכולת מים בנוזל‬

]54[

SYSTEM AND METHOD FOR
MANAGING WATER CONTENT
IN A FLUID

]22[
]31[
]51[
]71[

07.12.2006
60/748123
]32[ 07.12.2005
]33[ US
Int. Cl.(2010.01) B01D 05//00, E03B 03//28, F25D 17//00
DUCOOL LTD.
‫ קבוץ החותרים‬,‫דוקול בע"מ‬

369

December 29, 2011-‫ג' בטבת התשע"ב‬

]87[
]74[

]57[

WO/2007/066212
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O.B. 2081,
HERZLIYA 46120

‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬2081 .‫ד‬.‫ ת‬,
A system and method for managing water content in a fluid (19, 38) includes a
collection chamber (12) for collecting water from the fluid (19) with a desiccant (20),
and a regeneration chamber (14) for collecting water from the desiccant (20) and
transferring it to a second fluid (38). An evaporator (28) cools the desiccant (20)
entering the collection chamber (12), and a second evaporator 52) cools the second
fluid (38) to extract the water. The evaporators (28, 54) use a refrigerant, the flow of
which is controlled by a flow control valve (70). When the temperature in the second
evaporator (54) drops below a set point, the refrigerant flow to the second evaporator
(54) is stopped, and the refrigerant flow to the first evaporator (28) is increased. This
increases the water collection in the collection chamber (12), and causes a rise in the
temperature in the second evaporator (54). The valve (70) is then opened to increase
the cooling in the second evaporator (54).

__________________
]11[]21[
]54[

MULTIFUNCTIONAL EXPLOSIVE
SYSTEM

]22[
]31[
]51[
]71[
]87[
]74[

06.12.2006
05027055.2
]32[ 12.12.2005
Int. Cl.(2010.01) F42B 03//02
RECCONN AG, SWITZERLAND
WO/2007/068386
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]57[
370

192087
‫מערכת מטען נפץ רבת משימות‬

]33[

EP

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

Explosive apparatus having at least two cuboid mouldings, which have at least one
December 29, 2011-‫ג' בטבת התשע"ב‬

firing hole, composed of explosive material, whose edge lengths have a ratio of 1:2:4
and having a container (1) with at least one aperture (80) to an internal area (60) with a
square outline, whose side length corresponds at least approximately to the longest
edge length of the moulding, and whose height corresponds at least approximately to
the shortest edge length of the moulding, or to an integer multiple of this. The
mouldings can be placed in the internal area (60) of the container (1) such that at least
the firing hole in one of the mouldings is aligned with the aperture (80) in the container
(1), and the aperture (80) is intended for introduction of an explosive capsule into the
firing hole of the relevant moulding.

__________________
]11[]21[
]54[

OPEN PROBE METHOD AND
DEVICE FOR SAMPLE
INTRODUCTION FOR MASS
SPECTROMETRY ANALYSIS

]22[
]51[
]71[
]72[

23.07.2008
Int. Cl.(2010.01) G01N 21//01
AVIV AMIRAV
AVIV AMIRAV, ALEXANDER
GORDIN
DR. EYAL BRESSLER,
11 TUVAL ST.,
RAMAT GAN 52522

]74[

]57[

371

193003
‫שיטה והתקן "מבחן פתוח" להכנסת דוגמה‬
‫לאנליזת מס ספקטרומטריה‬

‫ הוד השרון‬,‫אביב עמירב‬
‫ אלכסנדר גורדין‬,‫אביב עמירב‬

,‫דר' אייל ברסלר עו"פ‬
11 ‫תובל‬
‫ גן‬- ‫רמת‬
An open probe method for sample introduction into a mass spectrometer is disclosed,
comprising the steps of: loading a sample holder with sample compounds to be
analyzed; heating a probe oven; introducing said sample compounds in said sample
holder into said heated probe oven; flowing inert gas into said heated probe oven;
vaporizing said sample in said heated probe oven by the combined effect of oven
temperature and inert gas flow; entraining said vaporized sample in said inert gas; and,
December 29, 2011-‫ג' בטבת התשע"ב‬

transferring said vaporized sample in inert gas into an ion source of a mass
spectrometer; wherein said heated probe oven remains open to the ambient atmosphere
during sample introduction and analysis; said inert gas is flowing in said heated probe
oven in two directions of a transfer line to a mass spectrometer ion source and to the
oven opening; said vaporized sample in inert gas is transferred through a heated
transfer line directly into the ionization chamber of an ion source of a mass
spectrometer. An apparatus for this method of sample introduction is also disclosed.
The primary advantage of this method and apparatus is that the heated probe oven
remains open to the ambient atmosphere during sample introduction and analysis
thereby enabling faster sample analysis.

__________________
]11[]21[
]54[

CERAMIC DRILL BIT FOR HIGHSPEED DRILLING OF
COMPOSITES

]22[
]31[
]51[
]71[
]74[

24.07.2008
0705457
]32[ 26.07.2007
Int. Cl.(2010.01) B23B 51//00, 51//02
SNECMA, FRANCE
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O.B. 2081,
HERZLIYA 46120

]57[

372

193030
‫מקדח קרמי לקדיחה במהירות גבוהה בחומר‬
‫מרוכב‬

]33[

FR

‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬2081 .‫ד‬.‫ ת‬,
A drill bit comprising a shank, a body in the form of a truncated cone extending as far
as the shank and the base of which is located at a free axial end of the drill bit, said end
having at least two main cutting edges joined together by two central edges, said body
having two lips and two flutes extending in a helical fashion alternately around a
longitudinal rotation axis of the drill bit, the lips and the flutes extending from the free
axial end to the shank of the drill bit, each lip having a land and each flute having a
main cutting face adjacent a land and adjacent a main cutting edge, said main cutting
edge forming an intersection with a flank face at the free axial end of the drill bit, the
flank faces each being extended, on the side with the lips, by a rake face, two recesses
extending from the central edges to the periphery of the drill bit and forming two
secondary cutting faces, at least one end portion of the body of the drill bit being made
of a ceramic, wherein each land is radially extended, toward the rotation axis of the
drill bit, by a curved bevel, followed by a flank face, such that the intersection between
each curved bevel and the adjacent flute is formed by an edge whose radially external
end is further away axially, along the rotation axis of the drill bit, from the shank of the
December 29, 2011-‫ג' בטבת התשע"ב‬

drill bit than a radially internal end of said edge, and wherein the curved bevels are
each extended, on the side with the rake faces, by a bevel.

__________________
]11[]21[

193059
‫תרכיז חומוס נטול חומר משמר ותהליך להכנתם‬

]54[

PRESERVATIVE-FREE HUMMUS
CONCENTRATE AND PROCESS
FOR ITS PREPARATION

]22[
]31[
]51[
]71[

01.02.2007
173523
]32[ 02.02.2006
]33[ IL
Int. Cl.(2010.01) A23L 01//212
ELI HUGO BUDMAN
‫אלי הוגו בודמן‬
MARCELO ADRIAN ADATTO
‫חנה‬-‫ פרדס‬,‫מרסלו אדריאן אדטו‬
WO/2007/088540
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
An edible paste concentrate consisting of ground chickpeas, cooked and dried, and
crushed sesame seeds is provided. The paste has a shelf life of at least three months,
and when mixed with water, provides a dip or a spread with the flavor and texture of
freshly prepared hummus. Also provided is a process for manufacturing a spread or a
dip from chickpeas or other legumes.

]87[
]74[

]57[

__________________
]11[]21[
]54[
373

TRANS-[1R, 2S]-2-[3,4-

193071
–R1,S2]–2–[3,4[–‫טרנס‬

December 29, 2011-‫ג' בטבת התשע"ב‬

DIFLUOROPHENYL]CYCLOPROPANAMINIUM[2R]-2-HYDROXY-2-PHENYLETHANOATE
]22[
]31[
]51[
]62[
]71[
]72[
]87[
]74[

]57[

–‫דיפלוארופניל]ציקלופרופנאמיניום‬
‫–פנילאתנואט‬2–‫–חידרוקסי‬R2]–2[

31.05.2001
0013487.4
]32[
02.06.2000
]33[ GB
0002101-4
06.06.2000
SE
Int. Cl.(2010.01) C07C 21/1/40, 24/7/22, 67//347, 69//00, 69//743
DIVISION FROM 152778
ASTRAZENECA AB, SWEDEN
ADRIAN CLARK, ELFYN JONES, ULF LARSSON,
ANNA MINIDIS
WO/2001/092200
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The compound trans-(1R,2S)-2-(3,4difluorophenyl)cyclopropanaminium(2R)-2-hydroxy-2phenylethanoate.
5022526

The applications for division from this
application have not yet been published

‫בקשות חלוקה‬
‫מבקשה זו שטרם‬
9‫פורסמו‬

__________________
]11[]21[

193223
‫מערכת ושיטה לאימות מילים לא מזוהות‬
OCR ‫במערכת‬

]54[

METHOD AND SYSTEM FOR
VERIFICATION OF
UNCERTAINLY RECOGNIZED
WORDS IN AN OCR SYSTEM

]22[
]31[
]51[
]71[
]87[
]74[

15.02.2007
20060787
]32[ 17.02.2006
Int. Cl.(2010.01) G06K 09//00
LUMEX AS, NORWAY
WO/2007/094684
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]57[

The present invention provides a method and system for confirming uncertainly
recognized words as reported by an Optical Character or speech Recognition process
by using spelling alternatives as search arguments for an Internet search engine. The
measured number of hits for each spelling alternative is used to provide a confirmation
measure for the most probable spelling alternative. Whenever the confirmation

374

]33[

NO

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

December 29, 2011-‫ג' בטבת התשע"ב‬

measure is inconclusive, a plurality of search strategies are used to reach a measured
result comprising zero hits except for one spelling alternative that is used as the correct
alternative.

__________________
]11[]21[

193310
‫נוגדן כנגד פוליפפטיד אשר מגיב עם פרקין‬
‫ותכשירים רפואיים המכילים אותו‬

]54[

ANTIBODY DIRECTED AGAINST
A POLYPEPTIDE THAT
INTERACTS WITH PARKIN AND
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THE SAME

]22[
]31[

15.02.2001
00/01980
]32[ 17.02.2000
]33[ FR
60/198489
18.04.2000
US
Int. Cl.(2010.01) A61K 39//395, A61P 25//28, C07K 16//18
DIVISION FROM 151211
INSERM (INSTITUT NATIONALE
DE LA SANTE ET DE LA
RECHERCHE MEDICALE), FRANCE
AVENTIS PHARMA S.A., FRANCE
WO/2001/060857
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
Antibody or antibody fragment or derivative, characterized in that it is directed against

]51[
]62[
]71[

]87[
]74[

]57[
375

December 29, 2011-‫ג' בטבת התשע"ב‬

a polypeptide that interacts with parkin, said polypeptide comprising a sequence
having at least 80% identity to SEQ ID NO: 2, or comprising the sequences SEQ ID
NO: 13, SEQ ID NO: 15, SEQ ID NO: 43 OR SEQ ID NO: 45.

__________________
]11[]21[

193387
‫מערכת מיגון‬

]54[

PROTECTION SYSTEM

]22[
]31[
]51[
]71[
]74[

12.08.2008
01282/07
]32[ 13.08.2007
Int. Cl.(2010.01) B60N 02//42
MOWAG GMBH, SWITZERLAND
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]57[

The protection system is used especially for the protection against a fatal effect of
vertical accelerations triggered by a landmine on the passengers of an armoured
vehicle. For this, the sitting unit consisting of a seat body (7) and a backrest (8) is held
movable in vertical direction and is coupled with an end area (15) of a longitudinally
variable damping device (11), whose other end (13) is connected to the roof (4) of the
vehicle (2) through a carrying equipment (6). In addition, the sitting unit is carried
with vertical distance from the vertical guide (18) in a lower guide path (19)
transversally directed so that the sitting unit executes both a downward as well as a
tilting movement relative to the vehicle together with a passenger (3) during loading
through vertical acceleration. In this way, an improved usage of the constructively
limited effective length of the damping device (11) occurs so that the effect of the
protection system is essentially improved. It is sensible to apply the same principle for
the protection of all objects, which must be protected against the reaching or exceeding
of a maximum load due to a too large acceleration or deceleration.

376

]33[

CH

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

193502
‫מגבר כוח למערכת כבלים‬

]54[

POWER BOOSTER FOR CABLE
SYSTEMS

]22[
]51[
]71[

17.08.2008
Int. Cl.(2010.01) G05F 01//14, H02J 09//06
DAVID ZILBERBERG
‫מונד‬-‫ תל‬,‫דויד זילברברג‬
H.T. HULDA TRANSFORMERS
‫ קיבוץ חולדה‬,‫ש"ח שנאי חולדה‬
SELIGSOHN GABRIELI & CO.,
,'‫זליגסון גבריאלי ושות‬
31 YAVNE ST.,
31 ‫רח' יבנה‬
P.O.B. 1426,
‫תל אביב‬1426 .‫ד‬.‫ ת‬,
TEL AVIV 61013
A device for regulating the voltage level at a desired section of a telecommunications
network, said device comprising: an input port, connected to a portion of said network
and receiving an input RF telecommunications signal with an input AC voltage;
isolating circuitry, connected with said input port, for isolating said input AC voltage
from said input RF telecommunications signal; a transformer, connected with said
isolating circuitry, said transformer comprising a primary winding receiving said
isolated input AC voltage and a secondary winding; a plurality of relays, connected to
respective points of said secondary winding of said transformer, said relays operative
for providing a selected voltage gain by selectively switching on a connection from
said secondary winding of said transformer, thereby deriving a regulated AC voltage
at a predetermined level; control circuitry, connected with said transformer and with
said relays, said control circuitry operative for monitoring said input AC voltage, and
selectively activating a selected relay while deactivating the other relays, to provide
said selected voltage gain; recombining circuitry, connected with said relays, for
recombining said regulated AC voltage with said isolated input RF
telecommunications signal to produce a recombined regulated AC voltage and RF
telecommunications signal; and an output port, connected to said recombining

]74[

]57[

377

December 29, 2011-‫ג' בטבת התשע"ב‬

circuitry and to another portion of said network, said output port providing said
recombined regulated AC voltage and RF telecommunications signal to said another
portion of said network.

__________________
]11[]21[
]54[

OPTICALLY ADDRESSED
SPATIAL LIGHT MODULATOR
AND METHOD

]22[
]31[
]51[
]71[
]87[
]74[

02.03.2007
60/778704
]32[ 02.03.2006
Int. Cl.(2010.01) G02F 01//13, 01//135
COMPOUND PHOTONICS, U.S.A.
WO/2007/103274
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122

]57[

378

193789
‫שיטה ואפנון של אור אופטי המופנה מרחבית‬

]33[

US

,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
An optical device has an electrically insulating first barrier layer disposed over a first
electrode layer, a photoconductive layer disposed over the first barrier layer, and a
carrier confining layer disposed over the photoconducting layer. The carrier confining
layer defines a volume throughout which a plurality of carrier traps are dispersed.
Further, an electrically insulating second barrier layer is disposed over the carrier
confining layer, a light blocking layer is disposed over the second barrier layer for
blocking light of a selected wavelength band. A reflective layer is disposed over the
light blocking layer for reflecting light within the selected wavelength band, a
birefringent or dispersive layer is disposed over the reflective layer, and an optically
December 29, 2011-‫ג' בטבת התשע"ב‬

transmissive second electrode layer is disposed over the birefringent or dispersive
layer. A method is also disclosed, as are additional layers intervening between those
detailed above.

__________________
]11[]21[

193848
‫סטנט היברידי מסגסוגת מתכת אמורפית וחומר‬
‫ביוקומפטבילי‬

]54[

HYBRID STENT HAVING AN
AMORPHOUS METAL ALLOY
AND BIOCOMPATIBLE
MATERIAL

]22[
]31[
]51[
]71[
]87[
]74[

14.03.2007
11/377769
]32[ 15.03.2006
]33[ US
Int. Cl.(2010.01) A61F 02//88, A61K 51//04, A61L 31//02, 31//10
MEDINOL LTD.
‫אביב‬-‫ תל‬,‫מדינול בע"מ‬
WO/2007/105088
EITAN MEHULAL LAW GROUP,
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
10 ABBA EBEN BLVD.,
,‫פטנטים‬
P.O.B. 2081,
10 ‫שדרות אבא אבן‬
HERZLIYA 46120
‫הרצליה‬2081 .‫ד‬.‫ ת‬,
An expandable stent is provided, wherein the stent is advantageously formed of at least
one amorphous metal alloy and a biocompatible material. The stent is formed from flat
metal in a helical strip which is wound to form a tubular structure. The tubular
structure is not welded but rather is wrapped or coated with a biocompatible material
in order to maintain the amorphous metal in its tubular configuration. Said stent can be
balloon expanded or self expanding.

]57[

379

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[
]54[

METHODS AND SYSTEMS FOR
GENERATING VIRTUAL RADAR
TARGETS

]22[
]31[
]51[
]71[

01.03.2007
174746
]32[ 03.04.2006
Int. Cl.(2010.01) G01S 07//40
ISRAEL AEROSPACE INDUSTRIES
LTD.
WO/2007/113790
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]87[
]74[

]57[

380

193866
‫שיטות והתקנים ליצירת מטרות דמי למכ"ם‬

]33[

IL

‫ לוד‬,‫התעשייה האוירית לישראל בע"מ‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

A virtual radar target generator, comprising: a transceiver and a controller coupled to
the transceiver, wherein the transceiver is adapted to receive a signal transmitted from
a radar antenna, store signal information representative of the received signal within a
digital radio frequency memory and transmit an output signal representative of a
virtual target such that at least a fraction of the output signal is received by the radar
antenna; wherein the controller is adapted to determine a timing of the transmission of
the output signal in response to a virtual distance between the virtual target and the
radar antenna, a required virtual target direction and direction information
representative of a direction of the radar antenna; wherein the transceiver further
comprises a transmission antenna, the transmission antenna and the radar antenna
being positioned within a space that is at least partially defined by a radome, and
wherein the transmission antenna transmits the output signal towards the radome such
that at least a fraction of the output signal is reflected towards the radar antenna.
December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

193932
‫התקן ושיטה להתפשטות אלמנטים מתכתיים‬

]54[

DEVICE AND METHOD FOR
WIDENING METAL ELEMENTS

]22[
]31[
]51[
]71[

28.02.2007
102006010795.0 ]32[ 08.03.2006
]33[ DE
Int. Cl.(2010.01) B21D 31//04
PROTEKTORWERK FLORENZ
MAISCH GMBH & CO. KG,
GERMANY
WO/2007/101594
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
A device and a method for widening elongated metal elements (11, 65) which move in
the longitudinal direction and are planar at least in certain regions are described. The
device comprises at least two clamping sections (19, 38, 49, 50) which are opposite
one another and of which one is arranged and designed for clamping a first
longitudinal side (22, 67) of the metal element in place and the other is arranged and
designed for clamping a second longitudinal side of the metal element in place, said
second longitudinal side being opposite the first longitudinal side of the metal element.
The clamping sections are each provided on a support unit (15, 35, 36, 39, 40), by
means of which the clamping sections, during the forward movement of the metal
element, are automatically moved apart essentially perpendicularly to the direction of
movement of the metal element.

]87[
]74[

]57[

381

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

194135
‫מערכת מיתוג חשמלית ומתג המכיל סוגר‬
‫וברגים לחיזוקו‬

]54[

ELECTRICAL SWITCHING
APPARATUS AND CIRCUIT
BREAKER INCLUDING A
MOLDED ENCLOSURE AND
MACHINE SCREWS
REINFORCING THE SAME

]22[
]31[
]51[
]71[
]87[
]74[

12.04.2007
11/402732
]32[ 12.04.2006
Int. Cl.(2010.01) H01H 71//02
EATON CORPORATION, U.S.A.
WO/2007/116307
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]57[

A circuit breaker comprising: an arc chamber; separable contacts proximate said arc
chamber; an operating mechanism structured to open and close said separable contacts;
a trip unit cooperating with said operating mechanism to trip open said separable
contacts; a molded enclosure comprising a first molded portion and a second molded
portion; a plurality of thread cutting screws fastening said first molded portion to said
second molded portion; and a plurality of machine screws, wherein said first molded
portion and said second molded portion cooperate to form a plurality of exterior side
walls, wherein said exterior side walls define an interior volume, wherein said interior
volume encloses said separable 4Q contacts, said arc chamber and at least a portion of
said operating mechanism, wherein said exterior side walls include a first wall portion

382

]33[

US

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

December 29, 2011-‫ג' בטבת התשע"ב‬

proximate said operating mechanism and a second wall portion proximate said trip
unit, wherein a first one of said machine screws is intermediate the first wall portion
and the second wall portion of a first one of said exterior side walls, wherein a second
one of said machine screws is intermediate the first wall portion and the second wall
portion 50 of a second one of said exterior side walls, and wherein said first and
second ones of said machine screws hold said first molded portion to said second
molded portion and restrict expansion of said first and second ones of said exterior side
walls away from said interior volume.

__________________
]11[]21[

194244
‫תרחיף רוקחי מימי ושיטה להכנתו‬

]54[

AQUEOUS PHARMACEUTICAL
SUSPENSION AND A PROCESS
FOR PREPARATION OF THE
SAME

]22[
]31[

10.05.2007
0610058.0
]32[ 19.05.2006
]33[ GB
0610246.1
23.05.2006
GB
0708375.1
30.04.2007
GB
Int. Cl.(2010.01) A61K 09//10, 31//5415, 31//723, 31//79
NORBROOK LABORATORIES
LIMITED, IRELAND
WO/2007/135362
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
An aqueous pharmaceutical suspension comprising: (i) at least one non-steroidal antiinflammatory drug; (ii) an aqueous buffer system; (iii) xanthan gum; (iv) polyvinyl
pyrrolidone; and (v) glycerol wherein the suspension is free from pregelatinised starch,

]51[
]71[
]87[
]74[
]57[

383

December 29, 2011-‫ג' בטבת התשע"ב‬

amino polycarboxylic acid, microcrystalline cellulose, hydroxypropylmethyl cellulose,
polyoxyethylene sorbitan monooleate, silicon dioxide and taste modifying agents
selected from the group consisting of bulk sweeteners, intense sweeteners, flavouring
agents and mixtures thereof.

__________________
]11[]21[

194287
‫ תהליך להכנתו והשימוש‬,‫גרנולאט מפוזר במים‬
‫בו להכנת תכשיר לטיפול באי–סדרים נפשיים‬

]54[

WATER DISPERSIBLE
GRANULATE, A PROCESS FOR
ITS PREPARATION AND ITS USE
IN THE MANUFACTURE OF A
COMPOSITION FOR
TREATMENT OF MENTAL
DISORDERS

]22[
]31[
]51[
]71[

23.03.2007
06075938.8
]32[ 21.04.2006
]33[ EP
Int. Cl.(2010.01) A23L 01//304, 02//02, 02//38, 02//385, 02//39, 02//60
UNILEVER PLC, UNITED
KINGDOM
WO/2007/122053
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬

]87[
]74[

]57[

One aspect of the invention relates to a water-dispersible granulate having a mass
weighted average diameter of at least 100 m, said granulate comprising: 40-90 wt.% of
carbohydrates; 2-30 wt.% of lipids containing at least 1% unsaturated fatty acids by
weight of the granulate and at least 30 mg/kg of a pro-oxidative metal selected from
the group consisting of iron, copper and combinations thereof; wherein at least 50
wt.% of the lipids is present as non- dispersed lipids. Despite the fact that the present
granulate contains a substantial amount of unsaturated fatty acids as well as a high
level of iron and/or copper, said granulate is nonetheless very stable against oxidation.
The granulate of the present invention is easy to manufacture by a process that does
not employ emulsification or pro-oxidative conditions.; The present invention also
provides a process for the manufacture of the aforementioned granulate.

__________________

384

December 29, 2011-‫ג' בטבת התשע"ב‬

]11[]21[
]54[

MONOLITHIC HIGH ASPECT
RATIO NANO-SIZE SCANNING
PROBE MICROSCOPE (SPM) TIP
FORMED BY NANOWIRE
GROWTH

]22[
]31[
]51[
]71[
]87[
]74[

08.03.2007
11/388132
]32[ 23.03.2006
Int. Cl.(2010.01) G01N 23//00
IBM CORPORATION, U.S.A.
WO/2008/054467
IBM LABORATORIES,
HAIFA UNIVERSITY,
HAIFA 31905

]57[

194297
‫קצה מיקרוסקופ בעל חיישן סורק מונוליטי עם‬
‫יחס מימדים גבוה ובגודל ננומטרי הנוצר בגידול‬
‫ננומטרי‬

]33[

US

,‫מעבדות יבמ מחלקת קנין רוחני‬
‫אוניברסיטת חיפה הר הכרמל‬
‫חיפה‬

A method of forming a scanning probe comprising: forming an array of cantilevers;
forming a silicon pyramid having sidewalls and a tip by anisotropic etching over each
of said cantilevers; depositing a catalyst on the sidewalls and the tip of said silicon
pyramid; growing a plurality of nanowires from said catalyst over said sidewalls and
said tip of said silicon pyramid; and removing nanowires from said sidewalls of said
silicon pyramid.

__________________
]11[]21[
]54[

METHODS FOR DETERMINING
PREDISPOSITION TO WARFARIN
RESISTANCE

]22[
]31[

28.03.2007
60/786350
]32[ 28.03.2006
60/834559
01.08.2006
Int. Cl.(2010.01) C12Q 01//68
TEL HASHOMER MEDICAL
RESEARCH INFRASTRUCTURE
AND SERVICES LTD.
EVA GAK, HILLEL HALKIN

]51[
]71[
]72[
385

194299
–‫שיטות לקביעת סיכון לעמידות ל‬
WARFARIN

]33[

US
US

‫תשתית ושירותים‬, ‫מחקרים‬-‫תל השומר‬
‫ גן‬- ‫ רמת‬,‫רפואיים בע"מ‬
‫ הלל הלקין‬,‫אוה ג'ק‬
December 29, 2011-‫ג' בטבת התשע"ב‬

]87[
]74[

]57[

WO/2007/110869
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬1995( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
The present invention is of the high association of the 5417T allele of the
VKORC1 gene with high coumarin dose requirements and which can be used to
determine the predisposition of an individual to coumarin resistance .
Specifically, the present invention provides methods and kits for determining
the predisposition of an individual to coumarin resistance and for predicting
the responsiveness of an individual to coumarin treatment .

__________________
]11[]21[

194464
‫מסוע סרק לקו ייצור‬

]54[

CONVEYOR IDLER ASSEMBLY

]22[
]31[

30.03.2007
2006901674
]32[ 31.03.2006
]33[ AU
2006906126
03.11.2006
AU
Int. Cl.(2010.01) B65G 39//12
ALLENVEE HOLDINGS PTY LTD.,
AUSTRALIA
WO/2007/112484
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
279 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬6451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
A conveyor idler assembly (10) for supporting a conveyor belt (11) comprising a
support frame (12) having at least one elongated linear or longitudinally curved
support beam (16) which extends transversely of the conveyor belt (11) and at least
one idler cassette (13) having an idler roller (30), the cassette (13) being mounted to
the support beam (16) for slidable movement therealong.

]51[
]71[
]87[
]74[

]57[

__________________

386

December 29, 2011-‫ג' בטבת התשע"ב‬

]11[]21[

194656
‫פורמולציה שעברה ייבוש בהקפאה המכילה‬
‫צימוד של ניקוטין וחלקיק דמוי–נגיף‬

]54[

LYOPHILIZED FORMULATION
COMPRISING A NICOTINEVIRUS-LIKE PARTICLE
CONJUGATE

]22[
]31[
]51[
]71[

11.05.2007
06113895.4
]32[ 12.05.2006
]33[ EP
Int. Cl.(2010.01) A61K 09//19, 39//385, 47//06
CYTOS BIOTECHNOLOGY AG,
SWITZERLAND
WO/2007/131972
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The present invention is in the fields of medicine, public health, vaccine and drug
formulation. The invention provides composition formulations comprising a nicotinecarrier conjugate and a stabilizer, wherein said stabilizer comprises a non-reducing
disaccharide and a non-ionic surfactant. The composition formulations are stable after
a long time of storage at room temperature.

]87[
]74[

]57[

__________________
]11[]21[

194687

]54[

MULTILAYERED FILM AND
METHOD FOR MANUFACTURING
SAME

]22[
]31[
]51[
]71[

11.04.2007
102006018060.7 ]32[ 14.04.2006
]33[ DE
Int. Cl.(2010.01) B32B 09//02, 27//36, B65D 65//46
BIO-TEC BIOLOGISCHE
NATURVERPACKUNGEN GMBH &
CO. KG, GERMANY
WO/2007/118828
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]87[
]74[

]57[

387

‫פילם רב–שכבתי ושיטה לייצורו‬

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

A multilayered film is shown and described that is used in particular for packaging,
which comprises at least one first layer A and at least one second layer B, wherein
layer A contains thermoplastic polyester and layer B contains thermoplastic starch. The
December 29, 2011-‫ג' בטבת התשע"ב‬

multilayered film according to the invention is characterized by excellent barrier
properties, low sensitivity to moisture, and good mechanical strength.

__________________
]11[]21[

194909
‫מערכת ושיטה לניטור רכבים ונהגים‬

]54[

SYSTEM AND METHOD FOR
MONITORING VEHICLES AND
DRIVERS

]22[
]31[
]51[
]71[
]87[
]74[

17.04.2007
60/745632
]32[ 26.04.2006
]33[ US
Int. Cl.(2010.01) G08B 17//00
ILAN ROSEN
‫ בנימינה‬,‫אילן רוזן‬
WO/2007/122607
DR. YORAM TSIVION,
,‫ד"ר יורם צביון‬
2 HATOCHEN ST.
‫ פארק התעשיה‬,2 ‫רח' הטוחן‬
P.O.B. 3148,
‫קיסריה‬3148 .‫ד‬.‫ ת‬,
CAESAREA 38900
Implementing the system and method in accordance with the present invention affords
ability to determine whether a driver is guilty of bearing a faulty set of driving
regulatory documents DRDs. The law-enforcement agent using the system and method
in accordance with the present invention is able to identify remotely vehicles having
faulty DRDs. In accordance with the present invention, the currently used hard copies
of the DRD are supplemented or altogether replaced by stored data in a digital storage
medium. The storage medium can be installed in the driver's car or the data may be
stored in a centralized law enforcement database. The police may access the database
in order to retrieve information regarding the validity of the driver's permits. In the
scenario wherein the digital storage medium is located in the driver's car, typically one
or more smart cards or RFID cards or flash memory devices or discs may be used to
store the current data.

]57[

__________________
]11[]21[
388

195661
December 29, 2011-‫ג' בטבת התשע"ב‬

‫מכשיר הכולל מעבר שאיבה להכנת משקה‬
‫מחומר אבקתי ונוזל חם וכמו כן מעבר הוצאה‬

]54[

DEVICE WITH A SUCTION DUCT
FOR PREPARING A BEVERAGE
FROM A POWDERY SUBSTANCE
AND A HOT LIQUID AS WELL AS
AN EXTRACTION DUCT

]22[
]31[
]51[
]71[

31.05.2007
1031947
]32[ 02.06.2006
]33[ NL
Int. Cl.(2010.01) A47J 31//40, 31//60
BRAVILOR HOLDING B.V., THE
NETHERLANDS
RAMON EDUARD VERHOEVEN,
JOHANNES JACOBUS VAN
STEENDEREN DE KOK, CARLOS
NICOLAAS JOZEF MARIA
KOOPMAN
WO/2007/142519
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬1995( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
Preparing device (1) for preparing a beverage from a powdery substance and a hot
liquid, the device comprising: at least one mixing chamber (11) for mixing a quantity
of the powdery substance and a quantity of the hot liquid; an inlet (38) into the mixing
chamber for the quantity of hot liquid; an inlet (21) into the mixing chamber for the
quantity of powdery substance; an extractor hood (4) placed on the mixing chamber;
an extraction duct connected to the extractor hood and provided with suction means,
such as a ventilating fan, for extracting vapour and dust particles from the mixing
chamber via the extraction duct (3) and the extractor hood; a first housing (26)
accommodating further components of the preparing device, such as electrical
components and pipework, in which the extraction duct extends entirely along the
exterior of the first housing, as well as an extraction duct.

]72[

]87[
]74[

]57[

__________________
389

December 29, 2011-‫ג' בטבת התשע"ב‬

]11[]21[

196221
‫יוני כרום וגליום עבור הגברת קצב הסרת‬
‫תחמוצת‬

]54[

GALLIUM AND CHROMIUM IONS
FOR OXIDE REMOVAL RATE
ENHANCEMENT

]22[
]31[
]51[
]71[

10.07.2007
11/491055
]32[ 21.07.2006
]33[ US
Int. Cl.(2010.01) B24B 01//00, C09K 03//14
CABOT MICROELECTRONICS
CORPORATION, U.S.A.
WO/2008/013668
SELIGSOHN GABRIELI & CO.,
,'‫זליגסון גבריאלי ושות‬
31 YAVNE ST.,
31 ‫רח' יבנה‬
P.O.B. 1426,
‫תל אביב‬1426 .‫ד‬.‫ ת‬,
TEL AVIV 61013
The invention provides a chemical-mechanical polishing composition comprising
silica, a compound in an amount sufficient to provide 0.2 mM to 10 mM of a metal
cation selected from the group consisting of gallium (III), chromium (II), and
chromium (III), and water, wherein the polishing composition has a pH of 1 to 6. The
invention further provides a method of chemically-mechanically polishing a substrate
with the aforementioned polishing composition.

]87[
]74[

]57[

__________________
]11[]21[
]54[

CALCANEAL PLATE

]22[
]31[

17.07.2007
60/831647
]32[ 18.07.2006
60/880910
17.01.2007
11/879118
16.07.2007
Int. Cl.(2010.01) A61B 17//58
ORTHO-HELIX SURGICAL
DESIGNS, INC., U.S.A.
WO/2008/011018
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122

]51[
]71[
]87[
]74[

390

196257
‫פלטת עצם העקב‬
]33[

US
US
US

,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
December 29, 2011-‫ג' בטבת התשע"ב‬

]57[

The present invention is a fully contoured calcaneal plate having substantially no
planar surfaces except at the origin. The contoured plate includes radiused sections,
one extending inferior to superior is curved inferior to superior in a shape which is
close to cylindrical and which approximates the shape of the cuboid bone. The second
radiused section is curved in the vicinity of the anterior strut, and in particular at the
inferior portion of the plate, to accommodate the peroneal tubercle. The plate has a
rectangular or modified ovoid body section and a dog boned shaped tail with triangular
placed holes for fixation.

__________________
]11[]21[

196327
–1,1,1 ‫הידרוגנציה אסימטרית של‬
‫טריפלואורואצטון‬

]54[

ASYMMETRIC
HYDROGENATION OF 1,1,1TRIFLUOROACETONE

]22[
]31[
]51[
]71[

17.07.2007
06117928.9
]32[ 27.07.2006
]33[ EP
Int. Cl.(2010.01) C07C 29//145
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND
WO/2008/012240
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The invention relates to the preparation of enantiomerically pure (S)-1,1,1-trifluoro-2propanol by an asymmetric hydrogenation of 1,1,1-trifluoroacetone which process
comprises hydrogenating 1,1,1-trifluoroacetone in the presence of a ruthenium
phosphine complex represented by formula Ru(E)(E')(L)(A) wherein E, E' are both
chloro or E is hydrogen and E' is BH4; L is a chiral diphosphine ligand; and A is an
optionally chiral diamine comprising the variants a) in the presence of a weak base and
with or without an additive in case when E and E' are both chloro or b) in the absence
of a base and an additive in case when E and E' are hydrogen and BH 4.

]87[
]74[

]57[

391

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

196716
‫בדים בלתי–ארוגים אלסטים וחומר מרוכב‬
‫בלתי–ארוג הכולל אותם‬

]54[

ELASTIC SPUNBONDED
NONWOVEN AND COMPOSITE
NONWOVEN COMPRISING THE
SAME

]22[
]31[
]51[
]71[
]87[
]74[

06.08.2007
06016946.3
]32[ 14.08.2006
]33[ EP
Int. Cl.(2010.01) B32B 27//02, D01F 08//16, D04H 03//00
ALBIS SPA, ITALY
WO/2008/019775
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]57[

The spunbonded nonwoven (W) has high elastic recovery properties and comprises a
plurality of multi-component filaments. Each filament, preferably of the sheath/core
type, comprises at least a first polymeric component and a second polymeric
component. The first polymeric component comprises thermoplastic polyurethane, and
the second polymeric component comprises an elastic propylene-based olefin
copolymer, and more particularly an ethylene propylene copolymer, preferably
comprising at least 80wt% of propylene units. Said spunbonded nonwoven (W) can be
easily thermal- bonded with polyolefin-based nonwoven layer(s), especially
polypropylene-based layer(s), in order to make a composite nonwoven, particularly
suitable for the hygienic industry (e.g., diapers(.

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

__________________
]11[]21[
]54[

STEERABLE MULTI-LINKED
DEVICE HAVING MULTIPLE
WORKING PORTS

]22[
]31[

14.08.2007
60/822280
60/862636

392

]32[

14.08.2006
24.10.2006

197032
‫התקן רב–קישורים בעל יכולת ניווט עם ממשקי‬
‫עבודה מרובים‬

]33[

US
US
December 29, 2011-‫ג' בטבת התשע"ב‬

]51[
]71[
]87[
]74[

]57[

Int. Cl.(2010.01) A61B 01//00
CARDIOROBOTICS, INC., U.S.A.
WO/2008/022114
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O.B. 2081,
HERZLIYA 46120

‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬2081 .‫ד‬.‫ ת‬,
A steerable multi-linked device. The device includes a first multi-linked mechanism
and a second multi-linked mechanism. The first mechanism defines a first plurality of
grooves. The second mechanism defines a second plurality of grooves. The first and
second pluralities of grooves cooperate to define at least two working ports along a
length of the device. At least one of the first and second mechanisms are steerable.

__________________
]11[]21[

197165
‫מסרק נגד כינים‬

]54[

LICE COMB

]22[
]31[
]51[
]71[

23.08.2007
2006904564
]32[ 23.08.2006
]33[ AU
Int. Cl.(2010.01) A01K 13//00, A45D 24//02, 24//10
DAVID JACOB SCHWARTZ,
AUSTRALIA
MOSHE MAOR, AUSTRALIA
MOSHE MAOR, EDWARD JOSEPH
KHOURY, ROBERT CHARLES
ALEXANDER CULLEY
WO/2008/022387
SOROKER-AGMON,
14 SHENKAR ST.,
HERZLIYA PITUAH 46725

]72[
]87[
]74[

]57[
393

,‫אגמון‬-‫סורוקר‬
14 ‫ רחוב שנקר‬,‫בית נולטון‬
‫הרצליה פיתוח‬
A lice comb (10) comprising a plurality of parallel teeth (12) having upper surfaces
December 29, 2011-‫ג' בטבת התשע"ב‬

(16) and lower surfaces (18). Each pair of adjacent teeth (12) includes a first set of
projections (22) on a side surface (24) of one tooth and a second set of projections (26)
on a side surface (28) of the adjacent tooth. The first set of projections (22) are
provided along at least a portion of the length of the tooth such that hair moving
downwardly between the pair of teeth (12) passes through gaps (32) defined between
the first set of projections (22). The second set of projections (26) are interspersed
between and in a direction toward the lower surface (18) of the teeth (12) such that the
strands of hair passing through the gaps (32) are deflected in a direction parallel to the
teeth (12) in use by the second set of projections (26).

__________________
]11[]21[
]54[

MODIFIED NEOMYCIN
PHOSPHOTRANSFERASE GENE
AND METHODS USING SAID
GENE

]22[
]31[

25.11.2003
10256081.1
]32[ 29.11.2002
10330686.2
08.07.2003
Int. Cl.(2010.01) C12N 09//12, 15//85
DIVISION FROM 168806
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH,
GERMANY
WO/2004/050884
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]51[
]62[
]71[
]87[
]74[

]57[

394

197377
‫גן ניאומיצין פוספוטרנספראז שעבר שינוי‬
‫ושיטות המשתמשות בגן הנ"ל‬

]33[

DE
DE

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

Modified neomycin phosphotransferase gene characterized in that the modified
neomycin phosphotransferase gene codes for a different amino acid than the wild-type
neomycin phosphotransferase gene at at least one of the following positions: either at
amino acid position 182, 227 or 261, whereby the modified neomycin
December 29, 2011-‫ג' בטבת התשע"ב‬

phosphotransferase gene compared with the wild-type gene codes for glycine at amino
acid position 182, for alanine or valine at amino acid position 227, or for glycine at
amino acid position 261, whereby the modified neomycin phosphotransferase which is
encoded by the neomycin phosphotransferase gene has a lower enzyme activity than
the wild-type neomycin phosphotransferase.
The parent application from which
this application has been divided has
not yet been published

2466/4

‫בקשת הורה לבקשה זו שטרם‬
‫פורסמה‬

__________________
]11[]21[

197988
‫נוגדן או פרגמנט של הנוגדן הנקשר ספציפית‬
PC–LECTIN ‫לפוליפפטיד‬

]54[

ANTIBODY OR FRAGMENT
THEREOF THAT SPECIFICALLY
BINDS TO A PC-LECTIN
POLYPEPTIDE

]22[
]31[
]51[
]62[
]71[
]87[
]74[

11.08.2000
60/148935
]32[ 12.08.1999
]33[ US
Int. Cl.(2010.01) A61K 39//395, C07K 14//435, 14//705, 16//18, C12N 05//12
DIVISION FROM 147902
AGENSYS, INC., U.S.A.
WO/2001/012811
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬

]57[

An antibody or fragment thereof that specifically binds to a PC-LECTIN polypeptide
encoded by a polynucleotide selected from the group:
a polynucleotide comprising SEQ ID NO:1, wherein T can also be U,
a polynucleotide comprising SEQ ID NO: 1, from nucleotide residue number 201
through nucleotide residue number 2378, wherein T can also be U,
a polynucleotide encoding a PC-LECTIN protein comprising the amino acid sequence
of SEQ ID NO:2.

__________________
]11[]21[
]54[
395

USE OF A RETROVIRAL VECTOR
COMPRISING CPPT AND CTS

198076
cPPT ‫שימוש בוקטור רטרווירוס המכיל אזורי‬
‫ של לנטיוירוס ווקטור רטרווירוס‬CTS–‫ו‬
December 29, 2011-‫ג' בטבת התשע"ב‬

REGIONS OF LENTIVIRAL AND A
RETROVIRAL VECTOR
]22[
]31[
]51[
]62[
]71[

]87[
]74[

]57[

10.10.2000
60/158387
]32[ 12.10.1999
]33[
Int. Cl.(2010.01) A61K 48//00, C12N 15//867
DIVISION FROM 148900
INSTITUT PASTEUR, FRANCE
INSTITUT NATIONAL DE LA
SANTE ET DE LA RECHERCHE
MEDICALE -I.N.S.E.R.M., FRANCE
WO/2001/027304
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

US

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

Use of a retroviral vector, comprising cPPT and CTS regions of lentiviral origin in
which the LTR is deleted for the promoter and enhancer of U3, for increasing in vitro
the rate of import of a nucleic acid in a host cell nucleus and medical uses thereof.

__________________
]11[]21[
]54[

CULTURES OF E1-IMMORTALIZED
CELLS

]22[
]31[

06.05.2004
PCT/EP03/50155 ]32[ 09.05.2003
PCT/EP03/50390
01.09.2003
PCT/EP03/50940
04.12.2003
PCT/EP04/50061
30.01.2004
Int. Cl.(2010.01) C12N 05//10
DIVISION FROM 171680
CRUCELL HOLLAND B.V., THE
NETHERLANDS
CHRISTOPHER ADAM YALLOP
WO/2004/099396
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O.B. 2081,
HERZLIYA 46120

]51[
]62[
]71[
]72[
]87[
]74[

]57[
396

198861
E1–‫תרביות של תאי אלמוות מסוג‬

]33[

WO
WO
WO
WO

‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬2081 .‫ד‬.‫ ת‬,
A culture of cells wherein the culture of cells is a serum-free suspension culture of
human embryonic retina cells immortalized by adenovirus E1 sequences, wherein cells
December 29, 2011-‫ג' בטבת התשע"ב‬

in the culture of cells produce a recombinant protein, the serum-free suspension culture
comprises culture medium exchanged at a rate of at least 1 culture volume/day, said
culture of cells comprises at least 40X106 viable cells/ml which can be maintained for
at least five days without a cell bleed, and at least 80% of the total cells are viable, and
wherein said cells are PER.C6 cells as represented by the cells deposited under
ECACC No. 96022940.

__________________
]11[]21[
]54[

RTP PAYLOAD FORMAT

]22[
]31[
]51[
]62[
]71[

02.06.2004
10/612851
]32[ 03.07.2003
Int. Cl.(2010.01) H04L 29//06
DIVISION FROM 162304
MICROSOFT CORPORATION,
U.S.A.
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]74[

]57[

199658
‫ להעברת קבצים‬RTP ‫מערך‬
]33[

US

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

A method comprising computer-instructions executable by a processor, the method
changing a plurality of single media packets into a composite packet, wherein: each
single media packet includes: a payload of one data stream, wherein the payload is
encrypted and has an arbitrary block size; a payload header for the payload and
including a boundary for the arbitrary block size; the composite packet corresponds to
the plurality of single media packets and includes: one or more payloads of a like data
stream and corresponding to the respective payloads of the plurality of single media
packets; and a payload profile format header for each payload in the composite packet
and corresponding to the payload headers of the plurality of single media packets,
wherein the payload profile format header has a payload boundary for a respective
payload in the composite packet that identifies an order thereof in the plurality of
single media packets

__________________
]11[]21[

397

200172
December 29, 2011-‫ג' בטבת התשע"ב‬

‫תהליך להכנת דפטומיצין‬

]54[

PROCESS FOR THE
PRODUCTION OF DAPTOMYCIN

]22[
]31[
]51[
]71[
]74[

30.07.2009
08161630.2
]32[ 01.08.2008
]33[
Int. Cl.(2010.01) A61K 31//00, C12P 21//04
ANTIBIOTICOS S.P.A., ITALY
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]57[

Process for the production of daptomycin by fermentation of Streptomyces
roseosporus in the presence of n-decanal or cuphea oil as sources of the n-decanoyl
side chain.

EP

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

__________________
]11[]21[

200959
‫פורמולציות נוזליות של מלחים‬
–4(–2[–4 ‫של‬
‫מתילפנילסולפניל)פניל]פיפרדין‬

]54[

LIQUID FORMULATIONS OF SALTS OF 4-[2-(4METHYLPHENYLSULFANYL)PHENYL]PIPERIDINE

]22[
]31[

14.03.2008
PA200700423
]32[
20.03.2007 ]33[ DK
PCT/DK2007/050076
15.06.2007
WO
PA200701790
14.12.2007
DK
Int. Cl.(2010.01) A61K 31//451
H. LUNDBECK A/S, DENMARK
WO/2008/113358
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
124 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11490 .‫ד‬.‫ ת‬,
TEL AVIV 62038
Liquid formulations of the DL-lactic acid, the glutaric acid, the L-asρartic acid and the
glutamic acid salts of 4- [2- (4-methylphenylsulfanyl) phenyl] piperidine and their use in the
manufacture of a medicament to be used in the treatment of CNS diseases are provided.

]51[
]71[
]87[
]74[

]57[

__________________

398

December 29, 2011-‫ג' בטבת התשע"ב‬

]11[]21[

201461
‫מערכת ושיטה להתראת בטיחות תינוק‬

]54[

INFANT SAFETY ALERT
SYSTEM AND METHOD

]22[
]51[
]71[

01.08.2009
Int. Cl.(2010.01) B60N 02//26, B60R 21//015, G08B 21//24
IDAN NACHMANI
‫ קרית ביאליק‬,‫עידן נחמני‬
YAMIT NACHMANY, U.S.A.
MOSHE ATTIAS, U.S.A.

]72[

IDAN NACHMANI, YAMIT
‫עידן נחמני‬
NACHMANY, MOSHE ATTIAS
GIL LIVNE,
,‫גיל לבנה‬
P.O.BOX 152
‫נתניה‬152 .‫ד‬.‫ ת‬,
NETANYA 42101
Apparatus for alerting on an infant left in a vehicle, the apparatus comprising: an
occupant sensor installed on an infant seat deployable in a vehicle, configured to sense
presence of an infant within the infant seat, an infrared light sensor installed on the
infant seat, configured to sense infrared light being emitted within the vehicle, and an
alarm activator installed on the infant seat and connected to the occupant sensor and
the infrared light sensor, configured to activate an alarm upon the presence of the
infant being sensed by the occupant sensor and the infrared light being sensed by the
infrared light sensor.

]74[
]57[

This specification was examined in
accordance with regulation 35 of the Patent
Regulations, 5728 - 1968

‫ לתקנות‬13 ‫פירוט זה נבחן בהתאם לתקנה‬
2746 – ‫ תשכ"ח‬5‫הפטנטים‬

__________________
399

December 29, 2011-‫ג' בטבת התשע"ב‬

]11[]21[
]54[

INTERMEDIATES FOR
PREPARATION OF SHORTACTING SEDATIVE HYPNOTIC
AGENTS

]22[
]31[

24.01.2003
60/351385
]32[ 25.01.2002
60/379219
09.05.2002
Int. Cl.(2010.01) C07C 69//614
DIVISION FROM 162862
THERAVANCE, INC., U.S.A.
WO/2004/037750
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]51[
]62[
]71[
]87[
]74[

]57[

201639
‫חומרי ביניים להכנת גורמים היפנוטיים‬
‫משככים לטווח קצר‬

]33[

US
US

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

The invention provides compounds compositions and methods useful for inducing or
maintaining general anesthesia or sedation in mammals.

__________________
]11[]21[
]54[

INJECTION DEVICE

]22[
]31[

03.06.2008
202007008068.9 ]32[ 08.06.2007
202007012637.9
08.09.2007
Int. Cl.(2010.01) A61M 05//20
BAYER PHARMA
AKTIENGESELLSCHAFT, GERMANY
WO/2008/148518
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013

]51[
]71[
]87[
]74[

400

201694
‫התקן הזרקה‬
]33[

DE
DE

,‫ ברגמן וגולר‬,‫וולף‬
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
December 29, 2011-‫ג' בטבת התשע"ב‬

]57[

Disclosed is an injection device comprising parts, the relative movement of which
causes the active substance to be injected. For this purpose, a receptacle (103, 203),
into and in which a carpule/syringe can be inserted and mounted, is retained in a
housing (101, 201), the receptacle (103, 203) can be moved by means of a carriage
(108, 208), and a plunger (104, 204) that applies a force to the piston/s (111A, 111B;
211) of the carpule/syringe is movably retained in the receptacle (103, 203). A traction
rope (114, 214) which is deflected by means of a roll (109, 209) mounted on the
carriage (108, 208) is provided for performing the pricking stroke, injection stroke, and
retracting stroke. One end of the traction rope (114, 214) is connected to the receptacle
(103, 204) while the other end thereof is connected to a tension spring (110, 210) that
is retained on the housing (101, 201). Automatically and/or manually actuatable
mechanisms between the housing (101, 201), the receptacle (103, 203), the plunger
(104, 204), and the carriage (108, 208) control the reciprocal coupling thereof to the
traction rope (114, 214) and thus the sequence of the pricking stroke, injection stroke,
and retracting stroke and are fitted with at least one means that allows the user to adjust
the progress profile of at least one of the strokes.

__________________
]11[]21[
]54[

]22[
]31[
]51[
401

LACTAM-CONTAINING
TETRAHYDRO-PYRAZOLO [3,4C] PYRIDINE COMPOUNDS
USEFUL AS FACTOR XA
INHIBITORS AND
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THE SAME FOR TREATING
THROMBOEMBOLIC DISORDERS

203533
‫]פירידין‬C–3,4[ ‫תרכובת טטרההידרו–פיראזולו‬
XA ‫המכילה לקטם פעילה כמעכבת פקטור‬
‫ותכשירים פרמצבטיים המכילים אותה לטיפול‬
‫בהפרעות טרומבואמבוליות‬

17.09.2002
60/324165
]32[ 21.09.2001
]33[ US
Int. Cl.(2010.01) A61K 31//437, 31//444, A61P 07//02, 43//00, C07D 47/1/04
December 29, 2011-‫ג' בטבת התשע"ב‬

]62[
]71[
]87[
]74[

]57[

DIVISION FROM 160693
BRISTOL-MYERS SQUIBB
COMPANY, U.S.A.
WO/2003/026652
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
124 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11490 .‫ד‬.‫ ת‬,
TEL AVIV 62038
The present application describes lactam-containing compounds and derivatives
thereof of Formula I: P¿4?-P-M-M¿4? or pharmaceutically acceptable salt forms
thereof, wherein ring P, if present is a 5-7 membered carbocycle or heterocycle and
ring M is a 5-7 membered carbocycle or heterocycle. Compounds of the present
invention are useful as inhibitors of trypsin-like serine proteases, specifically factor
Xa.

__________________
]11[]21[

204984

]54[

VEGF BINDING FUSION
PROTEINS AND NUCLEIC ACIDS
ENCODING THE SAME

]22[
]31[
]51[
]62[
]71[

29.06.2004
10/609775
]32[ 30.06.2003
]33[ US
Int. Cl.(2010.01) A61K 38//17, C07K 14//71, 19//00, C12N 15//12, 15//62
DIVISION FROM 172404
REGENERON
PHARMACEUTICALS, INC., U.S.A.
WO/2005/000895
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬

]87[
]74[

]57[

402

‫ וחומצות גרעין‬VEGF ‫חלבוני איחוי קושרי‬
‫המקודדות להם‬

An isolated nucleic acid molecule encoding a fusion polypeptide which binds and
inhibits VEGF consisting of components (RlR2) x, wherein X >= 1, R1 is vascular
endothelial cell growth factor (VEGF) receptor component Ig domain 2 of Flt-1 and
R2 is Ig domain 3 of FIk-1.

__________________
December 29, 2011-‫ג' בטבת התשע"ב‬

]11[]21[
]54[

SUBSTITUTED
OXAZOLIDINONES, PROCESSES
FOR THEIR PREPARATION,
COMPOSITIONS COMPRISING
THEM AND USES THEREOF FOR
THE MANUFACTURE OF
MEDICAMENTS FOR THE
TREATMENT OF DISEASES

]22[
]31[
]51[
]62[
]71[

11.12.2000
19962924.2
]32[ 24.12.1999
Int. Cl.(2010.01) C07D 41/3/00
DIVISION FROM 149896
BAYER PHARMA
AKTIENGESELLSCHAFT,
GERMANY
WO/2001/047919
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710

]87[
]74[

]57[

205242
,‫ שיטות להכנתם‬,‫אוקסזולידינונים מותמרים‬
‫תכשירים המכילים אותם ושימוש בהם להכנת‬
‫תרופות לטיפול במחלות‬

]33[

DE

,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬

The invention relates to the field of blood coagulation, more specifically it relates to
novel oxazolidinone derivatives of the general formula (I), to methods for producing
them as well as to their use as active substances for medicaments for the prophylaxis
and/or the treatment of diseases.

The parent application from which
this application has been divided has
not yet been published

227674

‫בקשת הורה לבקשה זו שטרם‬
‫פורסמה‬

__________________
403

December 29, 2011-‫ג' בטבת התשע"ב‬

]11[]21[
]54[

METHOD AND DEVICE FOR A
PHOTOCHEMICAL PROCESS

]22[
]31[

27.01.2009
A152/2008
]32[ 31.01.2008
A889/2008
03.06.2008
Int. Cl.(2010.01) C12M 01//00
ECODUNA OG, AUSTRIA
WO/2009/094680
SHILON ZUCKERSTEIN & CO.,
AZRIELI CENTER 1, ROUND
TOWER, 19TH FLOOR,
TEL AVIV 67021

]51[
]71[
]87[
]74[

]57[

206869
‫שיטה ומכשיר לתהליך פוטוכימי‬

]33[

AT
AT

,'‫שילון צוקרשטיין ושות‬
19 ‫ קומה‬,‫ המגדל העגול‬1 ‫מרכז עזריאלי‬
‫תל אביב‬

The invention relates to a method and a device for a photochemical, such as
photocatalytic and/or photosynthetic process, particularly for the breeding and
production or hydrocultivation of preferably phototrophic microorganisms. A reactor,
particularly a biosolar reactor (1), comprising at least one reactor element (2), is
provided. The reactor element (2) is formed by two perpendicular pipes (3) connected
at the bottom. Furthermore, an inlet (4) and an outlet (5) are provided at the upper
reactor edge. The meander-shaped conductance of the reaction medium (6) is carried
out perpendicularly or inclined at an angle at least once from the top down or in the
direction of gravity, and from the bottom up or against the direction of gravity. Both
the introduction and removal of the reaction medium (6) into and from the reactor are
preferably carried out continuously, without pressure and freely to the atmosphere via
the upper reaction medium surface, wherein due to the hydrostatic pressure
compensation and leveling a flow of the reaction medium (6) that is stress-free for the
microorganisms is produced.
‫ לתקנות‬13 ‫פירוט זה נבחן בהתאם לתקנה‬
2746 – ‫ תשכ"ח‬5‫הפטנטים‬

This specification was examined in accordance
with regulation 35 of the Patent Regulations,
5728 - 1968

__________________
]11[]21[
]54[

SINGLE CRYSTAL DIAMOND

]22[
]31[
]51[
404

14.07.2004
60/486435
]32[ 14.07.2003
Int. Cl.(2010.01) C30B 33//02

207054
‫יהלום גביש יחיד‬
]33[

US
December 29, 2011-‫ג' בטבת התשע"ב‬

]62[
]71[
]87[
]74[
]57[

DIVISION FROM 173100
CARNEGIE INSTITUTION OF
WASHINGTON, U.S.A.
WO/2005/007935
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013

,‫ ברגמן וגולר‬,‫וולף‬
‫ירושלים‬1352 .‫ד‬.‫ ת‬,

A single crystal diamond grown by microwave plasma chemical vapor deposition has a
fracture toughness of 11-20 MPa m 1/2.

__________________
]11[]21[

207067
‫מערכת למתן טרנסדרמלי של ביופרנאורפין‬
‫לשימוש לטיפול בכאב‬

]54[

TRANSDERMAL DELIVERY
SYSTEMS OF BUPRENORPHINE
FOR USE IN TREATING PAIN

]22[
]31[

24.02.1998
60/038919
]32[ 24.02.1997
]33[ US
60/939068
29.09.1997
US
Int. Cl.(2010.01) A61K 09//70, 31//485, 45//00, A61P 25//04, 25//36, C07D 48/9/12
DIVISION FROM 201437
EURO-CELTIQUE S.A.,
LUXEMBOURG
WO/1998/036728
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013

]51[
]62[
]71[
]87[
]74[
]57[

405

The use of buprenorphine in the preparation of a medicament for a method of
effectively treating pain in humans is achieved by administering buprenorphine in a
manner indicative of first order pharmacokinetics over an initial three-day dosing
interval, such that a maximum plasma concentration from about 20 pg/ml to about
December 29, 2011-‫ג' בטבת התשע"ב‬

1052 pg/ml is attained, and thereafter maintaining the administration of buprenorphine
for at least an additional two-day dosing interval in a manner indicative of zero order
kinetics, such that the patients experience analgesia throughout the at least two-day
additional dosing interval.

__________________
]11[]21[

209736
‫שיטות ומערכות לעיבוד תחתית באמצעי סהרון‬
‫נוזל דינמי‬

]54[

METHODS AND SYSTEMS FOR
PROCESSING A SUBSTRATE
USING A DYNAMIC LIQUID
MENISCUS

]22[
]31[

29.09.2003
10/261839
]32[ 30.09.2002
]33[ US
10/330843
24.12.2002
US
10/330897
24.12.2002
US
10/404692
31.03.2003
US
10/603427
24.06.2003
US
Int. Cl.(2010.01) H01G 02//02
DIVISION FROM 161684
LAM RESEARCH CORPORATION,
U.S.A.
JOHN M. DE LARIOS, JAMES P.
GARCIA, CARL A. WOODS,
MICHAEL RAVKIN, FRED C.
REDEKER
WO/2004/032160
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45087 .‫ד‬.‫ ת‬,
JERUSALEM 91450
A system and method of moving a meniscus from a first surface to a second surface
includes forming a meniscus between a head and a first surface. The meniscus can be
moved from the first surface to an adjacent second surface, the adjacent second surface
being parallel to the first surface. The system and method of moving the meniscus can
also be used to move the meniscus along an edge of a substrate.
December 29, 2011-‫ג' בטבת התשע"ב‬

]51[
]62[
]71[
]72[

]87[
]74[

]57[

406

242462

The parent application from which
this application has been divided has
not yet been published

‫בקשת הורה לבקשה זו שטרם פורסמה‬

__________________
]11[]21[

209737
‫שיטות ומערכות לעיבוד תחתית באמצעי סהרון‬
‫נוזל דינמי‬

]54[

METHODS AND SYSTEMS FOR
PROCESSING A SUBSTRATE
USING A DYNAMIC LIQUID
MENISCUS

]22[
]31[

29.09.2003
10/261839
]32[ 30.09.2002
]33[ US
10/330843
24.12.2002
US
10/330897
24.12.2002
US
10/404692
31.03.2003
US
10/603427
24.06.2003
US
Int. Cl.(2010.01) H01G 02//02
DIVISION FROM 161684
LAM RESEARCH CORPORATION,
U.S.A.
JOHN M. DE LARIOS, JAMES P.
GARCIA, CARL A. WOODS,
MICHAEL RAVKIN, FRED C.
REDEKER
WO/2004/032160
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45087 .‫ד‬.‫ ת‬,
JERUSALEM 91450
A system and method of moving a meniscus from a first surface to a second surface
includes forming a meniscus between a head and a first surface. The meniscus can be
moved from the first surface to an adjacent second surface, the adjacent second surface

]51[
]62[
]71[
]72[

]87[
]74[

]57[

407

December 29, 2011-‫ג' בטבת התשע"ב‬

being parallel to the first surface. The system and method of moving the meniscus can
also be used to move the meniscus along an edge of a substrate.

The parent application from which
this application has been divided has
not yet been published

242462

‫בקשת הורה לבקשה זו שטרם פורסמה‬

__________________
]11[]21[

210701
‫גלגל המונע בכח לרכב צבאי‬

]54[

POWER-DRIVEN WHEEL FOR A
MILITARY VEHICLE

]22[
]31[

01.11.2007
TO2006A
]32[ 15.12.2006
]33[ IT
000894
Int. Cl.(2010.01) B60K 07//00, 17//04
DIVISION FROM 187093
OTO MELARA S.P.A., ITALY
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The invention relates to a power-driven wheel (1) having an axis (A) and comprising
an axial-flow motor (4) coaxial with said axis (A), a casing (5) housing said motor (4),
and a tubular hub (2) connected functionally to said motor (4). In order to facilitate
repairs, said casing (5) comprises a housing (6) with an open axial end (14) defining a
seat for said motor (4), and an end member (8) releasably engaging said open axial end
(14) of said housing (6) to grip said motor (4) inside said casing (5). The wheel (1) is
connectable to a frame (45) of a vehicle by connecting means (43) interposed between
said wheel (1) and said frame (45) so that, when said end member (8) is removed from
said housing (6), said motor (4) can be withdrawn completely through said open axial
end (14).

]51[
]62[
]71[
]74[

]57[

408

December 29, 2011-‫ג' בטבת התשע"ב‬

__________________
]11[]21[

210702
‫גלגל המונע בכח לרכב צבאי‬

]54[

POWER-DRIVEN WHEEL FOR A
MILITARY VEHICLE

]22[
]31[

01.11.2007
TO2006A
]32[ 15.12.2006
]33[ IT
000894
Int. Cl.(2010.01) B60K 07//00, 17//04
DIVISION FROM 187093
OTO MELARA S.P.A., ITALY
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The invention relates to a power-driven wheel (1) comprising an axial-flow motor (4),
a hub (2) connected functionally to said motor (4) and a tyre (3) angularly integral with
said hub (2). Motion transmission means (22) are interposed functionally between an
output member (7) of said motor (4) and said hub (2), and housed inside said hub (2).
To allow for inflation and deflation of the tyre, the wheel further comprises fluidic
connecting means (50) connecting an inner tube of said tyre (3) to the outside,
extending at least partly through said hub (2) and housed at least partly inside said
transmission means (22).

]51[
]62[
]71[
]74[

]57[

409

December 29, 2011-‫ג' בטבת התשע"ב‬

‫__________________‬

‫ג' בטבת התשע"ב‪December 29, 2011-‬‬

‫‪410‬‬

‫פטנטים‬

PATENTS
‫פטנטים שניתנו‬
PATENTS GRANTED
160182
162405
164845
183257
183946
184884
185692
186449
186922
187548
188568
150148
166755
167209
168359
170108
190896
192273
194074
196060
171851
172674
173773
175597
199123
207057
176556
177939
178705
179412
180060
181179
182236

411

160598
162854
165002
183286
184107
184922
185765
186676
186962
187853
188875
165226
166830
167218
168371
190414
191048
192771
194361
197546
171870
172702
173802
175632
200260
207587
176765
178006
178757
179594
180135
181195
182306

160843
163066
165022
183348
184263
184931
185880
186698
187125
187965
189086
165248
167013
167273
168405
190494
191580
192849
194548
134527
171956
172801
174065
176342
201428
143394
177148
178102
178824
179606
180172
181464
182350

161472
163285
182797
183539
184462
184952
185992
186725
187182
188017
189200
165304
167058
167436
169008
190546
191662
193006
194579
154589
172101
172815
174705
176357
202331
144988
177191
178192
178830
179658
180236
181522
182513

161721
163770
182937
183804
184498
184992
186160
186748
187266
188130
189350
166085
167060
167567
169123
190560
191666
193262
194842
170689
172410
172901
174716
176380
202468
145821
177335
178353
179028
179695
180277
181569
182669

161735
163843
183046
183868
184599
185375
186163
186769
187313
188527
113909
166390
167145
167623
169409
190597
191769
193365
195020
171119
172469
172922
175433
176471
202827
156770
177453
178452
179127
179792
180933
181821
208460

161843
164773
183099
183901
184623
185475
186213
186831
187352
188543
147881
166433
167173
167862
169519
190685
191828
193534
195539
171643
172484
173031
175533
198096
205411
157374
177728
178518
179239
179885
180986
181836
208799

162214
164783
183220
183916
184819
185537
186327
186858
187542
188545
147979
166501
167194
167937
169720
190805
192219
193730
195749
171798
172590
173303
175534
198978
205779
157922
177870
178672
179281
180047
181058
182161
208800

December 29, 2011-‫ג' בטבת התשע"ב‬

‫פטנטים שחודשו‬
PATENTS RENEWED
107675
107980
108017
108126
110388
122429
122601
122695
122777
125715
129792
130013
130239
130298
130449
130524
130601
131429
141916
146981
147110
150381
153816
155709
155992
156086
156204
156244
156278
156341
156396
156432
156505
156553
156635
156693
156928
157633
159305
161051
162063
163843
412

107822
107999
108018
108129
121280
122430
122602
122711
122840
125866
129836
130026
130243
130309
130450
130528
130629
132194
142009
146985
147137
150617
154577
155760
156055
156088
156206
156245
156280
156346
156398
156437
156508
156562
156640
156694
156967
157741
159451
161084
162111
164135

107868
108000
108027
108154
122273
122497
122630
122716
122871
126016
129911
130085
130247
130311
130459
130533
130653
134356
144988
146999
147213
150629
155097
155771
156058
156091
156238
156247
156303
156353
156403
156440
156516
156563
156644
156723
156975
157867
160432
161379
162376
164222

107870
108002
108029
108171
122292
122529
122631
122732
123012
126531
129912
130109
130255
130330
130464
130534
130657
135242
146386
147016
147221
151159
155373
155805
156076
156102
156239
156248
156306
156361
156410
156444
156523
156564
156646
156764
157002
158102
160498
161589
162405
164228

107967
108003
108051
108204
122300
122556
122632
122767
124478
129338
129937
130120
130267
130345
130482
130549
130734
136396
146694
147050
147276
153114
155428
155806
156080
156103
156240
156251
156308
156369
156415
156446
156531
156568
156657
156766
157161
158309
160659
161735
163066
164377

107969
108007
108061
108234
122327
122563
122666
122768
125281
129558
129938
130125
130277
130351
130492
130558
130764
136934
146737
147058
147506
153145
155497
155900
156083
156154
156241
156258
156310
156371
156421
156456
156532
156586
156658
156810
157164
158352
160784
161741
163102
164803

107974
108013
108115
108235
122375
122578
122669
122771
125386
129694
129979
130178
130278
130403
130501
130575
130793
138708
146823
147100
149933
153187
155662
155922
156084
156171
156242
156270
156325
156389
156423
156476
156542
156588
156661
156878
157201
158376
160843
161746
163600
164845

107977
108014
108118
108240
122420
122587
122671
122776
125635
129695
129999
130187
130293
130418
130515
130594
130918
141877
146924
147102
150282
153558
155689
155939
156085
156175
156243
156277
156331
156395
156427
156480
156550
156630
156678
156889
157505
158526
161031
161784
163653
164910

December 29, 2011-‫ג' בטבת התשע"ב‬

‫‪165528‬‬
‫‪166981‬‬
‫‪167465‬‬
‫‪168359‬‬
‫‪169337‬‬
‫‪170354‬‬
‫‪171693‬‬
‫‪172470‬‬
‫‪172674‬‬
‫‪172856‬‬
‫‪174062‬‬
‫‪174848‬‬
‫‪175859‬‬
‫‪176610‬‬
‫‪177327‬‬
‫‪178050‬‬
‫‪179109‬‬
‫‪179451‬‬
‫‪180047‬‬
‫‪181047‬‬
‫‪181850‬‬
‫‪183156‬‬
‫‪183391‬‬
‫‪183574‬‬
‫‪183763‬‬
‫‪183950‬‬
‫‪184081‬‬
‫‪184823‬‬
‫‪185635‬‬
‫‪186895‬‬
‫‪187965‬‬
‫‪188815‬‬
‫‪190494‬‬
‫‪192052‬‬
‫‪195446‬‬
‫‪197059‬‬
‫‪200260‬‬

‫‪165510‬‬
‫‪166802‬‬
‫‪167382‬‬
‫‪168323‬‬
‫‪169032‬‬
‫‪169775‬‬
‫‪171666‬‬
‫‪172469‬‬
‫‪172644‬‬
‫‪172838‬‬
‫‪173773‬‬
‫‪174797‬‬
‫‪175552‬‬
‫‪176512‬‬
‫‪177191‬‬
‫‪177986‬‬
‫‪179080‬‬
‫‪179402‬‬
‫‪180046‬‬
‫‪180740‬‬
‫‪181643‬‬
‫‪183091‬‬
‫‪183360‬‬
‫‪183573‬‬
‫‪183745‬‬
‫‪183946‬‬
‫‪184080‬‬
‫‪184784‬‬
‫‪185475‬‬
‫‪186882‬‬
‫‪187853‬‬
‫‪188527‬‬
‫‪190164‬‬
‫‪191886‬‬
‫‪194548‬‬
‫‪197052‬‬
‫‪199438‬‬
‫‪207492‬‬

‫‪165309‬‬
‫‪166445‬‬
‫‪167273‬‬
‫‪168207‬‬
‫‪169024‬‬
‫‪169704‬‬
‫‪171638‬‬
‫‪172454‬‬
‫‪172591‬‬
‫‪172837‬‬
‫‪173505‬‬
‫‪174729‬‬
‫‪175508‬‬
‫‪176433‬‬
‫‪177119‬‬
‫‪177980‬‬
‫‪179028‬‬
‫‪179395‬‬
‫‪179955‬‬
‫‪180670‬‬
‫‪181522‬‬
‫‪182924‬‬
‫‪183348‬‬
‫‪183550‬‬
‫‪183722‬‬
‫‪183930‬‬
‫‪184068‬‬
‫‪184770‬‬
‫‪185452‬‬
‫‪186858‬‬
‫‪187653‬‬
‫‪188408‬‬
‫‪190070‬‬
‫‪191874‬‬
‫‪194274‬‬
‫‪196372‬‬
‫‪199123‬‬
‫‪205693‬‬

‫ג' בטבת התשע"ב‪December 29, 2011-‬‬

‫‪165304‬‬
‫‪166433‬‬
‫‪167218‬‬
‫‪168118‬‬
‫‪168980‬‬
‫‪169683‬‬
‫‪171520‬‬
‫‪172447‬‬
‫‪172586‬‬
‫‪172819‬‬
‫‪173303‬‬
‫‪174676‬‬
‫‪175507‬‬
‫‪176357‬‬
‫‪177033‬‬
‫‪177939‬‬
‫‪179006‬‬
‫‪179356‬‬
‫‪179830‬‬
‫‪180556‬‬
‫‪181503‬‬
‫‪182860‬‬
‫‪183286‬‬
‫‪183548‬‬
‫‪183707‬‬
‫‪183924‬‬
‫‪184044‬‬
‫‪184462‬‬
‫‪185341‬‬
‫‪186550‬‬
‫‪187542‬‬
‫‪188403‬‬
‫‪189559‬‬
‫‪191662‬‬
‫‪193365‬‬
‫‪196048‬‬
‫‪198448‬‬
‫‪204960‬‬

‫‪165264‬‬
‫‪166243‬‬
‫‪167173‬‬
‫‪167937‬‬
‫‪168739‬‬
‫‪169677‬‬
‫‪171192‬‬
‫‪172323‬‬
‫‪172571‬‬
‫‪172805‬‬
‫‪173031‬‬
‫‪174642‬‬
‫‪175228‬‬
‫‪176336‬‬
‫‪176765‬‬
‫‪177808‬‬
‫‪178830‬‬
‫‪179286‬‬
‫‪179779‬‬
‫‪180413‬‬
‫‪181460‬‬
‫‪182690‬‬
‫‪183264‬‬
‫‪183547‬‬
‫‪183689‬‬
‫‪183917‬‬
‫‪184019‬‬
‫‪184300‬‬
‫‪185233‬‬
‫‪186382‬‬
‫‪187402‬‬
‫‪188169‬‬
‫‪189552‬‬
‫‪190720‬‬
‫‪192827‬‬
‫‪195677‬‬
‫‪198051‬‬
‫‪203892‬‬

‫‪165248‬‬
‫‪165966‬‬
‫‪167103‬‬
‫‪167750‬‬
‫‪168632‬‬
‫‪169657‬‬
‫‪170972‬‬
‫‪172101‬‬
‫‪172542‬‬
‫‪172702‬‬
‫‪172995‬‬
‫‪174618‬‬
‫‪175217‬‬
‫‪176270‬‬
‫‪176717‬‬
‫‪177684‬‬
‫‪178810‬‬
‫‪179255‬‬
‫‪179749‬‬
‫‪180384‬‬
‫‪181239‬‬
‫‪182494‬‬
‫‪183257‬‬
‫‪183546‬‬
‫‪183683‬‬
‫‪183872‬‬
‫‪184009‬‬
‫‪184297‬‬
‫‪185230‬‬
‫‪186317‬‬
‫‪187313‬‬
‫‪188130‬‬
‫‪189463‬‬
‫‪190685‬‬
‫‪192765‬‬
‫‪195539‬‬
‫‪197993‬‬
‫‪202308‬‬

‫‪165038‬‬
‫‪165719‬‬
‫‪167082‬‬
‫‪167652‬‬
‫‪168631‬‬
‫‪169575‬‬
‫‪170721‬‬
‫‪172075‬‬
‫‪172541‬‬
‫‪172695‬‬
‫‪172917‬‬
‫‪174606‬‬
‫‪175077‬‬
‫‪176150‬‬
‫‪176655‬‬
‫‪177648‬‬
‫‪178576‬‬
‫‪179124‬‬
‫‪179658‬‬
‫‪180172‬‬
‫‪181195‬‬
‫‪181864‬‬
‫‪183256‬‬
‫‪183437‬‬
‫‪183655‬‬
‫‪183812‬‬
‫‪184007‬‬
‫‪184245‬‬
‫‪184952‬‬
‫‪186226‬‬
‫‪187294‬‬
‫‪188017‬‬
‫‪189197‬‬
‫‪190597‬‬
‫‪192687‬‬
‫‪195448‬‬
‫‪197520‬‬
‫‪201967‬‬

‫‪165022‬‬
‫‪165717‬‬
‫‪167060‬‬
‫‪167641‬‬
‫‪168555‬‬
‫‪169535‬‬
‫‪170689‬‬
‫‪171870‬‬
‫‪172500‬‬
‫‪172680‬‬
‫‪172904‬‬
‫‪174510‬‬
‫‪175070‬‬
‫‪175925‬‬
‫‪176635‬‬
‫‪177557‬‬
‫‪178353‬‬
‫‪179117‬‬
‫‪179466‬‬
‫‪180116‬‬
‫‪181058‬‬
‫‪181863‬‬
‫‪183220‬‬
‫‪183435‬‬
‫‪183640‬‬
‫‪183786‬‬
‫‪184005‬‬
‫‪184156‬‬
‫‪184886‬‬
‫‪186213‬‬
‫‪187030‬‬
‫‪187994‬‬
‫‪188875‬‬
‫‪190546‬‬
‫‪192273‬‬
‫‪195447‬‬
‫‪197164‬‬
‫‪201966‬‬

‫‪413‬‬

‫פטנטים שתוקפם פקעו בגלל אי תשלום אגרת חידוש‬
PATENTS NOT IN FORCE DUE TO NON-PAYMENT OF RENEWAL
FEES
120295
120407
120465
120656
120751
122011
122699
140951
141758
177777
141961
142431
142884
143998
168462
151248
151428
151637
151703
151789
151922
152063
152215
152379
152487
152650
152798
153205
104830
104984
105063
105329
105456
105588
105625
105710
125772
125939
126057
126176
126262
414

120328
120420
120492
120688
120796
122139
122823
141584
141777
178018
141963
142455
142892
145774
168588
151249
151447
151647
151706
151822
151948
152073
152229
152388
152488
152657
152814
153233
104839
105003
105131
105344
105465
105591
105627
124426
125796
125954
126075
126180
126282

120332
120425
120504
120696
120806
122318
122916
141592
141822
178204
141989
142611
142994
145799
150792
151311
151471
151668
151708
151850
151976
152077
152249
152392
152495
152664
152817
154072
104880
105009
105141
105345
105468
105592
105637
124572
125850
125968
126086
126204
126283

120350
120430
120512
120700
120813
122520
122931
141632
155664
129789
142156
142732
143013
167179
150985
151329
151492
151669
151736
151864
151983
152085
152298
152448
152534
152677
152835
161961
104891
105017
105146
105369
105470
105593
105642
124848
125869
125969
126091
126207
126296

120358
120435
120523
120709
120817
122525
123201
141638
156650
130955
142208
142773
143042
167193
151075
151336
151524
151674
151751
151878
151989
152124
152300
152459
152550
152728
152868
161962
104915
105056
105183
105371
105498
105607
105658
125504
125893
125986
126097
126212
126304

120361
120436
120554
120719
120821
122526
123629
141676
158490
131019
142227
142774
143073
167646
151083
151373
151596
151687
151756
151894
152023
152132
152307
152461
152551
152730
152932
161963
104954
105058
105203
105382
105513
105614
105684
125590
125895
125987
126115
126219
126337

120380
120442
120612
120723
120824
122565
138011
141727
158522
132071
142325
142784
143217
167726
151084
151392
151626
151695
151766
151899
152045
152149
152327
152463
152600
152745
152971
183570
104957
105061
105204
105403
105516
105619
105695
125709
125911
126028
126120
126237
126338

120388
120455
120652
120746
120838
122647
138499
141740
177775
132616
142416
142825
143997
168162
151095
151416
151630
151699
151786
151913
152050
152172
152376
152482
152615
152789
153057
104829
104965
105062
105306
105449
105554
105622
105709
125764
125912
126054
126146
126248
126354

December 29, 2011-‫ג' בטבת התשע"ב‬

126358
126470
126582
126643
126854
126970
127033
146935

126363
126478
126584
126646
126897
126971
127044
147226

126368
126486
126591
126677
126911
126973
127111
147339

126371
126496
126596
126717
126917
126975
127130
147430

126395
126497
126605
126754
126918
126976
127177
147532

126403
126541
126607
126770
126944
126989
127218
148537

126420
126556
126614
126823
126968
127013
127726
148538

126423
126581
126628
126853
126969
127015
146001
149030

97455
97565
97620
97645
97701
97730
97851
97915
98014
98081
98157
111028

97464
97584
97623
97646
97709
97740
97867
97924
98025
98100
98161
111029

‫פטנטים שחודשו לעשרים שנה‬
PATENTS RENEWED FOR 20 YEARS
183176

‫צווי הארכה שחודשו‬
EXTENSION ORDERS RENEWED
94634

102138

‫פטנטים שפג תוקפם‬
PATENTS EXPIRED
97328
97465
97585
97631
97658
97714
97741
97884
97935
98027
98101
98163
111030

415

97376
97485
97592
97632
97674
97715
97744
97892
97944
98028
98126
98175
112575

97396
97487
97594
97633
97677
97720
97746
97904
97982
98033
98127
104253
119396

97413
97503
97596
97635
97690
97723
97779
97910
97992
98055
98137
107308
165071

97425
97516
97602
97641
97693
97727
97800
97912
98002
98060
98143
107309
170719

97426
97532
97619
97644
97695
97729
97837
97914
98008
98077
98152
110820

December 29, 2011-‫ג' בטבת התשע"ב‬

‫פטנטים שלגביהם הוגשו‬
‫בקשות להארכת תקופת‬
‫ההגנה על פי פרק ד' סימן‬
‫ לחוק הפטנטים‬1'‫ב‬

Patents for which
applications have been filed
for extension of the patent
term under chapter 4, part
B1 of the Patens Law
No. of basic patent:

225353

?‫מס' פטנט בסיסי‬
?‫שם המבקש‬

Proprietors:
BIOVITRUM AB (PUBL)
Date of application:

416

27.11.2011

?‫תאריך הגשת הבקשה‬

December 29, 2011-‫ג' בטבת התשע"ב‬

‫הודעה‬

NOTICE
Under section 60 of the
Patent Law, 5727-1967
Application has been filed
for the restoration of the
patent recorded below,
which has lapsed through
non-payment of the
prescribed renewal fees:
No. of Patent
Acceptance published in
journal no:
Proprietors:

‫ לחוק‬60 ‫לפי סעיף‬
1967-‫ תשכ"ז‬,‫הפטנטים‬
‫הוגשה בקשה להחזר תוקפו‬
,‫של הפטנט המפורט מטה‬
‫שתוקפו פקע מחמת אי‬
‫תשלום אגרות החידוש‬
:‫הקבועות‬
203137
7/0///

‫מס' הפטנט‬
?'‫קיבול פורסם ביומן מס‬
?‫שם בעל הפטנט‬

CECA S.A.
Title of invention:
?‫שם האמצאה‬
‫ קריוגנית של גזים תעשייתיים‬-‫ תהליך לייצורו והשימוש בו להפרדה לא‬5‫אמצעי סופח‬
ADSORBENT, PROCESS FOR THE PRODUCTION THEREOF AND USE THEREOF
FOR THE NON- CRYOGENIC SEPARATION OF INDUSTRIAL GASES
Any person may oppose the
‫כל אדם רשאי להתנגד‬
said application within three
‫לבקשה האמורה תוך‬
months from the date of this
‫שלושה חודשים מתאריך‬
Patents Journal, as
‫ כפי שנקבע‬,‫יומן פטנטים זה‬
prescribed by section 61 of
92 ‫ לחוק ובתקנה‬61 ‫בסעיף‬
the law and by regulation 92
‫ תשכ"ח‬,‫לתקנות הפטנטים‬
of the Patent Regulations,
1968
5728-1968

417

December 29, 2011-‫ג' בטבת התשע"ב‬

‫הודעה‬

NOTICE
Under section 60 of the
Patent Law, 5727-1967
Application has been filed
for the restoration of the
patent recorded below,
which has lapsed through
non-payment of the
prescribed renewal fees:
No. of Patent
Acceptance published in
journal no:
Proprietors:

‫ לחוק‬60 ‫לפי סעיף‬
1967-‫ תשכ"ז‬,‫הפטנטים‬
‫הוגשה בקשה להחזר תוקפו‬
,‫של הפטנט המפורט מטה‬
‫שתוקפו פקע מחמת אי‬
‫תשלום אגרות החידוש‬
:‫הקבועות‬
213236
3/0//0

‫מס' הפטנט‬
?'‫קיבול פורסם ביומן מס‬
?‫שם בעל הפטנט‬

‫אודיס תעשיית אביזרי השקיה בע"מ‬
ODIS IRRIGATION EQUIPMENT LTD.
?‫שם האמצאה‬
‫משקע עבור נוזלים בעלי עכירות גבוהה‬
SETTLER FOR HIGH-TURBIDITY LIQUIEDS
Any person may oppose the
‫כל אדם רשאי להתנגד‬
said application within three
‫לבקשה האמורה תוך‬
months from the date of this
‫שלושה חודשים מתאריך‬
Patents Journal, as
‫ כפי שנקבע‬,‫יומן פטנטים זה‬
prescribed by section 61 of
92 ‫ לחוק ובתקנה‬61 ‫בסעיף‬
the law and by regulation 92
-‫ תשכ"ח‬,‫לתקנות הפטנטים‬
of the Patent Regulations,
1968
5728-1968
Title of invention:

418

December 29, 2011-‫ג' בטבת התשע"ב‬

‫הודעה‬

NOTICE
Under section 60 of the
Patent Law, 5727-1967
Application has been filed
for the restoration of the
patent recorded below,
which has lapsed through
non-payment of the
prescribed renewal fees:
No. of Patent
Acceptance published in
journal no:
Proprietors:

‫ לחוק‬60 ‫לפי סעיף‬
1967-‫ תשכ"ז‬,‫הפטנטים‬
‫הוגשה בקשה להחזר תוקפו‬
,‫של הפטנט המפורט מטה‬
‫שתוקפו פקע מחמת אי‬
‫תשלום אגרות החידוש‬
:‫הקבועות‬
236006
3/0//7

‫מס' הפטנט‬
?'‫קיבול פורסם ביומן מס‬

?‫שם בעל הפטנט‬
‫ידע חברה למחקר ופיתוח בע"מ‬
YEDA RESEARCH AND DEVELOPMENT CO. LTD.
Title of invention:
?‫שם האמצאה‬
‫ להכנת תכשירי רוקחות לטיפול במחלות אוטואימוניות של‬C26 ‫שימוש באסטרים של חומצות שומניות‬
‫איברים ספציפיים‬
USE OF ESTERS OF C18 FATTY ACIDS FOR THE PREPARTION OF
MEDICAMENTS FOR TREATMENT OF ORGAN - SPECIFIC AUTOIMMUNE
DISEASES
Any person may oppose the
‫כל אדם רשאי להתנגד‬
said application within three
‫לבקשה האמורה תוך‬
months from the date of this
‫שלושה חודשים מתאריך‬
Patents Journal, as
‫ כפי שנקבע‬,‫יומן פטנטים זה‬
prescribed by section 61 of
92 ‫ לחוק ובתקנה‬61 ‫בסעיף‬
the law and by regulation 92
‫ תשכ"ח‬,‫לתקנות הפטנטים‬
of the Patent Regulations,
1968
5728-1968

419

December 29, 2011-‫ג' בטבת התשע"ב‬

‫הודעה‬

NOTICE
Under section 60 of the
Patent Law, 5727-1967
Application has been filed
for the restoration of the
patent recorded below,
which has lapsed through
non-payment of the
prescribed renewal fees:
No. of Patent
Acceptance published in
journal no:
Proprietors:

‫ לחוק‬60 ‫לפי סעיף‬
1967-‫ תשכ"ז‬,‫הפטנטים‬
‫הוגשה בקשה להחזר תוקפו‬
,‫של הפטנט המפורט מטה‬
‫שתוקפו פקע מחמת אי‬
‫תשלום אגרות החידוש‬
:‫הקבועות‬
237312
3/0//7

‫מס' הפטנט‬
?'‫קיבול פורסם ביומן מס‬

?‫שם בעל הפטנט‬
‫מוסד הטכניון למחקר ופיתוח בע"מ‬
TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD.
Title of invention:
?‫שם האמצאה‬
‫שיטה להכנת קורולים המותמרים באופן סלקטיבי וקורולים מותמרים חדשים‬
METHOD FOR THE PREPARATION OF SELECTIVELY-SUBSTITUTED CORROLES
AND NEW SUBSTITUTED CORROLES
Any person may oppose the
‫כל אדם רשאי להתנגד‬
said application within three
‫לבקשה האמורה תוך‬
months from the date of this
‫שלושה חודשים מתאריך‬
Patents Journal, as
‫ כפי שנקבע‬,‫יומן פטנטים זה‬
prescribed by section 61 of
92 ‫ לחוק ובתקנה‬61 ‫בסעיף‬
the law and by regulation 92
‫ תשכ"ח‬,‫לתקנות הפטנטים‬
of the Patent Regulations,
1968
5728-1968

420

December 29, 2011-‫ג' בטבת התשע"ב‬

‫הודעה‬

NOTICE
Under section 60 of the
Patent Law, 5727-1967
Application has been filed
for the restoration of the
patent recorded below,
which has lapsed through
non-payment of the
prescribed renewal fees:
No. of Patent
Acceptance published in
journal no:
Proprietors:

‫ לחוק‬60 ‫לפי סעיף‬
1967-‫ תשכ"ז‬,‫הפטנטים‬
‫הוגשה בקשה להחזר תוקפו‬
,‫של הפטנט המפורט מטה‬
‫שתוקפו פקע מחמת אי‬
‫תשלום אגרות החידוש‬
:‫הקבועות‬
241645
5/0//7

‫מס' הפטנט‬
?'‫קיבול פורסם ביומן מס‬
?‫שם בעל הפטנט‬

BASF AKTIENGESELLSCHAFT
?‫שם האמצאה‬
‫שיטה לטיהור קוטל חרקים‬
METHOD OF PURIFYING A PESTICIDE
Any person may oppose the
‫כל אדם רשאי להתנגד‬
said application within three
‫לבקשה האמורה תוך‬
months from the date of this
‫שלושה חודשים מתאריך‬
Patents Journal, as
‫ כפי שנקבע‬,‫יומן פטנטים זה‬
prescribed by section 61 of
92 ‫ לחוק ובתקנה‬61 ‫בסעיף‬
the law and by regulation 92
‫ תשכ"ח‬,‫לתקנות הפטנטים‬
of the Patent Regulations,
1968
5728-1968
Title of invention:

421

December 29, 2011-‫ג' בטבת התשע"ב‬

‫הודעה‬

NOTICE
Under section 60 of the
Patent Law, 5727-1967
Application has been filed
for the restoration of the
patent recorded below,
which has lapsed through
non-payment of the
prescribed renewal fees:
No. of Patent
Acceptance published in
journal no:
Proprietors:

‫ לחוק‬60 ‫לפי סעיף‬
1967-‫ תשכ"ז‬,‫הפטנטים‬
‫הוגשה בקשה להחזר תוקפו‬
,‫של הפטנט המפורט מטה‬
‫שתוקפו פקע מחמת אי‬
‫תשלום אגרות החידוש‬
:‫הקבועות‬
243264
3/0//6

‫מס' הפטנט‬
?'‫קיבול פורסם ביומן מס‬
?‫שם בעל הפטנט‬

‫מולטילוק טכנולוגיות בע"מ‬
MUL-T-LOCK TECHNOLOGIES LTD.
?‫שם האמצאה‬
‫מנעול צילינדר רב–כיווני‬
MULTI-DIRECTIONAL CYLINDER LOCK
Any person may oppose the
‫כל אדם רשאי להתנגד‬
said application within three
‫לבקשה האמורה תוך‬
months from the date of this
‫שלושה חודשים מתאריך‬
Patents Journal, as
‫ כפי שנקבע‬,‫יומן פטנטים זה‬
prescribed by section 61 of
92 ‫ לחוק ובתקנה‬61 ‫בסעיף‬
the law and by regulation 92
-‫ תשכ"ח‬,‫לתקנות הפטנטים‬
of the Patent Regulations,
1968
5728-1968
Title of invention:

422

December 29, 2011-‫ג' בטבת התשע"ב‬

NOTICE under section 64E of the
‫ה לחוק‬64 ‫הודעה לפי סעיף‬
Patents Law, 5727-1967
1967-‫הפטנטים התשכ"ז‬
It is the intention of the
‫בכוונת רשם הפטנטים ליתן צו‬
Commissioner of Patents to grant an
‫להארכת תקופת הגנה ע"פ פרק‬
order for the extension of the period
,‫ לחוק הפטנטים‬1‫ סימן ב‬,'‫ד‬
of protection of the following patent
‫ לגבי הפטנט‬1967-‫התשכ"ז‬
in accordance with Chapter Four,
:‫המפורט מטה‬
Article Two bis, of the Patents Law,
5727-1967
No. of basic patent:
103098
:‫מס' פטנט בסיסי‬
The order will be in effect until
14.04.2017
:‫הצו יעמוד בתוקפו עד ליום‬
Acceptance published in Journal
2/1996
:'‫קיבול פורסם ביומן מס‬
No.:
Title of invention:
:‫שם האמצאה‬
‫ פירידין פיורו ופירולו אנאלוגים שלהןתהליכים‬-[C-3,2]-‫תולדות טטראהידרותיאנו‬
‫המכילים אותם‬
‫להכנתן ותכשירי רוקחות‬
TETRAHYDROTHIENO-[3,2-c]- PYRIDENE DERIVATIVES, FURO AND PYRROLO
ANALOGS THEREOF, PROCESSES FOR THE PREPARATION THEREOF AND
PHARMACEUT
Proprietors:
:‫בעלי הפטנט‬
UBE INDUSTRIES LTD9
Any person desiring to oppose the
‫כל המעוניין להתנגד למתן צו‬
said grant of an order may, within
‫הארכה רשאי תוך שלושה‬
three months from the date of this
‫ להגיש‬,‫חודשים מתאריך יומן זה‬
journal, serve to the Commissioner
‫לרשם הפטנטים הודעה התנגדות‬
of Patents a notice of opposition
‫ בדרך‬,‫ו לחוק‬64 ‫לפי סעיף‬
under Section 64F of the Law, as
‫לתקנות‬
3 ‫הקבועה בתקנה‬
prescribed by Rule 3 of the Patent

‫הגנה‬
‫תקופה‬
‫(הארכת‬
‫הפטנטים‬
Regulations (extension of period of
protection – procedure of
‫ בהתנגדות‬,‫סדרי דין בבקשה לצו‬
application for order, opposition to
-‫ התשנ"ח‬,)‫ ובבקשה לביטול‬,‫לצו‬
order, application to annul) 57581998
1998.

423

December 29, 2011-‫ג' בטבת התשע"ב‬

‫שינויים בפרטים רשומים בפנקס‬
CHANGES IN PARTICULARS ENTERED IN REGISTER

424

December 29, 2011-‫ג' בטבת התשע"ב‬

‫מדגמים‬

DESIGNS

‫מדגמים שנרשמו‬
DESIGNS REGISTERED

Class

49052
3)01(
21.02.2010

‫סוג פרסום‬

MERCK SERONO SA
Tablet dispenser
Convention date (WIPO)

Class

‫מנפק לגלולות‬
)‫תאריך האמנה (וויפו‬

08.09.2009

49169 ,49168
9)03(
22.03.2010

CAESAREA LANDSCAPE DESIGN
LTD.

‫סוג פרסום‬
‫קיסריה עיצוב בנוף בע"מ‬
‫אשפתון‬

Dustbin

Class

49261
26)01(
11.04.2010

‫סוג פרסום‬
‫גישאי אחזקות בע"מ‬
‫נר זיכרון‬

GISHAY HOLDING LTD.
Memorial candle

Class

49066
9)03(
23.02.2010

CAESAREA LANDSCAPE DESIGN
LTD.
425

‫סוג פרסום‬
‫קיסריה עיצוב בנוף בע"מ‬

December 29, 2011-‫ג' בטבת התשע"ב‬

‫אשפתון‬

Dustbin

49213
3)01(
25.03.2010

Class

‫סוג פרסום‬
‫עיבוד לוחות פלסטיים בע"מ‬-‫עלפלסט‬

ALPLAST-PLASTIV SHEETS
CONVERTING LTD.

‫מארז‬

Case

49214
19)02(
25.03.2010

Class

‫סוג פרסום‬
‫עיבוד לוחות פלסטיים בע"מ‬-‫עלפלסט‬

ALPLAST-PLASTIV SHEETS
CONVERTING LTD.

‫אוגדנית עם תפס לדפים‬

Clip case

Class

50110
7)02(
21.09.2010

‫סוג פרסום‬

STRAUSS COFFEE B.V.
‫כלי בישול‬

Cooking container

Class

49263 ,49262
24)04(
11.04.2010

‫סוג פרסום‬

VECTURA DELIVERY DEVICES LIMITED
Inhaler
Convention date (OHIM)

Class
426

09.10.2009

49263
24)04(

‫משאף‬
)‫תאריך האמנה (איחוד אירופי‬

‫סוג פרסום‬
December 29, 2011-‫ג' בטבת התשע"ב‬

11.04.2010

VECTURA DELIVERY DEVICES LIMITED
Inhaler
Convention date (OHIM)

427

09.10.2009

‫משאף‬
)‫תאריך האמנה (איחוד אירופי‬

December 29, 2011-‫ג' בטבת התשע"ב‬

Class

49598 ,49597
12)16(
15.06.2010

‫סוג פרסום‬
‫ אביזרי רכב בע"מ‬.‫ק‬.‫ט‬
‫כיסוי מושב לרכב‬

T.C. AVISAREI RECHEV B.M.
Vehicle seat cover

Class

51395 ,49609
24)02(
16.06.2010

‫סוג פרסום‬

ROCHE DIAGNOSTICS S.L.
Portable medical equipment for clinical
analysis
Convention date (U.S.A.)

Class

‫מכשיר רפואי נייד לביצוע אבחון קליני‬
19.03.2010

)‫תאריך האמנה (ארצות הברית‬

49657
3)01(
21.06.2010

‫סוג פרסום‬
‫שוגון תיקים ומוצרי עור בע"מ‬

SHUGON BAGS &
LEATHERGOODS LTD.

‫תיק גב‬

Backpack

Class

49922
7)05(
03.08.2010

K. VISION SYSTEM SOLUTIONS
LTD.

‫סוג פרסום‬
‫קיי ויז'ן סיסטם סולושנס בע"מ‬
‫מייבש כלים‬

Dish dryer

Class

428

50085
9)01(
16.09.2010

‫סוג פרסום‬
December 29, 2011-‫ג' בטבת התשע"ב‬

GUERLAIN S.A.
Bottle
Convention date (OHIM)

429

17.03.2010

‫בקבוק‬
)‫תאריך האמנה (איחוד אירופי‬

December 29, 2011-‫ג' בטבת התשע"ב‬

Class

50177
6)09(
09.12.2010

‫סוג פרסום‬
‫דגנית בודק לוי‬
‫אהובה זעירי שטרית‬
‫כרית הנקה‬

DGANIT BODEK LEVI
AHUVA ZAIRI SHITRIT
Nursing pillow

Class

50273
21)01(
11.11.2010

‫סוג פרסום‬
‫ירחמיאל ברנשטיין‬
‫בנימין חוטה‬
‫צעצוע הרכבה‬

YERACHMEL BERENSHTEIN
BINYAMIN HUTA
Construction toy

Class

50410
23)01(
13.12.2010

‫סוג פרסום‬
‫אתי שגב‬
‫מכשיר להתזת מים‬

ETI SEGEV
A water spraying device

Class

50442
7)02(
21.12.2010

‫סוג פרסום‬
‫ארגו פיתוח וייצור בע"מ‬

ARGO DEVELOPMENT AND
MANUFACTURING LTD.

‫מכשיר להכנת קפה‬

Coffee maker

Class

JOSEFF ZAKARIYA
Ornament
430

50141
11)02(
11.10.2010

‫סוג פרסום‬
‫יוסף זקריה‬
‫קישוט‬
December 29, 2011-‫ג' בטבת התשע"ב‬

50506
9)01(
11.01.2011

Class

‫סוג פרסום‬

SOURCE VAGABOND SYSTEM LTD.
Bottle
Convention date (U.S.A.)

13.07.2010

50607
25)01(
07.02.2011

Class

Profile

50707 ,50706 ,50704
2)04(
21.02.2011

ANTELOPE SHIVUK (1994) LTD.
Sole

Class

50738
24)04(
24.02.2011

SHLOMO NORMATOV
Apparatus for weakening and/or cessation of
snoring

Class

SHOKET ALUMINIUM LTD.
431

‫סוג פרסום‬
‫שוקת אלומיניום בע"מ‬
‫פרופיל‬

SHOKET ALUMINIUM LTD.

Class

‫בקבוק‬
)‫תאריך האמנה (ארצות הברית‬

50770
6)06(
06.03.2011

‫סוג פרסום‬
‫) בע"מ‬1994( ‫אנטילופ שיווק‬
‫סוליה‬

‫סוג פרסום‬
‫שלמה נורמטוב‬
‫או הפסקת נחירות‬/‫התקן להחלשת ו‬

‫סוג פרסום‬
‫שוקת אלומיניום בע"מ‬
December 29, 2011-‫ג' בטבת התשע"ב‬

Furniture profile

432

‫פרופיל לרהיט‬

December 29, 2011-‫ג' בטבת התשע"ב‬

Class

50812
6)06(
17.03.2011

‫סוג פרסום‬
‫שוקת אלומיניום בע"מ‬
‫פרופיל לארון‬

SHOKET ALUMINIUM LTD.
Profile for cabinet

Class

50857
8)03(
27.03.2011

‫סוג פרסום‬

KOMET GROUP HOLDING GMBH
Cutting tools
Convention date (OHIM)

Class
.H.

27.10.2010

50868 ,50867
11)01(
28.03.2011

‫כלי חיתוך‬
)‫תאריך האמנה (איחוד אירופי‬

‫סוג פרסום‬

STERN COMERCIO E INDUSTRIA S.A
‫תכשיט‬

Jewel

Class

50911
25)01(
07.04.2011

‫שוקת אלומיניום בע"מ‬
‫פרופיל‬

SHOKET ALUMINIUM LTD.
Profile

Class

AMIT LEVI
Bottles compressor
433

‫סוג פרסום‬

50878
8)05(
29.03.2011

‫סוג פרסום‬
‫עמית לוי‬
‫דוחס בקבוקים‬
December 29, 2011-‫ג' בטבת התשע"ב‬

Class

50888
12)16(
30.03.2011

‫סוג פרסום‬

SAFECAR THEFT PREVANTION
SYSTEMS LTD.

‫סייף קאר מערכות מניעת גניבה בע"מ‬

Defensive equipment for igniting computer

‫מתקן הגנה למחשב הצתה‬

Class

49756
25)02(
06.07.2010

‫סוג פרסום‬
‫רוקח יוסף ובניו יבוא ושיווק בע"מ‬

JOSEPH ROKACH AND SONS
IMPORT AND DISTRIBUTION
LTD.

‫כיסוי לתא בקרה‬

Manhole cover

Class

50737
25)01(
24.02.2011

‫סוג פרסום‬
‫ארנון ברק‬
‫פרופיל‬

ARNON BARAK
Profile

Class

50901
2)01(
05.04.2011

‫סוג פרסום‬
‫שרה כהן‬
‫לבוש תחתון‬

SARAH COHEN
Under garment

Class

49899
26)03(
29.07.2010

‫סוג פרסום‬

KONINKLIJKE PHILIPS ELECTRONICS N.V
434

December 29, 2011-‫ג' בטבת התשע"ב‬

Luminaire for road lighting
Convention date (OHIM)

435

18.02.2010

‫אמצעי תאורה לדרך‬
)‫תאריך האמנה (איחוד אירופי‬

December 29, 2011-‫ג' בטבת התשע"ב‬

Class

50454
25)03(
27.12.2010

‫סוג פרסום‬
‫יוסף זקריה‬
‫מבנה נייד‬

JOSEFF ZAKARIYA
Mobile structure

Class

50814
25)03(
21.03.2011

‫סוג פרסום‬
‫ רוט תעשיות בע"מ‬.‫צ‬
‫סככה לנוסעים‬

Z. ROTH INDUSTRIES LTD.
Passenger shelter

Class

50314
21)01(
21.11.2010

‫סוג פרסום‬
‫כתר פלסטיק בע"מ‬
‫בית משחק‬

KETER PLASTIC LTD.
Play house

Class

50484
21)01(
04.01.2011

‫קמאל חסן‬
‫אסמעיל טורק‬
‫קוביית שפות ומתמטיקה‬

KAMAL HASAN
ISMAIL TURK
Cube of languages & mathmatics

Class

TAL KAMIL
Solar collector
436

‫סוג פרסום‬

49982
23)03(
19.08.2010

‫סוג פרסום‬
‫טל קמיל‬
‫קולט סולארי‬
December 29, 2011-‫ג' בטבת התשע"ב‬

Class

50024
21)01(
26.08.2010

‫סוג פרסום‬
‫סופי נסיכה ברמן‬
‫משחק‬

SOPHIE NESIHA BERMAN
Game

Class

SOPHIE NESIHA BERMAN
Cube game

437

50025
21)01(
26.08.2010

‫סוג פרסום‬
‫סופי נסיכה ברמן‬
‫קוביית משחק‬

December 29, 2011-‫ג' בטבת התשע"ב‬

‫מדגמים שבוטלו‬
DESIGNS VOID
27054
35215
27043
35104

27126
35216
27044
35121

35157
35217
35082
35131

35166
35222
35083

35168
35223
35084

35170
35225
35085

35200
27004
35097

35213
27026
35101

43594
43846
43893
44097
44743
40807
43409

43596
43847
43901
44452
35864
43210
43518

43632
43848
43902
44745
35995
43213
43644

‫מדגמים שחודשו‬
DESIGN RENEWED
35911
43703
43849
43904
44746
36053
43314
43645

35948
43835
43850
43905
49537
36084
43316
43762

43423
43836
43851
43906
49538
36118
43317
43770

Asa Kling
Commissioner of Patents,
Designs and Trade Marks

438

43424
43837
43852
43945
45939
36119
43318
43686

43537
43845
43892
44048
45941
36155
43389

‫אסא קלינג‬
‫ המדגמים‬,‫רשם הפטנטים‬
‫וסימני מסחר‬

December 29, 2011-‫ג' בטבת התשע"ב‬

‫מפתחות לבקשות שקובלו‬
‫‪INDICES OF APPLICATIONS ACCEPTED‬‬
‫מפתח שמי‬

‫‪NAME INDEX‬‬
‫ישקר בע"מ ‪174670 -‬‬

‫א‪.‬פ‪.‬מ‪ .‬פתרונות אוטומציה בע"מ ‪185534 -‬‬
‫אביב עמירב ‪193003 -‬‬
‫אוניברסיטת בן גוריון בנגב הרשות למחקר‬
‫ופיתוח ‪172944 -‬‬
‫אי‪ .‬סי‪ .‬איי‪ .‬טלקום בע"מ ‪, 171722 -‬‬
‫‪189342‬‬
‫איי‪.‬בי‪.‬איי ישראל ביומדיקל אינוביישנס‬
‫בע"מ ‪188582 -‬‬
‫אילן רוזן ‪194909 -‬‬
‫אלונים אחזקות אגש"ח בע"מ ‪177414 -‬‬
‫אלי הוגו בודמן ‪193059 -‬‬
‫אלתא מערכות בע"מ ‪183398 -‬‬
‫אמנון מאור ‪167142 -‬‬
‫אמנון שילוני ‪167142 -‬‬
‫אפוסנס בע"מ ‪145210 -‬‬
‫גאורגי נאומוב ‪189284 , 188649 -‬‬
‫גדעון אלון ‪174148 -‬‬
‫גיוון אימג'ינג בע"מ ‪167782 -‬‬
‫גל זילכה ‪161938 -‬‬
‫גמסוניק בע"מ ‪184362 -‬‬
‫דויד זילברברג ‪193502 -‬‬
‫דוקול בע"מ ‪192011 -‬‬
‫דקסל בע"מ ‪139894 -‬‬
‫הוק מדיקל טכנולוג'יס בע"מ ‪172326 -‬‬
‫התעשייה האוירית לישראל בע"מ ‪-‬‬
‫‪193866 , 163609‬‬
‫חניתה מפעלי מתכת בע"מ ‪181562 -‬‬
‫חסין אש תעשיות בע"מ ‪168332 -‬‬
‫יוסי סלע ‪168298 -‬‬
‫יעקב צרור ‪179893 -‬‬
‫ישקר בע"מ ‪174670 -‬‬
‫ג' בטבת התשע"ב‪December 29, 2011-‬‬

‫לייט בוק בע"מ ‪161938 -‬‬
‫ליתוטק מדיקל בע"מ ‪188067 -‬‬
‫מארוול ישראל (אמ‪.‬איי‪.‬אס‪.‬אל) בע"מ ‪-‬‬
‫‪189514‬‬
‫מדיגייד בע"מ ‪187667 -‬‬
‫מדינול בע"מ ‪193848 , 186786 -‬‬
‫מייקל ברוגמן ‪181639 -‬‬
‫מיכאל נאומוב ‪188649 -‬‬
‫מיכאל נאומוב ‪189284 -‬‬
‫מרסלו אדריאן אדטו ‪193059 -‬‬
‫סויטרון בע"מ ‪192005 -‬‬
‫סנו מפעלי ברונוס בע"מ ‪168686 -‬‬
‫עידן נחמני ‪201461 -‬‬
‫פואמיקס בע"מ ‪168399 -‬‬
‫פיטרקס בע"מ ‪188645 -‬‬
‫קורנית דיגיטל בע"מ ‪177323 -‬‬
‫קורנית דיגיטל טכנולוגיות בע"מ ‪177323 -‬‬
‫קמרו‪-‬טק בע"מ ‪170726 -‬‬
‫רונן כרמונה ‪161938 -‬‬
‫רמות ליד אוניברסיטת תל אביב בע"מ ‪-‬‬
‫‪167400‬‬
‫רן סימן‪-‬טוב ‪192005 -‬‬
‫רפא"ל מערכות לחימה מתקדמות בע"מ ‪-‬‬
‫‪183320‬‬
‫ש"ח שנאי חולדה ‪193502 -‬‬
‫תדיראן טלקום בע"מ ‪164577 -‬‬
‫תל השומר‪-‬מחקרים ‪,‬תשתית ושירותים‬
‫‪439‬‬

194299 - ‫רפואיים בע"מ‬

3M INNOVATIVE PROPERTIES
COMPANY - 26212/
A.P.M. AUTOMATION SOLUTIONS
LTD. - 185534
ABBOTT LABORATORIES - 172457
ABGENOMICS COOPERATIEF U.A. 174172
ABGENOMICS CORPORATION - 174172
ADIR SEGAL, LTD - 192011
AGENSYS, INC. - 197988
AIMSCO LIMITED - 180487
ALBERT EINSTEIN COLLEGE OF
MEDICINE OF YESHIVA UNIVERSITY
- 155791
ALBIS SPA - 196716
ALCATEL LUCENT - 180440
ALCHEMIA ONCOLOGY PTY LIMITED
- 189972
ALCON, INC. - 183323 , 183368
ALLENVEE HOLDINGS PTY LTD. 194464
ALLERGAN, INC. - 167410
ALONIM HOLDINGS AGRICULTURAL
COOPERATIVE SOCIETY LTD. - 177414
ALPHAMED MEDIZINTECHNIK
FISCHER GMBH - 183030
ALZA CORPORATION - 156090
AMNON MAOR - 167142
AMNON SHILONI - 167142
AMPHENOL CORPORATION - 184200
ANTHROGENESIS CORPORATION 190731
ANTIBIOTICOS S.P.A. - 200172
APOSENSE LTD. - 145210
APPLIED DESIGN AND ENGINEERING
LIMITED - 173997
AQUARIUS TECHNOLOGIES INC. 183881
ARES TRADING S.A. - 161309
ARM LIMITED - 189206
440

ASTELLAS PHARMA INC. - 168121
ASTION PHARMA A/S - 186491
ASTRAZENECA AB - 193071
AVANTOR PERFORMANCE
MATERIALS, INC. - 190088
AVENTIS PHARMA S.A. - 193310
AVENTIS PHARMACEUTICALS INC. 159506 , 190673
AVIV AMIRAV - 193003
BAE SYSTEMS BOFORS AB - 191614
BASF SE - 186680
BAYER ANIMAL HEALTH GMBH 183200
BAYER PHARMA
AKTIENGESELLSCHAFT - 183200 ,
201694 , 205242
BAYER S.A.S. - 169527
BEN-GURION UNIVERSITY OF THE
NEGEV RESEARCH AND
DEVELOPMENT AUTHORITY - 172944
BETH ISRAEL DEACONESS MEDICAL
CENTER - 178002
BIOAVAILABILITY, INC - 183157
BIOGEN IDEC MA INC. - 170178
BIONICHE LIFE SCIENCES INC. 164664
BIOSENSE WEBSTER INC. - 156377
BIOSENSE WEBSTER INC. - 181119
BIOSENSE WEBSTER, INC. - 180516
BIO-TEC BIOLOGISCHE
NATURVERPACKUNGEN GMBH & CO.
KG - 194687
BIOTEMPT, B.V. - 178515
BOARD OF REGENTS, THE
UNIVERSITY OF TEXAS SYSTEM 174374
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH - 166584 ,
175017 , 197377
BOEHRINGER INGELHEIM PHARMA
December 29, 2011-‫ג' בטבת התשע"ב‬

GMBH & CO. KG - 157326
BOTULINUM TOXIN RESEARCH
ASSOCIATES, INC. - 168745
BRAVILOR HOLDING B.V. - 195661
BRISTOL-MYERS SQUIBB COMPANY 157443
BRISTOL-MYERS SQUIBB COMPANY 203533
BURLE TECHNOLOGIES, INC. - 160873

DAVID ZILBERBERG - 193502
DENDERAH PHARMA SA - 182747
DEUTSCHE POST AG - 166911
DEXCEL LTD. - 139894
DONG WHA PHARMACEUTICAL CO.,
LTD. - 180524
DUCOOL LTD. - 192011
DURECT CORPORATION - 176649
DYNTEK PTE LTD. - 190071

CABOT MICROELECTRONICS
CORPORATION - 182170 , 196221
CAMERO-TECH LTD. - 170726
CARDIOROBOTICS, INC. - 197032
CARLO CHIAVES - 170438
CARNEGIE INSTITUTION OF
WASHINGTON - 207054
CHEN CHUANO-CHUAN - 187048
CHEN MING-TE - 187048
CHOUDHARY CHARAN SINGH
HARYANA AGRICULTURAL
UNIVERSITY, - 179254
CHUGAI SEIYAKU KABUSHIKI
KAISHA - 187604
CLARIANT FINANCE (BVI) LIMITED 186384
COLGATE-PALMOLIVE COMPANY 177761
COLUMBIA LABORATORIES
(BERMUDA) LIMITED - 161513
COMBUSTION SCIENCE &
ENGINEERING INC. - 183500
COMMISSARIAT A L'ENERGIE
ATOMIQUE - 175936
COMPOUND PHOTONICS - 193789
CORDIS CORPORATION - 168361
COUNCIL OF SCIENTIFIC AND
INDUSTRIAL RESEARCH - 171177 ,
171178
CRUCELL HOLLAND B.V. - 146479 ,
198861
CSL BEHRING GMBH - 157360
CVTRON LTD. - 192005
CYTOS BIOTECHNOLOGY AG - 194656

EATON CORPORATION - 194135
ECI TELECOM LTD. - 171722 , 189342
ECODUNA OG - 206869
EGIS GYOGYSZERGYAR NYRT 183739
EISAI R&D MANAGEMENT CO., LTD. 180486 , 184983 , 188670
ELAN PHARMA INTERNATIONAL
LTD. - 163626
ELECTRONIC NAVIGATION
RESEARCH INSTITUTE - 158325
ELEMENT SIX LIMITED - 166905
ELI HUGO BUDMAN - 193059
ELTA SYSTEMS LTD. - 183398
ENZON PHARMACEUTICALS, INC. 183054
ERNEST FRIEDEN - 192087
ESPERION THERAPEUTICS, INC. 155213
EURO-CELTIQUE S.A. - 187813 , 207067

DAS AJEE KAMATH - 171444
DAVID JACOB SCHWARTZ - 197165

GABA INTERNATIONAL AG - 188246
Gal Zilkha - 161938

441

F. HOFFMANN-LA ROCHE AG - 154008
, 163563 , 170829 , 174075 , 174513 ,
179370 , 179737 , 181317 , 183594 ,
185631 , 189664 , 196327
FABIO PERINI S.P.A. - 177886
FITRACKS INC. - 188645
FITRACKS LTD. - 188645
FN HERSTAL S.A. - 183891
FOAMIX LTD. - 168399
FRED ZACOUTO - 186988
FUJIKIN INCORPORATED - 191738
FUJIMOTO CO., LTD. - 183028
FUNCTIONAL GENETICS, INC. - 167774

December 29, 2011-‫ג' בטבת התשע"ב‬

GALLAHER SNUS AB - 185874
GAMASONIC LTD. - 184362
GE MEDICAL SYSTEMS GLOBAL
TECHNOLOGY COMPANY, LLC 165619
GEBR. SCHMID GMBH & CO. - 189168
GENENTECH, INC. - 157378 , 170076 ,
174786 , 191077 , 191078 , 191824
GENERAL ELECTRIC COMPANY 187519
GENSTRUCT, INC. - 167629
GEORGE NAUMOV - 188649 , 189284
GERON CORPORATION - 177324 ,
188264
GIDEON ALON - 174148
GILEAD SCIENCES, INC. - 180758 ,
180781
GIVEN IMAGING LTD. - 167782
GLAXO GROUP LIMITED - 184438
GLAXOSmithKLINE ISTRAZIVACKI
CENTAR ZAGREB D.O.O. - 184438
GLIDE PHARMACEUTICAL
TECHNOLOGIES LIMITED - 166508
GLIDE PHARMACEUTICAL
TECHNOLOGIES LIMITED - 185100
GRACEWAY PHARMACEUTICALS,
LLC - 184310
H. LUNDBECK A/S - 200959
H.T. HULDA TRANSFORMERS - 193502
HANITA METAL WORKS LTD. - 181562
HANMI HOLDINGS CO., LTD. - 188600
HANMI PHARM. CO., LTD. - 188600
HARTMUT ENGELMANN - 161309
HASSIN ESH INDUSTRIES LTD. 168332
HAWK MEDICAL TECHNOLOGIES
LTD - 172326
HERAEUS QUARZGLAS GMBH & CO.
KG - 180213
HUTCHISON WHAMPOA THREE G IP
(BAHAMAS) LIMITED - 184887
I.B.I. ISRAEL BIOMEDICAL
INNOVATIONS LTD. - 188582
IBM CORPORATION - 173422 , 188757 ,
191952 , 194297
442

IDAN NACHMANI - 201461
ILAN ROSEN - 194909
INDENA S.P.A. - 165436 , 181024 ,
182396
INSERM (INSTITUT NATIONALE DE
LA SANTE ET DE LA RECHERCHE
MEDICALE) - 193310
INSTITUT NATIONAL DE LA SANTE
ET DE LA RECHERCHE MEDICALE I.N.S.E.R.M. - 198076
INSTITUT PASTEUR - 198076
INTARCIA THERAPEUTICS, INC. 156090
INTERDIGITAL TECHNOLOGY
CORPORATION - 180004 , 184083 ,
189716
INTERNATIONAL STEM CELL
CORPORATION - 190869
INTEVAC, INC. - 174681
ISCAR LTD. - 174670
ISCAR LTD. - 174670
ISRAEL AEROSPACE INDUSTRIES
LTD. - 163609 , 193866
JACKOB TSROR - 179893
JACOBUS PHARMACEUTICAL
COMPANY, INC. - 168718
JAN BASTIAAN CILLIERS - 153456
JANSSEN PHARMACEUTICA, N.V. 164003 , 180411
JOHN N. RASSIAS - 163231
JOMA INTERNATIONAL AS - 171363
KAKUICHI SHIOMI - 158325
KISSEI PHARMACEUTICAL CO., LTD. 171713
KORNIT DIGITAL LTD. - 177323
KORNIT DIGITAL TECHNOLOGIES
LTD. - 177323
KYOCERA AMERICA, INC. - 168429
LABORATOIRES BESINS
INTERNATIONAL - 177778
LAM RESEARCH CORPORATION 190454 , 209736 , 209737
LAURENTIU DUMITRU BREAZ 189909
December 29, 2011-‫ג' בטבת התשע"ב‬

LEHIGH TECHNOLOGIES, LLC - 175722
LG LIFE SCIENCES LTD. - 173638
LIGHT BOOK LTD. - 161938
LITHOTECH MEDICAL LTD. - 188067
LONZA LTD. - 177561
LTS LOHMANN THERAPIE-SYSTEME
AG - 168606
LTS LOHMANN THERAPIE-SYSTEME
AG - 184145
LUMEX AS - 193223
LUMIDIGM, INC. - 179699
MALAFON ELECTRONIC (SUZHOU)
CO. LTD. - 190011
MARCELO ADRIAN ADATTO - 193059
MARTHA SOPHIA CILLIERS - 153456
MARVELL ISRAEL (M.I.S.L) LTD. 189514
MAX-PLANCK-GESELLSCHAFT ZUR
FOERDERUNG DER
WISSENSCHAFTEN E.V. - 185147
MEDA AB - 184310
MEDA AB - 184310
MEDELA HOLDING AG - 168355
MEDESIS PHARMA SA - 182747
MEDIGUIDE LTD. - 187667
MEDINOL LTD. - 186786 , 193848
MEDION DIAGNOSTICS AG - 172998
MEDION DIAGNOSTICS GMBH 172998
MERCK PATENT GMBH - 159426
MERCK SERONO S.A. - 172354
MERCK SERONO S.A. - 172354
MICHAEL BRUGGEMAN - 181639
MICHAEL NAUMOV - 188649
MICHAEL NAUMOV - 189284
MICROSOFT CORPORATION - 178202 ,
199658
MILLISECOND TECHNOLOGIES
CORPORATION - 184161
MITSUBISHI SPACE SOFTWARE CO.,
LTD. - 158325
MORPHOSYS AG - 163563
MOSHE ATTIAS - 201461
MOSHE MAOR - 197165
MOWAG GMBH - 193387

NATIONAL RESEARCH
DEVELOPMENT CORPORATION 179254
NATIONAL UNIVERSITY
CORPORATION KYUSHU UNIVERSITY
- 183028
NDS LIMITED - 178041
NDS LIMITED - 186288
NEURALAB LIMITED - 163626
NEXTER SYSTEMS - 191606
NIKKEN SOHONSHA CORPORATION 189030
NORBROOK LABORATORIES LIMITED
- 194244
NOVARTIS VACCINES AND
DIAGNOSTICS, INC. - 175225
NUTRINOVA NUTRITION
SPECIALTIES & FOOD INGREDIENTS
GMBH - 175521
OBSCHESTVO S OGRANICHENNOI
OTVETSTVENNOSTIYU
"PHARMENTERPRISES" - 163763
ONO PHARMACEUTICAL CO., LTD. 187840
OOO MILLISEKUNDNIYE
TEKHNOLOGII - 184161
OPED AG - 189804
OPTIMAIR HOLDING B.V.I.O. - 191720
ORTHO-HELIX SURGICAL DESIGNS,
INC. - 196257
OTO MELARA S.P.A. - 187093 , 210701 ,
210702
OXXIUS SA - 174764
PARATEK PHARMACEUTICALS, INC. 173022
PFIZER PRODUCTS, INC. - 174299 ,
189666
PHARMACIA & UPJOHN COMPANY
LLC - 174414
PROMETHEUS LABORATORIES INC. 191679
PROTEKTORWERK FLORENZ MAISCH
GMBH & CO. KG - 193932
QUALCOMM INCORPORATED - 173982

443

December 29, 2011-‫ג' בטבת התשע"ב‬

QUALCOMM INCORPORATED - 178446
, 179802 , 180338
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD. - 183320
RAMOT AT TEL AVIV UNIVERSITY
LTD. - 167400
RAN SIMAN-TOV - 192005
RAYTHEON BBN TECHNOLOGIES
CORP. - 181510
RAYTHEON COMPANY - 152185
RAYTHEON COMPANY - 181274
RAYTHEON COMPANY - 182473
RECCONN AG - 192087
RECON OIL INDUSTRIES PRIVATE
LIMITED - 185888
REGENERON PHARMACEUTICALS,
INC. - 172404 , 204984
REIFENHAUSER GMBH & CO. KG
MASCHINENFABRIK - 189823
RESOURCE BALLAST TECHNOLOGIES
(PROPRIETARY) LIMITED - 191066
RIGEL PHARMACEUTICALS, INC. 166241
ROHDE & SCHWARZ GMBH & CO. KG
- 182301 , 185228
Ronen Carmona - 161938
SAFEAWAKE, LLC - 183500
SANO BRUNO'S ENTERPRISES LTD. 168686
SANOFI - 174941
SANOFI AVENTIS - 190585
SANOFI-AVENTIS DEUTSCHLAND
GMBH - 166494
SANOFI-AVENTIS DEUTSCHLAND
GMBH - 172008
SANTARIS PHARMA A/S - 183054
SANTARIS PHARMA A/S - 183054
SAVIO S.P.A. - 183773 , 183776 , 183777 ,
191839
SCHERING CORPORATION - 191417
SHANGHAI INSTITUTE OF MATERIA
MEDICA, CHINESE ACADEMY OF
SCIENCES - 188199
SHELL INTERNATIONALE RESEARCH
MAATSCHAPPIJ B.V. - 186203 , 186206 ,
444

186207 , 186211 , 186214
SHIONOGI & CO., LTD. - 180331
SNECMA - 173067 , 193030
SNECMA SERVICES - 173067
SOLVAY PHARMACEUTICALS GMBH
- 174373
SONY CORPORATION - 152589
SOURCE PRECISION MEDICINE, INC. 147349
SRU BIOSYSTEMS, INC. - 187808
STOKKE AS - 172928
STOREWIZ INC. - 178694
STRAKAN INTERNATIONAL LIMITED
- 169881
STRAKAN LIMITED - 169881
SYNGENTA PARTICIPATIONS AG 169307 , 177563
TADIRAN TELECOM LTD. - 164577
TAKEDA PHARMACEUTICAL
COMPANY LIMITED - 181462
TECRES S.P.A. - 188469
TEIJIN ARAMID GMBH - 188228
TEL HASHOMER MEDICAL
RESEARCH INFRASTRUCTURE AND
SERVICES LTD. - 194299
TELECOM ITALIA S.P.A. - 182824
TELEFONAKTIEBOLAGET L M
ERICSSON (PUBL) - 179003 , 183492 ,
186577
THE BRIGHAM AND WOMEN'S
HOSPITAL, INC. - 178002
THE GERD BORCHERS FAMILY
TRUST - 153456
THE JOHNS HOPKINS UNIVERSITY
SCHOOL OF MEDICINE - 163312
THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA - 180219
THE UNIVERSITY OF MIAMI - 180995
THERAVANCE, INC. - 201639
TRUEPOSITION, INC. - 171217
UCB PHARMA GMBH - 173062
UNILEVER PLC - 194287
UNITED STATES GYPSUM COMPANY
- 179810
UNIVERSITE DE LAUSANNE - 172783
December 29, 2011-‫ג' בטבת התשע"ב‬

UNIVERSITY OF NORTH CAROLINA
AT CHAPEL HILL - 155249
UT-BATTELLE, LLC - 191897
VARLEY AND GULLIVER LIMITED 186517
VIPERGEN APS - 183013
VLAAMSE INSTELLING VOOR
TECHNOLOGISCH ONDERZOEK
(VITO) - 184877
VLADIMIR EVGENIEVICH NEBOLSIN 163763

WERLATONE, INC. - 185696
WESTERN UNIVERSITY OF HEALTH
SCIENCES - 183490
WILLEM MEIJER - 191720
WYETH LLC - 163626 , 176147
YALE UNIVERSITY - 177591
YAMIT NACHMANY - 201461
YM BIOSCIENCES AUSTRALIA PTY
LTD. - 175572
YOSSY SELA - 168298
ZAMBON GROUP S.P.A. - 175765

WARNER CHILCOTT (IRELAND)
LIMITED - 172620
WARNER-LAMBERT COMPANY LLC. 178433
WEBER AIRCRAFT LP - 188641

445

December 29, 2011-‫ג' בטבת התשע"ב‬

‫מפתח ענייני‬

SUBJECT MATTER INDEX
A01N - 153456, 177563
A23L - 184161, 193059, 194287
A43D - 188645
A44C - 179893
A45D - 197165
A46B - 188246
A47B - 173997
A47C - 172928
A47J - 195661
A61B - 156377, 158325, 165619,
167400, 167782, 172326,
183323, 187667, 188067,
188582, 196257, 197032
A61F - 183030, 186786, 188469
A61G - 189804
A61J - 168355
A61K - 154008, 155213, 155791,
157326, 157360, 157443,
161513, 163312, 164664,
166241, 168399, 168606,
168745, 169881, 171713,
172620, 172783, 173062,
174172, 174374, 176649,
177778, 178002, 178515,
179254, 180487, 182747,
183157, 183200, 183490,
184145, 186491, 187604,
187813, 189030, 189972,
193848, 194244, 194656,
200959
A61M - 156090, 166508, 175017,
180995, 185100, 201694
B21D - 193932
B23B - 174148,
B23C - 181562
B23P - 187519
B24B - 182170,
B29D - 187048
B32B - 188228,
B41J - 177323
B60K - 187093,
B60N - 188641,
446

174670, 193030

196221
194687
210701, 210702
193387

B60R - 201461
B64G - 182473
B65D - 168361, 185874
B65G - 194464
B65H - 177886
C01G - 171363
C02F - 183881,
C03B - 180213
C04B - 168332
C07C - 168718,
177561,
186680,
196327,
C07D - 139894,
164003,
166584,
169527,
173638,
174373,
174941,
178433,
180331,
180524,
183028,
184310,
188600,
189666,
203533,
C07F - 180758,
C07H - 183054,
C07K - 163626,
170076,
191077,
193310,
C08J - 175722
C11B - 185888
C11D - 168686,
C12M - 206869
C12N - 146479,
170178,
177324,
188264,

191066

170829,
181024,
188199,
201639
159426,
165436,
168121,
172457,
174075,
174414,
175572,
179370,
180411,
181462,
183594,
184983,
188670,
190673,
205242,
180781
184438
163763,
175225,
191078,
197988

175765,
181317,
193071,
159506,
166494,
169307,
173022,
174299,
174513,
176147,
179737,
180486,
182396,
183739,
187840,
189664,
191417,
207067

167774,
185147,
191824,

177761
155249,
172404,
183013,
190088,

157378,
174786,
186988,
190731,

December 29, 2011-‫ג' בטבת התשע"ב‬

190869,
198861,
C12P - 175521,
C12Q - 145210,
177591,
194299
C22C - 173067
C25D - 177414,
C30B - 166905,

197377, 198076,
204984
200172
167410, 172008,
190585, 191897,

189168
207054

D01F - 196716
D04H - 189823
D21H - 186384
E01F - 186517
E02D - 170438
E04B - 190071
E04C - 189909
E05B - 190011,
E05C - 183773
E05D - 183776,
E21B - 186203,
186211,
F01C - 171444
F16H - 192005
F16K - 191738
F21V - 184362
F24F - 191720
F25D - 179810,
F41A - 183891,
F41B - 167142
F41C - 163231
F41G - 152185,
F42B - 191614,
G01C - 188649,
G01F - 185534
G01N - 147349,
171177,
172998,
181119,

447

191839
183777
186206, 186207,
186214

192011
191606

163609
192087

191679,
G01S - 170726,
193866
G02C - 183368
G02F - 193789
G06F - 161938,
178694,
G06K - 179699,
G06T - 183320
G07F - 166911
G08B - 194909
G11B - 152589

193003, 194297
171217, 181510,

167629, 178202,
189206, 191952
181639, 193223

H01G - 209736, 209737
H01H - 194135
H01J - 160873, 180440
H01J - 174681
H01L - 168429, 173422, 181274,
190454
H01M - 172944
H01P - 185696
H01R - 184200
H01S - 174764
H02J - 193502
H04B - 182301, 183500, 186577
H04L - 178041, 179003, 179802,
180338, 182824, 184887,
185228, 189514, 199658
H04M - 164577, 183492
H04N - 186288, 188757
H04Q - 171722, 189342
H04R - 180516
H04W - 168298, 173982, 178446,
180004, 184083, 189716
H05H - 184877
H05K - 183398

189284
161309,
171178,
175936,
185631,

163563,
172354,
180219,
187808,

December 29, 2011-‫ג' בטבת התשע"ב‬

‫קודים למדינת המופיעים ביומן‬
COUNTRY CODES APPEARING IN THIS JOURNAL
Code
AR
AT
AU
BA
BE
BR
CA
CH
CN
CU
CZ
DE
DK
EC
EP
ES
FI
FR
GB
GE
GR
GT
HR
HU
IE
IL
IN
IT
JP
KR
LK
LU
LV

448

Country or Organization
Argentina
Austria
Australia
Herzegovina
Belgium
Brazil
Canada
Switzerland
China
Cuba
Czech Republic
Germany
Denmark
Ecuador
European Patent Office
Spain
Finland
France
United Kingdom
Georgia
Greece
Guatemala
Croatia
Hungary
Ireland
Israel
India
Italy
Japan
Republic of Korea
Sri Lanka
Luxembourg
Latvia

Code
MX
MY
NL
NO
NZ
PL
PT
RU
SE
SG
SI
SK
TH
TR
TW
UA
US
UY
UZ
WO
ZA

Country or Organization
Mexico
Malaysia
The Netherlands
Norway
New Zealand
Poland
Portugal
Russian Federation
Sweden
Singapore
Slovenia
Slovakia
Thailand
Turkey
Taiwan
Ukraine
United States of America
Uruguay
Uzbekistan
World Intellectual Property
Organization (W.I.P.O.)
South Africa

December 29, 2011-‫ג' בטבת התשע"ב‬

‫ ירושלים‬,‫ משרד המשפטים‬,‫נערך ע"י רשות הפטנטים‬
EDITED BY THE PATENT OFFICE, MINISTRY OF JUSTICE, JERUSALEM

449

December 29, 2011-‫ג' בטבת התשע"ב‬

Sign up to vote on this title
UsefulNot useful